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ABBREVIATIONS 
 
CDCl3 Deuterated chloroform 
DMF N, N’-dimethylformamide 
NMP N-Methyl-2-pyrrolidone 
DMA Dimethylacetamide 
DMSO Dimethylsulphoxide 
DMSO-d6 Deuterated Dimethyl sulfoxide 
NMR Nuclear Magnetic Resonance 
FTIR Fourier transform infrared 
1, 10-Phen 1, 10-Phenanthroline 
DMAP 4-Dimethylaminopyridine 
DCC N,N'-Dicyclohexylcarbodiimide 
MeCN Acetonitrile 
DCM Dichloromethane 
K2S2O8 Potassium persulfate 
TBHP tert-Butyl hydroperoxide 
H2O2 Hydrogen peroxide 
AcOH Acetic Acid 
TEMPO (2, 2, 6, 6-Tetramethylpiperidin-1-yl)oxyl 
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CHAPTER I 
Transition Metal-Catalyzed Decarboxylative Cross-Coupling Reactions 
I.1. Introduction 
Transition metal-catalyzed cross-coupling reactions have been recognized as one of the 
most powerful tools for the synthesis of natural products, bioactive molecules, polymers, 
and functionalized materials.
1
 Several types of reactions with different organometallic 
reagents have been reported and widely used to prepare those compounds, such as 
Kumada, Negishi, Stille, Suzuki, Hiyama, Heck, Sonogashira, and Buchwald-Hartwig 
coupling reactions.
2
 The first five of these reactions consist of the coupling reaction 
between aryl halides (or pseudo halides) and organometallic compounds bearing Mg, Zn, 
Sn, B, and Si respectively. These coupling partners have to be prepared from their 
corresponding simple arenes via multiple steps prior to the coupling reaction.
3
 Most of 
the cases, these organometallic reagents are air and moisture sensitive, therefore special 
reaction skills and set up is required.
4
 To overcome this drawbacks, direct C-H bond 
activation for coupling reactions have received much attention recently.
5
 Several catalysts 
have been used, including palladium, ruthenium, rhodium, iridium, copper, and others. 
However, typical C-H bond activation methods require aryl halides or organometallic 
reagents as one of the coupling partners, which produces stoichiometric metal or acid 
waste. On the other hand, C-H bond activation methods require installation of the 
directing groups in the substrates to control site-selectivity and their subsequent removal 
precludes the synthetic fidelity.
6 As an alternative to conventional cross-coupling or C-H 
functionalization, decarboxylative cross-coupling has emerged as a modern strategy using 
readily available and inexpensive; air and moisture stable carboxylic acids as coupling 
partner.
7
 As compared to traditional cross-coupling methods, decarboxylative couplings 
has several potential advantages; (i) carboxylic acids are ubiquitous and inexpensive 
reactants; (ii) decarboxylation can provides the reactive intermediates under neutral 
conditions; and (iii) the only stoichiometric amount of byproduct is CO2, which is 
nontoxic, nonflammable, and easily removed from the reaction medium. In this case, a 
mechanistically distinct decarboxylative metalation occurs in lieu of oxidative addition or 
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transmetalation to form organometallic species which have been used as an alternative to 
aryl halides or organometallic reagents and subsequently coupled with electrophiles 
affording the desired coupled products via reductive elimination. However, recently the 
chemist generates the same organometallic species using some activated carboxylic acid 
derivatives such as acid chlorides
8
, anhydrides
9
, esters
10
 etc. via decarbonylative process 
and further coupled with electrophiles. Mechanistically, transition metal undergoes 
oxidative addition to the activated carboxylic acid derivatives to generate an acyl-metal 
species. Subsequently, aryl-metal species is formed through the extrusion of carbon 
monoxide. Moreover, other approaches such as radical photoredox and metal-free 
decarboxylative coupling reactions are presently under investigation and rapid growth 
over time.
11
 
  
Scheme 1. Traditional cross-couplings vs decarboxylative cross-couplings 
Very recently, synthetic chemists have applied the in situ generated aryl-metal 
species generated through decarboxylation for the C-H bond functionalization, thus 
taking full advantage of both C-H bond activation and decarboxylation to develop a novel 
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synthetic approach, that is, decarboxylative C-H bond cross-coupling reactions.
12
 
However, there is no exact definition of decarboxylative C-H bond functionalization. 
Normally, decarboxylative C-H bond cross-coupling reactions refer to these reactions in 
which carboxylic acids undergo decarboxylative metalation to generate an intermediate 
that couple with C-H bonds of the other coupling partners to form a new C-C bond. 
Carboxyl group also acts as a deciduous directing group for ortho C-H bond 
functionalization, and then subsequent oxidative decarboxylation reactions involved in a 
stepwise manner under single operation.
13
  
Notably, depending on the catalytic system and the reaction conditions employed, 
carboxylic acids can be used as radical or electrophilic synthetic equivalents of the 
aryl/alkyl unit for regiospecific cross-coupling reactions.
14
 
 
Scheme 2. Generation of coupling intermediates from carboxylic acids 
 
Figure 1. Different types of carboxylic acids used in the decarboxylative cross-couplings 
There are six types of carboxylic acids have been used as a coupling partner in the 
decarboxylative cross-coupling reactions- a) the aryl carboxylic acids mainly used for 
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decarboxylative biaryls synthesis and decarboxylative Heck type couplings; b) α-
ketocarboxylic acids serves as a acyl anion donor used for decarboxylative ketone 
synthesis; c) alkynyl carboxylic acids used for decarboxylative alkynylation reactions; d) 
alkyl carboxylic acids used as sp
3
-sp
3 
counterpart in decarboxylative cross-coupling 
reactions; e) recently, the use of cinnamic acids for decarboxylative alkenylation 
reactions is also increasing; and f) the α-amino acids which are another different class of 
carboxylic acids to produce azomethine ylide after decarboxylation and used for further 
α-functionalization.15 The mode of these six types of carboxylic acids is in Figure 1. 
I.2. Decarboxylative protonation 
First, we will discuss about the transition metal-catalyzed decarboxylative protonation or 
metalation reactions. In decarboxylative protonation reactions, the C-COOH bond is 
converted to the C-H or C-metal bond through the decarboxylation. This step is the 
initiation step for all the transition metal-catalyzed decarboxylative cross-coupling 
reactions.  
I.2a. Copper-catalyzed decarboxylative protonation 
Since 1960s, Nilsson,
16
 Cohen,
17
 and Shepard
18
 group reported that some Cu complexes 
can promote the decarboxylative protonation of aromatic carboxylic acids. But these 
methods were not practical due to harsh reaction conditions. To enhance copper's ability 
to influence the decarboxylative transformations further, the Goossen’s group developed 
a copper-catalyzed decarboxylative protonation method using Cu/phenanthroline 
combination.
19
 It has been observed that benzoic acid derivatives bearing electron-
withdrawing substituents and/or ortho substituents were particularly susceptible to 
decarboxylation. However, the use of microwave heating can also accelerate the 
protodecarboxylation process (Scheme 3).
20
 Mechanistically, first Cu(I) salt is combined 
with phenanthroline ligand to form a stable chelate complex. The chelate complex is then 
coordinate with carboxylic acid generating the Cu(I) complex II. A four-membered 
transition state III with carbon dioxide extrusion leads to an aryl-copper(I) species I. 
Finally, the aryl-copper(I) intermediate I can undergo protonolysis with acids (or water) 
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to yield the product and regenerating the copper(I) active catalyst for subsequent catalytic 
cycles (Scheme 3). 
 
Scheme 3. Copper-catalyzed decarboxylative protonation of aromatic carboxylic acids 
I.2b. Palladium-catalyzed decarboxylative protonation 
Kozlowski and co-workers
21 
reported Pd(II)-catalyzed decarboxylative protonation of 
aromatic carboxylic acids at 70 °C. The scope of the reaction is strictly restricted to 
highly electron-rich arene carboxylic acids bearing ortho, ortho-dialkoxy substituents 
(Scheme 4). The ortho, ortho-dialkoxy substituents are essential for this transformation 
may be due to coordination between oxygen and palladium to stabilize the aryl-palladium 
intermediate. While this method was extended to mono-ortho-substituted or less electron-
rich benzoic acid derivatives, a stoichiometric amount of palladium(II) catalyst is 
required may be due to absence of  such type of stabilization in the intermediate and 
catalytic cycle is not under going for subsequent runs. Mechanistically, they have showed 
that first Pd(II) catalyst is coordinated with a carboxylic acid generating the Pd(II) 
complex A with the loss of a trifluoroacetic acid molecule. In the intermediate two 
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DMSO molecule is coordinated with palladium and here DMSO acts as a ligands on the 
palladium. A four-membered transition state B facilities carbon dioxide extrusion 
generating an aryl-palladium(II) species C. Finally, the aryl-palladium(II) intermediate C 
could undergo protonolysis with trifluoroacetic acid to provide the desired protonated 
product and regenerating the palladium(II) catalyst for next cycle (Scheme 4). 
 
Scheme 4. Palladium-catalyzed/promoted decarboxylative protonation of aromatic acids 
I.2c. Silver-catalyzed decarboxylative protonation 
The Goossen’s22 group and Larrosa’s23 group independently reported the silver(I)-
catalyzed decarboxylative protonation of aromatic carboxylic acids and heteroaryl 
carboxylic acids (Scheme 5). They have observed that using silver as a catalyst the 
reaction temperature decreases and also the reaction proceed under relatively mild 
conditions, indicating that the silver(I) salts are more effective in the decarboxylation 
cross-coupling reactions. This method is applicable to both electron-rich and electron-
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deficient benzoic acids. However, ortho substitutions on the carboxylic acids are essential 
for decarboxylative protonation which is a major limitation of this protocol. 
Mechanistically, first acid-base reaction is occurred between carboxylic acid and silver(I) 
salt generates silver carboxylate I. Subsequently, the silver carboxylate undergoes 
decarboxylation to yield aryl-silver(I) species II. Finally, the aryl-silver(I) species can 
undergo protonolysis with acids to furnish the product and regenerating the silver(I) 
catalyst for the next catalytic cycle (Scheme 5). 
 
Scheme 5. Silver-catalyzed decarboxylative protonation of aromatic acids 
 
Scheme 6. Decarboxylative protonation under radical conditions 
A unique system for the decarboxylation protonation via radical pathway was 
reported by Greaney and co-workers.
24
 Although, in the system silver is present as a 
catalyst but in the presence of a strong single-electron oxidant the reaction proceed via 
radical pathway (Scheme 6). Mechanistically, the silver(I) catalyst in presence of K2S2O8 
can generates the carboxyl radical II from the carboxylate I. Subsequently from the 
intermediate II, the aryl radical III is formed via radical decarboxylation process. Finally, 
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the aryl radical can abstract proton from the solvent to form the desired arene product. 
Most remarkable point for this method is that the unsubstituted benzoic acid also 
provided decarboxylative protonation product, which was unsuccessful in other 
procedures and also ortho substituents are not an essential for this transformation.  
I.3. Decarboxylative cross-coupling reactions 
Decarboxylative metalation of the C-COOH moiety of a carboxylic acid can generate an 
intermediate containing a C-metal bond. This organometallic intermediate can couple 
with electrophiles such as aryl halide or pseudo-halide forming a new C-C bond. 
Depending on the nature of the C-COOH moiety, a variety of aryl compounds such as 
biaryls, aryl alkynes, aryl esters, aryl ketones, and others be can produced via 
decarboxylative cross-couplings. 
I.3.1. Decarboxylative biaryls synthesis 
Biaryls are important ubiquitous structural motifs found in various biologically active 
compounds (Figure 2).
25
 Decarboxylative cross-coupling reactions between aromatic 
carboxylic acids and aryl halides or triflates or tosylates can generate the biaryl 
compounds. This reaction complements to the typical Suzuki and Stille cross-coupling 
reactions. In 1966, Nilsson et al. first reported biaryl synthesis through decarboxylation 
process with using stoichiometric copper but this method is not attractive due to drastic 
reaction conditions.
26
 
 
Figure 2. Some biologically active biaryl compounds constructed via decarboxylation 
method  
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I.3.1a. Decarboxylative biaryl synthesis using Pd/Cu bimetallic catalyst 
system 
In 2006 Goossen et al. first reported a Pd/Cu-catalyzed decarboxylative cross-coupling of 
aromatic carboxylic acids with aryl halides.
27
 In this protocol, 2-nitrobenzoic acids and 
aryl bromides were stirred in NMP for 24 h at 120 
o
C in the presence of stoichiometric 
amounts of basic copper carbonate and potassium fluoride, an excess amount of 
powdered molecular sieves and 2.0 mol % of Pd(acac)2/P(
i
Pr)Ph2 catalyst. A 
ArC(O)OCuF salts were generated which undergo decarboxylation to form a aryl-copper-
fluoride species. Finally, the aryl copper species can be coupled with various types of aryl 
bromides by the palladium co-catalyst (Scheme 7). Subsequently, a second-generation 
catalytic system has also been developed by Goossen’s group consisting of 10 mol % of 
CuBr/phenanthroline and 3.0 mol % of PdBr2. This method is more broadly applicable to 
a wide range of substrate with respect to carboxylates and aryl halides providing 
excellent yields of the decarboxylative cross-coupling product.
28
 
 
Scheme 7. Palladium catalyzed decarboxylative biaryl synthesis  
The proposed mechanism for the decarboxylative biaryl synthesis using bimetallic 
catalyst system is outlined in Scheme 8. The reaction starts with the extrusion of CO2 
from a metal carboxylate B, which is generated by salt exchange from a potassium salt of 
carboxylic acid and a copper salt A. The resulting aryl-copper species C transfers its aryl 
group to an aryl-palladium(II) complex E which is generated by oxidative addition of 
palladium co-catalyst D to aryl halide giving rise to a biaryl-palladium species F via 
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transmetalation process. The catalytic cycle for the palladium is completed by reductive 
elimination with the formation of biaryl product and regenerating the initial palladium(0) 
catalyst D for the subsequent runs. 
 
Scheme 8. Mechanism for decarboxylative biaryl synthesis using bimetallic system 
Subsequently the Goossen’s group has optimized the catalysts system and ligands 
to expand the scope. As a result, they were able to extend the above cross-coupling 
reaction to triflates
29
 and also less expensive tosylates
30
 (Scheme 9). It has been observed 
that the chloride or bromide anion generated in the reaction can inhibits the Cu-catalyzed 
decarboxylation process.
28 
Therefore, when aryl triflates were used, the substrate scope 
was extended to some less activated aromatic carboxylates carrying no ortho-substituent. 
The reaction can be performed either using conventional heating (170 
o
C, 24 h) or 
microwave heating (190 
o
C, 5-10 min).
31
 The microwave method is superior than 
conventional heating protocol and given higher yield particularly when deactivated 
carboxylates were used in the reaction. 
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Scheme 9. Decarboxylative biaryl synthesis using aryl triflates or aryl tosylates 
In 2013, the Batra group has successfully developed an interesting protocol for 
the synthesis of a variety of fused-heterocyclic via intermolecular cascade imine 
formation/decarboxylative coupling of potassium 5-amino-1-phenyl-1H-pyrazole-4-
carboxylates and 3-amino-thiophene-2-carboxylate with 2-haloarylaldehydes (Scheme 
10).
32
  
 
Scheme 10. Synthesis of heterocycles via cascade imination/decarboxylative coupling 
I.3.1b. Decarboxylative biaryl synthesis using Pd/Ag bimetallic catalyst 
system 
Becht et al. first reported a Pd(II)-catalyzed decarboxylative biaryl synthesis between 
aromatic carboxylic acids and aryl iodides
33
 or diaryl-iodonium salts
34
 in the presence of 
silver. In the reaction 30 mol % of palladium chloride, 60 mol % of triphenylarsine ligand 
and stoichiometric amount of silver carbonate was used in DMSO (Scheme 11). In 2009, 
a similar type of reaction was reported by the Wu group using a PdCl2/BINAP catalyst 
system and Ag2CO3 as a base in the reaction. A good to excellent yield were achieved for 
ortho-substituted aromatic carboxylic acids.
35 
 
In 2010, the Greaney group reported a decarboxylative cross-coupling reaction of 
substituted oxazole- or thiazole-5-carboxylic acids with aryl bromides and iodides 
(Scheme 12).
36
 They have used a Pd/Ag bimetallic catalyst system for this 
transformation. The reaction is interesting due to prevalence of the products in medicinal 
and agrochemistry.
37 
However, most of the cases a stoichiometric amount of Ag salt is 
required in Pd/Ag bimetallic system. This is due to the formation of insoluble silver 
halides in the reaction medium which prevents the regeneration of silver catalyst in the 
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catalytic cycle for subsequent runs. To overcome this problem, the Goossen’s group first 
successfully developed a decarboxylative cross-coupling reaction between arene 
carboxylates and aryl triflates, where both Pd- and Ag-salts were used in catalytic 
amount.
38
 
 
Scheme 11. Decarboxylative biaryl synthesis using Ag/Pd bimetallic system 
 
Scheme 12. Decarboxylative (het)arylation of thiazoles and oxazoles using Ag/Pd system 
I.3.1c. Palladium-catalyzed decarboxylative biaryl synthesis 
Without other metal complexes, palladium complexes can also participate in the 
decarboxylative cross-coupling reaction of some particularly activated carboxylates. The 
Steglich group first successfully described such reaction in their total synthesis of 
lamellarin L via intramolecular fashion.
39
 Subsequently, Forgione and Bilodeau et al. 
successfully reported an intermolecular decarboxylative cross-coupling reaction 
catalyzed by palladium only using a number of heteroaromatic carboxylic acids with aryl 
halides.
40
 Shang et al. showed polyfluorinated benzoic acids can also undergo Pd-
catalyzed decarboxylative cross coupling with aryl bromides, chlorides, and even 
triflates.
41
 The presence of fluorine substitution at the ortho position of the carboxylates 
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is crucial to the reaction outcome. The presence of fluorine group at the ortho position 
may facilitate the carbon dioxide extrusion (Scheme 13).  
Based on DFT calculations, they showed that the palladium-mediated 
decarboxylation step is the rate-determining step in the catalytic cycle. Mechanistically, 
first active Pd(0) catalyst is generated from the combination of Pd(II) and phosphine 
ligand which reacts with aryl halides or aryl triflates via oxidative addition to generate an 
aryl-Pd(II) intermediate A. Then aryl-Pd(II) intermediate A reacts with the carboxylate 
forming intermediate B. From the intermediate B a bisarylated-Pd(II) complex D is 
formed via four member cyclic  transition state followed by decarboxylation. Finally, 
reductive elimination furnish the desired C-C coupled product and re-generate the Pd(0) 
catalyst for subsequent catalytic cycles (Scheme 13). 
 
Scheme 13. Palladium-catalyzed decarboxylative arylation 
I.3.1d. Copper-catalyzed decarboxylative biaryl synthesis 
In 2009, Shang et al. first reported a monometallic copper-catalyzed decarboxylative 
cross coupling of potassium polyfluorobenzoates with aryl bromides and iodides 
affording fluorinated biaryls (Scheme 14).
42
 Based on DFT calculations, they have 
proposed the mechanism in which the decarboxylation occurs from the Cu(I) complex of 
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the polyfluorinated aromatic acid, generating an aryl-Cu(I) intermediate. The aryl-Cu(I) 
intermediate can reacts with the aryl halide through oxidative addition to form a bis-
arylated Cu(III) complex. Finally, the biaryl product is produced from bis-arylated 
Cu(III) complex via reductive elimination and re-generating the Cu(I) catalyst for next 
catalytic cycle. In contrast to palladium-catalyzed decarboxylative couplings, here the 
oxidative addition step is the rate-determining step in the catalytic cycle (Scheme 14).  
 
Scheme 14. Cu-catalyzed decarboxylative coupling of polyfluorobenzoates with aryl 
halides 
I.3.2. Decarboxylative ketone synthesis 
Aryl ketones are important structural motifs in biologically active compounds and 
functional materials.
43
 In 2008, Goossen and coworkers have successfully developed a 
Cu/Pd-catalyzed decarboxylative coupling of α-oxocarboxylic acids with aryl halides or 
pseudo-halides to give aryl ketones (Scheme 15).
44
 This transformation is mainly 
interesting due to the generation of acyl anion equivalent which is reverse polarity of the 
keto group and the acyl anion equivalents coupled with carbon electrophiles. 
Initially, the potassium α-oxocarboxylate reacts with the copper(I) complex A by 
ligand exchange to form the copper-carboxylate B. The copper-carboxylate B afforded 
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the acyl-copper species C via decarboxylation. On the other hand, the aryl-palladium(II) 
species E, which is formed through the oxidative addition of the palladium(0) catalyst D 
to the aryl halide. Then from the species C transfers its acyl moiety to the aryl-
palladium(II) species E afforded the acyl-aryl-palladium(II) intermediate F via 
transmetalation and the copper(I) complex is released in the copper catalytic cycle, 
Finally, aryl ketone is formed via reductive elimination and regenerating the palladium(0) 
catalyst D for next catalytic cycles (Scheme 15). 
 
Scheme 15. Cu/Pd-catalyzed decarboxylative ketone synthesis 
I.3.3. Decarboxylative esters synthesis 
Oxalic acid monoesters are another important class of carboxylates that can also be cross-
coupled with aryl halides using monometallic palladium catalyst via decarboxylation 
process producing the corresponding arenecarboxylate esters (Scheme 16).
45
 This 
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reaction is a distinct class of cross-coupling with an acyl anion species which is generated 
via decarboxylation of oxalic acid monoesters. In the reaction copper salt is not required 
for the decarboxylation but bulky and electron-rich bidentate phosphine ligands favor for 
the reaction. Theoretical calculation showed that decarboxylation via a five-coordinated 
Pd(II) transition state is the rate-limiting step in the catalytic cycle. 
 
Scheme 16. Decarboxylative ester synthesis 
I.4. Decarboxylative allylation 
Decarboxylative allylation reaction is a powerful synthetic approach in organic 
synthesis.
46
 In the decarboxylative allylation reactions, allyl electrophiles coupled with 
nucleophiles formed via decarboxylation in a chemo-, regio-, and stereo-selective 
manner. In the presence of a base, β-ketocarboxylic acid allyl esters undergo 
decarboxylation at higher temperature (170 
o
C) to furnish γ,δ-unsaturated alkyl ketones. 
This reaction occurred via the thermal rearrangement of the β-keto allyl ester, followed 
by decarboxylation and then an anion-assisted Claisen rearrangement.
47
 In 1980, the 
Saegusa
48
 and Tsuji
49
 group first independently showed that palladium catalysts can 
promote this decarboxylative process under very mild conditions. In Tsuji’s method, they 
have used allyl esters of acetoacetic acid in the presence of catalytic amount of Pd(OAc)2 
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and PPh3 providing γ,δ-unsaturated methyl ketones in high yield (Scheme 17, Method A). 
In Saegusa’s method, they used a variety of acyclic and cyclic keto-esters in the presence 
of 5.0 mol % of Pd(PPh3)4 as the catalyst which undergo decarboxylative coupling 
providing the allylated product with excellent yields (Scheme 17, Method B).  
Mechanistically, palladium(0) undergoes an oxidative addition to the allyl ester to 
form a π-allyl-Pd complex and corresponding carboxylate. Then subsequent 
decarboxylation occurs from the carboxylate, generating the incipient carbanion which is 
resonance stabilized by the adjacent keto group. Finally, incipient anion acts as a 
nucleophile coupled with the electrophile, π-allyl-Pd complex to yield the desired 
allylation product via reductive elimination and regenerating Pd(0) catalyst for next 
catalytic cycles (Scheme 17). 
 
Scheme 17. Decarboxylative allylation reaction 
Over the last decade, different types of decarboxylative allylation reaction have 
been developed and it has wide application in organic synthesis.
50
 Detailed discussion is 
in Chapter II. 
I.5. Decarboxylative benzylation 
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Decarboxylative benzylation reaction is also a powerful synthetic approach for the C-C 
and C-hetero bond formation in organic synthesis.
51
 In intramolecular decarboxylative 
benzylation reactions, initially, a stabilized π-benzyl-Pd intermediate is formed through 
oxidative addition with palladium which act as an electrophile. Subsequently, it cross-
couples with the nucleophile, that is generated through decarboxylation (Scheme 18). 
 
Scheme 18. Decarboxylative benzylation reactions 
I.6. Oxidative decarboxylative cross-coupling reactions 
The reactions discussed earlier, the carboxylic acids serve as a source of carbon 
nucleophile which further couples with a carbon electrophile under metal catalysis. The 
decarboxylative cross-coupling can also takes place with a nucleophilic coupling partner 
by the addition of stoichiometric amounts of an oxidant. Examples of such oxidative 
transformations are decarboxylative Heck reactions or direct decarboxylative C-H 
functionalization. 
I.6.1. Decarboxylative Heck reaction 
In 2002, Myers and coworkers have developed a novel palladium-catalyzed 
decarboxylative olefination reaction of arene carboxylic acids with olefins (Scheme 19).
52
 
The methodology is only applicable to heteroaromatic 2-carboxylic acids or ortho 
substituted aromatic carboxylic acids providing variety of vinylarenes. In the reaction, a 
stoichiometric amount of Ag2CO3 was used as an oxidant along with a catalytic amount 
of Pd(TFA)2 in 5% DMSO-DMF. 
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Scheme 19. Decarboxylative Heck reaction 
Based on NMR studies and X-ray crystallographic analysis,
53
 they showed that 
Pd(II)-mediated decarboxylation creates the first step of the catalytic cycle generating an 
aryl-palladium(II) intermediate B from a palladium(II) carboxylate species A. In the 
traditional Heck reaction, the same intermediate is formed via the oxidative addition of 
palladium(0) to an aryl halide. The subsequent elementary steps such as alkene insertion, 
internal migration and finally β-hydride elimination are common in both processes to 
produce aryl alkene product. However, in oxidative or decarboxylative Heck reaction, an 
additional step is required to regenerate the Pd(II) catalyst in the catalytic cycle from 
Pd(0) via oxidation. In this method Ag2CO3 was used for re-oxidation of the catalyst for 
the catalytic turnover (Scheme 19). 
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Over the past decade, a remarkable advancement has been achieved for different 
kinds of decarboxylative Heck reaction and it has wide application in organic synthesis.
 
Details we discussed in Chapter III. 
I.6.2. Decarboxylative C-H functionalization 
The organometallic species which is generated via a decarboxylative metalation step has 
been coupled with metal-catalyzed C-H bond of other coupling partner to form a new C-
C bond. This method merges modern C-H functionalization processes with state-of-the-
art decarboxylation protocols, giving birth to a new attractive field called decarboxylative 
C-H functionalization.
12
 
 
Scheme 20. Decarboxylative C-H functionalization 
Aromatic compounds, such as anilines, phenols, pyridines, thiophenes, and also 
heteroaromatic compounds, represent a highly important class of organic compounds. 
The synthetic transformations of this compounds using transition metal-catalyzed C-H 
functionalization via decarboxylation can provide a vast amount of structurally diverse 
molecules. This cross-coupling is feasible between (hetero)arenes and carboxylic acids 
with or without the assistance of a directing group. 
I.6.2a. Decarboxylative C-H arylation 
In their seminal work in 2008, Crabtree and coworkers first reported the direct 
decarboxylative C-H arylation of simple arene.
54
 Anisole and 2,6-dimethoxybenzoic acid 
were utilized as the coupling partners affording a mixture of meta- and para-arylated 
products in 3:1 ratio. Besides the desired coupling products, large quantities of 
decarboxylative protonation product, 1,3-dimethoxybenzene from 2,6-dimethoxybenzoic 
acid was formed. 
   Chapter I 
 
25 
 
Subsequently, the Glorius group have developed a highly chemo- and 
regioselective, palladium(II)-catalyzed intramolecular direct arylation of ether linked 
benzoic acids by tandem decarboxylative C-H bond activation to produce the 
dibenzofuran moiety (Scheme 21).
55
 They showed that Ag salts not only assist the 
decarboxylation step, but also act as oxidant to the palladium for catalytic turnover. 
Mechanistically, silver-mediated decarboxylation of 2-phenoxybenzoic acid afforded 
silver-aryl species A followed by transmetalation with a Pd(II) complex results in the 
formation of an aryl-palladium (II) intermediate B, which can undergo intramolecular C-
H activation to generate palladacycle intermediate C. Finally, the product dibenzofuran is 
formed via reductive elimination and generating the catalyst Pd(II) from Pd(0) by 
silver(I) carbonate for next catalytic cycle (Scheme 21). 
 
Scheme 21. Pd-catalyzed intramolecular decarboxylative arylation reaction 
For functionalization of the heteroaromatic C-H bond, the Larrosa group have 
successfully established a Pd/Ag bimetallic catalytic system for direct decarboxylative 
C3-H arylation of indoles using benzoic acids as the aryl donors (Scheme 22).
56
 The 
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reaction occurred in the presence of Pd(MeCN)2Cl2 as a catalyst and Ag2CO3 as an 
oxidant. It has been observed that the reactions showed excellent regioselectivity only 
given the C3 arylated products of the N-protected indole.  
 
Scheme 22. Pd-catalyzed decarboxylative C3-H arylation of indoles 
To understand the reaction mechanism, they performed several control 
experiments and reveals that the silver is responsible for the decarboxylation process, and 
palladium is responsible for C-H activation process in the reaction where both metals are 
necessary for the C-H arylation. Mechanistically, palladium activated the C3-H bond of 
indole generates an aryl-palladium species D, which reacts with an aryl-silver species C 
derived from silver-mediated decarboxylation of arene carboxylic acid to form a diaryl-
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palladium complex E via transmetalation process. From the diaryl-palladium complex E, 
the biaryl product is furnished through reductive elimination. The generated Pd(0) species 
can be oxidized into Pd(II) species by Ag2CO3 for next cycle (Scheme 22). 
 
Scheme 23. Palladium-catalyzed decarboxylative C-H hetero-arylation of azoles 
In 2010, Greaney and co-workers developed a Cu/Pd catalytic system for the 
decarboxylative C-H hetero-arylation reaction of azoles moiety for the synthesis of 
biologically and pharmaceutically important oxazoles, thiazoles, and imidazoles using 
heteroaromatic acids (Scheme 23).
57
 The reaction is catalyzed by Pd(OAc)2 in the 
presence of stoichiometric amounts of copper salts and sterically hindered bidentate 
bis(dicyclohexylphosphino)ethane(dcpe) ligand in dioxane/DMSO. Mechanistically, 
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copper-mediated decarboxylation of the heteroaromatic acid generates an aryl-copper 
species C. On the other hand, the acidic C-H bond of the oxazole undergoes 
deprotonation in the presence of base CO3
-2
, generating an aryl-palladium(II) species D, 
which then reacts with the aryl-copper species to give a diaryl-palladium(II) intermediate 
E through transmetalation process. Finally, reductive elimination affords the hetero-
biaryl product and Pd(0) catalyst, which is oxidized to Pd(II) by Cu(II) to complete the 
catalytic turnover (Scheme 23). 
Aryl radicals are useful synthetic intermediates in organic transformation.
58
 Due 
to their high reactivity, aryl radicals can be generate only from limited functional groups 
such as aryl boronic acids,
59 
aryl diazonium salts
60
 and also aryl halides.
61
 But these 
methods are not practical due to less availability, unstable and expensive starting 
materials. Very recently, the Li group reported a simple and efficient method for the 
generation of aryl radical from less expensive aryl triflates (Scheme 24).
62
 Recently, 
taking the advantages of carboxylic acids in the decarboxylative cross-coupling reaction,  
Su and co-workers showed the generation of aryl radical species from simple arene 
carboxylic acids via radical decarboxylative process.
63
 The Glorius group also reported 
visible light mediated decarboxylation of aromatic carboxylic acids to provide aryl 
radical species.
64
 In the reaction, aryl radical species is formed via the extrusion of carbon 
dioxide which is then coupled with arenes via Minisci type radical reaction (Scheme 
25).
65
 
 
Scheme 24. Generation of aryl radical from different methods 
For the generation of aryl radical from the corresponding benzoic acid derivatives, 
the Su group has adopted catalytic amount of inexpensive silver salt and stoichiometric 
amount of K2S2O8 as a catalyst and oxidant respectively.
63 Mechanistically, the silver(I) 
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salt is oxidized to a silver(II) in the presence of persulfate anion. Then the silver(II) 
species oxidizes the aromatic carboxylic acids leading to decarboxylation and producing 
an aryl radical species A. Subsequently, the aryl radical combined with benzene or 
pyridine to generate the cyclohexadienyl radical intermediate B. Finally, B is oxidized by 
the silver(II) species to re-aromatize forming the desired arylated product 4 (Scheme 25).  
 
Scheme 25. Silver-catalyzed decarboxylative C-H arylation of simple arenes 
I.6.2b. Decarboxylative C-H acylation 
The α-ketocarboxylic acids have been explored for the transition metal-catalyzed 
decarboxylative C-H bond functionalization reactions. In this case, the α-ketocarboxylic 
acids act as the acyl donor towards synthesis of ketones. Recently, Zhang group reported 
a Cu-catalyzed decarboxylative C3-H acylation of indoles.
69
 Ge and co-workers have 
successfully developed a Ni-catalyzed acylation reaction of azoles with α-ketocarboxylic 
acids (Scheme 26).
67
 The proposed mechanism is similar to the decarboxylative C-H 
bond (hetero)arylation reactions, involving Ni-catalyzed C-H bond activation and Ag-
mediated decarboxylation process. In the catalytic cycle, first nickelation of azole is 
occurred in the presence of Ag2CO3 generating an aryl-Ni (II) intermediate A. Then 
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transmetalation between the intermediate A and the acyl-Ag species B, which is formed 
by silver mediated decarboxylation of α-ketocarboxylic acid, generating an acyl-aryl-Ni 
(II) species C. Finally, the desired product ketone is formed via reductive elimination of 
species C, and Ni(0) catalyst is generated in the catalytic cycle, which could be re-
oxidized to the divalent Ni(II) species by a Ag(I) species for catalytic turnover (Scheme 
26). 
 
Scheme 26. Ni-catalyzed decarboxylative C-H acylation 
I.6.2c. Directed decarboxylative C-H arylation 
Functional groups containing heteroatoms, such as N, O, and S, are generally used as 
directing groups to promote the transition metal catalyzed inert C-H bond 
functionalization. The directing groups can locate the position of the metals in the 
substrate for the chemo- and/or regioselective C-H functionalization. On the other hand, 
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directing groups can also stabilizes the organometallic species generated by C-H bond 
cleavage, such as palladacycle and rhodacycle intermediate, which can take part for 
further transformations to furnish the desired products. Consequently, variety of directing 
groups has been successfully explored for the decarboxylative C-H bond cross-couplings. 
In this vein, Yu and coworkers demonstrated chelation-assisted decarboxylative 
sp
2
 C-H arylation using aryl acyl-peroxides (Scheme 27).
68
 In the reaction, it has been 
observed that various types of N-containing directing groups such as pyridine, oxazole, 
and also oxime are compatible in the reaction and exhibit good reactivity and selectivity 
toward the Pd-catalyzed decarboxylative sp
2
 C-H arylation reactions. To understand the 
reaction mechanism, they have done several control experiments and proposed the 
reaction intermediate in scheme 27. The pyridine-assisted cyclopalladation of Pd(II) via 
electrophilic palladation generates 5-membered palladacycle dimer intermediate which 
undergoes oxidative addition with the aryl radical which is generated by thermal 
decomposition of aryl acyl-peroxides to afford the biaryl product.  
 
Scheme 27. Chelation assisted Pd(II)-catalyzed decarboxylative C-H arylation 
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Very recently, the Miura group has developed a copper-mediated decarboxylative 
C-H arylation of benzamides with ortho-nitrobenzoic acids by 8-aminoquinoline directed 
(Scheme 28).
69
 In the reaction, the 8-aminoquinoline moiety in the substrate is crucial for 
the reaction outcome and the N-H bond in the amide is also essential. Other bidentate 
directing groups did not work under the reaction conditions. Mechanistically, they have 
shown that an initial deprotonation of relatively acidic NH in the substrate generates the 
N,N-bidentate chelated complex A. Subsequent reversible C-H bond cleavages forms a 
five-membered metallacycle intermediate B. The copper(III) intermediate C is then 
generated from the intermediate B via disproportionation with another copper(II) and 
carboxylate species. The aryl-copper species D is generated from the intermediate C via 
copper-mediated decarboxylation. Finally, the corresponding arylated product is formed 
by reductive elimination (Scheme 28). 
 
Scheme 28. Chelation assisted Cu(II)-mediated decarboxylative C-H arylation 
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I.6.2d. Directed decarboxylative C-H acylation 
(Details we discussed in Chapter IV) 
I.7. Decarboxylative cross-couplings of cinnamic acids 
Over the last few years, an efficient and versatile method has been development 
particularly using cinnamic acids as a coupling partner in decarboxylative cross-
couplings.
70
 Apart from the transition metal catalysts, cinnamic acids are also found to 
undergo decarboxylation under metal-free conditions
 
and photoredox conditions.
70,71  
In 2009, Wu and coworkers first developed an efficient method for Pd-catalyzed 
decarboxylative arylation of cinnamic acids with aryl halides (Scheme 29).
72
 The Pd/Ag 
bimetallic catalyst systems were used for this transformation. The mechanism of this 
alkenylation is similar to decarboxylative arylation using aromatic carboxylic acids. 
Presumably, silver mediates the extrusion of carbon dioxide affording alkenyl-silver 
species. Subsequently, transmetalation may occur with the aryl-Pd(II) intermediate which 
is formed via oxidative addition of Pd(0) to  aryl halides resulting in the formation of 
alkenyl-aryl Pd(II) species which undergo reductive elimination to provide the desired 
product and regenerate the Pd(0) for next catalytic cycle.  
 
Scheme 29. Pd/Ag-mediated decarboxylative arylation of cinnamic acids 
Very recently, the Goossen’s group has utilized the cinnamic acids and aryl 
halides for regioselective preparation of 1,1-diarylalkenes (Scheme 30).
73
 Here, the 
carboxylate acts as a transient directing group to direct the arylation into a position 
opposite to that generally obtained by decarboxylative Heck reactions. For this 
   Chapter I 
 
34 
 
transformation, they have developed a bimetallic palladium(II)/Cu(I) catalytic system 
with sterically bulky and electron rich phosphorous ligand. To understand the reaction 
pathway they have done several control experiments and proposed the reaction 
mechanism as depicted in scheme 30. Initially, oxidative addition of Pd(0) to aryl halides 
affords aryl-Pd(II) species A which then reacts with cinnamic carboxylates generating the 
intermediate B via carbopalladation followed by alkene insertion and aryl migration. In 
this step carboxylate group directs the addition of aryl moiety at the β-position of the 
alkene. Then from the intermediate B, 1,1-disubstituted alkene carboxylates C is 
produces via β-hydride elimination. Finally, 1,1-disubstituted alkene carboxylate C 
undergoes decarboxylative protonation to yield the desired 1,1-diarylalkene. At the same 
time the Maiti group has also showed the same selectivity in the decarboxylative 
alkenylation reaction using unbiased simple arenes and cinnamic acids via C-H 
activation.
74
  
 
Scheme 30. Decarboxylative 1,1-disubstituted alkenes synthesis 
I.8. Decarboxylative alkynylation reactions 
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Propiolic acids have been used in decarboxylative cross-coupling reactions for the 
introduction of alkyne moiety into the organic backbone.
75
 This reaction is 
complementary to the typical Sonogashira cross-coupling reactions.
76
 The 
decarboxylative cross-coupling reactions using alkynyl carboxylic acids go through under 
mild reaction conditions due its facile decarboxylative metalation process. Initially, the Li 
group has reported a palladium catalyzed decarboxylative cross-coupling between aryl 
halides/benzyl halides and propiolic acids for the synthesis of aryl alkynes (Scheme 31).
77
 
Because of the faster kinetics of the decarboxylation step, propiolic acids caught special 
attention for alkynylation reactions in the last decades. Details we discussed in Chapter 
V. 
 
Scheme 31. Decarboxylative alkynylation reactions 
I.9. Decarboxylative cross-couplings using alkyl carboxylic acids 
Very recently, not only aromatic carboxylic acids but also alkyl carboxylic acids have 
been used as a coupling partner in the decarboxylative cross-coupling reaction.
14,78
 
Decarboxylation of aliphatic carboxylic acids generally occurs through radical pathway 
under mild reaction conditions.
79
 Taking full potential of this, a wide variety of 
photoredox catalytic systems as well as transition metal catalyst system have been 
developed for the decarboxylative cross-coupling using aliphatic carboxylic acids. In this 
vein, the MacMillan group has showed the generation of alkyl radical from alkyl 
carboxylic acid under photoredox conditions and subsequently they were able to use this 
alkyl radical with a variety of quencher to provide different types of C-C and C-
heteroatom cross-coupled products.
80
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Very recently, a decarboxylative Michael-type 1,4-addition reaction between 
activated olefin and aliphatic carboxylic acids was reported by the same group in the 
presence of Ir-photocatalyst without requirement of others organometallic species 
(Scheme 32).
81
 Initially, base-promoted deprotonation from the carboxylic acid to 
generate corresponding carboxylate and then subsequent oxidative single-electron 
transfer (SET) from the carboxylate to the photoactivated Ir-catalyst can generate a 
carboxyl radical. This carboxyl radical can easily produce nucleophilic alkyl radical A via 
decarboxylation process. Now, the alkyl radical can undergo conjugate 1,4-addition with 
an electron deficient Michael acceptor to form a new C-C bond through the generation of 
a new alkyl radical species B. Finally, reduction of B by Ir(III) species and subsequent 
protonation  produces the desired 1,4-conjugate addition product with the regeneration of 
photocatalyst for next catalytic cycle (Scheme 32). 
 
Scheme 32. Decarboxylative alkylation reaction using photoredox catalyst system 
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Allylation and vinylation reaction was also achieved successfully by the Overman 
group using allyl/vinyl halide and N-(acyloxy)-phthalimide derivatives of tertiary alkyl 
carboxylic acids in the presence of a Ru-photocatalyst and diisopropylethylamine 
(DIPEA) as a reductive quencher (Scheme 33).
82
 A similar type of reaction has also been 
developed by the Chen group using allyl sulfone as surrogates of the allylating agent 
under photocatalytic condition.
83 
Interestingly, primary, secondary, tertiary and also 
benzyl carboxylic acid derivatives were used as an efficient substrates in the reaction 
providing excellent yields. 
 
Scheme 33. Decarboxylative allylation/vinylation of alkyl carboxylic acids 
 
Scheme 34. Nickel-catalyzed decarboxylative alkyl-alkyl cross-coupling reaction 
Recently, Baran group have developed an alkyl-alkyl decarboxylative cross 
coupling reaction between alkyl carboxylic acids and dialkylzinc reagents in the presence 
of nickel-catalyst (Scheme 34).
84
 Dialkylzinc reagent is effective because of its facile 
transmetalation and ease of preparation from the corresponding alkyl halide. The redox-
active esters can readily generate alkyl radical by accepting one electron via 
   Chapter I 
 
38 
 
decarboxylation process in the presence nickel catalyst. Then this alkyl radical can couple 
with a low valent Ni-complex to produce the desired cross-coupled product via 
transmetallation with alkyl zinc reagents followed by reductive elimination. 
I.10. Decarboxylative C-heteroatom bond formation 
Most of the decarboxylative couplings reactions have proceed through the formation of 
C-C bonds. There are also some examples of C-heteroatom bond forming 
decarboxylative cross-coupling reactions. These are discussed bellow- 
I.10a. Decarboxylative C-N bond formation 
The preparation of aromatic amines have received much attention owing to their 
important role in the pharmaceutical, material, and dye industries.
85
 In 2012, Zhang et al. 
have developed a novel method to prepare such aromatic amines via intermolecular 
decarboxylative process using aromatic carboxylic acids and N-nucleophiles (Scheme  
 
Scheme 35. Cu-catalyzed decarboxylative amination 
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35).
86
 The reaction is catalyzed by copper(II)/phen combination in the presence of base 
and molecular oxygen (O2). Here molecular oxygen acts as an oxidant for the catalytic 
turnover and copper is responsible for both decarboxylation as well as the C-N coupling. 
Mechanistically, they have found that the reaction proceed through 
decarboxylation/amination sequence which is shown in scheme 35. Very recently, 
another very interesting palladium-catalyzed intramolecular decarboxylative animation 
reaction has been reported by the Hu group.
87
 
I.10b. Decarboxylative C-P bond formation 
The phosphorus-containing compounds are ubiquitously found in pharmaceuticals and 
bioactive products.
88
 In 2014, the Wu group have developed a method for the synthesis of 
alkynylphosphonates via decarboxylation method using arylpropiolic acids and dialkyl 
H-phosphonates (Scheme 36).
89
  
 
Scheme 36. Decarboxylative C-P bond formation 
   Chapter I 
 
40 
 
It has been observed that stoichiometric amount of Cu(OAc)2.H2O and 1,10-
phennanthroline ligand is essential to achieve synthetically useful yield. Interestingly, this 
decarboxylation reaction was occurred in water. To understand the reaction mechanism 
they have done several control experiments and proposed the reaction mechanism which 
is shown in scheme 36. First, the coordination of 1,10-phenanthroline to Cu(OAc)2 
generates active copper(II) intermediate and the ligand exchange occurs with the 
arylpropiolic acid to afford the copper(II) intermediate A, which is then undergo the 
copper mediated decarboxylation reaction to give copper(II) intermediate B. Then, the 
intermediate B reacts with a phosphonate anion which is generated from H-phosphonate 
and K3PO4 generating the copper(II) intermediate C. Finally, the reductive elimination of 
the intermediate C affords the desired product and the copper(I) species. 
I.10c. Decarboxylative C-S bond formation 
The aryl sulfides moiety also have broad applications in pharmaceutical and materials 
science.
90b 
In addition, this compounds are used as intermediates in organic synthesis.
90a
 
Recently, the Hoover group have successfully achieved copper-catalyzed decarboxylative 
thiolation of aromatic carboxylic acids with thiols under molecular oxygen (Scheme 
37).
91
 Here molecular oxygen used as a sole oxidant for this transformation. From the 
control experiments it was found that diaryldisulfide was formed in situ during the course 
of the reaction. 
 
Scheme 37. Cu-catalyzed decarboxylative thiolation 
I.11. Double decarboxylative cross-coupling reaction 
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The decarboxylative cross-couplings between carboxylic acid derivatives and simple 
arenes are attractive because of their ready availability and inexpensiveness. However, 
because of the abundance of multiple C-H bonds in the arenes moiety, regioselectivity 
problems arise as a negative outcome. To circumvent the regioselectivity issue, a second 
carboxylic acid can be used as coupling partner and the reaction may proceed via double 
decarboxylation. 
 
Scheme 38. Pd(II)-catalyzed double decarboxylative cross-coupling reaction 
The Su group have successfully developed an efficient method for the double 
decarboxylative cross-coupling process using electronically variant two aromatic 
carboxylic acids (Scheme 38).
92
 The reaction is catalyzed by Pd(II) in the presence of 
bulky phosphorous ligand  in DME/DMSO solvent. Here stoichiometric amount of 
Ag2CO3 is used not only as oxidant for catalytic turnover but also used for 
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decarboxylation. They have found excellent reactivity towards cross-coupling products 
rather than homocoupling products. 
I.12. Conclusion 
The development of transition metal-catalyzed decarboxylative cross-coupling reactions 
for the formation of C-C and C-heteroatom bonds has made significant progress over the 
last decade. Most of the decarboxylative cross-coupling reactions proceed through the 
formation of well-defined carbon-metal bonds via catalytic process and offers several 
advantages including the avoidance of using air sensitive or expensive organometallic 
reagents compare to typical cross-coupling reactions. Despite remarkable progresses on 
this field, the major drawback of this protocol is that most of the decarboxylative cross-
coupling reactions require high reaction temperature and harsh reaction conditions which 
restricts their application in the synthesis of complex molecular frameworks. To further 
expand the scope of decarboxylative cross-coupling reactions in organic synthesis as a 
standard tool, several challenges must be overcome. First the reaction temperature needs 
to be lowered and the catalyst loading needs to be reduced. Secondly, the substrate scope 
of the reactions should be generalized with using new catalytic systems. Further efforts 
need to be focused toward the investigation of decarboxylative cross-coupling reactions 
involving aliphatic carboxylic acids. Thirdly, another important development will be to 
extend the decarboxylative cross-coupling reactions using less expensive transition 
metals like Co, Fe and Ni.  
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CHAPTER II 
 
Palladium(0)-Catalyzed Intramolecular Decarboxylative Allylation of 
Ortho Nitrobenzoic Esters 
 
 
 
Abstract: A Pd/Ag bimetallic system has been developed for the decarboxylative 
allylation of ortho-nitrobenzoic esters in intramolecular fashion. In contrast to the typical 
sp
2
-sp
3
 cross-coupling approach which requires air and moisture sensitive preformed 
organometallic reagents, we provide an alternative route to the synthesis of ortho-allyl 
nitroarenes from the corresponding ortho-nitrobenzoic acid derivatives. The reaction 
proceeds through a mechanistically distinct decarboxylative metalation pathway. A 
cooperative reactivity of palladium and silver is crucial for the reaction outcome. 
 
1. Hossian, A.; Singha, S.; Jana, R. Org. Lett. 2014, 16, 3934-3937.  
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Palladium(0)-Catalyzed Intramolecular Decarboxylative Allylation of 
Ortho Nitrobenzoic Esters 
II. 1. Introduction  
Allylic aromatic compounds are ubiquitous structural motifs found in various natural 
products (Figure 1).
1
 In addition, these compounds represent important organic 
intermediates to the synthesis of complex molecular frameworks due to the versatility of 
olefin functionalizations.
2
 In the past decades, several methods have been used to 
construct the allylic arenes (Scheme 1). In particular, the transition metal catalyzed 
allylation of aryl metal species with allylic electrophiles provided the allylated arenes.
3
 
Although this protocol is valuable but suffer from the preactivation of arenes which needs 
stoichiometric amount of metal. Alternatively, the Lewis acid-catalyzed Friedel-Crafts 
aromatic allylation reaction is useful because it avoids the prior preparation of the aryl 
metal species from the arenes.
4
 But, these protocols are limited to substrate scope and 
harsh reaction conditions. The mild Tsuji-Trost allylation reaction has also attracted 
attention towards the synthesis of allylated arenes.
5
 Recently, taking the advantages of C-
H activation method, the transition metal catalyzed allylation reactions via C-H activation 
have been developed using various allylic surrogates.
6
 However, the C-H bond activation 
methods require installation of directing groups in the substrates to control 
regioselectivity and their subsequent removal prohibits the synthetic fidelity. To 
overcome this problem, a regioselective, decarboxylative allylation reactions using 
inexpensive, commercially available, air and moisture stable aromatic carboxylic acids 
has been developed. 
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Figure 1. Some selected examples of naturally occurring allylated products 
 
Scheme 1. Synthesis of aromatic allylic compounds 
II. 2. Review  
The palladium-catalyzed decarboxylative sp
3
-sp
3
 allylic alkylation has been widely 
explored.
7
 In sp
3
-sp
3
 allylation reaction, the incipient anion generates after 
decarboxylation, which is stabilized by the proximal electron withdrawing groups. In this 
vein the Tunge group have showed that the allyl nitroacetic esters in the presence of 5.0  
 
Scheme 2. Decarboxylative allylation of allyl nitroacetic esters 
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mol % Pd(PPh3)4 undergoes decarboxylative allylation to provide the desired allylation 
products with excellent yield (Scheme 2).
8
 A wide range of α,α-dialkyl substrates as well 
as an α-phenyl α-fluoro ester participate in the reaction smoothly. Here the incipient 
anion after decarboxylation is stabilized by the proximal nitro group in the reaction. 
However, the other functional groups such as keto,
9
 ester,
10
 cyano,
11
 sulfone,
12
 etc. have 
been utilized for such stabilization in sp
3
-sp
3
 decarboxylative allylation reactions. 
The decarboxylative sp
2
-sp
3
 allylation using arene carboxylic acids is not reported 
earlier due to the instability and rapid protonation of the anion on the sp
2
-carbon which is 
generated after decarboxylation. Therefore, selective sp
2
-sp
3 
decarboxylative allylation is 
an extremely challenging target to achieve. In this vein, Jana et al. reported a palladium 
catalyzed decarboxylative allylation of allyl esters of 3-carboxylcoumarins moiety to 
furnish allylation product under very mild reaction condition (Scheme 3).
13
 The reaction 
is very interesting due to the formation of functionalized coumarins which are privileged 
structures in biomedical sciences.
14
 Here the anion on sp
2
-carbon which is formed after 
decarboxylation is stabilized by the proximal keto ester group present in the coumarin 
moiety and regioselective allylation occurred selectively at the C3-carbon of coumarins.  
 
Scheme 3. Decarboxylative allylation of allylic ester of coumarins 
Interestingly, when 4-methyl-3-allylcoumarate was used, the reaction did not 
furnish any desired C3-allylation product instead a migratory sp
3
-sp
3
 cross-coupling 
product was formed. Presumably, this is due to the destabilization of the Csp
2
 anion 
which prefers to migrate at the sp
3
-carbon through proton exchange. After rigorous 
screening, they optimized reaction conditions for this remote decarboxylative γ-allylation 
of the coumarins moiety in good to excellent yields of allylation product with excellent 
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selectivity at sp
3
 center (Scheme 4).
15
 To understand the mechanism for this unusual 
decarboxylative γ-allylation they performed several control experiments Scheme 4. First 
palladium undergoes oxidative addition with substrates to form a π-allyl palladium 
complex and the coumarin carboxylate A. Then intramolecular 1,5-proton transfer occurs 
to generate a stabilized carbanion at the C4-carbon B. Next, nucleophilic substitution or 
reductive elimination of the π-allyl palladium complex forms the C-C bond at C4 
position. Finally, palladium catalyzed decarboxylative protonation occurs at C3 position. 
 
Scheme 4. Migratory decarboxylative γ-allylation of coumarins 
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The liu group also reported a palladium catalyzed intermolecular sp
2
-sp
3
 
decarboxylative allylation using arene carboxylic acids and allyl bromides (Scheme 5).
16
 
However, the methodology was limited to electron-rich substrates mainly and moderate 
to low yield of the desired product was obtained. Mechanistically, aryl-palladium species 
is generated through palladium mediated decarboxylation and subsequently nucleophile 
attacks to an allyl halide to give the desired aromatic allylated product. 
 
Scheme 5. Palladium-catalyzed intermolecular decarboxylative allylation 
 
Scheme 6. Palladium-catalyzed decarboxylative allylation of α-oxocarboxylates 
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In 2011, Goossen and coworkers have developed a palladium catalyzed decarboxylative 
sp
2
-sp
3
 allylation of non-activated α-oxocarboxylates resulted in α,β-unsaturated ketones 
through alkene isomerization (Scheme 6).
17
 Interestingly, here α-oxocarboxylic acid 
serve as a acyl anion donor for this transformation. Initially, oxidative addition of the 
carboxylates substrate to Pd(0) lead to the formation of  π-allyl-Pd-carboxylate 
complexes A. From the complex A, an extrusion of CO2 leads to the formation of the acyl 
π-allyl-Pd complex B. Finally, reductive elimination of the acyl π-allyl-Pd complex 
affords the allyl ketone 10, which is then isomerize to the corresponding conjugated vinyl 
ketone D in the presence of palladium (Scheme 6). 
Recently, the Goossen’s group has showed a decarboxylative sp2-sp3 allylation of 
arene benzoates under palladium catalysis (Scheme 7).
18
 For this transformation no 
stoichiometric additive is required and the reaction proceeds under mild conditions. In the 
reaction only fluorinated benzoates provided good to high yield of the desired allylation 
product with excellent linear selectivity. However, other electron deficient benzoates like 
allyl ester of nitrobenzoic acids did not provide any desired product. 
 
Scheme 7. Palladium-catalyzed decarboxylative allylation of fluorinated benzoates  
II. 3. Present work 
Aromatic nitro compounds are useful intermediates for the synthesis of agrochemicals, 
pharmaceuticals, dyes, photo-reactive compounds, high energetic materials, 
radiopharmaceutical tracers, etc.
19
 A facile reduction of the aromatic nitro groups to their 
corresponding anilines provides common starting materials for the syntheses of a plethora 
of  N-heterocycles and natural products.
20
 Despite their interesting properties, access to 
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ortho-substituted nitroarenes is limited due to inherent incompatibility with some 
organometallic reagents.
21
 To overcome this problem the Knochel group introduced an 
elegant approach for the generation of nitro-containing organometallics via I-Mg 
exchange.
22
 However, this protocol suffers from serious limitations such as the use of air 
and moisture sensitive preformed organometallic reagents, highly toxic copper(I)cyanide 
and expensive organohalides. Therefore, alternative routes to the synthesis of ortho-
allylnitroarenes using inexpensive, air and moisture stable starting materials are in high 
demand. Recently, nitrobenzoic acid derivatives have been widely used in palladium-
catalyzed decarboxylative cross-coupling reactions.
23
 Therefore, synthesis of ortho-
allylnitroarenes using ortho nitrobenzoic acids through novel decarboxylative allylation 
reaction will be attractive in view of practical applicability. We hypothesized that the 
nitro group at the ortho position could be beneficial in decarboxylative allylation as it can 
stabilize the aryl anion which is formed after decarboxylation. 
 
Scheme 8. Palladium-catalyzed intramolecular decarboxylative allylation of ortho 
nitrobenzoic esters 
II. 4. Results and discussion 
We started optimization of the reaction conditions by heating a mixture of ortho-
nitrobenzoic acid and allyl bromide and a catalytic amount of Pd(0) at 160 
o
C, but no 
allylation product was formed. Switching to allyl acetate from allyl bromide resulted in a 
trace amount of allylation product along with nitrobenzene as a major product. We 
realized that the carboxylic acid proton could be detrimental for the allylation product 
formation and may lead to the undesired decarboxylative protonation product. Therefore, 
the potassium salt of the corresponding nitrobenzoic acid was employed but 
unfortunately, no allylation product was observed. Next, allyl ester of the corresponding 
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acid was prepared and subjected to the intramolecular decarboxylative allylation (Table 
1). Interestingly, all starting material was consumed and a mixture of corresponding allyl 
and styrenyl products was isolated in slightly improved yield (entry 18, Table 1). Still, 
the undesired ortho-nitrobenzoic acid and nitrobenzene were formed predominantly. The 
poor mass balance toward allylation product can be attributed due to decomposition of 
the π-allyl-Pd species24 and double bond isomerization at elevated temperature to 
generate undesired styrenyl product. Therefore, we decided to use the silver(I) salt as an 
additive since it is known to promote decarboxylation at lower temperature
25
 and  
decreases double bond isomerization.
26
 Gratifyingly, yield was improved to 55% with the 
addition of only 10 mol % of the silver carbonate (entry 5, Table 1). After a rigorous 
study with catalyst, ligand, solvent and the amount of additive the allylation product was 
isolated in excellent yields using a combination of 5 mol % Pd2dba3, 10 mol % dppp with 
1.5 equiv of Ag2CO3 in DMA at 110 
o
C. 
Table 1. Optimization of the reaction conditions
a
 
 
  entry         Pd cat.          ligand            x        yield (%)
b
             2a:2a':2a"
b
 
    1
c
        Pd(PPh3)4               -             0                 0                       - 
    2
c
        Pd(PPh3)4               -            0.2                30                 70:10:20 
    3
c
        Pd(OAc)2               -             0.2                  0                         - 
    4
c
       Pd(tfa)2               -             1.5                  0                         - 
    5       Pd2dba3          xantphos              0.1                  55                   80:7:13 
    6       Pd2dba3           dppf              0.1                  50                  75:10:15 
    7       Pd2dba3        rac-BINAP   0.1                  63                   73:7:20 
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    8       Pd2dba3          dppp              0.1                  68                   82:10:8 
    9       Pd2dba3         dppp              0.5                  72                    85:6:9 
    10       Pd2dba3         dppp                    1.0                  80                   85:5:10 
    11       Pd2dba3         dppp               1.5                  90                    94:0:6 
    12       Pd2dba3         dppp               2.0                  88                    92:0:8 
    13       Pd2dba3         dppe               1.5                  40                   78:13:9 
    14       Pd2dba3         dppb               1.5                  50                   80:12:8 
    15       Pd2dba3         PCy3               1.5                  45                   82:10:8 
    16       Pd2dba3         xphos                1.5                  60                  77:13:10 
    17
d
       Pd2dba3        dppp                 0                   0                        - 
    18
e
       Pd2dba3        dppp                 0                  55                  30:43:27 
    19       Pd(tfa)2        dppp                1.5                  48                 63:27:10 
    20
f
       Pd(tfa)2          -                           3.0                   7                      - 
a
All reactions were carried out in 0.1 mmol scale, in DMA 0.06 M. 
b
Yields refer to here 
are overall isolated yields and product distributions were determined by 
1
H NMR of the 
crude product. 
c
10 mol % of the Pd catalyst was used. 
d
100 mol % of the Pd2dba3 and 200 
mol % of the dppp was used. 
e
The reaction was heated at 160 
o
C, mixture of allyl and 
styrenyl product was isolated. 
f
20 mol % of Pd(tfa)2, DMF:DMSO (19:1), 120 
o
C. 
Under the optimized reaction conditions, we explored substrate scope for the 
decarboxylative allylation reaction (Scheme 9). A variety of substituted nitroarenes allow 
the formation of allylation products in good to excellent yields. A careful study revealed 
that electron donating substituents such as p-OMe on o-nitrobenzoate favours allylation 
product formation (14b, 14m, 14q, 14r, 14v, Scheme 9) and two m-OMe groups which 
are electron withdrawing in nature, lower the yields to some extent (14i, 14n, 14w,  
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Scheme 9. Substrate scope of decarboxylative allylation.  
Note: All reactions were carried out in 0.3 mmol scale. Yields refer to the average of 
isolated yields of at least two experiments. 
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Scheme 9). However, yields of the allylation products are decreased drastically with a 
substitution of three adjacent -OMe groups due to low conversion, substantial amounts of 
protonation product and carboxylic acid formation (14j, 14o, 14u, Scheme 9). Substrates 
with electron-deficient substituent, e.g. 2,4-dinitro benzoic ester resulted in 
decarboxylative protonation product only. Therefore, electron-withdrawing substituents 
on the o-nitro-benzoate facilitate decarboxylation but they decrease the ability of the aryl 
anion to serve as a σ-donor for the Pd(II)allyl cation. Halogen substituents, such as Br, Cl 
are compatible with the reaction conditions (14d, 14e, Scheme 9) which may undergo 
further cross-coupling reactions. In addition to the cross-couplings of unsubstituted allyl 
esters, a variety of substituted and functionalized allyl esters also underwent couplings to 
provide allylation products (14k-14q, Scheme 9). Allyl esters from the corresponding 
cinnamyl alcohols and its derivatives produced the linear product selectively (14r-14w, 
Scheme 9). However, allyl esters that possess β-hydrogens such as crotyl, prenyl, 2-
cyclohexenyl esters preferentially formed conjugated dienes via β-hydrogen elimination 
and protonation product
6g
. A selective reduction of the nitro group afforded o-allyl 
aniline in excellent yields (procedure in experimental section). 
Subsequently, several heteroaromatic carboxylic esters were tested under the 
reaction conditions. Unfortunately, nitrogen-containing heterocycles such as indole and 
pyridine-2-carboxylic esters did not furnish any desired product. However, benzofuran-2-
carboxylic esters furnished allylation product in good to moderate yields (Scheme 10). 
 
Scheme 10. Decarboxylative allylation of benzofuran-2-carboxylates 
The decarboxylative allylation reaction with crotyl, prenyl, 2-cyclohexenyl esters 
afforded protonation product formation exclusively and consistently. After, β-hydrogen 
elimination the allyl part forms gaseous or highly volatile 1,3-diene compounds which is 
difficult to isolate. Therefore, we performed the reaction with 15a, Scheme 11 which 
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contains a β-hydrogen and the corresponding diene 15b was isolated to confirm β-
hydrogen elimination. 
 
Scheme 11. Decarboxylative allylation and β-hydride elimination to 1,3-diene formation 
II. 5. Investigation of the reaction mechanism 
Next, we turned our attention to gaining insight of the reaction mechanism. After 
oxidative addition of palladium(0) to the allyl ester 13a the reaction may proceed in three 
distinct pathways. In path a, the solvent-separated ion pair may undergo decarboxylation 
via a two-electron process
27
 followed by carbopalladation to generate 13a" which is 
converted to the desired product after reductive elimination. Whereas, in path b, a silver-
assisted decarboxylation via anionic route can generate the aryl-silver species 13a' which 
can undergo transmetalation with palladium followed by reductive elimination to furnish  
 
Scheme 12. Possible mechanistic pathways 
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allylation product. Alternatively, this silver-assisted decarboxylation may proceed via 
Hunsdiecker-type free radical pathway as depicted in path c (Scheme 12). The ortho-
nitro group can stabilize to either the organosilver(I) or organopalladium(II) prior to and 
after decarboxylation through coordination. 
To elucidate, several control experiments were performed. Heating the reaction 
mixture at 110 
o
C without any silver salt resulted in only nitrobenzoic acid. Even a 
stoichiometric amount of palladium also failed to promote decarboxylation at this 
temperature (entry 17, Table 1). Whereas, heating the reaction mixture at 160 
o
C with 
catalytic amount of palladium afforded the desired product albeit in low yield (entry 18, 
Table 1). On the other hand, when ortho-nitro benzoic acid was heated at 110 
o
C only 
with the silver carbonate the nitrobenzene was formed indicating silver-assisted 
decarboxylation. To elucidate further, the reaction was carried out under the standard 
reaction conditions in the presence of 1.0 equiv of TEMPO, a radical scavenger. Almost 
the same yield of 14a as under the standard conditions (84%) was obtained, which rules 
out the radical mechanism as shown in path c. When Pd(II)/Ag(I) was used in lieu of 
Pd(0)/Ag(I), only starting material was recovered which indicates that Pd(0) is essential 
to initiate the reaction (entry 20, Table 1). An extensive cross-over was also observed 
between two structurally disparate allyl esters. It supports that the solvent-separated ion 
pairs are formed and undergo all possible combinations to provide the cross-over 
products (Scheme 13). 
 
Scheme 13. Cross-over experiment 
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Based on these observations, we presumed that the reaction may proceed through 
path a at an elevated temperature whereas in path b under Pd/Ag bimetallic system at a 
lower temperature. Initially, palladium(0) undergoes an oxidative addition to the allyl 
ester 1a to form a π-allyl-Pd complex and ortho-nitrobenzoate anion. Subsequently, silver 
salt of the corresponding ortho-nitrobenzoic acid may form and undergo Ag(I)-assisted 
decarboxylation to afford the corresponding aryl-Ag species 13a'. A transmetalation 
between aryl-Ag and π-allyl-Pd complex generates an aryl-Pd species 13a''. Finally, 
reductive elimination yields the desired allylation product and the Pd(0) to complete the 
catalytic cycle (Scheme 14). 
 
Scheme 14. Plausible catalytic cycle for the decarboxylative allylation 
II. 6. The role of nitro group 
Finally, to demonstrate the role of the nitro group in decarboxylative allylation, we 
synthesized diallyl ester 16a where both ester groups are at ortho to the nitro group and 
its corresponding regioisomer 16b where one allyl ester group at the ortho and other one 
at the meta position. Under slight modified reaction conditions, 16a afforded diallylation 
product in good yield via double decarboxylative allylations. Whereas, 16b afforded the 
mono-allylation along with the decarboxylative protonation product at the ortho position 
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leaving the meta allyl ester intact (Scheme 15). Similarly, para-nitro benzoic ester was 
inactive under the reaction conditions. Presumably, the nitro group at the ortho position 
has a dual role in decarboxylation. First, it can coordinate to either the Ag(I) or Pd(II) 
prior to and after decarboxylation. This is particularly important for “post-
decarboxylation” acting as a C/O bidentate ligand to form a relatively stable 5-membered 
palladacycle. Secondly, it imparts strong inductive effect that stabilizes the incipient 
anion which leads to rapid decarboxylation followed by allylation. 
 
Scheme 15. Selective decarboxylative allylation of nitro benzoic esters    
II. 7. Conclusion 
In conclusion, we have developed a Pd/Ag bimetallic system for the decarboxylative sp
2
-
sp
3
 allylation of ortho-nitrobenzoic esters in intramolecular fashion. A synergistic effect 
of palladium and silver was observed in this decarboxylative allylation. Mechanistic 
studies suggest that silver-assisted decarboxylation occurs in an anionic pathway at the 
present reaction conditions which lead to an allylation product via transmetalation and 
reductive elimination. 
II. 8. Experimental section 
Preparation of the starting materials 
A. Preparation of allylic ester of 2-nitrobenzoic acids using Steglich’s Conditions 
(13a-14y).
28
 2-nitrobenzoic acids (1.2 mmol, 1.2 equiv), DMAP ( 0.2 equiv) and DCC 
(1.2 mmol, 1.2 equiv), were successively added to a solution of respective allyl alcohols 
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(1.0 mmol, 1.0 equiv) in dry dichloromethane (10 mL) and the resulting mixture was 
stirred at room temperature until TLC showed complete consumption of the starting 
materials. Subsequently, the mixture was filtered and concentrated. Purification of the 
residue by column chromatography (ethyl acetate:hexane, 1:9) afforded the pure product 
of 2-nitrobenzoic allylic esters. 
B. Preparation of diallylic ester of 2-nitrobenzene-1,3-dioic acid (16a). 2-
nitrobenzene-1,3-dioic acid (1.0 mmol, 1.0 equiv), activated K2CO3 (16 mmol, 16 equiv) 
were successively added to a solution of allyl bromide (6 mmol, 6.0 equiv) in dry acetone 
(15 mL) and the resulting mixture was stirred at room temperature until TLC showed 
complete consumption of the starting materials. Subsequently, the mixture was filtered 
and concentrated. Purification of the residue by column chromatography (ethyl 
acetate:hexane, 1:3) afforded the pure product of 2-nitrobenzeze-1,3-dioic diallylic ester. 
C. Preparation of diallylic ester of 3-nitrobenzene-1,2-dioic acid (16b). 3-
nitrobenzene-1,2-dioic acid (1.0 mmol, 1.0equiv), activated K2CO3 (16 mmol, 16 equiv) 
were successively added to a solution of allyl bromide (6 mmol, 6.0 equiv) in dry acetone 
(15 mL) and the resulting mixture was stirred at room temperature until TLC showed 
complete consumption of the starting materials. Subsequently, the mixture was filtered 
and concentrated. Purification of the residue by column chromatography (ethyl 
acetate:hexane, 1:3) afforded the pure product of diallyl 3-nitrobenzene-1,2-dioate. 
D. Preparation of (Z)-but-2-ene-1,4-di-2-nitrobenzoate from 2-nitrobenzoic acid 
using Steglich’s Conditions (15a).28 2-nitrobenzoic acid (1.2 mmol, 2.4 equiv), DMAP ( 
0.4 equiv) and DCC (1.2  mmol, 2.4 equiv), were successively added to a solution of (Z)-
but-2-ene-1,4-diol (0.5 mmol, 1.0 equiv) in dry dichloromethane (10 mL) and the 
resulting mixture was stirred at room temperature until TLC showed complete 
consumption of the starting materials. Subsequently, the mixture was filtered and 
concentrated. Purification of the residue by column chromatography (ethyl 
acetate:hexane, 1:3) afforded the pure product of 2-nitrobenzoic allylic esters. 
Allyl 2-nitrobenzoate, 13a, Scheme 9. Column chromatography (SiO2, eluting with 10:1 
hexane/ethyl acetate) afforded the desired product as a pale yellow oil (186 mg, 90%). 
1
H 
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NMR (600 MHz, CDCl3): δ 7.90 (dd, J1 = 7.8 Hz, J2 = 1.2 Hz, 1H), 7.75 (dd, J1 = 7.2 Hz, 
J2 = 1.2 Hz, 1H), 7.67 (dt, J1 = 7.2 Hz, J2 = 1.2 Hz, 1H), 7.63 (dt, J1 = 7.8 Hz, J2 = 1.2 
Hz, 1H), 5.94 -6.01 (m, 1H), 5.29-5.40 (m, 2H), 4.81 (d, J = 6.6 Hz, 2H); 
13
C NMR (150 
MHz, CDCl3): δ 165.1, 148.2, 132.9, 131.8, 131.0, 129.9, 127.5, 123.9, 119.4, 67.0; IR 
(neat): υmax 1737, 1535, 1356, 1290, 1127, 940, 699 cm
-1
; HRMS (ESI, m/z) calcd. for 
C10H9NO4Na [M + Na]
+
: 230.0429; found: 230.0466. 
Allyl 4-methoxy-2-nitrobenzoate, 13b, Scheme 9. Column chromatography (SiO2, 
eluting with 6:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil 
(206 mg, 87%). 
1
H NMR (300 MHz, CDCl3): δ 7.81 (d, J = 8.7 Hz, 1H), 7.24 (d, J = 2.4 
Hz, 1H), 7.11 (dd, J1 = 8.7 Hz, J2 = 2.4 Hz, 1H), 5.91-6.04 (m, 1H), 5.28-5.41 (m, 2H), 
4.78 (d, J = 6 Hz, 2H), 3.91 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 164.2, 162.4, 150.7, 
132.1, 131.3, 119.1, 117.9, 117.4, 109.2, 66.7, 56.2; IR (neat): υmax 1726, 1615, 1543, 
1367, 1272, 1124, 1027, 802 cm
-1
; HRMS (EI, m/z) calcd. for C11H11NO5 [M]
+
: 
237.0637; found: 237.0614. 
Allyl 4-methyl-2-nitrobenzoate, 13c, Scheme 9. Column chromatography (SiO2, eluting 
with 10:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil (190 mg, 
86%). 
1
H NMR (300 MHz, CDCl3): δ 7.68 (d, J = 8.1 Hz, 1H), 7.67 (s, 1H), 7.46 (d, J = 
7.5 Hz, 1H), 5.92-6.05 (m, 1H), 5.28-5.42 (m, 2H), 4.80 (d, J = 6 Hz, 2H), 2.48 (s, 3H);
 
13
C NMR (75 MHz, CDCl3): δ 164.9, 148.6, 143.3, 133.1, 131.1, 130.0, 124.2, 119.2, 
66.8, 21.3; IR (neat): υmax 1733, 1618, 1538, 1359, 1287, 1131, 840 cm
-1
; HRMS (ESI, 
m/z) calcd. for C11H11NO4Na [M + Na]
+
: 244.0586; found: 244.0588. 
Allyl 4-bromo-2-nitrobenzoate, 13d, Scheme 9. Column chromatography (SiO2, eluting 
with 10:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil, (234 
mg, 82%). 
1
H NMR (300 MHz, CDCl3): δ 8.02 (d, J = 1.8 Hz, 1H), 7.81 (dd, J1 = 8.4 Hz, 
J2 = 1.8 Hz, 1H), 7.67 (d, J = 8.4 Hz, 1H), 5.91- 6.03 (m, 1H), 5.30 - 5.42 (m, 2H), 4.81 
(dd, J1 = 6 Hz, J2 = 1.2 Hz, 2H);
 13
C NMR (75 MHz, CDCl3): δ 164.1, 148.9, 135.8, 
131.3, 130.8, 127.0, 125.8, 125.78, 119.7, 67.2; IR (neat): υmax 1735, 1541, 1357, 1283, 
1132, 1091 cm
-1
; HRMS (ESI, m/z) calcd. for C10H8BrNO4Na [M + Na]
+
: 307.9534; 
found: 307.9679.    
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Allyl 4-chloro-2-nitrobenzoate, 13e, Scheme 9. Column chromatography (SiO2, eluting 
with 10:1 hexane/ethyl acetate) afforded the desired product as a colourless oil (200 mg, 
83%). 
1
H NMR (300 MHz, CDCl3): δ 7.87 (d, J = 1.8 Hz, 1H), 7.76 (d, J = 8.1 Hz, 1H), 
7.65 (dd, J1 = 8.4 Hz, J2 = 1.8 Hz, 1H), 5.91- 6.04 (m, 1H), 5.30 -5.43 (m, 2H), 4.82 (d, J 
= 5.7 Hz, 2H); 
13
C NMR (75 MHz, CDCl3): δ 163.9, 148.9, 138.0, 132.7, 131.2, 130.8, 
125.2, 124.1, 119.6, 67.2; IR (neat): υmax 1737, 1603, 1545, 1357, 1278, 1104, 1065, 769 
cm
-1
, HRMS (ESI, m/z) calcd. for C10H8ClNO4Na [M + Na]
+
: 264.0040; found: 
264.0084. 
Allyl 4-phenyl-2-nitrobenzoate, 13f, Scheme 9. Column chromatography (SiO2, eluting 
with 5:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil (232 mg, 
82%). 
1
H NMR (300 MHz, CDCl3): δ 8.08 (s, 1H), 7.88 (d, J = 9 Hz, 2H), 7.62 (d, J = 
7.5 Hz, 2H), 7.44-7.54 (m, 3H), 5.94-6.07 (m, 1H), 5.31-5.44 (m, 2H), 4.84 (d, J = 5.7 
Hz, 2H); 
13
C NMR (75 MHz, CDCl3): δ 164.7, 149.1, 145.4, 137.5, 131.1, 130.7, 130.6 , 
129.25, 129.16, 127.1, 125.2, 122.2, 119.3, 66.9; IR (neat): υmax 1731, 1614, 1538, 1360, 
1277, 1133, 1073, 762 cm
-1
; HRMS (EI, m/z) calcd. for C16H13NO4 [M]
+
: 283.0845; 
found: 283.0844. 
Allyl 2-methyl-6-nitrobenzoate, 13g, Scheme 9. Column chromatography (SiO2, eluting 
with 10:1 hexane/ethyl acetate) afforded the desired product as a light yellow oil, (187 
mg, 85%). 
1
H NMR (300 MHz, CDCl3): δ 8.00 (d, J = 8.1 Hz, 1H), 7.55 (d, J = 7.5 Hz, 
1H), 7.47 (dd, J1 = 7.8 Hz, J2 = 7.8 Hz, 1H), 5.99-6.08  (m, 1H), 5.31-5.45 (m, 2H), 4.88 
(d, J = 6.0 Hz, 2H), 2.43 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 166.1, 146.2, 137.6, 
136.0, 131.3, 129.7, 129.4, 121.8, 119.8, 67.0, 19.1; IR (neat): υmax 1739, 1534, 1349, 
1266, 1113, 1073, 804 cm
-1
; HRMS (ESI, m/z) calcd. for C11H11NO4Na [M + Na]
+
: 
244.0586; found: 244.0619. 
Allyl 3-methyl-2-nitrobenzoate, 13h, Scheme 9. Column chromatography (SiO2, eluting 
with 10:1 hexane/ethyl acetate) afforded the desired product as a colourless liquid (187 
mg, 85%). 
1
H NMR (300 MHz, CDCl3): δ 7.88 (dd, J1 = 7.2 Hz, J2 = 1.8 Hz, 1H), 7.43-
7.52 (m, 2H), 5.91-6.04 (m, 1H), 5.29-5.43 (m, 2H), 4.79 (dd, J1 = 5.7 Hz, J2 = 0.9 Hz, 
2H), 2.36 (s, 3H);
 13
C NMR (75 MHz, CDCl3): δ 163.2, 150.7, 135.6, 131.1, 130.5, 
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129.9, 128.8, 123.1, 119.2, 66.7, 17.1; IR (neat): υmax 1722, 1538, 1372, 1285, 1191, 934, 
763 cm
-1
; HRMS (EI, m/z) calcd. for C11H11NO4 [M]
+
: 221.0688; found: 221.0688.  
Allyl 4,5-dimethoxy-2-nitrobenzoate, 13i, Scheme 9. Column chromatography (SiO2, 
eluting with 5:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil 
(219 mg, 82%).
 1
H NMR (300 MHz, CDCl3): δ 7.47 (s, 1H), 7.09 (s, 1H), 5.93-6.04 (m, 
1H), 5.30-5.43 (m, 2H), 4.82 (d, J = 6 Hz, 2H), 3.99 (s, 3H), 3.98 (s, 3H); 
13
C NMR (75 
MHz, CDCl3): δ 165.5, 152.4, 150.3, 141.2, 131.2, 121.6, 119.4, 110.7, 106.9, 67.0, 56.6, 
56.58; IR (neat): υmax 1722, 1535, 1381, 1287, 1218, 986, 746 cm
-1
; HRMS (EI, m/z) 
calcd. for C12H13NO6 [M]
+
: 267.0743; found: 267.0743.   
Allyl 3,4,5-trimethoxy-2-nitrobenzoate, 13j, Scheme 9. Column chromatography 
(SiO2, eluting with 5:1 hexane/ethyl acetate) afforded the desired product as a colourless 
solid (237 mg, 80%), m.p. 107 
o
C.
 1
H NMR (300 MHz, CDCl3): δ 7.29 (s, 1H), 5.89-6.02 
(m, 1H), 5.29-5.46 (m, 2H), 4.78 (d, J = 5.4 Hz, 2H), 3.96 (s, 9H);
 13
C NMR (75 MHz, 
CDCl3): δ 162.5, 154.0, 146.4, 145.7, 130.9, 119.2, 117.7, 108.5, 66.8, 62.6, 61.2, 56.5; 
IR (neat): υmax 2946, 1724, 1541, 1365, 1339, 1227, 1117, 982, 767 cm
-1
; HRMS (EI, 
m/z) calcd. for C13H15NO7 [M]
+
: 297.0849; found: 297.0839.   
2-Methylallyl 2-nitrobenzoate, 13k, Scheme 9. Column chromatography (SiO2, eluting 
with 10:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil (183 mg, 
83%).
 1
H NMR (300 MHz, CDCl3): δ 7.91 (dd, J1 = 7.8 Hz, J2 = 1.2 Hz, 1H), 7.78 (dd, J1 
= 7.2 Hz, J2 = 1.8 Hz, 1H), 7.62-7.72 (m, 2H), 5.05 (s, 1H), 5.00 (s, 1H), 4.75 (s, 2H), 
1.81 (s, 3H);
 13
C NMR (75 MHz, CDCl3): δ 165.0, 148.2, 139.0, 132.8, 131.8, 129.9, 
127.4, 123.8, 114.3, 69.8, 19.5; IR (neat): υmax 1736, 1536, 1356, 1293, 1128, 698 cm
-1
; 
HRMS (EI, m/z) calcd. for C11H11NO4 [M]
+
: 221.0688; found: 221.0688.   
2-Methylallyl 3-methyl-2-nitrobenzoate, 13l, Scheme 9. Column chromatography 
(SiO2, eluting with 10:1 hexane/ethyl acetate) afforded the desired product as a light 
yellow oil (183 mg, 78%).
 1
H NMR (300 MHz, CDCl3): δ 7.89 (dd, J1 = 7.2 Hz, J2 = 1.8 
Hz, 1H), 7.44-7.52 (m, 2H), 5.05 (s, 1H), 5.0 (s, 1H), 4.71 (s, 2H), 2.36 (s, 3H), 1.81 (s, 
3H); 
13
C NMR (75 MHz, CDCl3): δ 163.2, 150.6, 139.0, 135.6, 130.5, 129.9, 128.8, 
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123.1, 114.1, 69.5, 19.5, 17.1; IR(neat): υmax 1730, 1540, 1370, 1284, 1186, 768 cm
-1
; 
HRMS (ESI, m/z) calcd. for C12H13NO4Na [M + Na]
+
: 258.0742; found: 258.0771. 
2-Methylallyl 4-methoxy-2-nitrobenzoate, 13m, Scheme 9. Column chromatography 
(SiO2, eluting with 5:1 hexane/ethyl acetate) afforded the desired product as a pale yellow 
oil (216 mg, 86%). 
1
H NMR (300 MHz, CDCl3): δ 7.83 (d, J = 8.7 Hz, 1H), 7.23 (d, J = 
2.1 Hz, 1H), 7.11 (dd, J1 = 8.7 Hz, J2 = 2.4 Hz, 1H), 5.03 (s, 1H), 5.0 (s, 1H), 4.70 (s, 
2H), 3.91 (s, 3H), 1.80 (s, 3H);
 13
C NMR (75 MHz, CDCl3): δ 164.1, 162.4, 150.8, 139.2, 
132.2, 117.7, 117.3, 114.0, 109.1, 69.5, 56.1, 19.5; IR(neat): υmax 1725, 1617, 1533, 
1382, 1328, 1288, 1141, 1023, 845 cm
-1
; HRMS (EI, m/z) calcd. for C12H13NO5 [M]
+
: 
251.0794; found: 251.0796. 
2-Methylallyl 4,5-dimethoxy-2-nitrobenzoate, 13n, Scheme 9. Column 
chromatography (SiO2, eluting with 5:1 hexane/ethyl acetate) afforded the desired 
product as a pale yellow oil (230 mg, 82%).
 1
H NMR (300 MHz, CDCl3): δ 7.46 (s, 1H), 
7.12 (s, 1H), 5.04 (s, 1H), 4.99 (s, 1H), 4.73 (s, 2H), 3.99 (s, 3H), 3.98 (s, 3H), 1.8 (s, 
3H);
 13
C NMR (75 MHz, CDCl3): δ 165.5, 152.4, 150.4, 141.3, 139.1, 121.4, 114.3, 
110.8, 106.9, 69.8, 56.6, 56.57, 19.5; IR (neat): υmax 1731, 1582, 1527, 1347, 1287, 1221, 
1052, 757 cm
-1
; HRMS (ESI, m/z) calcd. for C13H15NO6Na [M + Na]
+
: 304.0797; found: 
304.0818.   
2-Methylallyl 3,4,5-trimethoxy-2-nitrobenzoate, 13o, Scheme 9. Column 
chromatography (SiO2, eluting with 4:1 hexane/ethyl acetate) afforded the desired 
product as a pale yellow oil (242 mg, 78%).
 1
H NMR (300 MHz, CDCl3): δ 7.31 (s, 1H), 
5.03 (s, 1H), 4.99 (s, 1H), 4.70 (s, 2H), 3.97 (s, 3H), 3.96 (s, 3H), 3.956 (s, 3H), 1.80 (s, 
3H);
 13
C NMR (75 MHz, CDCl3): δ 162.6, 154.0, 146.3, 145.7, 138.9, 117.6, 114.1, 
108.6, 69.6, 62.6, 61.2, 56.4, 19.4; IR (neat): υmax 1727, 1658, 1580, 1371, 1341, 1227, 
1116, 1026 cm
-1
; HRMS (EI, m/z) calcd. for C14H17NO7 [M]
+
: 311.1005; found: 
311.1002. 
2-(Methoxycarbonyl)allyl 2-nitrobenzoate, 13p, Scheme 9. Column chromatography 
(SiO2, eluting with 3:1 hexane/ethyl acetate) afforded the desired product as a pale yellow 
oil (201 mg, 76%).
 1
H NMR (300 MHz, CDCl3): δ 7.92 (dd, J1 = 7.8 Hz, J2 = 1.2 Hz, 
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1H), 7.77 (dd, J1 = 7.2 Hz, J2 = 1.5 Hz, 1H), 7.58-7.72 (m, 2H), 6.45 (s, 1H), 5.95 (s, 
1H), 5.07 (s, 2H), 3.80 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 165.5, 164.8, 148.2, 134.2, 
132.9, 132.0, 130.0, 129.1, 127.3, 124.0, 64.4, 52.2; IR (neat): υmax 2932, 1736, 1662, 
1531, 1348, 1074, 737 cm
-1
; HRMS (EI, m/z) calcd. for C12H11NO6 [M]
+
: 265.0586; 
found: 265.0580. 
2-(Methoxycarbonyl)allyl 4-methoxy-2-nitrobenzoate, 13q, Scheme 9. Column 
chromatography (SiO2, eluting with 3:1 hexane/ethyl acetate) afforded the desired 
product as a pale yellow oil (221 mg, 75%).
 1
H NMR (600 MHz, CDCl3): δ 7.78 (d, J = 
8.4 Hz, 1H), 7.2 (s, 1H), 7.09 (d, J = 7.8 Hz, 1H), 6.40 (s, 1H), 5.89 (s, 1H), 4.99 (s, 2H), 
3.88 (s, 3H), 3.78 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 165.5, 163.8, 162.5, 150.8, 
134.3, 132.2, 128.6, 117.4, 117.3, 109.3, 63.94, 56.2, 52.1; IR (neat): υmax 2926, 1726, 
1703, 1619, 1527, 1330, 1287, 1137, 1026, 803 cm
-1
; HRMS (EI, m/z) calcd. for 
C13H13NO7 [M]
+
: 295.0692; found: 295.0693. 
Cinnamyl 4-methoxy-2-nitrobenzoate, 13r, Scheme 9. Column chromatography (SiO2, 
eluting with 5:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil 
(263 mg, 84%).
 1
H NMR (600 MHz, CDCl3): δ 7.81 (d, J = 9 Hz, 1H), 7.41 (d, J = 7.2 
Hz, 2H), 7.33 (t, J = 7.8 Hz, 2H), 7.25-7.28 (m, 1H), 7.24 (d, J = 2.4 Hz, 1H), 7.1 (dd, J1 
= 9 Hz, J2 = 3 Hz, 1H), 6.71 (d, J = 16.2 Hz, 1H), 6.31-6.36 (m, 1H), 4.94 (dd, J1 = 6.6 
Hz, J2 = 1.2 Hz, 2H), 3.89 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 164.3, 162.3, 150.8, 
136.1, 134.9, 132.1, 128.6, 128.2, 126.7, 122.2, 117.9, 117.4, 109.2, 66.6, 56.2; IR (neat): 
υmax 1726, 1542, 1371, 1280, 1138, 742 cm
-1
; HRMS (ESI, m/z) calcd. for C17H15NO5Na 
[M + Na]
+
: 336.0848; found: 336.0839. 
Cinnamyl 2-nitrobenzoate, 13s, Scheme 9. Column chromatography (SiO2, eluting with 
8:1 hexane/ethyl acetate) afforded the desired product as a pale yellow oil (243 mg, 
86%).
 1
H NMR (300 MHz, CDCl3): δ 7.94 (dd, J1 = 7.8 Hz, J2 = 1.2 Hz, 1H), 7.77 (dd, J1 
= 7.5 Hz, J2 = 1.5 Hz, 1H), 7.61-7.71 (m, 2H), 7.42 (d, J = 6.9 Hz, 2H), 7.24-7.36 (m, 
3H), 6.73 (d, J = 15.9 Hz, 1H), 6.30-6.40 (m, 1H), 5.0 (dd, J1 = 6.6 Hz, J2 = 1.2 Hz, 2H); 
13
C NMR (75 MHz, CDCl3): δ 165.2, 148.1, 136.0, 135.2, 132.9, 131.8, 129.8, 128.6, 
128.2, 127.6, 126.7, 123.9, 121.9, 67.0; IR (neat): υmax 1726, 1531, 1359, 1281, 1132, 
1068, 748 cm
-1
; HRMS (EI, m/z) calcd. for C16H13NO4 [M]
+
: 283.0845; found: 283.0850. 
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Cinnamyl 3-methyl-2-nitrobenzoate, 13t, Scheme 9. Column chromatography (SiO2, 
eluting with 8:1 hexane/ethyl acetate) afforded the desired product as a colourless liquid 
(246 mg, 83%).
 1
H NMR (300 MHz, CDCl3): δ 7.89 (dd, J1 = 7.2 Hz, J2 = 1.2 Hz, 1H), 
7.48-7.52 (m, 2H), 7.41-7.46 (m, 2H), 7.27-7.36 (m, 3H), 6.73 (d, J = 15.9 Hz, 1H), 6.28-
6.38 (m, 1H), 4.95 (dd, J1 = 6.6 Hz, J2 = 0.9 Hz, 2H), 2.36 (s, 3H);
 13
C NMR (75 MHz, 
CDCl3): δ 163.3, 150.6, 136.0, 135.6, 135.0, 130.4, 129.8, 128.7, 128.6, 128.2, 126.7, 
123.12, 121.9, 66.6, 17.0; IR (neat): υmax 1723, 1541, 1374, 1280, 1159, 1123, 725 cm
-1
; 
HRMS (EI, m/z) calcd. for C17H15NO4 [M]
+
: 297.1001; found: 297.0999. 
Cinnamyl 3,4,5-trimethoxy-2-nitrobenzoate, 13u, Scheme 9. Column chromatography 
(SiO2, eluting with 4:1 hexane/ethyl acetate) afforded the desired product as a colourless 
solid (291 mg, 78%), m.p. 84 
o
C.  
1
H NMR (300 MHz, CDCl3): δ 7.41-7.43 (m, 2H), 
7.30-7.36 (m, 4H), 6.72 (d, J = 15.6 Hz, 1H), 6.26-6.36 (m, 1H), 4.94 (d, J = 6.3 Hz, 2H), 
3.97 (s, 3H), 3.96 (s, 3H), 3.95 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 162.5, 153.9, 
146.2, 145.6, 140.2, 135.9, 135.0, 128.5, 128.1, 126.6, 121.8, 117.6, 108.4, 66.7, 62.5, 
61.1, 56.4; IR (neat): υmax 1724, 1541, 1377, 1340, 1232, 1111, 969 cm
-1
; HRMS (ESI, 
m/z) calcd. for C19H19NO7Na [M + Na]
+
: 396.1059; found: 396.1037. 
4-Methoxy cinnamyl 4-methoxy-2-nitrobenzoate, 13v, Scheme 9. Column 
chromatography (SiO2, eluting with 4:1 hexane/ethyl acetate) afforded the desired 
product as a light yellow oil (282 mg, 82%).
 1
H NMR (300 MHz, CDCl3): δ 7.81 (d, J = 
8.1 Hz, 1H), 7.35 (d, J = 8.7 Hz, 2H), 7.25 (d, J = 2.4 Hz, 1H), 7.11 (dd, J1 = 8.7 Hz, J2 = 
2.4 Hz, 1H), 6.86 (d, J = 8.7 Hz, 2H), 6.66 (d, J = 15.9 Hz, 1H), 6.15-6.24 (m, 1H), 4.92 
(dd, J1 = 6.6 Hz, J2 = 0.6 Hz, 2H), 3.90 (s, 3H), 3.81 (s, 3H);
 13
C NMR (75 MHz, CDCl3): 
δ 164.1, 162.2, 159.5, 150.6, 134.6, 131.9, 128.6, 127.8, 127.5, 119.7, 117.8, 117.2, 
113.9, 113.7, 109.1, 66.8, 56.0, 55.1; IR (neat): υmax 1714, 1610, 1540, 1380, 1275, 1126, 
1026, 836 cm
-1
; HRMS (ESI, m/z) calcd. for C18H17NO6Na [M + Na]
+
: 366.0954; found: 
366.0948. 
4-Methoxycinnamyl 4,5-dimethoxy-2-nitrobenzoate, 13w, Scheme 9. Column 
chromatography (SiO2, eluting with 4:1 hexane/ethyl acetate) afforded the desired 
product as a light yellow oil (298 mg, 80%).
 1
H NMR (300 MHz, CDCl3): δ 7.48 (s, 1H), 
7.36 (d, J = 8.4 Hz, 2H), 7.09 (s, 1H), 6.86 (d, J = 8.7 Hz, 2H), 6.68 (d, J = 15.6 Hz, 1H), 
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6.17-6.27 (m, 1H), 4.95 (d, J = 6.6 Hz, 2H), 3.99 (s, 3H), 3.98 (s, 3H), 3.81 (s, 3H); 
13
C 
NMR (150 MHz, CDCl3): δ 165.7, 159.7, 152.5, 150.3, 141.1, 135.0, 128.8, 128.0, 121.9, 
119.7, 114.0, 110.7, 106.9, 67.4, 56.64, 56.56, 55.3; IR (neat): υmax 2926, 1721, 1606, 
1513, 1384, 1286, 1217, 772 cm
-1
; HRMS (EI, m/z) calcd. for C19H19NO7 [M]
+
: 
373.1162; found: 373.1141. 
Allyl benzofuran-2-carboxylate, 13x, Scheme 10. Column chromatography (SiO2, 
eluting with 10:1 hexane/ethyl acetate) afforded the desired product as a colourless liquid 
(174 mg, 86%).
 1
H NMR (300 MHz, CDCl3): δ 7.69 (d, J = 7.8 Hz, 1H), 7.57-7.62 (m, 
2H), 7.43 (dt, J1 = 7.2 Hz, J2 = 1.2 Hz, 1H), 7.32 (t, J1 = 7.8 Hz, 1H), 6.12-6.00 (m, 1H), 
5.32-5.49 (m, 2H), 4.89 (d, J = 5.7 Hz, 2H);
 13
C NMR (75 MHz, CDCl3): δ 159.2, 155.8, 
145.4, 131.6, 127.7, 126.9, 123.8, 122.8, 119.1, 114.1, 112.4, 66.0; IR (neat): υmax 2926, 
1730, 1567, 1294, 1177, 749 cm
-1
; HRMS (ESI, m/z) calcd. for C12H10O3Na [M + Na]
+
: 
225.0528; found: 225.0536. 
Cinnamyl benzofuran-2-carboxylate, 13y, Scheme 10. Column chromatography (SiO2, 
eluting with 9:1 hexane/ethyl acetate) afforded the desired product as a colourless liquid 
(234 mg, 84%).
 1
H NMR (600 MHz, CDCl3): δ 7.69 (d, J = 7.8 Hz, 1H), 7.61 (d, J = 8.4 
Hz, 1H), 7.58 (s, 1H), 7.43-7.47 (m, 3H), 7.27-7.36 (m, 4H), 6.78 (d, J = 16.2 Hz, 1H), 
6.45-6.40 (m, 1H), 5.05 (d, J = 6.6 Hz, 2H); 
13
C NMR (150 MHz, CDCl3): δ 159.4, 
155.8, 145.4, 136.0, 135.2, 128.6, 128.3, 127.7, 126.9, 126.7, 123.8, 122.9, 122.5, 114.2, 
112.4, 66.0; IR (neat): υmax 1724, 1711, 1570, 1447, 1299, 1175, 952, 749 cm
-1
; HRMS 
(EI, m/z) calcd. for C18H14O3 [M]
+
: 278.0943; found: 278.0934.  
Diallyl 2-nitrobenzene-1,3-dioate, 16a, Scheme 15. Column chromatography (SiO2, 
eluting with 3:1 hexane/ethyl acetate) afforded the desired product as a light yellow oil 
(221 mg, 76%).
 1
H NMR (300 MHz, CDCl3): δ 8.22 (dd, J1 = 8.1 Hz, J2 = 3.9 Hz, 2H), 
7.66 (dd, J1 = 7.8 Hz, J2 = 7.8 Hz, 1H), 5.91-6.04 (m, 2H), 5.31-5.44 (m, 4H), 4.81 (d, J = 
5.7 Hz, 4H); 
13
C NMR (75 MHz, CDCl3): δ 162.4, 135.1, 130.7, 130.2, 124.2, 119.6, 
67.2; IR (neat): υmax 1737, 1605, 1557, 1261, 1218, 802 cm
-1
; HRMS (EI, m/z) calcd. for 
C14H13NO6 [M]
+
: 291.0743; found: 291.0742.  
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Diallyl 3-nitrobenzene-1,2-dioate, 16b, Scheme 15. Column chromatography (SiO2, 
eluting with 3:1 hexane/ethyl acetate) afforded the desired product as a light yellow oil 
(209 mg, 72%).
 1
H NMR (300 MHz, CDCl3): δ 8.37 (dd, J1 = 8.4 Hz, J2 = 2.4 Hz, 2H), 
7.69 (t, J = 8.1 Hz, 1H), 5.94-6.13 (m, 2H), 5.31-5.46 (m, 4H), 4.92 (d, J = 6 Hz, 2H), 
4.84 (d, J = 5.7 Hz, 2H);
 13
C NMR (75 MHz, CDCl3): δ 164.9, 163.3, 146.3, 135.7, 131.2, 
131.0, 130.8, 130.13, 130.09, 128.2, 119.5, 67.4, 66.9; IR (neat): υmax 1731, 1610, 1540, 
1461, 1354, 1269, 1142, 709 cm
-1
; HRMS (ESI, m/z) calcd. for C14H13NO6Na [M + Na]
+
: 
314.0641; found: 314.0625.  
(Z)-But-2-ene-1,4-di-2-nitrobenzoate, 15a, Scheme 11. Column chromatography (SiO2, 
eluting with 3:1 hexane/ethyl acetate) afforded the desired product as a colourless oil 
(137 mg, 71%).
 1
H NMR (600 MHz, CDCl3): δ 7.92 (d, J = 7.8 Hz, 2H), 7.75 (dd, J1 = 
7.8 Hz, J2 = 1.2 Hz, 2H), 7.68 (dt J1 = 7.8 Hz, J2 = 1.2 Hz, 2H), 7.62-7.65 (m, 2H), 5.92 
(t, J = 4.2 Hz, 2H), 4.98 (d, J = 5.4 Hz, 4H); 
13
C NMR (150 MHz, CDCl3): δ 165.1, 
148.1, 133.0, 131.8, 129.9, 127.9, 127.5, 123.9, 61.6; IR (neat): υmax 1735, 1534, 1351, 
1285, 1254, 1124, 1071, 735 cm
-1
; HRMS (ESI, m/z) calcd. for C18H14N2O8Na [M + 
Na]
+
: 409.0648; found: 409.0615. 
General experimental procedure for the decarboxylative allylation of ortho-
nitrobenzoic esters.  
In a 10 mL two necked round bottom flask equipped with magnetic stir bar was added 
allyl 2-nitrobenzoate (62.2 mg, 0.30 mmol), silver carbonate (124 mg, 0.45 mmol), dppp 
(12.4 mg, 0.03 mmol), and Pd2(dba)3 (13.7 mg, 0.015 mmol). Dimethylacetamide (DMA) 
5.0 mL was added into it. The reaction mixture was then evacuated and refilled with 
nitrogen three times and it was heated at 110 
o
C under nitrogen atmosphere for 12 hours. 
After the consumption of the starting materials as indicated by TLC, the reaction mixture 
was cooled to room temperature, poured into water (25 mL) and extracted with diethyl 
ether (3 x 25 mL). The combined organic extract was dried (anh. Na2SO4) and evaporated 
under reduced pressure. The crude product was purified by column chromatography on 
silica gel using pentane eluent. The pure product was isolated as yellow oil in 84% yield 
(41 mg). Note: This compound is volatile in nature therefore low volatile solvents such as 
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pentane, diethyl ether were used for column chromatography and medium vacuum was 
applied for solvent evaporation.
 
1-Allyl-2-nitrobenzene, 14a, Scheme 9.
22a
 Column chromatography (SiO2, eluting with 
pentane) afforded the desired product as a yellow oil (41 mg, 84%). 
1
H NMR (300 MHz, 
CDCl3): δ 7.92 (dd, J1 = 7.8 Hz, J2 = 0.9 Hz, 1H), 7.54 (t, J = 7.2 Hz, 1H), 7.35-7.39 (m, 
2H), 5.91-6.04 (m, 1H), 5.05-5.13 (m, 2H), 3.69 (d, J = 6.3 Hz, 2H); 
13
C NMR (75 MHz, 
CDCl3): δ 149.3, 135.0, 134.8, 133, 131.9, 127.3, 124.7, 117.1, 36.9. 
1-Allyl-4-methoxy-2-nitrobenzene, 14b, Scheme 9. Column chromatography (SiO2, 
eluting with 95:5 pentane/diethyl ether) afforded the desired product as a yellow oil (49 
mg, 85%).
 1
H NMR (600MHz, CDCl3): δ 7.44 (d, J = 3 Hz, 1H), 7.25 (d, J = 7.8 Hz, 1H), 
7.09 (dd, J1 = 8.4 Hz, J2 = 2.4 Hz, 1H), 5.92-5.98 (m, 1H), 5.03-5.09 (m, 2H), 3.85 (s, 
3H), 3.62(d, J = 6 Hz, 2H); 
13
C NMR (150 MHz, CDCl3): δ 158.4, 149.5, 135.5, 132.7, 
126.8, 119.8, 116.6, 109.2, 55.8, 36.3; IR (neat): υmax 2933, 1622, 1529, 1251, 1035, 811 
cm
-1
; HRMS (EI, m/z) calcd. for C10H11NO3 [M]
+
: 193.0739; found: 193.0714. 
1-Allyl-4-methyl-2-nitrobenzene, 14c, Scheme 9. Column chromatography (SiO2, 
eluting with pentane) afforded the desired product as a yellow oil (40 mg, 75%).
 1
H NMR 
(300MHz, CDCl3):  δ 7.726 (s, 1H), 7.34 (d, J = 7.5 Hz, 1H), 7.24 (d, J = 7.8 Hz, 1H), 
5.89-6.02 (m, 1H), 5.02-5.10 (m, 2H), 3.64 (d, J = 6.3 Hz, 2H), 2.40 (s, 3H); 
13
C NMR 
(75 MHz, CDCl3): δ 149.1, 137.6, 135.3, 133.8, 131.8, 131.7, 124.9, 116.8, 36.6, 20.7; IR 
(neat): υmax 2927, 1636, 1527, 1360, 786 cm
-1;
 HRMS (EI, m/z) calcd. for C10H11NO2 
[M]
+
: 177.0790; found: 177.0758. 
1-Allyl-4-bromo-2-nitrobenzene, 14d, Scheme 9. Column chromatography (SiO2, 
eluting with pentane) afforded the desired product as a yellow liquid (48 mg, 67%).
 1
H 
NMR (300MHz, CDCl3): δ 8.06 (d, J = 2.1 Hz, 1H), 7.66 (dd, J1 = 8.1 Hz, J2 = 1.8 Hz, 
1H), 7.25 (d, J = 8.4 Hz, 1H), 5.86-5.99 (m, 1H), 5.05-5.16 (m, 2H), 3.64 (d, J = 6.3 Hz, 
2H); 
13
C NMR (75 MHz, CDCl3): δ 136.0,134.4, 133.9, 133.3, 127.6, 120.2, 117.7, 36.5; 
IR (neat): υmax 2923, 1637, 1529, 1350, 875 cm
-1
; HRMS (ESI, m/z) calcd. for 
C9H8BrNO2Na [M + Na]
+
: 263.9636; found: 263.9609. 
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1-Allyl-4-chloro-2-nitrobenzene, 14e, Scheme 9. Column chromatography (SiO2, 
eluting with pentane) afforded the desired product as a yellow liquid (32 mg, 54%).
 1
H 
NMR (600MHz, CDCl3): δ 7.92 (s, 1H), 7.52 (d, J = 6 Hz, 1H), 7.32 (d, J = 6 Hz, 1H), 
5.90-5.97 (m, 1H), 5.07-5.15 (m, 2H), 3.66 (d, J = 6 Hz, 2H); 
13
C NMR (150 MHz, 
CDCl3): δ 149.5, 134.4, 133.4, 133.1, 133.0, 132.9, 124.8, 117.6, 36.4; IR (neat): υmax 
2923, 1639, 1533, 1352, 1118, 885 cm
-1
; HRMS (EI, m/z) calcd. for C9H8ClNO2 [M]
+
: 
197.0244; found: 197.0214. 
1-Allyl-4-phenyl-2-nitrobenzene, 14f, Scheme 9. Column chromatography (SiO2, 
eluting with pentane) afforded the desired product as a yellow oil (54 mg, 76%).
 1
H NMR 
(300 MHz, CDCl3): δ 8.15 (d, J = 1.8 Hz, 1H), 7.76 (dd, J1 = 8.1 Hz, J2 = 1.8 Hz, 1H), 
7.59-7.65 (m, 2H), 7.39-7.51 (m, 4H), 5.94-6.08 (m, 1H), 5.10-5.16 (m, 2H), 3.73 (d, J = 
6.3 Hz, 2H); 
13
C NMR (75 MHz, CDCl3): δ 149.6, 140.8, 138.4, 135.0, 133.5, 132.4, 
131.3, 129.1, 128.3, 127.0, 123.0, 117.2, 36.7; IR (KBr): υmax 2923, 1531, 1506, 1350, 
761, 696 cm
-1
 ; HRMS (EI, m/z) calcd. for C15H13NO2 [M]
+
: 239.0946; found: 239.0943. 
2-Allyl-1-methyl-3-nitrobenzene, 14g, Scheme 9. Column chromatography (SiO2, 
eluting with pentane) afforded the desired product as a yellow oil (38 mg, 73%).
 1
H NMR 
(300MHz, CDCl3): δ 7.62 (d, J = 8.1 Hz, 1H), 7.39 (d, J = 7.2 Hz, 1H), 7.22-7.28 (m, 
1H), 5.88-5.99 (m, 1H), 4.92-5.10 (m, 2H), 3.55 (d, J = 5.7 Hz, 2H), 2.40 (s, 3H); 
13
C 
NMR (75 MHz, CDCl3): δ 151.1, 139.8, 134.3, 134.2, 131.6, 126.8, 122.0, 116.3, 32.8, 
19.8; IR (neat): υmax 2925, 1637, 1527, 1350, 800 cm
-1
; HRMS (ESI, m/z) calcd. for 
C10H11NO2Na [M + Na]
+
: 200.0687; found: 200.0647. 
1-Allyl-3-methyl-2-nitrobenzene, 14h, Scheme 9. Column chromatography (SiO2, 
eluting with pentane) afforded the desired product as a yellow oil (35 mg, 66%).
 1
H NMR 
(300MHz, CDCl3):  δ 7.29-7.34 (m, 1H), 7.14-7.17 (m, 2H), 5.82-5.95 (m, 1H), 5.06-5.12 
(m, 2H), 3.36 (d, J = 6.6 Hz, 2H), 2.32 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 151.5, 
134.8, 131.3, 130.1, 129.6, 129.3, 128.2, 117.3, 35.5, 17.4; IR (neat): υmax 2923, 1639, 
1527, 1369, 1217, 757 cm
-1
; HRMS (ESI, m/z) calcd. for C10H11NO2Na [M + Na]
+
: 
200.0687; found: 200.0677. 
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1-Allyl-4,5-dimethoxy-2-nitrobenzene, 14i, Scheme 9. Column chromatography (SiO2, 
eluting with 95:5 pentane/diethyl ether) afforded the desired product as a yellow oil (54 
mg, 80%).
 1
H NMR (600 MHz, CDCl3): δ 7.60 (s, 1H), 6.74 (s, 1H), 5.95-6.02 (m, 1H), 
5.06-5.12 (m, 2H), 3.95 (s, 3H), 3.93 (s, 3H), 3.71 (d, J = 6.6 Hz, 2H); 
13
C NMR (150 
MHz, CDCl3): δ 153.0, 147.3, 141.1, 135.4, 130.2, 116.8, 113.0, 108.1, 56.3, 37.5; IR 
(KBr): υmax 2965, 1577, 1519, 1263, 1059, 796 cm
-1
; HRMS (EI, m/z) calcd. for 
C11H13NO4 [M]
+
: 223.0845; found: 223.0847. 
1-Allyl-3,4,5-trimethoxy-2-nitrobenzene, 14j, Scheme 9. Column chromatography 
(SiO2, eluting with 95:5 pentane/diethyl ether) afforded the desired product as a yellow 
oil (40 mg, 53%).
 1
H NMR (600 MHz, CDCl3): δ 6.51 (s, 1H), 5.84-5.90 (m, 1H), 5.09-
5.13 (m, 2H), 3.97 (s, 3H), 3.89 (s, 3H), 3.87 (s, 3H), 3.33 (d, J = 6.6 Hz, 2H); 
13
C NMR 
(150 MHz, CDCl3): δ 154.9, 146.1, 140.8, 139.8, 134.5, 127.9, 117.6, 107.6, 62.3, 61.1, 
56.2, 35.5; IR (KBr): υmax 2943, 1579, 1528, 1342, 1118, 800 cm
-1
; HRMS (EI, m/z) 
calcd. for C12H15NO5 [M]
+
: 253.0950; found: 253.0949. 
1-(2-Methylallyl)-2-nitrobenzene, 14k, Scheme 9. Column chromatography (SiO2, 
eluting with pentane) afforded the desired product as a yellow oil (43 mg, 81%).
 1
H NMR 
(600 MHz, CDCl3): δ 7.89 (dd, J1 = 7.8 Hz, J2 = 1.8 Hz, 1H), 7.5 (dt, J1 = 7.8 Hz, J2 = 
1.2 Hz, 1H), 7.35-7.39 (m, 2H), 4.84 (s, 1H), 4.51 (s, 1H), 3.64 (s, 2H), 1.74 (s, 3H); 
13
C 
NMR (150 MHz, CDCl3): δ 149.7, 143.1, 134.3, 132.7, 132.3, 127.4, 124.6, 112.5, 40.4, 
22.7; IR (neat): υmax 2916, 1650, 1608, 1525, 1348, 734 cm
-1
; HRMS (ESI, m/z) calcd. for 
C10H11NO2Na [M + Na]
+
: 200.0687; found: 200.0667. 
1-Methyl-3-(2-methylallyl)-2-nitrobenzene, 14l, Scheme 9. Column chromatography 
(SiO2, eluting with pentane) afforded the desired product as a yellow oil (33 mg, 57%).
 
1
H NMR (600 MHz, CDCl3): δ 7.31 (t, J = 7.2 Hz, 1H), 7.16 (t, J = 7.2 Hz, 2H), 4.86 (s, 
1H), 4.68 (s, 1H), 3.32 (s, 2H), 2.32 (s, 3H), 1.68 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 
151.9, 142.5, 130.9, 129.9, 129.5, 129.4, 128.5, 113.4, 39.4, 22.1, 17.4; IR (neat): υmax 
2925, 1652, 1529, 1369, 783 cm
-1
; HRMS (ESI, m/z) calcd. for C11H13NO2Na [M + Na]
+
: 
214.0844; found: 214.0821. 
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4-Methoxy-1-(2-methylallyl)-2-nitrobenzene, 14m, Scheme 9. Column 
chromatography (SiO2, eluting with 98:2 pentane/acetone) afforded the desired product 
as a yellow oil (53 mg, 85%).
 1
H NMR (600 MHz, CDCl3): δ 7.42 (d, J = 2.4 Hz, 1H), 
7.23 (d, J = 8.4 Hz, 1H), 7.08 (dd, J1 = 8.4 Hz, J2 = 3 Hz, 1H), 4.80 (s, 1H), 4.49(s, 1H), 
3.85 (s, 3H), 3.56 (s, 2H), 1.73 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 158.4, 149.9, 
143.5, 133.1, 126.2, 119.5, 112.1, 109.2, 55.7, 39.8, 22.7; IR (neat): υmax 1649, 1530, 
1353, 1251, 1037, 771 cm
-1
; HRMS (EI, m/z) calcd. for C11H13NO3 [M]
+
: 207.0895; 
found: 207.0881. 
1,2-Dimethoxy-4-(2-methylallyl)-5-nitrobenzene, 14n, Scheme 9. Column 
chromatography (SiO2, eluting with 98:2 pentane/acetone) afforded the desired product 
as a yellow oil (53 mg, 74%).
 1
H NMR (600 MHz, CDCl3): δ 7.60 (s, 1H), 6.73 (s, 1H), 
4.82 (s, 1H), 4.48 (s, 1H), 3.94(s, 3H), 3.93 (s, 3H), 3.66 (s, 2H), 1.77 (s, 3H); 
13
C NMR 
(150 MHz, CDCl3): δ 152.8, 147.3, 143.6, 141.5, 129.7, 113.5, 111.9, 108.1, 56.29, 
56.28, 40.9, 22.9; IR (neat): υmax 1649, 1580, 1521, 1329, 1269, 1063, 883 cm
-1
; HRMS 
(EI, m/z) calcd. for C12H15NO4 [M]
+
: 237.1001; found: 237.1004. 
1,2,3-Trimethoxy-5-(2-methylallyl)-4-nitrobenzene, 14o, Scheme 9. Column 
chromatography (SiO2, eluting with 97:3 pentane/acetone) afforded the desired product 
as a yellow oil (41 mg, 52%).
 1
H NMR (600 MHz, CDCl3): δ 6.52 (s, 1H), 4.87 (s, 1H), 
4.71 (s, 1H), 3.97 (s, 3H), 3.92 (s, 3H), 3.88 (s, 3H), 3.28 (s, 2H), 1.69 (s, 3H); 
13
C NMR 
(150 MHz, CDCl3): δ 154.7, 146.0, 142.4, 140.8, 140.2, 127.4, 113.5, 107.8, 62.3, 61.1, 
56.2, 39.4, 22.1; IR (neat): υmax 2941, 1650, 1577, 1529, 1116, 1027, 800 cm
-1
;
  
HRMS 
(EI, m/z) calcd. for C13H17NO5 [M]
+
: 267.1107; found: 267.1085. 
Methyl 2-(2-nitrobenzyl)acrylate, 14p, Scheme 9.
29
 Column chromatography (SiO2, 
eluting with 9:1 pentane/diethyl ether) afforded the desired product as a yellow oil (48 
mg, 73%).
 1
H NMR (600 MHz, CDCl3): δ 7.94 (dd, J1 = 8.4 Hz, J2 = 1.2 Hz, 1H), 7.54 
(dt, J1 = 7.8 Hz, J2 = 1.2 Hz , 1H), 7.36-7.41 (m, 2H), 6.27 (s, 1H), 5.40 (s, 1H), 3.96 (s, 
2H), 3.74 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 166.8, 149.4, 138.0, 133.5, 133.0, 
132.4, 127.7, 127.0, 124.9, 52.1, 34.8. 
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Methyl 2-(4-methoxy-2-nitrobenzyl)acrylate, 14q, Scheme 9. Column chromatography 
(SiO2, eluting with 97:3 pentane/acetone) afforded the desired product as a yellow oil (57 
mg, 75%). 
1
H NMR (600 MHz, CDCl3): δ 7.46 (d, J = 3 Hz, 1H), 7.25 (d, J = 8.4 Hz, 
1H), 7.09 (dd, J1 = 8.4 Hz, J2 = 2.4 Hz, 1H), 6.23 (d, J = 0.6 Hz, 1H), 5.37 (d, J = 1.2 Hz, 
1H), 3.90 (s, 2H), 3.85 (s, 3H), 3.73 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 166.9, 
158.6, 149.7, 138.4, 133.3, 126.5, 125.3, 119.7, 109.4, 55.8, 52.0, 34.2; IR (neat): υmax 
2952, 1720, 1623, 1529, 1137, 815 cm
-1
; HRMS (EI, m/z) calcd. for C12H13NO5 [M + 
Na]
+
: 251.0794; found: 251.0793. 
1-((E)-3-(4-Methoxy-2-nitrophenyl)prop-1-enyl)benzene, 14r, Scheme 9. Column 
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the desired 
product as a yellow oil (70 mg, 87%).
 1
H NMR (600 MHz, CDCl3): δ 7.47 (d, J = 3 Hz, 
1H), 7.35-7.31 (m, 3H), 7.30-7.28 (m, 2H), 7.21 (t, J = 7.2 Hz, 1H), 7.10 (dd, J1 = 8.4 Hz, 
J2 = 3 Hz, 1H), 6.45 (d, J = 15.6 Hz, 1H), 6.31-6.36 (m, 1H), 3.86 (s, 3H), 3.77 (dd, J1 = 
7.2 Hz, J2 = 0.6 Hz, 2H); 
13
C NMR (150 MHz, CDCl3): δ 158.4, 149.5, 137.1, 132.8, 
131.9, 128.5, 127.3, 127.2, 127.1, 126.2, 120.0, 109.2, 55.8, 35.6; IR (neat): υmax 2977, 
1636, 1577, 1532, 1323, 744, 805 cm
-1
; HRMS (ESI, m/z) calcd. for C16H15NO3Na [M + 
Na]
+
: 292.0950; found: 292.0931. 
1-((E)-3-(2-Nitrophenyl)prop-1-enyl)benzene, 14s, Scheme 9. Column 
chromatography (SiO2, eluting with 99:1 hexane/ethyl acetate) afforded the desired 
product as a yellow oil (62 mg, 86%).
 1
H NMR (600 MHz, CDCl3): δ 7.95 (dd, J1 = 8.4 
Hz, J2 = 1.2 Hz, 1H), 7.55 (dt, J1 = 7.2 Hz, J2 = 1.2 Hz, 1H), 7.44 (dd, J1 = 7.8 Hz, J2 = 
1.2 Hz, 1H), 7.39 (dt, J1 = 8.4 Hz, J2 = 1.2 Hz, 1H), 7.35-7.36 (m, 2H), 7.28-7.31 (m, 
2H), 7.22 (tt, J1 = 7.2 Hz, J2 = 1.2 Hz, 1H), 6.49 (d, J = 15.6 Hz, 1H), 6.33-6.38 (m, 1H), 
3.84 (dd, J1 = 6.6 Hz, J2 = 1.2 Hz, 2H); 
13
C NMR (150 MHz, CDCl3): δ 149.2, 137.0, 
135.2, 133.1, 132.4, 131.9, 128.5, 127.4, 127.3, 126.7, 126.2, 124.8, 36.2; IR (neat): υmax 
1724, 1604, 1525, 1344, 970, 738 cm
-1
; HRMS (EI, m/z) calcd. for C15H13NO2 [M]
+
: 
239.0946; found: 239.0948. 
1-((E)-3-(3-Methyl-2-nitrophenyl)prop-1-enyl)benzene, 14t, Scheme 9. Column 
chromatography (SiO2, eluting with 99:1 hexane/ethyl acetate) afforded the desired 
product as a yellow oil (45 mg, 60%). 
1
H NMR (600 MHz, CDCl3): δ 7.34-7.36 (m, 2H), 
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7.28-7.33 (m, 3H), 7.20-7.23 (m, 2H), 7.17 (d, J = 7.8 Hz, 1H), 6.46 (d, J = 15.6 Hz, 1H), 
6.23-6.28 (m, 1H), 3.51 (dd, J1 = 7.2 Hz, J2 = 1.2 Hz, 2H), 2.34 (s, 3H); 
13
C NMR (150 
MHz, CDCl3): δ 151.5, 136.9, 132.4, 131.6, 130.2, 129.7, 129.4, 128.5, 128.2, 127.4, 
126.4, 126.2, 34.7, 17.4; IR (neat): υmax 1577, 1525, 1368, 966, 851 cm
-1
; HRMS (EI, 
m/z) calcd. for C16H15NO2 [M]
+
: 253.1103; found: 253.1101. 
1-((E)-3-(3,4,5-Trimethoxy-2-nitrophenyl)prop-1-enyl)benzene, 14u, Scheme 9. 
Column chromatography (SiO2, eluting with 97:3 hexane/acetone) afforded the desired 
product as a yellow oil (49 mg, 50%).
 1
H NMR (500 MHz, CDCl3): δ 7.35-7.41 (m, 2H), 
7.29-7.32 (m, 2H), 7.21-7.24 (m, 1H), 6.56 (s, 1H), 6.48 (d, J = 15.5 Hz, 1H), 6.21-6.27 
(m, 1H), 3.98 (s, 3H), 3.88 (s, 6H), 3.48 (d, J = 6.5 Hz, 2H); 
13
C NMR (125 MHz, 
CDCl3):δ 155.1, 146.3, 141.1, 140.0, 137.0, 132.7, 128.9, 128.7, 128.3, 127.7, 126.4, 
126.3, 107.9, 62.4, 61.2, 56.4, 35.0; IR(neat): υmax 2941, 1579, 1529, 1365, 1116, 754 cm
-
1 
; HRMS (EI, m/z) calcd. for C18H19NO5 [M]
+
: 329.1263; found: 329.1263.  
 1-Methoxy-4-((E)-3-(4-methoxy-2-nitrophenyl)prop-1-enyl)benzene, 14v, Scheme 9. 
Column chromatography (SiO2, eluting with 97:3 hexane/acetone) afforded the desired 
product as a yellow oil (79 mg, 88%).
 1
H NMR (600MHz, CDCl3): δ 7.46 (d, J = 2.4 Hz, 
1H), 7.32 (d, J = 8.4 Hz, 1H), 7.28 (d, J = 8.4 Hz, 2H), 7.09 (dd, J1 = 8.4 Hz, J2 = 2.4 Hz, 
1H), 6.83 (d, J = 9 Hz, 2H), 6.39 (d, J = 16.2 Hz, 1H), 6.17-6.21 (m, 1H), 3.86 (s, 3H), 
3.80 (s, 3H), 3.74 (d, J = 6.6 Hz, 2H); 
13
C NMR (150 MHz, CDCl3): δ 159.0, 158.4, 
149.4, 132.8, 131.3, 129.9, 127.4, 127.3, 124.9, 119.9, 113.9, 109.2, 55.8, 55.3, 35.6; IR 
(neat): υmax 2970, 1606, 1510, 1251, 1029, 842 cm
-1
; HRMS (ESI, m/z) calcd. for 
C17H17NO4Na [M + Na]
+
: 322.1055; found: 322.1108. 
1-Methoxy-4-((E)-3-(4,5-dimethoxy-2-nitrophenyl)prop-1-enyl)benzene, 14w, 
Scheme 9. Column chromatography (SiO2, eluting with 97:3 hexane/acetone) afforded 
the desired product as a yellow oil (84 mg, 85%).
 1
H NMR (600 MHz, CDCl3): δ 7.63 (s, 
1H), 7.28 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 6.79 (s, 1H), 6.42 (d, J = 16.2 Hz, 
1H), 6.20-6.24 (m, 1H), 3.94 (s, 3H), 3.93 (s, 3H), 3.84 (d, J = 6.6 Hz, 2H), 3.79 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 159.0, 153.1, 147.3, 141.0, 131.3, 130.8, 129.9, 127.3, 
124.8, 113.9, 113.1, 108.2, 56.33, 56.30, 55.26, 36.9; IR (neat): υmax 1606, 1579, 1519, 
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1328, 1267, 1054, 796 cm
-1
; HRMS (EI, m/z) calcd. for C18H19NO5 [M]
+
: 329.1263; 
found: 329.1264. 
2-Allylbenzofuran, 14x, Scheme 10.
30
 Column chromatography (SiO2, eluting with 
pentane) afforded the desired product as a colourless oil (26 mg, 53%).
 1
H NMR (600 
MHz, CDCl3): δ 7.48-7.50 (m, 1H), 7.42-7.43 (m, 1H), 7.17-7.23 (m, 2H), 6.43 (d, J = 
1.2 Hz, 1H), 5.99-6.06 (m, 1H), 5.24 (dq, J1 = 17.1 Hz, J2 = 1.8 Hz, 1H), 5.19 (dq, J1 = 
9.9 Hz, J2 = 1.2 Hz, 1H), 3.55 (dd, J1 = 6.6 Hz, J2 = 1.2 Hz, 2H); 
13
C NMR (150 MHz, 
CDCl3): δ 157.0, 154.8, 133.1, 128.8, 123.3, 122.5, 120.3, 117.6, 110.8, 102.6, 33.0. 
2-Cinnamylbenzofuran, 14y, Scheme 10.
31 
Column chromatography (SiO2, eluting with 
pentane) afforded the desired product as a colourless oil (42 mg, 60%). 
1
H NMR (600 
MHz, CDCl3): δ 7.49-7.51 (m, 1H), 7.43-7.44 (m, 1H), 7.39-7.40 (m, 2H), 7.31-7.33 (m, 
2H), 7.22-7.25 (m, 2H), 7.19 (dt, J1 = 7.8 Hz, J2 = 1.2 Hz, 1H), 6.58 (d, J = 16.2 Hz, 1H), 
6.48 (d, J = 0.6 Hz, 1H), 6.37-6.42 (m, 1H), 3.71 (d, J = 7.2 Hz, 2H); 
13
C NMR (150 
MHz, CDCl3): δ 157.1, 154.8, 137.0, 132.7, 128.8, 128.5, 127.4, 126.2, 124.6, 123.4, 
122.5, 120.4, 110.8, 102.7, 32.2; IR (neat): υmax 2925, 1600, 1454, 1253, 964, 750 cm
-1
; 
HRMS (EI, m/z) calcd. for C17H14O [M]
+
: 234.1045; found: 234.1048.
 
1,3-Diallyl-2-nitrobenzene, 17a, Scheme 15. Column chromatography (SiO2, eluting 
with pentane) afforded the desired product as a yellow oil (39 mg, 64%).
 1
H NMR (600 
MHz, CDCl3): δ 7.36 (t, J = 7.8 Hz, 1H), 7.19 (d, J = 7.8 Hz, 2H), 5.85-5.92 (m, 2H), 
5.08-5.13 (m, 4H), 3.36 (d, J = 6.6 Hz, 4H); 
13
C NMR (150 MHz, CDCl3): δ 151.1, 
134.7, 131.5, 130.3, 128.7, 117.4, 35.5; IR (neat): υmax  2923, 1639, 1529, 1369, 1218, 
921, 757 cm
-1
; HRMS (EI, m/z) calcd. for C12H13NO2 [M]
+
: 203.0946; found: 203.0940. 
Allyl 2-allyl-3-nitrobenzoate, 17b, Scheme 15. Column chromatography (SiO2, eluting 
with 95:5 pentane/diethyl ether) afforded the desired product as a yellow oil (39 mg, 
53%).
 1
H NMR (300 MHz, CDCl3): δ 8.00 (dd, J1 = 7.8 Hz, J2 = 0.9 Hz, 1H), 7.83 (dd, J1 
= 8.1 Hz, J2 = 0.9 Hz, 1H), 7.44 (t, J = 8.1 Hz, 1H), 5.86-6.09 (m, 2H), 5.31-5.45 (m, 
2H), 4.94-5.06 (m, 2H), 4.82 (d, J = 6 Hz, 2H), 3.90 (d, J = 6 Hz, 2H);
 13
C NMR (75 
MHz, CDCl3): δ 166.1, 151.8, 134.9, 133.9, 133.6, 133.4, 131.4, 127.1, 126.9, 119.3, 
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116.7, 66.4, 32.0; IR (KBr): υmax 1728, 1533, 1446, 1359, 1259, 1122, 921, 744 cm
-1
; 
HRMS (ESI, m/z) calcd. for C13H13NO4Na [M + Na]
+
: 270.0742; found: 270.0728. 
Experimental procedure for diene formation via β-hydride elimination of diallyl 
ester 15a. 
In a 10 mL two necked round bottom flask equipped with magnetic stir bar was added 
(Z)-But-2-ene-1,4-di-2-nitrobenzoate (116 mg, 0.30 mmol), silver carbonate (248 mg, 0.9 
mmol), dppp (24.8 mg, 0.06 mmol), and Pd2(dba)3 (27.4 mg, 0.03 mmol). 
Dimethylacetamide (DMA) 5 ml was added into it. The reaction mixture was then 
evacuated and refilled with nitrogen three times and it was heated at 110 
o
C under 
nitrogen atmosphere for 12 hours. After the consumption of the starting materials as 
indicated by TLC, the reaction mixture was cooled to room temperature, poured into 
water (25 mL) and extracted with diethyl ether (3 × 25 mL). The combined organic 
extract was dried (anh. Na2SO4) and evaporated under reduced pressure. The crude 
product was purified by column chromatography on silica gel using pentane eluent. The 
pure product was isolated as yellow solid in 43% yield (23 mg). 
1-((E)-Buta-1,3-dienyl)-2-nitrobenzene, 15b, Scheme 11.
32
 
1
H NMR (300 MHz, 
CDCl3): δ 7.91 (d, J = 8.1 Hz, 1H), 7.67 (d, J = 7.8 Hz, 1H), 7.56 (t, J = 7.5 Hz, 1H), 7.37 
(t, J = 7.2 Hz, 1H), 7.05 (d, J = 15.6 Hz, 1H), 6.78 (dd, J1 = 15.3 Hz, J2 = 10.5 Hz, 1H), 
6.50-6.63 (m, 1H), 5.44 (d, J = 16.8 Hz, 1H), 5.32 (d, J = 9.6 Hz, 1H); 
13
C NMR (75 
MHz, CDCl3) δ 148.05, 136.7, 134.6, 132.8, 132.6, 127.94, 127.9, 127.2, 124.7, 120.3. 
General experimental procedure for reduction of allyl nitro compounds.
33 
Sodium borohydride (40 mg, 1 mmol) was added to a stirring solution of ferrous 
sulphatehepta-hydrate [FeSO4, 7H2O] (167 mg, 0.6 mmol) and citric acid (11mg, 0.05 
mmol) in water (20 mL) and vigorous stirring was continued for 3-4 minutes. When the 
solution settled down the water layer was decanted. The residual black solid material of 
Fe nanoparticles was further washed with water two times to be ready for use in nitro 
reduction. The 1-allyl-2-nitrobenzene compound (0.2 mmol) was added to these Fe 
nanoparticles in water (3 mL) in the same pot under constant stirring at room temperature 
under argon. After completion of reaction (TLC) the mixture was extracted with diethyl 
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ether (3 x 10 mL) (all Fe-species remained around stirring bar). Evaporation of solvent 
and purification by column chromatography (SiO2, eluting with 94:6 pentane/diethyl 
ether) afforded the desired product as a yellow oil, (23 mg, 86%). 
2-Allylbenzenamine, 18a.
34 1
H NMR (300 MHz, CDCl3): δ 7.04-7.13 (m, 2H), 6.75 (t, J 
= 7.2 Hz, 1H), 6.68 (d, J = 7.8 Hz, 1H), 5.89-6.02 (m, 1H), 5.07-5.14 (m, 2H), 3.68 (br s, 
2H), 3.31 (d, J = 6.3 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 144.8, 135.9, 130.2, 127.5, 
124.0, 118.9, 116.1, 115.8, 36.5. 
 
II. 9. 
1
H and 
13
C Spectra 
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CHAPTER III 
 
Substrate-Dependent Mechanistic Divergence in Decarboxylative Heck 
Reaction at Room Temperature 
 
 
 
Abstract: We report herein, a Pd(II)-catalyzed Heck-type coupling between arene 
carboxylic acids and alkenes at room temperature. Mechanistically, the reaction proceeds 
in two distinct pathways where electron-rich substrates undergo a palladium(II)-catalyzed 
decarboxylation and electron-deficient substrates proceed through silver(I)-assisted 
decarboxylation. Dimethylsulfoxide (DMSO) or sulfide ligands have positive and 
negative roles in the reaction outcome respectively. The present protocol is combined for 
the peptide modification under physiological conditions. 
 
1. Hossian, A.; Bhunia, S. K.; Jana, R. J. Org. Chem. 2016, 81, 2521-2533. 
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Substrate-Dependent Mechanistic Divergence in Decarboxylative Heck        
Reaction at Room Temperature 
III. 1. Introduction 
The Heck reaction is one of the most attractive tools for the construction of C-C bonds 
between olefins and arenes.
1
 It is widely used in small molecule synthesis, natural 
product synthesis, polymers, material science and also in bioorganic chemistry in both the 
laboratory and industrial scale (Figure 1).
2
 Mizoroki
1g
 and Heck
1f
 first independently 
developed the palladium-catalyzed arylation of an alkene with an aryl electrophiles, today 
known as the classic Mizoroki-Heck reaction. Over the past decades, a variety of aryl 
halides,
3
 aryl triflates,
4
 aryl diazonium salts,
5
 aryl phosphates,
6
 and also arylsulfonyl 
halides,
7
 have been used as an aryl electrophiles in the Mizoroki-Heck reactions. 
Significant advances for the development of new catalytic methods and mechanistic 
insight have also been well-studied in the traditional Heck reactions.
8 
But still several 
drawbacks are there in the clasical Mizoroki-Heck reactions. From the environmental 
standpoint, the reaction producces stoichiometric amount of halide waste from the 
corresponding aryl halides and availability of the halogenated arene substrates is also 
limited and expensive. Moreover, some of the organometallic species are unstable, air 
and moisture sensitive thus limits their practical applicability. Alternatively, arenes 
carboxylates are low-cost, commercially available, air and moisture stable have been 
successfully accomplished in the Heck type reactions introducing a novel decarboxylative 
cross-coupling strategy (Scheme 1). 
 
Scheme 1. Mizoroki-Heck reaction 
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Figure 1. Representative example of some important stilbenes 
III. 2. Review 
In a seminal report in 2002, Myers and coworkers disclosed an efficient method for 
palladium-catalyzed decarboxylative Heck-type olefination of arenecarboxylic acids with 
styrene and α,β-unsaturated carbonyl compounds (Scheme 2).9 In the reaction, they used 
a catalytic amount of Pd(TFA)2 in 5% DMSO-DMF solvent and a stoichiometric amount 
of Ag2CO3 as a base as well as an oxidant for catalytic turnover. Based on NMR studies 
and X-ray crystallographic analysis,
10
 they have proposed the reaction pathways, initially 
carboxyl exchange between palladium(II) bis(trifluoroacetate) and an arene carboxylate 
substrates, then rate-determining palladium mediated decarboxylation to genertaes an 
arylpalladium(II) trifluoroacetate intermediate II where two DMSO molecules were 
bound to the intermediate in trans fashion through S-binding site. Here DMSO acts as a 
ligands on palladium and renders stability to the intermediates. Then the 
arylpalladium(II) trifluoroacetate intermediate undergoes migratory alkene insertion and 
finally  β-hydride elimination afforded the desired olefin product. From the study they 
have observed that the reactivity differences between arylpalladium(II) species generated 
by decarboxylative palladation and the same phosphine ligated palladium(II) intermediate 
produced in conventional Heck reactions. Specifically, they have found that more 
electron-rich alkenes react preferentially with an arylpalladium(II) trifluoroacetate 
intermediate generates by decarboxylative palladation, whereas an opposite trend was 
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found in conventional Heck reactions. In addition, they have found that the 
aralkylpalladium(II) trifluoroacetate intermediate which is formed upon olefin insertion is 
stable as compared to the corresponding phosphineligated aralkylpalladium(II) 
complexes in traditional Heck reactions. They have also crystallographically 
characterized an aralkylpalladium(II) trifluoroacetate intermediate derived from 
arylpalladium(II) insertion into norbornene and in the structure they have observed that 
still one S-bound dimethyl sulfoxide ligand and one trifluoroacetate group is bound with 
the palladium in the distorted square-planar palladium(II) intermediate and subsequent β-
hydride elimination afforded the desired product. The Myers‘s experimental results in 
decarboxylative Heck reaction was further cross validated by the Liu group through 
theoritical calculations.
11 
 
Scheme 2. Palladium-catalyzed decarboxylative Heck reaction 
Although, the Myers work represents a breakthrough development for the 
palladium catalyzed decarboxylative cross-coupling reactions, still several limitations 
there were for practical application such as higher catalyst loading, requirement of super 
stoichiometric toxic silver salt and high reaction temperature. Also, they have showed 
limited scope with respect to olefinic substrates in the reaction. In this vein, the Su group 
have developed an efficient methodology for the decarboxylative Heck coupling of 
arenecarboxylic acids with a wide range of alkene substrates including unactivated 
terminal alkenes (Scheme 3).
12
 In the reaction, they have employed 1-
adamantanecarboxylic acid as an additive and inexpensive 1,4-benzoquinone (BQ) as an 
oxidant on palladium for catalytic tournover which is alternative to stoichimetric toxic 
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silver carbonate in the Myers method. However, the major limitation of the Su method is 
that  only highly electron rich arene carboxylic acids underwent the reaction.  
 
Scheme 3. Palladium-catalyzed decarboxylative Heck coupling with simple alkenes 
In 2010, the Su group has developed a new Pd-catalytic system for the 
decarboxylative Heck coupling of various arene carboxylic acids with a wide range of 
olefins by using dioxygen as an oxidant for catalytic cycle (Scheme 4).
13
 They found that 
for electron-rich aromatic carboxylic acids only Pd(OAc)2 catalyst is sufficient for this 
transformation under oxygen atmosphere. But electron-deficient benzoic acids afforded 
low yield of the desired product under the similar conditions. This is presumably due to 
the poor reactivity of the Pd(II) catalyst toward decarboxylation of electron-deficient 
benzoic acids. The previous studies by Goossen, Larrosa, and Su, they have established 
that silver salts is effective for the decarboxylation of electron-deficient benzoic acids.
14
 
The difference in the reactivity between Ag(I) and Pd(II) towards decarboxylation of 
aromatic carboxylic acids may be due the fact that Ag(I) is more electron-rich than Pd(II) 
and Ag(I) is responsible for the decarboxylation of electron deficient benzoic acids. 
Therefore, they have used electron-donating ligand such as N-heterocyclic carbene on 
palladium catalyst and interestingly the yield of the reaction was improved. Finally, they 
have found Pd(OAc)2/SIPr (SIPr = 1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazol-
2-ylidene) catalytic combination is effective for this transformation for electron deficient 
arene carboxylic acids under dioxygen pressure providing moderate to good yields 
(Scheme 4). 
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Scheme 4. Decarboxylative Heck coupling with dioxygen as the terminal oxidant 
 
Scheme 5. Selective β-hydride elimination in the decarboxylative Heck coupling 
In 2013, another interesting example of oxidative decarboxylative Heck type 
reaction was reported by the Jiang group.
15 
They have developed a simple and efficient 
protocol for the palladium-catalyzed decarboxylative Heck type reaction of arene 
carboxylic acids with wide range of allylic alcohols to make β-aryl ketones and aldehydes 
  Chapter III  
105 
 
through selective β-hydrogen elimination (Scheme 5). To understand the reaction 
mechanism, they have performed several control experiments and proposed the reaction 
mechanism in scheme 5. First aryl-palladium intermediate I is generated through the 
palladium-mediated decarboxylation. Then the aryl-palladium intermediate I undergoes 
insertion reaction into the allylic alcohol to produce intermediate II and through the 
selective β-H elimination generated intermediate III from the intermediate II. The critical 
intermediate IV is formed via Pd-H insertion similar to the oxidative Wacker process. 
Finally, the desired products is obtained through β-H elimination of R-OH group or the 
anion-assisted reductive elimination from the intermediate IV and regenerated the 
palladium(II) active catalyst via the oxidation of Ag2CO3. 
Very recently, another very interesting example of decarboxylative Heck-type 
reaction was reported by the Li group (Scheme 6).
16
 They have developed a system for 
controlling the Z/E selectivity in the palladium catalyzed decarboxylative Heck type 
arylation reaction of trans-cinnamaldehydes by switching the reaction solvent. They 
found exclusive Z-isomer formation in good yield and stereoselectivity in THF, whereas 
the reaction afforded kinetically control E-isomer in DMF. Based on experimental and 
theoretical study they have explained the Z/E selectivity switch in the reaction. When 
DMF solvent was used in the reaction, the reaction proceed through the standard Heck 
type addition-elimination process providing the E-isomer. Whereas in THF solvent the 
reaction proceed via tautomerization of Pd(II)enolate and leads to the formation of 
thermodynamically more stable Z-isomer. 
 
Scheme 6. Z/E selectivity in the palladium-catalyzed decarboxylative Heck type reaction 
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III. 3. Present work 
The decarboxylative cross-coupling of arene carboxylic acids with olefins provides an 
attractive approach for the alkene functionalization.
17
 However, one of the major pitfalls 
in the decarboxylative cross-coupling is the requirement of high reaction temperature 
(120-190 
o
C) which restricts its application in the synthesis of complex molecular 
frameworks. Owing to the prevalence of stilbenes in numerous natural product, bioactive 
molecules and high tech materials,
18
 we were particularly interested to the development 
of decarboxylative Heck-type coupling at room temperature. 
            Although, palladium-catalyzed decarboxylative coupling of nitroalkanes19 and α-
ketocarboxylic acids20 at room temperature is known, there is no report of 
decarboxylative cross-coupling of arene carboxylates at room temperature. We report 
here for the first time a palladium-catalyzed decarboxylative Heck-type coupling at room 
temperature (Scheme 7). We also report the substrate-dependent mechanistic variation 
and distinct role of dimethylsulfoxide/sulfide ligands in the present transformation. 
 
Scheme 7. Decarboxylative Heck-arylation with olefins at room temperature 
III. 4. Results and discussion 
From literature it was evident that o,o’-disubstitution facilitates carbon dioxide 
extrusion.
15,21
 In addition, from our previous experience with the decarboxylative 
allylation of ortho- nitrobenzoic acids, we realized that the incipient anion which is 
generated after decarboxylation needs to be stabilized for further cross-couplings.
22
 Thus 
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we rationalized that either 2,6- dimethoxy benzoic acid or pentafluorobenzoic acid could 
be model substrates to study room temperature decarboxylative cross-coupling which will 
be a major advancement in this field.  
Initially, we started screening for decarboxylative Heck reaction between 2,6-
dimethoxybenzoic acid and styrene under the Myers’s original conditions. But a trace 
amount of corresponding Heck product was isolated at room temperature. However, a 
good yield of the coupling product was isolated after 36 h stirring. In search for 
alternative oxidants to stoichiometric silver carbonate, 1,4-benzoquinone (BQ) was found 
to be suitable.
12
 Finally, an excellent yield of the stilbene product was obtained after 
stirring the reaction mixture for 36 hours at room temperature with 10 mol % palladium 
catalyst loading and 2.0 equiv of 1,4-benzoquinone. 
Being encouraged, several alkene partners were examined. A wide variety of 
styrenes having electron-withdrawing and electron-donating substituents underwent 
decarboxylative coupling providing high to excellent yields (Scheme 8). Fluoro-, chloro-, 
bromo-, (14c-14e, 14ae, Scheme 8) and remarkably acetoxy- (14g, 14af, Scheme 8) 
groups were intact under the reaction conditions demonstrating the mild nature of this 
present protocol. Besides styrenes, activated alkenes such as acrylonitrile, (14n, Scheme 
8) acrylates (14o-14r, 14ag, Scheme 8) also provided the corresponding cross-coupling 
products. Interestingly, unactivated allylbenzenes (14s-14u, Scheme 8), allyl acetate 
(14v, Scheme 8), allyl malonate (14x, 14ah, Scheme 8), and unactivated terminal alkene 
(14y, Scheme 8) also afforded the corresponding coupling products in good to moderate 
yields and good styrenyl selective products under slightly higher catalyst loading. The 
Heck coupling with an allyl alcohol (14w, Scheme 8) provided the corresponding ketone 
product via selective β-hydride elimination in moderate yield.6b Remarkably, 1,4-
divinylbenzene provided the double cross-coupling product in one stroke (14m, Scheme 
8). 2,6-Diethoxy- (14z, Scheme 8) and 2,6-dibenzyloxy (14aa, Scheme 8) benzoic acid 
also provided the corresponding coupling products in excellent yields. However, benzoic 
acid, mesitylenecarboxylic acid, 2-methoxy benzoic acid, and heteroaryl carboxylic acids 
such as pyridine-2-carboxylic acid, and benzofuran-2-carboxylic acid did not furnish any 
desired product. It was found that o,o-dialkoxy substitution is essential for  
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Scheme 8. Substrate scope with electron-rich carboxylic acids 
Note: 
a
The reaction was carried out in 0.2 mmol scale, 0.06 M. 
b
Yield refer to here is the 
average of at least two experiments. 
c
Unless otherwise stated E/Z ratio of the Heck 
products are >20:1 as determined by 
1
H NMR. 
d
20 mol % Pd(TFA)2 and 3.0 equiv BQ 
were used. 
e
Reaction time 48 h.  
decarboxylative coupling at room temperature presumably due to coordination between 
oxygen and aryl-palladium species.   
Next we turned our attention to the pentafluoroarenes as they exhibit distinct 
chemical and physical properties to their hydrocarbon counterpart.
23
 Also an increasing 
use of perfluorinated compounds in material science, biomedical and bioanalytical 
research, defense, refrigeration, and domestic appliances has been observed.
24
 Therefore, 
introduction of perfluorinated moiety into the organic backbone has become a fascinating 
field of research in the last years.
25
 However, the metal-catalyzed cross-coupling reaction 
with this highly electron-deficient arenes poses a great challenge, due to poor 
coordination with the metal center and reluctance to undergo cross-coupling. A seminal 
work of palladium-catalyzed Heck coupling between pentafluorohalobenzene (X = I, Br) 
and styrenes was reported by the Espinet and Milstein groups.
26
 Recently, an oxidative 
Heck coupling between pentafluorobenzene and styrenes were reported by the Zhang 
group,
27a
 and a decarboxylative allylation of pentafluorobenzoates was reported by the 
Gooβen group at 120 oC and 110 oC respectively.27b Direct oxidative cross-coupling with 
perfluoroarenes also an emerging field of research.
28
  
To examine decarboxylative Heck coupling with electron-deficient substrates, 
pentafluorobenzoic acid was employed under the optimized reaction conditions but no 
product was formed. Since Pd
II
/Ag
I
 combination is essential for the decarboxylative 
coupling of electron-deficient substrates,
29
 benzoquinone was replaced by silver 
carbonate. Still no Heck product was isolated. Surprisingly, the reaction in pure DMF 
only provided the Heck product at room temperature. This is in sharp contrast to the 
earlier reports where addition of 5% dimethylsulphoxide (DMSO) in dimethylformamide 
(DMF) was found to improve the yield at elevated temperature. Finally, the desired 
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Heck-products were obtained with 10 mol % Pd(tfa)2 and 2.0 equiv of Ag2CO3 in good 
yields after 16 h stirring at room temperature. 
 
Scheme 9. Substrate scope with perfluorobenzoic acids
 
Note: 
a
The reaction was carried out in 0.2 mmol scale, 0.06 M. 
b
Yield refer to here is the 
average of at least two experiments. 
c
E/Z ratio of the Heck products are >20:1 as 
determined by 
1
H NMR. 
d
120 
o
C was used. 
e
20 mol % Pd(TFA)2, 3.0 equiv Ag2CO3 and 
5% DMSO-DMF were used, reaction time 4 h. 
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With this optimized reaction conditions we explored the substrate scope. A wide 
variety of substituted styrenes provided the Heck product in high yields. Besides alkyl 
substituents, halogens (17b-17d, 17k-17m, Scheme 9), labile acetoxy (17i, 17t, Scheme 
9) and tert-butyldimethylsilyoxy (17j, Scheme 9) groups were compatible under these 
mild reaction conditions. The reaction was also reproduced in gram scale in comparable 
yield. However, 2,3,4,5-tetrafluoro and 2,6-difluoro benzoic acids provided the coupling 
product at 120 
o
C (17u, 17v, Scheme 9). Interestingly, the reaction with allylbenzene at 
120 
o
C provided the corresponding allylation product in high yield and selectivity (17w, 
Scheme 9). Activated alkenes such as methyl acrylate afforded only a trace amount of 
Heck product under the same reaction conditions. 
III. 5. Reaction mechanism 
In their report, the Myers group applied a general reaction conditions for electron-rich 
and electron-deficient carboxylic acids. In addition, experimental and theoretical 
mechanistic investigation was performed exclusively based on the electron-rich 
substrates.
10,11
 In their study with catalytic and stoichiometric 
palladium(II)trifluoroacetate, it was observed that decarboxylation occurs by palladium 
salt where silver salt acts as an oxidant for catalytic turnover.
16b
 However, the mechanism 
for electron-deficient substrate was illusive. In this present study, we have also observed 
that electron-rich 2,6-dimethoxybenzoic acid undergoes decarboxylative Heck reaction 
by a catalytic amount of palladium(II) bistrifluoroacetate where silver(I) carbonate was 
replaced by benzoquinone for practical applications. A stoichiometric palladium salt also 
reproduced the same result in the absence of benzoquinone (Scheme 10a). Additionally, a 
control experiment suggests that even a super stoichiometric amount of silver(I) 
carbonate (2.0 equiv) did not furnish decarboxylation of the 2,6-dimethoxybenzoic acid 
in the absence of palladium at room temperature (Scheme 10b). However, exclusive 
decarboxylative protonation product was observed by the Larrosa group with 10 mol % 
Silver(I) carbonate at 120 
o
C.
30
 In sharp contrast, in the absence of silver salt the reaction 
with electron-deficient pentafluorobenzoic acid did not proceed even with stoichiometric 
amount of palladium(II) bistrifluoroacetate (Scheme 10c). However, either stoichiometric 
(2.0 equiv) or a catalytic amount (20 mol %) of silver(I) carbonate resulted in 
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decarboxylative protonation product exclusively (Scheme 10d). Additionally, a catalytic 
amount of silver(I) carbonate (20 mol %), palladium(II) bistrifluoroacetate (10 mol %), 
and benzoquinone (2.0 equiv) afforded the corresponding Heck product from the 
pentafluorobenzoic acid and styrene albeit in low yield (35%) (Scheme 10e). Therefore, 
electron-deficient substrates may follow a distinct pathway for the decarboxylative Heck 
reaction from electron-rich substrates at room temperature. A similar observation was 
also observed by the Su group where 2,4-dimethoxybenzoic acid underwent 
decarboxylative protonation with stoichiometric palladium(II)trifluoroacetate at 80 
o
C but 
2-nitrobenzoic acid was unreactive. On the other hand, electron-deficient 2-nitrobenzoic 
acid afforded decarboxylative protonation exclusively with super stoichiometric amount  
 
Scheme 10. Control experiments 
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of silver(I) carbonate (3.0 equiv) only. Ultimately, a Pd/Ag bimetallic system was applied 
for the C-3 selective arylation of indoles with electron-deficient nitrobenzoic acids.29,31          
 Interestingly, in the earlier reports dimethylsulfoxide (DMSO) or other sulfide 
ligands exhibited a prominent role in decarboxylative, direct alkenylation or allylic C-H 
activations where addition of 5% DMSO as a cosolvent was found to improve yields and 
catalytic efficiency.9,10,11,32 From NMR and crystal structure studies, the Myers group has 
also shown that DMSO acts as a ligand on the aryl-palladium species in decarboxylative 
Heck-type coupling.10 In sharp contrast, for the first time we have observed that DMSO 
or sulfide ligand exhibit a negative role in the decarboxylative alkenylation reaction 
between pentafluorobenzoic acid and styrene at room temperature. A careful study 
revealed that the yield of the alkenylation product was decreased successively with the 
increase of DMSO (Figure 2) with respect to the pentafluorobenzoic acid. In lieu of pure 
DMF (Scheme 10d), 5% DMSO-DMF also furnished the decarboxylative protonation 
product exclusively suggesting that DMSO has no role in siver-mediated 
decarboxylation. Therefore, DMSO may act as a ligand on the palladium and influence 
negatively for the subsequent cross-coupling processes with electron-deficient carboxylic 
acids. The same trend was also observed with phenyl methyl sulfide. Although, the exact 
reason for this negative effect of DMSO is not clear at this moment but this room 
temperature decarboxylation will leads to the development of new cross-coupling  
 
 
 
 
 
 
Figure 2. Negative role of sulfoxide or sulfide ligand in the heck reaction between 
pentafluorobenzoic acid and styrene at room temperature 
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reactions under mild conditions. 
          Based on earlier reports and the present study it is speculated that depending of the 
electronic nature of the carboxylic acids a mechanistic divergence is observed in the 
decarboxylative Heck coupling reaction. The electron-rich substrates may follow a 
palladium-catalyzed decarboxylation where dimethylsulfoxide acts as a ligand and 
benzoquinone plays as an oxidant for catalytic turnover as shown in path a, Scheme 11.27 
Whereas, pentafluorobenzoic acid may undergo a silver-assisted decarboxylation which 
forms a aryl-palladium species after transmetalation as depicted in path b, Scheme 11. 
Subsequently, the aryl-palladium species undergoes migratory alkene insertion and β-
hydride elimination to provide the Heck product and palladium(0). Finally, the 
palladium(0) is oxidized either by silver(I) salt or benzoquinone in path a and path b 
respectively to complete the catalytic cycle.   
 
Scheme 11. Plausible mechanism 
III. 6. Product derivatization 
Next we turned our attention to utilize the decarboxylative Heck product for further 
useful transformations. Under basic conditions, the pentafluoroarene moiety, 17a 
undergoes an activated aromatic nucleophilic substitution (SNAr) with indole selectively 
at the para-position to afford (21a, Scheme 12). The remaining fluorenes are further 
substituted by excess pyrazoles to provide (23a, Scheme 12).
33
 Development of novel 
synthetic methods for the postsynthetic modification of peptide is an attractive research 
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field.
34
 In this vein, we have applied the decarboxylative Heck product for the arylation 
with cysteine. To demonstrate with the sulfur nucleophiles, the Heck product 17a was 
reacted with benzyl mercaptan to afford (25a, Scheme 12) in excellent yield. Similarly, it 
also underwent activated aromatic nucleophilic substitution (SNAr) with the protected 
cysteine selectively at the para-position to provide (27a, Scheme 12). 
 
Scheme 12. Product derivatization 
III. 7. Conclusion 
In conclusion, we have developed a decarboxylative Heck-type coupling between arene 
carboxylic acids and alkenes at room temperature. A substrate-dependent mechanistic 
divergence was observed where electron-rich arene carboxylic acids undergo palladium-
catalyzed decarboxylation and electron-deficient arene carboxylic acids undergo silver-
assisted decarboxylation.  Similarly, dimethylsulfoxide or other sulfide ligands exhibit 
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positive and negative roles respectively in the present transformation.  The 
pentafluoroarene moiety obtained from the cross-coupling was further derivatized via 
activated aromatic nucleophilic substitution (SNAr) with nitrogen and sulfur 
nucleophiles. Therefore, this room temperature reaction sequence is useful for peptide 
modification under mild reaction conditions. 
III.8. Experiment section 
General experimental procedure for the decarboxylative Heck reaction between 
electron-rich carboxylic acids and alkenes 
To an oven-dried 15 mL sealed tube, a mixture of carboxylic acids (0.20 mmol, 1.0 
equiv), palladium (II)trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv) and 1,4-
benzoquinone (43 mg, 0.4 mmol, 2.0 equiv) was taken. Then dry DMF (3.0 mL) and 
DMSO (0.15 mL) were added to it. After purging the reaction vessel with nitrogen, the 
corresponding alkene (0.30 mmol, 1.5 equiv) was added to the reaction mixture via 
microliter syringe and the vessel was sealed with a screw cap. The reaction mixture was 
allowed to stir for 36 h at room temperature. After completion (as detected by TLC), the 
reaction mixture was poured into water (20 mL) and extracted with ethyl acetate (30 mL). 
The organic layer was washed with aqueous NaOH solution (2N, 10 mL), water (10 mL), 
and brine solution (10 mL), dried over anhydrous Na2SO4 and the solvent was evaporated 
under reduced pressure. The crude product was purified by column chromatography 
using ethyl acetate/hexane as eluent to afford the desired product. 
1-(2,6-Dimethoxystyryl)benzene, 14a, Scheme 8.
35
 The same general procedure was 
followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), styrene 
(35 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column chromatography 
(SiO2, eluting with 96:4 hexane/ethyl acetate) afforded the desired product as a colourless 
oil (45 mg, 94%). 
1
H NMR (300 MHz, CDCl3): δ 7.61 (d, J = 6.8 Hz, 1H), 7.57 (d, J = 
7.8 Hz, 2H), 7.49 (d, J = 16.5 Hz, 1H), 7.37 (t, J = 7.2 Hz, 2H), 7.24 (t, J = 7.5 Hz, 1H), 
7.19 (t, J = 8.4 Hz, 1H), 6.62 (d, J = 8.4 Hz, 2H), 3.92 (s, 6H); 
13
C{
1
H} NMR (75 MHz, 
CDCl3): δ 158.5, 139.2, 132.2, 128.4, 128.0, 126.8, 126.3, 119.8, 114.6, 103.9, 55.7; IR 
  Chapter III  
117 
 
(neat): υmax 2934, 1584, 1470, 1248, 1106, 976, 749 cm
-1
; HRMS (EI, m/z) calcd. for 
C16H16O2 [M]
+
: 240.1150; found: 240.1157. 
1-(2,6-Dimethoxystyryl)-4-tert-butylbenzene, 14b, Scheme 8. The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), 4-tert-butylstyrene (55 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate 
(6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). 
Column chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate) afforded the 
desired product as a white solid (56 mg, 94%), mp 98-100 ºC. 
1
H NMR (300 MHz, 
CDCl3): δ 7.54 (d, J = 16.8 Hz, 1H), 7.42-7.48 (m, 3H), 7.35 (d, J = 8.4 Hz, 2H), 7.14 (t, 
J = 8.4 Hz, 1H), 6.58 (d, J = 8.1 Hz, 2H), 3.87 (s, 6H), 1.33 (s, 9H); 
13
C{
1
H} NMR (75 
MHz, CDCl3): δ 158.6, 149.9, 136.6, 132.2, 127.8, 126.1, 125.4, 119.2, 115.1, 104.0, 
55.8, 34.5, 31.3; IR (neat): υmax 2958, 1581, 1470, 1252, 1108, 770 cm
-1
; HRMS (ESI, 
m/z) calcd. for C20H24O2Na [M + Na]
+
: 319.1674; found: 319.1694. 
1-(2,6-Dimethoxystyryl)-4-fluorobenzene, 14c, Scheme 8. The same general procedure 
was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-
fluorostyrene (36 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate) afforded the desired 
product as a colourless oil (45 mg, 87%). 
1
H NMR (600 MHz, CDCl3): δ 7.57 (d, J = 
16.8 Hz, 1H), 7.51-7.54 (m, 2H), 7.40 (d, J = 16.8 Hz, 1H), 7.20 (t, J = 8.4 Hz, 1H), 7.05 
(t, J = 8.4 Hz, 2H), 6.62 (d, J = 8.4 Hz, 2H), 3.92 (s, 6H); 
13
C{
1
H} NMR (150 MHz, 
CDCl3): δ 162.0 (d, J = 244.5 Hz), 158.6, 135.4 (d, J = 3.0 Hz), 131.1, 128.1, 127.8 (d, J 
= 7.5 Hz), 119.6 (d, J = 1.5 Hz), 115.3 (d, J = 2.1 Hz), 114.6, 104.0, 55.8; 
19
F NMR (470 
MHz, CDCl3): δ -119.0 (s, 1F); IR (neat): υmax 2935, 1590, 1506, 1470, 1246, 1106, 775 
cm
-1
; HRMS (ESI, m/z) calcd. for C16H15FO2Na [M + Na]
+
: 281.0954; found: 281.0929. 
1-(2,6-Dimethoxystyryl)-4-chlorobenzene, 14d, Scheme 8. The same general procedure 
was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-
chlorostyrene (38 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate) afforded the desired 
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product as a colourless oil (45 mg, 82%). 
1
H NMR (300 MHz, CDCl3): δ 7.54 (d, J = 
16.8 Hz, 1H), 7.41-7.48 (m, 3H), 7.30 (d, J = 8.4 Hz, 2H), 7.18 (t, J = 8.1 Hz, 1H), 6.60 
(d, J = 8.4 Hz, 2H), 3.90 (s, 6H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 158.6, 137.8, 132.4, 
130.9, 128.6, 128.4, 127.6, 120.5, 114.4, 103.9, 55.8; IR (neat): υmax 2935, 1585, 1484, 
1249, 1109, 975, 774 cm
-1
; HRMS (ESI, m/z) calcd. for C16H15ClO2Na [M + Na]
+
: 
297.0658; found: 297.0681.  
1-(2,6-Dimethoxystyryl)-4-bromobenzene, 14e, Scheme 8. The same general procedure 
was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-
bromostyrene (40 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate) afforded the desired 
product as a colourless oil (47 mg, 74%). 
1
H NMR (600 MHz, CDCl3): δ 7.53 (d, J = 
16.8 Hz, 1H), 7.46-7.48 (m, 3H), 7.42 (d, J = 8.4 Hz, 2H), 7.20 (t, J = 8.4 Hz, 1H), 6.61 
(d, J = 8.4 Hz, 2H), 3.91 (s, 6H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 158.6, 138.3, 
131.5, 130.9, 128.4, 127.9, 120.6, 120.5, 114.4, 103.9, 55.8; IR (neat): υmax 2935, 1584, 
1475, 1249, 1106, 772 cm
-1
; HRMS (ESI, m/z) calcd. for C16H15BrO2Na [M + Na]
+
: 
341.0153; found: 341.0155. 
2-(4-Methoxystyryl)-1,3-dimethoxybenzene, 14f, Scheme 8.
36
 The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), 4-vinylanisole (40 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired 
product as a white solid (32 mg, 60%), mp 71-73 ºC. 
1
H NMR (300 MHz, CDCl3): δ 7.54 
(d, J = 16.5 Hz, 1H), 7.49 (d, J = 8.7 Hz, 2H), 7.33 (d, J = 16.5 Hz, 1H), 7.16 (t, J = 8.4 
Hz, 1H), 6.90 (d, J = 8.7 Hz, 2H), 6.60 (d, J = 8.4 Hz, 2H), 3.90 (s, 6H), 3.84 (s, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 158.8, 158.4, 132.0, 131.8, 127.6, 127.5, 117.8, 
114.9, 113.8, 103.9, 55.7, 55.2; IR (neat): υmax 2937, 1601, 1581, 1469, 1249, 1106, 
1033, 773 cm
-1
; HRMS (EI, m/z) calcd. for C17H18O3 [M]
+
: 270.1256; found: 270.1257. 
4-(2,6-Dimethoxystyryl)phenyl acetate, 14g, Scheme 8. The same general procedure 
was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-
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acetoxystyrene (46 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired 
product as a colourless oil (57 mg, 95%). 
1
H NMR (300 MHz, CDCl3): δ 7.54-7.60 (m, 
3H), 7.42 (d, J = 16.5 Hz, 1H), 7.19 (t, J = 8.4 Hz, 1H), 7.08 (d, J = 8.4 Hz, 2H), 6.61 (d, 
J = 8.4 Hz, 2H), 3.91 (s, 6H), 2.32 (s, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 171.3, 
160.1, 151.3, 138.9, 133.0, 129.9, 129.0, 123.3, 122.0, 116.3, 105.7, 57.5, 22.9; IR (neat): 
υmax 2937, 1760, 1584, 1504, 1195, 1105, 772 cm
-1
; HRMS (ESI, m/z) calcd. for 
C18H18O4Na [M + Na]
+
: 321.1103; found: 321.1115. 
1-(2,6-Dimethoxystyryl)-3-nitrobenzene, 14h, Scheme 8. The same general procedure 
was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 3-
nitrostyrene (42 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv.). Column 
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired 
product as a yellow solid (53 mg, 93%), mp 116-118 ºC. 
1
H NMR (600 MHz, CDCl3): δ 
8.37 (s, 1H), 8.04-8.06 (m, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.59-7.66 (m, 2H), 7.49 (t, J = 
8.4 Hz, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.62 (d, J = 8.4 Hz, 2H), 3.93 (s, 3H); 
13
C{
1
H} 
NMR (150 MHz, CDCl3): δ 158.8, 148.6, 141.2, 132.0, 129.6, 129.2, 129.1, 122.9, 121.3, 
120.9, 113.7, 103.9, 55.8; IR (neat): υmax 1527, 1473, 1343, 1107, 737 cm
-1
; HRMS (EI, 
m/z) calcd. for C16H15NO4 [M]
+
: 285.1001; found: 285.1013. 
(E)-1-(2,6-Dimethoxyphenyl)-2-(3,5-dimethoxyphenyl)ethene, 14i, Scheme 8. The 
same general procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 
mmol, 1.0 equiv), 3,5-dimethoxystyrene (49 mg, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (50 mg, 0.4 mmol, 
2.0 equiv). Column chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) 
afforded the desired product as a colourless oil (45 mg, 84%). 
1
H  NMR (600 MHz, 
CDCl3): δ 7.53 (d, J = 16.8 Hz, 1H), 7.46 (d, J = 16.8 Hz, 1H), 7.19 (t, J = 8.4 Hz, 1H), 
6.73 (d, J = 1.8 Hz, 2H), 6.61 (d, J = 8.4 Hz, 2H), 6.40 (t, J = 2.4 Hz, 1H), 3.91 (s, 6H), 
3.86 (s, 6H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 160.8, 158.6, 141.4, 132.3, 128.2, 
120.4, 114.6, 104.5, 104.0, 99.4, 55.8, 55.3; IR (neat): υmax 2937, 2838, 1587, 1472, 
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1153, 773 cm
-1
; HRMS (ESI, m/z) calcd. for C18H20O4Na [M + Na]
+
: 323.1259; found: 
323.1278. 
2-(2,6-Dimethoxystyryl)naphthalene, 14j, Scheme 8. The same general procedure was 
followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 2-
vinylnaphthalene (46 mg, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 
0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate) afforded the desired 
product as a white solid (50 mg, 86%), mp 136-138 ºC. 
1
H NMR (300 MHz, CDCl3): δ 
7.75-7.87 (m, 6H), 7.62 (d, J = 16.8 Hz, 1H), 7.40-7.49 (m, 2H), 7.20 (t, J = 8.4 Hz, 1H), 
6.63 (d, J = 8.4 Hz, 2H), 3.94 (s, 6H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 158.7, 136.9, 
133.9, 132.9, 132.4, 128.2, 128.0, 127.96, 127.7, 126.2, 126.1, 125.4, 123.8, 120.4, 114.9, 
104.1, 55.8; IR (neat): υmax 1583, 1470, 1242, 1105, 772 cm
-1
; HRMS (EI, m/z) calcd. for 
C20H18O2 [M]
+
: 290.1307; found: 290.1310. 
1-(2,6-Dimethoxystyryl)-2,3,4,5,6-pentafluorobenzene, 14k, Scheme 8. The same 
general procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 
mmol, 1.0 equiv), pentafluorostyrene (42 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 
2.0 equiv). Column chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate) 
afforded the desired product as a white solid (56 mg, 85%), mp 146-148 ºC. 
1
H  NMR 
(600 MHz, CDCl3): δ 7.75 (d, J = 17.4 Hz, 1H), 7.47 (d, J = 16.8 Hz, 1H), 7.24 (t, J = 8.4 
Hz, 1H), 6.61 (d, J = 8.4 Hz, 2H), 3.92 (s, 6H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 
158.9, 144.6 (dm, J = 249.0 Hz), 139.1, (dm, J = 250.5 Hz), 137.7 (dm, J = 247.5 Hz), 
129.6, 128.6 (t, J = 9.0 Hz), 116.2, 114.2 (td, J = 13.5 Hz, 4.5 Hz), 113.8, 103.8, 55.8 (d, 
J = 3.0 Hz); 
19
F NMR (470 MHz, CDCl3): δ -144.6 (dd, J = 26.8 Hz, 8.9 Hz, 2F), -159.5 
(t, J = 26.3 Hz, 1F), -165.0 (td, J = 26.3 Hz, 8.9 Hz, 2F); IR (neat): υmax 1585, 1496, 
1245, 1108, 1000, 774 cm
-1
; HRMS (EI, m/z) calcd. for C16H11F5O2 [M]
+
: 330.0679; 
found: 330.0665. 
2-(2-Methoxystyryl)-1,3-dimethoxybenzene, 14l, Scheme 8. The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), 2-vinylanisole (40 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
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mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate) afforded the desired 
product as a white solid (41 mg, 76%), mp 66-68 ºC. 
1
H NMR (300 MHz, CDCl3): δ 7.87 
(d, J = 16.8 Hz, 1H), 7.64 (dd, J = 7.5 Hz, 0.9 Hz, 1H), 7.39 (d, J = 16.8 Hz, 1H), 7.11-
7.25 (m, 2H), 6.96 (t, J = 7.5 Hz, 1H), 6.87 (d, J = 8.1 Hz, 1H), 6.58 (d, J = 8.4 Hz, 2H), 
3.88 (s, 6H), 3.86 (s, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 158.6, 156.7, 128.6, 128.0, 
127.8, 127.2, 126.2, 120.7, 120.4, 115.4, 110.8, 104.0, 55.8, 55.6; IR (neat): υmax 2935, 
2837, 1586, 1468, 1243, 1106, 746 cm
-1
; HRMS (ESI, m/z) calcd. for C17H18O3Na [M + 
Na]
+
: 293.1154; found: 293.1147. 
1,4-Bis(2,6-dimethoxystyryl)benzene, 14m, Scheme 8. The same general procedure 
was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 1,4-
divinylbenzene (22 µL, 0.15 mmol, 0.75 equiv), palladium (II) trifluoroacetate (6.7 mg, 
0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
product as a yellow solid (29 mg, 72%), mp 180-182 ºC. 
1
H NMR (600 MHz, CDCl3): δ 
7.61 (d, J = 16.2 Hz, 2H), 7.54 (s, 4H), 7.50 (d, J = 16.8 Hz, 2H), 7.18 (t, J = 8.4 Hz, 2H), 
6.62 (d, J = 8.4 Hz, 4H), 3.93 (s, 12H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 158.6, 
138.0, 132.2, 127.9, 126.5, 119.3, 115.0, 104.0, 55.8; IR (neat): υmax 1582, 1472, 1251, 
1105, 770 cm
-1
; HRMS (EI, m/z) calcd. for C26H26O4 [M]
+
: 402.1831; found: 402.1833. 
(E)-3-(2,6-Dimethoxyphenyl)acrylonitrile, 14n, Scheme 8. The same general procedure 
was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 
acrylonitrile (20 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
product as a colourless oil (24 mg, 64%). 
1
H  NMR (600 MHz, CDCl3): δ 7.82 (d, J = 
16.8 Hz, 1H), 7.28-7.34 (m, 2H), 7.22 (d, J = 12.0 Hz, 1H), 6.59 (d, J = 8.4 Hz, 2H), 6.57 
(d, J = 8.4 Hz, 2H), 6.42 (d, J = 16.8 Hz, 1H), 5.58 (d, J = 12.0 Hz, 1H), 3.89 (s, 12H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 158.8, 158.2, 141.4, 141.0, 132.0, 131.6, 120.2, 
117.3, 111.9, 111.6, 103.7, 103.6, 99.9, 98.4, 55.8, 55.4; IR (neat): υmax 2936, 2210, 
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1696, 1601, 1475, 1249, 1112, 777 cm
-1
; HRMS (ESI, m/z) calcd. for C11H11NO2Na [M + 
Na]
+
: 212.0687; found: 212.0691. 
(E)-Methyl 3-(2,6-dimethoxyphenyl)acrylate, 14o, Scheme 8.
13
 The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), methyl acrylate (27 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
product as a white solid (36 mg, 81%), mp 70-72 ºC. 
1
H NMR (300 MHz, CDCl3): δ 8.14 
(d, J = 16.2 Hz, 1H), 7.26 (t, J = 8.4 Hz, 1H), 6.88 (d, J = 16.2 Hz, 1H), 6.55 (d, J = 8.4 
Hz, 2H), 3.87 (s, 6H), 3.79 (s, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 169.0, 160.0, 
135.6, 131.2, 120.2, 112.1, 103.6, 55.7, 51.4; IR (neat): υmax 2942, 1703, 1618, 1255, 
1161, 1104, 748 cm
-1
; HRMS (EI, m/z) calcd. for C12H14O4 [M]
+
: 222.0892; found: 
222.0902. 
(E)-Butyl 3-(2,6-dimethoxyphenyl)acrylate, 14p, Scheme 8. The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), butyl acrylate (43 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
product as a colourless oil (39 mg, 74%). 
1
H NMR (300 MHz, CDCl3): δ 8.14 (d, J = 
16.2 Hz, 1H), 7.26 (t, J = 8.4 Hz, 1H), 6.88 (d, J = 16.5 Hz, 1H), 6.55 (d, J = 8.4 Hz, 2H), 
4.20 (t, J = 6.6 Hz, 2H), 3.88 (s, 6H), 1.64-1.74 (m, 2H), 1.38-1.50 (m, 2H), 0.96 (t, J = 
7.5 Hz, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 168.6, 159.8, 135.2, 131.0, 120.5, 
112.1, 103.5, 63.9, 55.6, 30.8, 19.1, 13.7; IR (neat): υmax 2959, 1706, 1623, 1587, 1474, 
1255, 1109, 744 cm
-1
; HRMS (EI, m/z) calcd. for C15H20O4 [M]
+
: 264.1362; found: 
264.1346. 
(E)-Phenyl 3-(2,6-dimethoxyphenyl)acrylate, 14q, Scheme 8. The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), phenyl acrylate (45 mg, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
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product as a white solid (41.5 mg, 73%), mp 106-108 ºC. 
1
H NMR (300 MHz, CDCl3): δ 
8.36 (d, J = 16.2 Hz, 1H), 7.42 (t, J = 7.8 Hz, 2H), 7.33 (t, J = 8.4 Hz, 1H), 7.26 (d, J = 
8.1 Hz, 1H), 7.20 (d, J = 7.5 Hz, 2H), 7.11 (d, J = 16.2 Hz, 1H), 6.61 (d, J = 8.4 Hz, 2H), 
3.93 (s, 6H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 167.0, 160.2, 151.2, 137.4, 131.8, 
129.4, 125.5, 121.9, 119.6, 112.1, 103.7, 55.8; IR (neat): υmax 1735, 1619, 1478, 1254, 
1131, 738 cm
-1
; HRMS (ESI, m/z) calcd. for C17H16O4Na [M + Na]
+
: 307.0946; found: 
307.0957. 
(E)-Methyl 3-(2,6-dimethoxyphenyl)-2-methylacrylate, 14r, Scheme 8.
37
 The same 
general procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 
mmol, 1.0 equiv), methyl methacrylate (32 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 
2.0 equiv). Column chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) 
afforded the desired product as a colourless oil (19 mg, 40%). 
1
H  NMR (600 MHz, 
CDCl3): δ 7.54 (s, 1H), 7.28 (t, J = 8.4 Hz, 1H), 6.59 (d, J = 8.4 Hz, 2H), 3.83 (s, 6H), 
3.81 (s, 3H), 1.79 (d, J = 1.2 Hz, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 168.7, 157.7, 
131.9, 130.9, 129.7, 113.4, 103.5, 55.6, 51.8, 15.2; IR (neat): υmax 2950, 2840, 1710, 
1587, 1470, 1253, 1105, 745 cm
-1
; HRMS (ESI, m/z) calcd. for C13H16O4Na [M + Na]
+
: 
259.0946; found: 259.0934. 
1-((E)-3-(2,6-Dimethoxyphenyl)prop-1-enyl)benzene, 14s, Scheme 8. The same 
general procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 
mmol, 1.0 equiv), allylbenzene (40 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.4 
mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) 
afforded the desired product as a colourless oil (28 mg, 55%). 
1
H  NMR (600 MHz, 
CDCl3): δ 7.33 (d, J = 7.2 Hz, 2H), 7.25-7.28 (m, 2H), 7.13-7.20 (m, 2H), 7.09 (d, J = 8.4 
Hz, 2H), 6.32-6.41 (m, 2H), 3.85 (s, 6H), 3.58 (d, J = 6.0 Hz, 2H); 
13
C{
1
H} NMR (150 
MHz, CDCl3): δ 158.2, 138.1, 129.4, 129.0, 128.3, 127.1, 126.5, 126.0, 116.5, 103.8, 
55.8, 26.4; IR (neat): υmax 2927, 1728, 1593, 1469, 1254, 1110, 729 cm
-1
; HRMS (ESI, 
m/z) calcd. for C17H18O2Na [M + Na]
+
: 277.1204; found: 277.1179. 
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1-Fluoro-4-((E)-3-(2,6-dimethoxyphenyl)prop-1-enyl)benzene, 14t, Scheme 8. The 
same general procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 
mmol, 1.0 equiv), 4-fluoroallylbenzene (41 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.4 
mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) 
afforded the desired product as a white solid (31 mg, 57%), mp 68-70 ºC. 
1
H  NMR (600 
MHz, CDCl3): δ 7.28-7.31 (m, 2H), 7.19 (t, J = 8.4 Hz, 1H), 6.96 (t, J = 8.4 Hz, 2H), 6.60 
(d, J = 8.4 Hz, 2H), 6.36 (d, J = 15.6 Hz, 1H), 6.25-6.30 (m, 1H), 3.86 (s, 6H), 3.58 (d, J 
= 6.0 Hz, 2H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 161.7 (d, J = 243.0 Hz), 158.2, 134.2 
(d, J = 3.0 Hz), 128.7 (d, J = 3.0 Hz), 128.3, 127.3 (d, J = 7.5 Hz), 127.2, 116.4, 115.1 (d, 
J = 21.0 Hz), 103.8, 55.8, 26.4; 
19
F NMR (470 MHz, CDCl3): δ -119.6 (s, 1F); IR (neat): 
υmax 2929, 1592, 1470, 1255, 1107, 839 cm
-1
; HRMS (EI, m/z) calcd. for C17H17FO2 
[M]
+
: 272.1213; found: 272.1208. 
 2-(4-Methoxycinnamyl)-1,3-dimethoxybenzene, 14u, Scheme 8.
12
 The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), 4-methoxyallylbenzene (46 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.4 
mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) 
afforded the desired product as a white solid (24 mg, 42%), mp 70-72 ºC. 
1
H  NMR (600 
MHz, CDCl3): δ 7.26 (d, J = 9.0 Hz, 2H), 7.17 (t, J = 8.4 Hz, 1H), 6.81 (d, J = 8.4 Hz, 
2H), 6.58 (d, J = 8.4 Hz, 2H), 6.34 (d, J = 15.6 Hz, 1H), 6.18-6.23 (m, 1H), 3.85 (s, 6H), 
3.79 (s, 3H), 3.55 (d, J = 6.6 Hz, 2H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 158.4, 158.2, 
131.1, 128.8, 127.05, 127.02, 126.8, 116.8, 113.7, 103.8, 55.8, 55.2, 26.4; IR (neat): υmax 
2930, 1597, 1510, 1469, 1250, 1111, 833 cm
-1
; HRMS (EI, m/z) calcd. for C18H20O3 
[M]
+
: 284.1412; found: 284.1408. 
2,6-Dimethoxycinnamyl acetate, 14v, Scheme 8.
12
 The same general procedure was 
followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 
allylacetate (33 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (13.4 mg, 0.04 
mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.6 mmol, 3.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
  Chapter III  
125 
 
product as a colourless oil (32 mg, 67%). 
1
H  NMR (600 MHz, CDCl3): δ 7.18 (t, J = 8.4 
Hz, 1H), 6.99 (d, J = 16.2 Hz, 1H), 6.71-6.76 (m, 1H), 6.56 (d, J = 8.4 Hz, 2H), 4.75 (dd, 
J = 6.6 Hz, 0.6 Hz, 2H), 3.86 (s, 6H), 2.11 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 
171.0, 158.6, 128.6, 126.8, 125.0, 113.3, 103.8, 67.1, 55.7, 21.1; IR (neat): υmax 2938, 
1737, 1587, 1472, 1247, 772 cm
-1
; HRMS (ESI, m/z) calcd. for C13H16O4Na [M + Na]
+
: 
259.0946; found: 259.0923.   
3-(2,6-Dimethoxyphenyl)-1-phenylpropan-1-one, 14w, Scheme 8.
21b
 The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), 1-phenylprop-2-en-1-ol (40 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 
2.0 equiv) except the reaction was run for 48 h. Column chromatography (SiO2, eluting 
with 9:1 hexane/ethyl acetate) afforded the desired product as a white solid (20.5 mg, 
38%), mp 88-90 ºC. 
1
H  NMR (600 MHz, CDCl3): δ 8.02 (dd, J = 8.4 Hz, 1.2 Hz, 2H), 
7.54-7.57 (m, 1H), 7.45-7.47 (m, 2H), 7.18 (t, J = 8.4 Hz, 1H), 6.57 (d, J = 8.4 Hz, 2H), 
3.81 (s, 6H), 3.14-3.17 (m, 2H), 3.08-3.11 (m, 2H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 
200.6, 158.2, 137.0, 132.7, 128.4, 128.2, 127.1, 117.4, 103.5, 55.6, 38.3, 18.5; IR (neat): 
υmax 2937, 1682, 1593, 1471, 1254, 1107, 778, 693 cm
-1
; HRMS (ESI, m/z) calcd. for 
C17H18O3Na [M + Na]
+
: 293.1154; found: 293.1130. 
Diethyl 2-(2,6-dimethoxycinnamyl)malonate, 14x, Scheme 8.
12
 The same general 
procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 
equiv), diethyl 2-allylmalonate (60 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.6 
mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) 
afforded the desired product as a colourless oil (44 mg, 65%). 
1
H  NMR (600 MHz, 
CDCl3): δ 7.12 (t, J = 8.4 Hz, 1H), 6.74 (t, J = 16.2 Hz, 1H), 6.51-6.58 (m, 3H), 4.19-
4.26 (m, 4H), 3.82 (s, 6H), 3.51 (t, J = 7.8 Hz, 1H), 2.83 (td, J = 7.8 Hz, 1.2 Hz, 2H), 
1.28 (t, J = 6.6 Hz, 6H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 169.1, 158.2, 129.7, 127.7, 
123.0, 114.4, 103.9, 61.3, 55.6, 52.5, 34.0, 14.0; IR (neat): υmax 2981, 1732, 1585, 1472, 
1251, 1113, 772 cm
-1
; HRMS (ESI, m/z) calcd. for C18H24O6Na [M + Na]
+
: 359.1471; 
found: 359.1468. 
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(E)-4-Methoxybenzyl 5-(2,6-dimethoxyphenyl)pent-4-enoate, 14y, Scheme 8. The 
same general procedure was followed by using 2,6-dimethoxybenzoic acid (36.5 mg, 0.2 
mmol, 1.0 equiv), 4-methoxybenzyl pent-4-enoate (66 mg, 0.3 mmol, 1.5 equiv), 
palladium (II) trifluoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv), and 1,4-benzoquinone 
(65 mg, 0.6 mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 8:2 
hexane/ethyl acetate) afforded the desired product as colourless oil (28.5 mg, 40%). 
1
H  
NMR (600 MHz, CDCl3): δ 7.31 (d, J  = 8.4 Hz, 2H), 7.13 (t, J = 8.4 Hz, 1H), 6.88 (d, J 
= 8.4 Hz, 2H), 6.70 (d, J = 16.2 Hz, 1H), 6.57-6.62 (m, 1H), 6.56 (d, J = 8.4 Hz, 2H), 
5.08 (s, 2H), 3.83 (s, 6H), 3.82 (s, 3H), 2.58-2.61 (m, 2H), 2.53-2.56 (m, 2H); 
13
C{
1
H} 
NMR (150 MHz, CDCl3): δ 173.2, 159.5, 158.2, 132.7, 130.0, 128.2, 127.5, 121.2, 114.6, 
113.9, 103.9, 65.9, 55.7, 55.2, 34.5, 30.0; IR (neat): υmax 2928, 1732, 1586, 1514, 1469, 
1248, 1111, 823 cm
-1
; HRMS (ESI, m/z) calcd. for C21H24O5Na [M + Na]
+
: 379.1521; 
found: 379.1530. 
1-(2,6-Diethoxystyryl)benzene, 14z, Scheme 8. The same general procedure was 
followed by using 2,6-diethoxybenzoic acid (42 mg, 0.2 mmol, 1.0 equiv), styrene (35 
µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), 
and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2, 
eluting with 95:5 hexane/ethyl acetate) afforded the desired product as a white solid (48 
mg, 90%), mp 55-57 ºC. 
1
H  NMR (300 MHz, CDCl3): δ 7.72 (d, J = 16.5 Hz, 1H), 7.50-
7.56 (m, 3H), 7.36 (t, J = 7.5 Hz, 2H), 7.21-7.26 (m, 1H), 7.13 (t, J = 8.4 Hz, 1H), 6.57 
(d, J = 8.4 Hz, 2H), 4.12 (q, J = 6.9 Hz, 4H), 1.51 (t, J = 7.2 Hz, 6H); 
13
C{
1
H} NMR (75 
MHz, CDCl3): δ 158.1, 139.5, 132.1, 128.4, 128.0, 126.8, 126.3, 120.2, 114.8, 104.9, 
64.2, 14.9; IR (neat): υmax 2978, 1582, 1458, 1247, 1116, 1083, 748 cm
-1
; HRMS (ESI, 
m/z) calcd. for C18H20O2Na [M + Na]
+
: 291.1361; found: 291.1352.   
1-((3-(Benzyloxy)-2-styrylphenoxy)methyl)benzene, 14aa, Scheme 8. The same 
general procedure was followed by using 2,6-dibenzyloxybenzoic acid (67 mg, 0.2 mmol, 
1.0 equiv), styrene (35 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 
0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired 
product as a white solid (59 mg, 75%), mp 88-90 ºC. 
1
H NMR (600 MHz, CDCl3): δ 7.70 
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(d, J = 16.8 Hz, 1H), 7.62 (d, J = 16.8 Hz, 1H), 7.51 (d, J = 7.8 Hz, 4H), 7.41-7.43 (m, 
6H), 7.36 (t, J = 7.8 Hz, 2H), 7.32 (t, J = 7.8 Hz, 2H), 7.21 (t, J = 7.2 Hz, 1H), 7.14 (t, J = 
7.8 Hz, 1H), 6.68 (d, J = 8.4 Hz, 2H), 5.19 (s, 4H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 
157.8, 139.2, 137.1, 132.7, 128.5, 128.4, 127.9, 127.8, 127.2, 126.9, 126.3, 119.7, 115.8, 
105.9, 70.8; IR (neat): υmax 2926, 1728, 1582, 1452, 1254, 1104, 741 cm
-1
; HRMS (ESI, 
m/z) calcd. for C28H24O2Na [M + Na]
+
: 415.1674; found: 415.1674. 
1,3,5-Trimethoxy-2-styrylbenzene, 14ab, Scheme 8.
38
 The same general procedure was 
followed by using 2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), styrene 
(35 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column chromatography 
(SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired product as a colourless 
oil (50 mg, 93%). 
1
H  NMR (600 MHz, CDCl3): δ 7.55 (d, J = 7.8 Hz, 2H), 7.50 (d, J = 
16.2 Hz, 1H), 7.44 (d, J = 16.2 Hz, 1H), 7.36 (t, J = 7.8 Hz, 2H), 7.22 (t, J = 7.2 Hz, 1H), 
6.20 (s, 2H), 3.91 (s, 6H), 3.86 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 160.2, 
159.5, 139.7, 129.9, 128.4, 126.5, 126.1, 119.8, 108.1, 90.8, 55.8, 55.3; IR (neat): υmax 
2938, 1597, 1461, 1328, 1210, 1119, 813 cm
-1
; HRMS (ESI, m/z) calcd. for C17H18O3Na 
[M + Na]
+
: 293.1154; found: 293.1140. 
2-(4-Phenylstyryl)-1,3,5-trimethoxybenzene, 14ac, Scheme 8. The same general 
procedure was followed by using 2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 4-vinylbiphenyl (54 mg, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
product as a white solid (57 mg, 82%), mp 150-152 ºC. 
1
H NMR (600 MHz, CDCl3): δ 
7.64-7.66 (m, 2H), 7.59-7.62 (m, 4H), 7.53 (d, J = 16.8 Hz, 1H), 7.45-7.49 (m, 3H), 7.35 
(t, J = 7.2 Hz, 1H), 6.21 (s, 2H), 3.92 (s, 6H), 3.87 (s, 3H); 
13
C{
1
H} NMR (150 MHz, 
CDCl3): δ 160.3, 159.6, 141.0, 139.1, 138.8, 129.3, 128.7, 127.1, 127.0, 126.8, 126.6, 
120.0, 108.2, 90.8, 55.8, 55.3; IR (neat): υmax 1592, 1458, 1326, 1218, 1153, 1119, 766 
cm
-1
; HRMS (ESI, m/z) calcd. for C23H22O3Na [M + Na]
+
: 369.1467; found: 369.1467.   
2-(2-Methylstyryl)-1,3,5-trimethoxybenzene, 14ad, Scheme 8.
39
 The same general 
procedure was followed by using 2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 
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equiv), 2-methylstyrene (39 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
product as a white solid (51 mg, 90%), mp 86-88 ºC. 
1
H NMR (300 MHz, CDCl3): δ 
7.62-7.69 (m, 2H), 7.24 (d, J = 16.5 Hz, 1H), 7.08-7.19 (m, 3H), 6.17 (s, 2H), 3.87 (s, 
6H), 3.84 (s, 3H), 2.39 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 160.2, 159.4, 138.7, 
135.3, 130.1, 128.0, 126.5, 126.0, 124.9, 120.8, 108.6, 90.8, 55.8, 55.3, 20.0; IR (neat): 
υmax 2936, 1586, 1460, 1198, 1118, 809 cm
-1
; HRMS (ESI, m/z) calcd. for C18H20O3Na 
[M + Na]
+
: 307.1310; found: 307.1308. 
2-(3-Chlorostyryl)-1,3,5-trimethoxybenzene, 14ae, Scheme 8.
39
 The same general 
procedure was followed by using 2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 3-chlorostyrene (38 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) afforded the desired 
product as a white solid (55 mg, 91%), mp 80-82 ºC. 
1
H NMR (600 MHz, CDCl3): δ 7.51 
(t, J = 1.8 Hz, 1H), 7.42 (d, J = 1.8 Hz, 2H), 7.38 (d, J = 7.8 Hz, 1H), 7.25 (t, J = 7.8 Hz, 
1H), 7.15-7.17 (m, 1H), 6.19 (s, 2H), 3.90 (s, 6H), 3.86 (s, 3H); 
13
C{
1
H} NMR (150 
MHz, CDCl3): δ 160.5, 159.6, 141.7, 134.3, 129.5, 128.2, 126.2, 125.9, 124.3, 121.2, 
107.6, 90.7, 55.7, 55.3; IR (neat): υmax 2961, 1586, 1462, 1326, 1220, 1117, 962, 796 cm
-
1
; HRMS (ESI, m/z) calcd. for C17H17ClO3Na [M + Na]
+
: 327.0764; found: 327.0783. 
4-(2,4,6-Trimethoxystyryl)-2-methoxyphenyl acetate, 14af, Scheme 8. The same 
general procedure was followed by using 2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 
mmol, 1.0 equiv), 4-acetoxy-3-methoxystyrene (57 mg, 0.3 mmol, 1.5 equiv), palladium 
(II) trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 
mmol, 2.0 equiv). Column chromatography (SiO2, eluting with 8:2 hexane/ethyl acetate) 
afforded the desired product as a white solid (61 mg, 85%), mp 105-107 ºC. 
1
H NMR 
(600 MHz, CDCl3): δ 7.43 (d, J = 16.8 Hz, 1H), 7.33 (d, J = 16.2 Hz, 1H), 7.10-7.11 (m, 
2H), 7.00 (d, J = 8.4 Hz, 1H), 6.19 (s, 2H), 3.898 (s, 3H), 3.896 (s, 6H), 3.86 (s, 3H), 2.33 
(s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 169.2, 160.3, 159.5, 150.9, 138.9, 138.4, 
129.3, 122.6, 120.2, 118.6, 110.0, 107.9, 90.8, 55.9, 55.8, 55.3, 20.7; IR (neat): υmax 
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2933, 1761, 1598, 1460, 1118, 817 cm
-1
; HRMS (ESI, m/z) calcd. for C20H22O6Na [M + 
Na]
+
: 381.1314; found: 381.1336. 
(E)-Butyl 3-(2,4,6-trimethoxyphenyl)acrylate, 14ag, Scheme 8.
40
 The same general 
procedure was followed by using 2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), butyl acrylate (43 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 8:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (41 mg, 70%), mp 79-81 ºC. 
1
H NMR (300 MHz, CDCl3): δ 8.09 
(d, J = 16.2 Hz, 1H), 6.75 (d, J = 16.2 Hz, 1H), 6.11 (s, 2H), 4.19 (t, J = 6.6 Hz, 2H), 3.87 
(s, 6H), 3.84 (s, 3H), 1.64-1.73 (m, 2H), 1.37-1.50 (m, 2H), 0.96 (t, J = 7.5 Hz, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 169.1, 162.6, 161.1, 135.4, 117.4, 105.7, 90.3, 63.8, 
55.6, 55.3, 30.9, 19.2, 13.8; IR (neat): υmax 2939, 1699, 1602, 1461, 1156, 1119, 815 cm
-
1
; HRMS (ESI, m/z) calcd. for C16H22O5Na [M + Na]
+
: 317.1365; found: 317.1360.   
Diethyl 2-(2,4,6-trimethoxycinnamyl)malonate, 14ah, Scheme 8. The same general 
procedure was followed by using 2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 mmol), 
diethyl 2-allylmalonate (60 µL, 0.3 mmol, 1.5 equiv.), palladium (II) trifluoroacetate 
(13.4 mg, 0.04 mmol, 0.1 equiv.), and 1,4-benzoquinone (65 mg, 0.6 mmol, 3.0 equiv.). 
Column chromatography (SiO2, eluting with 8:2 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (45 mg, 62%). 
 1
H NMR (600 MHz, CDCl3): δ 6.66 (d, 
J = 16.2 Hz, 1H), 6.38-6.43 (m, 1H), 6.12 (s, 2H), 4.18-4.23 (m, 4H), 3.81 (s, 3H), 3.80 
(s, 6H), 3.48 (t, J = 7.8 Hz, 1H), 2.80 (t, J = 7.8 Hz, 2H), 1.27 (t, J = 7.2 Hz, 6H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 169.2, 159.8, 159.0, 127.2, 122.8, 107.7, 90.6, 61.2, 
55.6, 55.2, 52.6, 34.0, 14.0; IR (neat): υmax 2939, 1729, 1604, 1462, 1124, 1036, 814 cm
-
1
; HRMS (ESI, m/z) calcd. for C19H26O7Na [M + Na]
+
: 389.1576; found: 389.1563. 
General experimental procedure for the decarboxylative Heck reaction between 
electron-deficient carboxylic acids and vinyl arenes 
To an oven-dried 15 mL sealed tube, a mixture of pentafluorobenzoic acid (0.20-0.24 
mmol, 1.0-1.2 equiv), palladium(II)trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 
silver carbonate (110 mg, 0.4 mmol, 2.0 equiv) was taken then dry DMF (3.0 mL) was 
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added to it. After purging with nitrogen, the corresponding styrenes (0.20-0.30 mmol, 
1.0-1.5 equiv) were added via microliter syringe and the vessel was sealed with a screw 
cap. The reaction mixture was allowed to stir for 16 h at room temperature. After 
completion (as detected by TLC), the reaction mixture was poured into water (20 mL) 
and extracted with ethyl acetate (30 mL). The organic layer was washed with water (10 
mL x 2) and brine (10 mL), dried over anhydrous Na2SO4 and the solvent was evaporated 
under reduced pressure. The crude product was purified by column chromatography 
using ethyl acetate/hexane as eluent to afford the desired product. 
1,2,3,4,5-Pentafluoro-6-styrylbenzene, 17a, Scheme 9.
32
 The same general procedure 
was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), styrene 
(35 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 
equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column chromatography 
(SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired product as a white 
solid (36 mg, 66%), mp 132-134 ºC. 
1
H NMR (300 MHz, CDCl3): δ 7.53 (d, J = 7.5 Hz, 
2H), 7.31-7.47 (m, 4H), 6.98 (d, J = 16.8 Hz, 1H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 
144.8 (dm, J = 248.8 Hz), 139.7 (dm, J = 252.8 Hz), 137.7 (dm, J = 248.2 Hz), 137.1 (td, 
J = 8.2 Hz, 2.6 Hz), 136.4, 128.9, 128.8, 126.8 112.6 (d, J = 2.4 Hz), 112.4 (td, J = 13.6 
Hz, 4.2 Hz); 
19
F NMR (470 MHz, CDCl3): δ -146.0 (dd, J = 21.6 Hz, 7.0 Hz, 2F), -159.8 
(t, J = 20.7 Hz, 1F), -166.2 (td, J = 20.7 Hz, 7.0 Hz, 2F); IR (neat): υmax 1523, 1493, 
1000, 959, 754 cm
-1
; HRMS (EI, m/z) calcd. for C14H7F5 [M]
+
: 270.0468; found: 
270.0448. 
1-(4-Fluorostyryl)-2,3,4,5,6-pentafluorobenzene, 17b, Scheme 9.
32
 The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 4-fluorostyrene (36 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (36 mg, 62%), mp 110-112 ºC. 
1
H NMR (600 MHz, CDCl3): δ 
7.51 (dd, J = 8.4 Hz, 5.4 Hz, 2H), 7.39 (d, J = 16.8 Hz, 1H), 7.09 (t, J = 8.4 Hz, 2H), 6.89 
(d, J = 16.8 Hz, 1H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 163.1 (d, J = 248.0 Hz), 144.8 
(dm, J = 249.0 Hz), 139.7 (dm, J = 253.5 Hz), 137.7 (dm, J = 249.0 Hz), 135.9 (td, J = 
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9.0 Hz, 1.5 Hz), 132.6 (d, J = 3.0 Hz), 128.5 (d, J = 7.5 Hz), 115.9 (d, J = 22.5 Hz), 
112.4, 112.2 (td, J = 13.5 Hz, 4.5 Hz); 
19
F NMR (470 MHz, CDCl3): δ -115.2 (s, 1F), -
146.1 (dd, J = 21.2 Hz, 7.5 Hz, 2F), -159.6 (t, J = 20.7 Hz, 1F), -166.1 (td, J = 21.2 Hz, 
7.5 Hz, 2F); IR (neat): υmax 1519, 1492, 1240, 1003, 958 cm
-1
; HRMS (EI, m/z) calcd. for 
C14H6F6 [M]
+
: 288.0374; found: 288.0365. 
1-(4-Chlorostyryl)-2,3,4,5,6-pentafluorobenzene, 17c, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 4-chlorostyrene (38 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (44 mg, 73%), mp 98-100 ºC. 
1
H  NMR (600 MHz, CDCl3): δ 
7.47 (d, J = 8.4 Hz, 2H), 7.37-7.41 (m, 3H), 6.96 (d, J = 16.8 Hz, 1H); 
13
C{
1
H} NMR 
(150 MHz, CDCl3): δ 144.8 (dm, J = 249.2 Hz), 139.8 (dm, J = 253.5 Hz), 137.8 (dm, J = 
249.2 Hz), 135.7 (td, J = 9.0 Hz, 3.0 Hz), 134.9, 134.7, 129.0, 128.0, 113.2 (d, J = 1.5 
Hz), 112.0 (td, J = 13.5 Hz, 4.5 Hz); 
19
F NMR (470 MHz, CDCl3): δ -142.6 (dd, J = 22.1 
Hz, 7.0 Hz, 2F), -156.0 (t, J = 20.7 Hz, 1F), -162.8 (td, J = 20.7 Hz, 6.6 Hz, 2F) ; IR 
(neat): υmax 1520, 1490, 1004, 958, 811 cm
-1
; HRMS (EI, m/z) calcd. for C14H6ClF5 [M]
+
: 
304.0078; found: 304.0061. 
1-(4-Bromostyryl)-2,3,4,5,6-pentafluorobenzene, 17d, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 4-bromostyrene (39 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (47 mg, 67%), mp 99-101 ºC. 
1
H  NMR (CDCl3, 300 MHz): δ 
7.52 (d, J = 8.1 Hz, 2H), 7.34-7.41 (m, 3H), 6.97 (d, J = 16.8 Hz, 1H); 
13
C{
1
H} NMR 
(CDCl3, 75 MHz): δ 144.7 (dm, J = 248.9 Hz), 139.8 (dm, J = 252.8 Hz), 137.7 (dm, J = 
249.8 Hz), 135.8 (td, J = 9.0 Hz, 1.5 Hz), 135.3, 132.0, 128.2, 122.9, 113.3 (d, J = 3.0 
Hz), 112.0 (td, J = 13.5 Hz, 4.5 Hz); 
19
F NMR (470 MHz, CDCl3): δ -142.6 (dd, J = 21.2 
Hz, 6.6 Hz, 2F), -155.9 (t, J = 21.6 Hz, 1F), -162.7 (td, J = 21.6 Hz, 7.0 Hz, 2F); IR 
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(neat): υmax 1519, 1492, 1002, 961, 810 cm
-1
; HRMS (EI, m/z) calcd. for C14H6BrF5 [M]
+
: 
347.9573, 349.9553; found: 347.9570, 349.9529. 
1-(4-Methylstyryl)-2,3,4,5,6-pentafluorobenzene, 17e, Scheme 9.
27a
 The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 4-methylstyrene (40 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (41 mg, 73%), mp 142-144 ºC. 
1
H  NMR (300 MHz, CDCl3): δ 
7.38-7.44 (m, 3H), 7.20 (d, J = 8.1 Hz, 2H), 6.93 (d, J = 16.8 Hz, 1H), 2.38 (s, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 144.7 (dm, J = 248.3 Hz), 139.5 (dm, J = 252.8 Hz), 
139.1, 137.7 (dm, J = 250.5 Hz), 137.1 (td, J = 8.2 Hz, 2.2 Hz), 133.7, 129.5, 126.8, 
112.6 (td, J = 13.5 Hz, 4.5 Hz), 111.6 (d, J = 2.2 Hz), 21.3; 
19
F NMR (470 MHz, CDCl3): 
-143.0 (dd, J = 22.6 Hz, 6.1 Hz, 2F), -157.1 (t, J = 20.7 Hz, 1F), -163.2 (td, J = 20.7 Hz, 
6.1 Hz, 2F); IR (neat): υmax 2924, 1519, 1492, 1001, 958, 804 cm
-1
; HRMS (EI, m/z) 
calcd. for C15H9F5 [M]
+
: 284.0624; found: 284.0615. 
1-(4-Ethylstyryl)-2,3,4,5,6-pentafluorobenzene, 17f, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 4-ethylstyrene (44 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (33 mg, 56%), mp 134-136 ºC. 
1
H NMR (300 MHz, CDCl3): δ 
7.39-7.47 (m, 3H), 7.32 (d, J = 8.1 Hz, 2H), 6.94 (d, J = 16.5 Hz, 1H), 2.67 (q, J = 7.5 
Hz, 2H), 1.26 (t, J = 7.5 Hz, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 144.7 (dm, J = 
248.4 Hz), 145.5, 139.5 (dm, J = 252.0 Hz), 137.8 (dm, J = 249.2 Hz), 137.1 (t, J = 8.2 
Hz), 134.0, 128.4, 126.9, 112.6 (td, J = 13.5 Hz, 3.8 Hz), 111.7 (d, J = 1.5 Hz), 28.7, 
15.4; 
19
F NMR (470 MHz, CDCl3): δ -143.0 (dd, J = 20.2 Hz, 5.2 Hz, 2F), -157.1 (t, J = 
20.7 Hz, 1F), -163.2 (td, J = 20.7 Hz, 5.6 Hz, 2F); IR (neat): υmax 2925, 1522, 1491, 1001, 
959, 819 cm
-1
; HRMS (EI, m/z) calcd. for C16H11F5 [M]
+
: 298.0781; found: 298.0784. 
1-(4-tert-Butylstyryl)-2,3,4,5,6-pentafluorobenzene, 17g, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 
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4-tert-butylstyrene (37 µL, 0.2 mmol, 1.0 equiv), palladium (II) trifluoroacetate (6.7 mg, 
0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (46 mg, 70%), mp 100-102 ºC. 
1
H NMR (300 MHz, CDCl3): δ 
7.35-7.49 (m, 5H), 6.94 (d, J = 16.8 Hz, 1H), 1.34 (s, 9H); 
13
C{
1
H} NMR (75 MHz, 
CDCl3): δ 152.4, 144.7 (dm, J = 248.2 Hz), 139.5 (dm, J = 252.0 Hz), 137.8 (dm, J = 
249.0 Hz), 137.0 (t, J = 8.2 Hz), 133.7, 126.6, 125.8, 122.6 (td, J = 13.5 Hz, 3.8 Hz), 
111.8, 34.8, 31.2; 
19
F NMR (470 MHz, CDCl3): -142.9 (dd, J = 21.6 Hz, 6.6 Hz, 2F), -
157.0 (t, J = 20.7 Hz, 1F), -163.2 (td, J = 21.2 Hz, 6.6 Hz, 2F); IR (neat): υmax 2971, 
1520, 1498, 1003, 960, 822 cm
-1
; HRMS (EI, m/z) calcd. for C18H15F5 [M]
+
: 326.1094; 
found: 326.1081. 
1-(4-Methoxystyryl)-2,3,4,5,6-pentafluorobenzene, 17h, Scheme 9.
32
 The same general 
procedure was followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 
4-vinylanisole (27 µL, 0.2 mmol, 1.0 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (43 mg, 72%), mp 128-130 ºC. 
1
H NMR (600 MHz, CDCl3): δ 
7.47 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 16.8 Hz, 1H), 6.92 (d, J = 9.0, 2H), 6.83 (d, J = 16.8 
Hz, 1H), 3.85 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 160.3, 144.6 (dm, J = 247.5 
Hz), 139.3 (dm, J = 252.0 Hz), 137.8 (dm, J = 247.5 Hz), 136.6 (td, J = 9.0 Hz, 1.5 Hz), 
129.2, 128.2, 114.2, 112.7 (td, J = 13.5 Hz, 4.5 Hz), 110.3 (d, J = 3.0 Hz), 55.3; 
19
F NMR 
(470 MHz, CDCl3): δ -143.2 (dd, J = 21.2 Hz, 5.2 Hz, 2F), -157.5 (t, J = 20.7 Hz, 1F), -
163.3 (td, J = 20.7 Hz, 5.6 Hz, 2F); IR (neat): υmax 2926, 1603, 1519, 1492, 1255, 1001, 
956, 816 cm
-1
; HRMS (EI, m/z) calcd. for C15H9OF5 [M]
+
: 300.0574; found: 300.0561. 
4-(Perfluorostyryl)phenyl acetate, 17i, Scheme 9. The same general procedure was 
followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 4-
acetoxystyrene (30 µL, 0.2 mmol, 1.0 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). In this case little 
bit unreacted styrene was there with the same polarity desired products. To purify the 
desired products high pressure vacuum pump was used to remove the unreacted styrene. 
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Column chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (38 mg, 58%), mp 130-132 ºC. 
1
H  NMR (600 MHz, 
CDCl3): δ 7.54 (d, J = 8.4 Hz, 2H), 7.41, (d, J = 16.8 Hz, 1H), 7.13 (d, J = 8.4 Hz, 2H), 
6.93 (d, J = 16.8 Hz, 1H), 2.3 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 169.3, 151.0, 
144.8 (dm, J = 249.0 Hz), 139.7 (dm, J = 252.0 Hz), 137.7 (dm, J = 250.5 Hz), 136.0 (td, 
J =  9.0 Hz, 3.0 Hz), 134.2, 127.9, 122.0, 112.8 (d, J = 1.5 Hz), 112.2 (td, J = 13.5 Hz, 
3.0 Hz), 21.1; 
19
F NMR (470 MHz, CDCl3): δ -142.7 (dd, J = 21.6 Hz, 6.1 Hz, 2F), -
156.4 (t, J = 20.7 Hz, 1F), -162.9 (td, J = 20.2 Hz, 5.6 Hz, 2F); IR (neat): υmax 2925, 
1761, 1518, 1497, 1197, 1007, 957 cm
-1
; HRMS (EI, m/z) calcd. for C16H9O2F5 [M]
+
: 
328.0523; found: 328.0525.  
(4-(Perfluorostyryl)phenoxy)(tert-butyl)dimethylsilane, 17j, Scheme 9. The same 
general procedure was followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 
1.2 equiv), 4-(tert-butyldimethylsiloxy)styrene (47 µL, 0.2 mmol, 1.0 equiv), palladium 
(II) trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 
mmol, 2.0 equiv). Here little bit unreacted styrene was there with the same polarity 
desired products. To purify the desired products high pressure vacuum pump was used to 
remove the unreacted styrene. Column chromatography (SiO2, eluting with 97:3 
hexane/ethyl acetate) afforded the desired product as a white solid (54 mg, 68%), mp 
116-118 ºC. 
1
H NMR (600 MHz, CDCl3): δ 7.42 (d, J = 8.4 Hz, 2H), 7.37 (d, J = 16.8 
Hz, 1H), 6.86 (d, J = 9.0 Hz, 2H), 6.84 (d, J = 16.8 Hz, 1H), 1.01 (s, 9H), 0.24 (s, 6H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 156.6, 144.6 (dm, J = 248.1 Hz), 139.3 (dm, J = 
252.0 Hz), 137.7 (dm, J = 248.7 Hz), 136.8 (td, J = 9.0 Hz, 1.5 Hz), 129.8, 128.2, 120.5, 
112.7 (td, J = 13.5 Hz, 4.5 Hz), 110.5 (d, J = 1.5 Hz), 25.6, 18.2, -4.4; 
19
F NMR (470 
MHz, CDCl3): δ -143.2 (dd, J = 22.6 Hz, 6.1 Hz, 2F), -157.5 (t, J = 20.7 Hz, 1F), -163.3 
(td, J = 20.7 Hz, 6.6 Hz, 2F); IR (neat): υmax 2858, 1600, 1521, 1492, 1276, 1003, 960, 
916 cm
-1
; HRMS (EI, m/z) calcd. for C20H21OSiF5 [M]
+
: 400.1282; found: 400.1278. 
1-(3-Fluorostyryl)-2,3,4,5,6-pentafluorobenzene, 17k, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 3-fluorostyrene (36 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
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chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (35 mg, 61%), mp 82-84 ºC. 
1
H  NMR (600 MHz, CDCl3): δ 
7.39 (d, J = 16.2 Hz, 1H), 7.34-7.37 (m, 1H), 7.29 (d, J = 7.8 Hz, 1H), 7.22-7.24 (m, 1H), 
7.04 (td, J = 8.4 Hz, 1.8 Hz, 1H), 6.98 (d, J = 16.8 Hz, 1H); 
13
C{
1
H} NMR (150 MHz, 
CDCl3): δ 163.1 (d, J = 246.0 Hz), 144.8 (dm, J = 249.0 Hz), 139.9 (dm, J = 253.5 Hz), 
138.7 (d, J = 7.5 Hz), 137.8 (dm, J = 247.5 Hz), 135.8 (t, J = 7.5 Hz), 130.3 (d, J = 9.0 
Hz), 122.8 (d, J = 3.0 Hz), 115.8 (d, J = 21.0 Hz), 114.0 (d, J = 3.0 Hz), 113.2 (d, J = 
22.5 Hz), 111.9 (td, J = 13.5 Hz, 3.0 Hz); 
19
F NMR (470 MHz, CDCl3): δ -112.8 (s, 1F), -
142.4 (dd, J = 20.7 Hz, 5.2 Hz, 2F), -155.7 (t, J = 20.7 Hz, 1F), -162.7 (m, 2F); IR (neat): 
υmax 1521, 1494, 1004, 955, 680 cm
-1
; HRMS (EI, m/z) calcd. for C14H6F6 [M]
+
: 
288.0374; found: 288.0365. 
1-(3-Chlorostyryl)-2,3,4,5,6-pentafluorobenzene, 17l, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 3-chlorostyrene (38 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (43 mg, 71%), mp 74-76 ºC. 
1
H  NMR (300 MHz, CDCl3): δ 
7.51 (s, 1H), 7.31-7.42 (m, 4H), 6.98 (d, J = 16.8 Hz, 1H); 
13
C{
1
H} NMR (75 MHz, 
CDCl3): δ 144.9 (dm, J = 246.8 Hz), 140.0 (dm, J = 256.5 Hz), 138.3, 137.8 (dm, J = 
251.2 Hz), 135.6 (t, J = 8.2 Hz), 134.9, 130.0, 128.8, 126.7, 125.1, 114.1, 111.9 (td, J = 
13.5 Hz, 4.5 Hz); 
19
F NMR (470 MHz, CDCl3): δ -142.4 (dd, J = 21.2 Hz, 5.6 Hz, 2F), -
155.6 (t, J = 20.7 Hz, 1F), 162.6 (td, J = 21.6 Hz, 7.0 Hz, 2F); IR (neat): υmax 1519, 1497, 
1003, 964, 782 cm-1; HRMS (EI, m/z) calcd. for C14H6ClF5 [M]
+
: 304.0078; found: 
304.0075. 
1-(3-Bromostyryl)-2,3,4,5,6-pentafluorobenzene, 17m, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 3-bromostyrene (39 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Here 
little bit unreacted styrene was there with the same polarity desired products. To purify 
the desired products high pressure vacuum pump was used to remove the unreacted 
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styrene. Column chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded 
the desired product as a white solid (42 mg, 60%), mp 76-78 ºC. 
1
H NMR (300 MHz, 
CDCl3): δ 7.67-7.68 (m, 1H), 7.43-7.48 (m, 2H), 7.36 (d, J = 16.8 Hz, 1H), 7.24-7.29 (m, 
1H), 6.97 (d, J = 16.8 Hz, 1H); 
13
C{
1
H}NMR (75 MHz, CDCl3): δ 144.9 (dm, J = 249.4 
Hz), 140.0 (dm, J = 253.6 Hz), 138.6, 137.8 (dm, J = 250.5 Hz), 135.5 (t, J = 8.2 Hz), 
131.8, 130.3, 129.6, 125.5, 123.0, 114.1, 111.9 (td, J = 13.5 Hz, 3.8 Hz); 
19
F NMR (470 
MHz, CDCl3): δ -145.6 (dd, J = 20.7 Hz, 7.0 Hz, 2F), -158.8 (t, J = 20.7 Hz, 1F), -165.9 
(td, J = 20.7 Hz, 7.0 Hz, 2F); IR (neat): υmax 1521, 1496, 1002, 964, 780 cm
-1
; HRMS 
(EI, m/z) calcd. for C14H6BrF5 [M]
+
: 347.9573, 349.9553; found: 347.9573, 349.9541. 
1-(3-Methylstyryl)-2,3,4,5,6-pentafluorobenzene, 17n, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 3-methylstyrene (32 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (37 mg, 65%), mp 104-106 ºC. 
1
H  NMR (600 MHz CDCl3): δ 
7.40 (d, J = 16.8 Hz, 1H), 7.33-7.34 (m, 2H), 7.29 (t, J = 7.2 Hz, 1H), 7.16 (d, J = 7.2 Hz, 
1H), 6.97 (d, J = 16.8 Hz, 1H), 2.40 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 144.8 
(dm, J = 249.0 Hz), 139.6 (dm, J = 253.5 Hz), 138.5, 137.7 (dm, J = 249.0 Hz), 137.3 (td, 
J = 9.0 Hz, 3.0 Hz), 136.4, 129.8, 128.7, 127.5, 124.0, 112.43 (td, J = 13.5 Hz, 3.0 Hz), 
112.40 (d, J = 3.0 Hz), 21.4; 
19
F NMR (470 MHz, CDCl3): δ -142.8 (dd, J = 21.6 Hz, 7.0 
Hz, 2F), -156.8 (t, J = 20.7 Hz, 1F), -163.1 (m, 2F); IR (neat): υmax 2924, 1521, 1493, 
1000, 962, 783 cm
-1
; HRMS (EI, m/z) calcd. for C15H9F5 [M]
+
: 284.0624; found: 
284.0598. 
1-(3-Methoxystyryl)-2,3,4,5,6-pentafluorobenzene, 17o, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 
3-vinylanisole (28 µL, 0.2 mmol, 1.0 equiv), palladium (II) trifluoroacetate (6.7 mg, 0.02 
mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (45 mg, 75%), mp 140-142 ºC. 
1
H  NMR (600 MHz, CDCl3): δ 
7.40 (d, J = 16.8 Hz, 1H), 7.31 (t, J = 7.8 Hz, 1H), 7.13 (d, J = 7.8 Hz, 1H), 7.05 (d, J = 
  Chapter III  
137 
 
1.8 Hz, 1H), 6.97 (d, J = 16.8 Hz, 1H), 6.90 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 3.86 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 159.9, 144.8 (dm, J = 249.0 Hz), 139.7 (dm, J = 
252.0 Hz), 137.8, 137.7 (dm, J = 247.5 Hz), 137.0 (td, J = 9.0 Hz, 3.0 Hz), 129.8, 119.5, 
114.6, 113.0 (d, J = 3.0 Hz), 112.3 (td, J = 13.5 Hz, 3.0 Hz), 112.1, 55.3; 
19
F NMR (470 
MHz, CDCl3): δ -142.7 (dd, J = 22.1 Hz, 6.1 Hz, 2F), -156.5 (t, J = 20.7 Hz, 1F), -163.0 
(td, J = 21.2 Hz, 6.1 Hz, 2F); IR (neat): υmax 1578, 1522, 1495, 1268, 1045, 1002, 965, 
778 cm
-1
; HRMS (EI, m/z) calcd. for C15H9OF5 [M]
+
: 300.0574; found: 300.0564. 
1-(3-(Trifluoromethyl)styryl)-2,3,4,5,6-pentafluorobenzene, 17p, Scheme 9. The same 
general procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 
1.0 equiv), 3-trifluoromethylstyrene (45 µL, 0.3 mmol, 1.5 equiv), palladium (II) 
trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 
2.0 equiv). Column chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) 
afforded the desired product as a white solid (45 mg, 67%), mp 76-78 ºC. 
1
H  NMR (600 
MHz, CDCl3): δ 7.76 (s, 1H), 7.71 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 7.8 Hz, 1H), 7.52 (t, J 
= 7.8 Hz, 1H), 7.46 (d, J = 16.2 Hz, 1H), 7.05 (d, J = 16.8 Hz, 1H); 
13
C{
1
H} NMR (150 
MHz, CDCl3): δ 144.9 (dm, J = 249.0 Hz), 140.1 (dm, J = 255.0 Hz), 137.2, 137.8 (dm, J 
= 251.7 Hz), 135.5 (td, J = 9.0 Hz, 1.5 Hz), 131.4 (q, J = 33.0 Hz), 129.8, 129.3, 123.9 
(q, J = 271.5 Hz), 125.4 (q, J = 4.5 Hz), 123.6 (q, J = 3.0 Hz), 114.6 (d, J = 3.0 Hz), 
111.7 (td, J = 13.5 Hz, 4.5 Hz); 
19
F NMR (470 MHz, CDCl3): δ -66.1 (s, 1F), -145.6 (dd, 
J = 21.2 Hz, 7.5 Hz, 2F), -158.6 (t, J = 20.7 Hz, 1F), -165.8 (td, J = 21.2 Hz, 7.5 Hz, 2F); 
IR (neat): υmax 2924, 1520, 1497, 1331, 1128, 1004, 961, 695 cm
-1
; HRMS (EI, m/z) 
calcd. for C15H6F8 [M]
+
: 338.0342; found: 338.0343. 
1-(2-Methylstyryl)-2,3,4,5,6-pentafluorobenzene, 17q, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), 2-methylstyrene (31 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a white solid (34 mg, 60%), mp 112-114 ºC. 
1
H  NMR (300 MHz, CDCl3): δ 
7.68 (d, J = 16.8 Hz, 1H), 7.57-7.61 (m, 1H), 7.19-7.28 (m, 3H), 6.86 (d, J = 16.5 Hz, 
1H), 2.42 (s, 3H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 144.8 (dm, J = 248.2 Hz), 139.7 
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(dm, J = 252.8 Hz), 137.8 (dm, J = 249.8 Hz), 136.4, 135.7, 135.2 (td, J = 8.2 Hz, 3.0 
Hz), 130.6, 128.8, 126.4, 125.3, 113.8 (d, J = 3.0 Hz), 112.6 (td, J = 13.5 Hz, 4.5 Hz), 
19.7; 
19
F NMR (470 MHz, CDCl3): δ -143.0 (dd, J = 20.2 Hz, 7.5 Hz, 2F), -156.7 (t, J = 
20.7 Hz, 1F), -163.0 (td, J = 21.2 Hz, 7.0 Hz, 2F); IR (neat): υmax 2924, 1522, 1494, 
1000, 962, 754 cm
-1
; HRMS (EI, m/z) calcd. for C15H9F5 [M]
+
: 284.0624; found: 
284.0620. 
1,3-Dimethoxy-5-(perfluorostyryl)benzene, 17r, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 
3,5-dimethoxystyrene (33 µL, 0.2 mmol, 1.0 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column 
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (46 mg, 69%), mp 103-105 ºC. 
1
H NMR (300 MHz, CDCl3): δ 
7.36 (d, J = 16.5 Hz, 1H), 6.95 (d, J = 16.8 Hz, 1H), 6.67 (d, J = 2.1 Hz, 2H), 6.46 (t, J = 
2.1 Hz, 1H), 3.84 (s, 6H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 161.1, 144.8 (dm, J = 
249.2 Hz), 139.7 (dm, J = 253.0 Hz), 137.7 (dm, J = 249.8 Hz), 138.4, 137.1 (td, J = 8.2 
Hz, 1.5 Hz), 113.1 (d, J = 2.2 Hz), 112.2 (td, J = 13.5 Hz, 4.5 Hz), 104.9, 101.1, 55.4; 
19
F 
NMR (470 MHz, CDCl3): δ -142.6 (dd, J = 20.7 Hz, 5.6 Hz, 2F), -156.4 (t, J = 20.7 Hz, 
1F), -163.0 (m, 2F); IR (neat): υmax 1593, 1522, 1494, 1296, 1155, 1061, 1005 cm
-1
; 
HRMS (EI, m/z) calcd. for C16H11O2F5 [M]
+
: 330.0679; found: 330.0678. 
1-(3,4-Dimethoxystyryl)-2,3,4,5,6-pentafluorobenzene, 17s, Scheme 9. The same 
general procedure was followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 
1.2 equiv), 3,4-dimethoxystyrene (30 µL, 0.2 mmol, 1.0 equiv), palladium (II) 
trifluoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 
2.0 equiv). Here little bit unreacted styrene was there with the same polarity desired 
products. To purify the desired products high pressure vacuum pump was used to remove 
the unreacted styrene. Column chromatography (SiO2, eluting with 97:3 hexane/ethyl 
acetate) afforded the desired product as a white solid (45 mg, 68%), mp 131-133 ºC. 
1
H  
NMR (600 MHz, CDCl3): δ 7.36 (d, J = 16.2 Hz, 1H), 7.08 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 
7.04 (d, J = 1.8 Hz, 1H), 6.87 (d, J = 7.8 Hz, 1H), 6.82 (d, J = 16.8 Hz, 1H), 3.95 (s, 3H), 
3.92 (s, 3H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 149.6, 149.2, 144.6 (dm, J = 247.5 
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Hz), 139.4 (dm, J = 247.5 Hz), 137.7 (dm, J = 247.5 Hz), 136.9 (td, J = 9.0 Hz, 1.5 Hz), 
120.6, 112.6 (td, J = 13.5 Hz, 4.5 Hz), 111.1, 110.5 (d, J = 3.0 Hz), 108.8, 55.92, 55.90; 
19
F NMR (470 MHz, CDCl3): δ -143.2 (dd, J = 20.7 Hz, 5.2 Hz, 2F), -157.3 (t, J = 20.7 
Hz, 1F), -163.2 (td, J = 20.7 Hz, 5.2 Hz, 2F); IR (neat): υmax 1520, 1494, 1262, 1022, 961 
cm
-1
; HRMS (ESI, m/z) calcd. for C16H11O2F5Na [M + Na]
+
: 353.0577; found: 353.0577. 
2-Methoxy-4-(perfluorostyryl)phenyl acetate, 17t, Scheme 9. The same general 
procedure was followed by using pentafluorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 
4-acetoxy-3-methoxystyrene (38 µL, 0.2 mmol, 1.0 equiv), palladium (II) trifluoroacetate 
(6.7 mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). 
Column chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (44 mg, 62%), mp 149-151 ºC. 
1
H  NMR (600 MHz, 
CDCl3): δ 7.40 (d, J = 16.8 Hz, 1H), 7.12 (dd, J = 8.4 Hz, 1.8 Hz, 1H), 7.09 (s, 1H), 7.06 
(d, J = 7.8 Hz, 1H), 6.91 (d, J = 16.8 Hz, 1H), 3.90 (s, 3H), 2.53 (s, 3H); 
13
C{
1
H} NMR 
(150 MHz, CDCl3): δ 168.9, 151.3, 144.8 (dm, J = 249.0 Hz), 140.3, 139.7 (dm, J = 
252.6 Hz), 137.7 (dm, J = 250.5 Hz), 136.4 (td, J = 9.0 Hz, 1.5 Hz), 135.4, 123.1, 119.6, 
112.9 (d, J = 1.5 Hz), 112.2 (td, J = 13.5 Hz, 3.0 Hz), 110.4, 55.9, 20.6; 
19
F NMR (470 
MHz, CDCl3): δ -142.7 (dd, J = 20.7 Hz, 5.6 Hz, 2F), -156.3 (t, J = 20.7 Hz, 1F), -162.9 
(m, 2F); IR (neat): υmax 1764, 1517, 1496, 1204, 1004, 968 cm
-1
; HRMS (ESI, m/z) calcd. 
for C17H11O3F5Na [M + Na]
+
: 381.0526; found: 381.0534. 
1,2,3,4-Tetrafluoro-5-styrylbenzene, 17u, Scheme 9.
27a
 The same general procedure 
was followed by using tetrafluorobenzoic acid (39 mg, 0.2 mmol, 1.0 equiv), styrene (35 
µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (13.4 mg, 0.04 mmol, 0.2 
equiv), and silver carbonate (165 mg, 0.6 mmol, 3.0 equiv). 5% DMSO was used as a co 
solvent and the reaction was run for 4 hours at 120 
o
C. Column chromatography (SiO2, 
eluting with 98:2 hexane/ethyl acetate) afforded the desired product as a white solid (30 
mg, 60%), mp 86-88 ºC. 
1
H  NMR (600 MHz, CDCl3): δ 7.52 (d, J = 7.8 Hz, 2H), 7.39 (t, 
J = 7.8 Hz, 2H), 7.33 (t, J = 7.8 Hz, 1H), 7.18-7.22 (m, 1H), 7.08 -7.15 (m, 2H); 
13
C{
1
H} 
NMR (150 MHz, CDCl3): δ 147.3 (dm, J = 244.8 Hz), 145.3 (dm, J = 248.4 Hz), 141.0 
(dm, J = 250.0 Hz), 139.6 (dm, J = 252.9 Hz), 136.1, 132.9 (t, J = 3.0 Hz), 128.8, 128.7, 
126.8, 121.7 (m), 117.9 (t, J = 3.0 Hz), 107.4 (dt, J = 21.0 Hz, 3.0 Hz); 
19
F NMR (470 
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MHz, CDCl3): δ -139.8 (dd, J = 21.2 Hz, 11.3 Hz, 1F), -144.1 (dd, J = 20.7 Hz, 10.8 Hz, 
1F) -156.0 (t, J = 19.3 Hz, 1F), -157.0 (t, J = 20.7 Hz, 1F); IR (neat): υmax 1527, 1477, 
1039, 942, 756, 693 cm
-1
; HRMS (EI, m/z) calcd. for C14H8F4 [M]
+
: 252.0562; found: 
252.0556. 
1-(2,6-Difluorostyryl)benzene, 17v, Scheme 9.
27a
 The same general procedure was 
followed by using difluorobenzoic acid (32 mg, 0.2 mmol, 1.0 equiv), styrene (35 µL, 0.3 
mmol, 1.5 equiv), palladium (II) trifluoroacetate (13.4 mg, 0.04 mmol, 0.2 equiv), and 
silver carbonate (165 mg, 0.4 mmol, 3.0 equiv). 5% DMSO was used as a co solvent and 
the reaction was run for 4 hours at 120 
o
C. Column chromatography (SiO2, eluting with 
98:2 hexane/ethyl acetate) afforded the desired product as a white solid (30 mg, 70%), 
mp 65-67 ºC. 
1
H  NMR (300 MHz, CDCl3): δ 7.54 (d, J = 7.2 Hz, 2H), 7.25-7.42 (m, 
4H), 7.11-7.18 (m, 2H), 6.91 (t, J = 8.4 Hz, 2H); 
13
C{
1
H} NMR (75 MHz, CDCl3): δ 
161.0 (dm, J = 249.8 Hz), 137.4, 135.1 (t, J = 8.1 Hz), 128.7, 128.2, 127.8 (t, J = 10.5 
Hz), 126.7, 115.2, 114.8 (t, J = 15.0 Hz), 111.5 (m); 
19
F NMR (470 MHz, CDCl3): δ -
113.0 (s, 2F); IR (neat): υmax 1565, 1463, 1210, 993, 748 cm
-1
. 
1-Cinnamyl-2,3,4,5,6-pentafluorobenzene, 17w, Scheme 9.
41
 The same general 
procedure was followed by using pentafluorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 
equiv), allylbenzene (40 µL, 0.3 mmol, 1.5 equiv), palladium (II) trifluoroacetate (6.7 
mg, 0.02 mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv) except 
the reaction was run at 120 
o
C. Column chromatography (SiO2, eluting with 98:2 
hexane/ethyl acetate) afforded the desired product as a colorless liquid (42 mg, 74%). 
1
H  
NMR (600 MHz, CDCl3): δ 7.23-7.36 (m, 5H), 6.50 (d, J = 15.6 Hz, 1H), 6.21-6.26 (m, 
1H), 3.62 (dd, J = 6.6 Hz, 0.6 Hz, 2H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 145.0 (dm, J 
= 244.5 Hz), 139.8 (dm, J = 250.5 Hz), 137.5 (dm, J = 249.0 Hz), 136.5, 132.4, 128.6, 
127.6, 126.2, 124.2, 113.2 (td, J = 19.5 Hz, 4.5 Hz), 25.6; 
19
F NMR (470 MHz, CDCl3): δ 
-143.9 (dd, J = 21.6 Hz, 7.0 Hz, 2F), -157.3 (t, J = 20.7 Hz, 1F), -162.5 (td, J = 20.7 Hz, 
7.0 Hz, 2F); IR (neat): υmax 1498, 1118, 990, 963, 911, 754, 694 cm
-1
; HRMS (EI, m/z) 
calcd. for C15H9F5 [M]
+
: 284.0624; found: 284.0608. 
Gram scale reaction: (Synthesis of 1,2,3,4,5-Pentafluoro-6-styrylbenzene, Scheme 9, 
17a). 
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To an oven-dried 250 mL round bottom flask, a mixture of pentafluorobenzoic acid (1.0 
g, 4.7 mmol, 1.0 equiv), palladium (II) trifluoroacetate (156 mg, 0.47 mmol, 0.1 equiv), 
and silver carbonate (2.6 g, 9.4 mmol, 2.0 equiv) was taken then dry DMF (80 mL) was 
added to it under nitrogen atmosphere. To this reaction mixture styrene (0.8 ml, 7.05 
mmol,) was added via syringe. The reaction mixture was allowed to stir for 16 h at room 
temperature under nitrogen atmosphere. After completion (as detected by TLC), the 
reaction mixture was poured into water (60 mL) and extracted with ethyl acetate (80 mL). 
The organic layer was washed with water (30 mL) and brine (20 mL), dried over 
anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. The pure 
1,2,3,4,5-pentafluoro-6-styrylbenzene (17a) was obtained as a white solid in 61% (775 
mg) yield after column chromatography of the crude reaction mixture using ethyl 
acetate/hexane (98:2) as eluent. 
Experimental procedure for the preparation of 1-(2,3,5,6-Tetrafluoro-4-
styrylphenyl)-1H-indole, 21a, Scheme 12 from 1,2,3,4,5-Pentafluoro-6-
styrylbenzene(17a). 
Sodium tert-butoxide (53 mg, 0.55 mmol, 1.1 equiv) was added to a glass vial containing 
indole (59 mg, 0.5 mmol, 1.0 equiv) in dry DMA (3.0 mL). The mixture was stirred at 
room temperature for 1.0 min. The mixture was cooled and added to a cooled solution of 
1,2,3,4,5-pentafluoro-6-styrylbenzene (162 mg, 0.6 mmol,1.2 equiv) in dry DMA (3.0 
mL) under stirring in a 10 mL round bottom flask. After 15 min the cooling bath was 
removed and the reaction mixture was allowed to stir for 1 h at room temperature under 
nitrogen atmosphere. After completion (as detected by TLC), the reaction mixture was 
mixed with sat. NH4Cl (aq.) (5.0 mL) and water (10 mL) then extracted with ethyl acetate 
(20 mL) The organic layer was washed with water (10 mL) and brine (10 mL), dried over 
anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. The crude 
product was purified by column chromatography eluting with hexane/ethyl acetate (8:2) 
afforded the desired product as a white solid (156 mg, 85%), mp 130-132 ºC. 
1
H  NMR 
(600 MHz, CDCl3): δ 7.75 (d, J = 7.8 Hz, 1H), 7.61-7.64 (m, 3H), 7.46 (t, J = 7.8 Hz, 
2H), 7.40 (t, J = 7.2 Hz, 1H), 7.33 (td, J = 8.4 Hz, 1.2 Hz, 1H), 7.28 (td, J = 7.8 Hz, 1.2 
Hz, 1H), 7.23-7.26 (m, 2H), 7.18 (d, J = 16.8 Hz, 1H), 6.83 (d, J = 3.6 Hz, 1H); 
13
C{
1
H} 
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NMR (150 MHz, CDCl3): δ 145.0 (dm, J = 249.2 Hz), 142.8 (dm, J = 250.0 Hz), 138.0 
(t, J = 9.0 Hz), 136.4, 136.3, 129.2, 128.9, 128.7, 128.3, 127.1, 123.1, 121.2 (d, J = 3.0 
Hz), 116.6 (m), 116.2 (t, J = 13.5 Hz), 113.2, 110.6, 105.5; 
19
F NMR (470 MHz, CDCl3): 
δ -145.6 (m, 2F), -150.7 (m, 2F); IR (neat): υmax 1519, 1487, 1204, 971, 748, 693 cm
-1
; 
HRMS (FAB, m/z) calcd. for C22H14NF4 [M + H]
+
: 368.1062; found: 368.1062. 
Experimental procedure for the preparation of 1-(2,3,5,6-Tetra(1H-pyrazol-1-yl)-4-
styrylphenyl)-1H-indole, 23a, Scheme 12 from 1-(2,3,5,6-Tetrafluoro-4-
styrylphenyl)-1H-indole(21a). 
Sodium tert-butoxide (48 mg, 0.5 mmol, 5.0 equiv) was added to a glass vial containing 
pyrazole (34 mg, 0.5 mmol, 5.0 equiv) in dry DMA (1.0 mL). The mixture was stirred at 
room temperature for 1.0 min. The mixture was cooled and added to a cooled solution of 
1-(2,3,5,6-tetrafluoro-4-styrylphenyl)-1H-indole (37 mg, 0.1 mmol, 1.0 equiv) in dry 
DMA (1.0 mL) under stirring in a 10 mL round bottom flask. After 15 min the cooling 
bath was removed and the reaction mixture was allowed to stir for 1 h at room 
temperature under nitrogen atmosphere. After completion (as detected by TLC), the 
reaction mixture was quenched with sat. NH4Cl (aq.) (1.0 mL) then extracted with 
ethylacetate (20 mL) and water (10 mL). The organic layer was washed with water (10 
mL) and brine (10 mL), dried over anhydrous Na2SO4 and the solvent was evaporated 
under reduced pressure. The crude product was purified by column chromatography 
eluting with hexane/ethyl acetate (7:3) afforded the desired product as a white solid (55 
mg, 98%), mp 280-282 ºC. 
1
H  NMR (600 MHz, CDCl3): δ 7.66 (d, J = 1.8 Hz, 2H), 7.53 
(d, J = 2.4 Hz, 2H), 7.42-7.43 (m, 1H), 7.27-7.28 (m, 2H), 7.23-7.24 (m, 3H), 7.00-7.05 
(m, 7H), 6.84 (d, J = 3.0 Hz, 1H), 6.41 (d, J = 3.0 Hz, 1H), 6.38 (d, J = 16.8 Hz, 1H), 
6.35 (t, J = 1.8 Hz, 2H), 5.90 (t, J = 1.8 Hz, 2H), 5.86 (d, J = 16.8 Hz, 1H); 
13
C{
1
H} 
NMR (150 MHz, CDCl3): δ 141.12, 141.10, 138.4, 137.17, 137.16, 136.9, 136.33, 
136.28, 132.7, 132.5, 131.3, 128.8, 128.6, 128.3, 127.9, 126.8, 122.4, 120.5, 117.7, 109.6, 
107.2, 106.8, 104.8; IR (neat): υmax 2923, 1519, 1480, 1389, 1037, 950, 756 cm
-1
; HRMS 
(EI, m/z) calcd. for C34H25N9 [M]
+
: 559.2233; found: 559.2235. 
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Experimental procedure for the preparation of Benzyl(2,3,5,6-tetrafluoro-4-
styrylphenyl)sulfane, 25a, Scheme 12 from 1,2,3,4,5-Pentafluoro-6-
styrylbenzene(17a). 
A mixture of 1,2,3,4,5-pentafluoro-6-styrylbenzene (27 mg, 0.1 mmol, 1.0 equiv.), 
phenylmethanethiol (14 µL, 0.12 mmol, 1.2 equiv) and TRIS (145 mg, 1.2 mmol, 12 
equiv) in dry DMF (2.0 mL) was stirred for 12 h at room temperature under argon 
atmosphere in a 10 mL round bottom flask. After completion (as detected by TLC), the 
reaction mixture was poured into water (10 mL) and extracted with ethyl acetate (20 mL). 
The organic layer was washed with water (10 mL) and brine (10 mL), dried over 
anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. The crude 
product was purified by column chromatography eluting with hexane/ethyl acetate (8:2) 
to afford the desired product as a white solid (34 mg, 90%), mp 108-110 ºC. 
1
H  NMR 
(600 MHz, CDCl3): δ 7.56 (d, J = 7.8 Hz, 2H), 7.50 (d, J = 16.8 Hz, 1H), 7.42 (t, J = 7.2 
Hz, 2H), 7.36 (t, J = 7.8 Hz, 1H), 7.25-7.31 (m, 5H), 7.06 (d, J = 16.8 Hz, 1H), 4.16 (s, 
2H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 147.1 (dm, J = 242.8 Hz), 144.4 (dm, J = 
250.2 Hz), 137.6 (t, J = 9.0 Hz), 136.5 (d, J = 1.5 Hz), 129.0, 128.83, 128.78, 128.6, 
127.7, 127.0, 117.0 (t, J = 13.5 Hz), 113.7, 111.4 (t, J = 21.0 Hz), 39.0 (t, J = 3.0 Hz); 
19
F 
NMR (470 MHz, CDCl3): δ -138.4 (dd, J = 22.6 Hz, 11.3 Hz, 2F), -146.2 (dd, J = 22.6 
Hz, 11.3 Hz, 2F); IR (neat): υmax 1468, 1064, 959, 752, 693 cm
-1
; HRMS (EI, m/z) calcd. 
for C21H14SF4 [M]
+
: 374.0752; found: 374.0734. 
Experimental procedure for the preparation of tert-Butyl (S)-1-(methoxycarbonyl)-
2-(2,3,5,6-tetrafluoro-4-styrylphenylthio)ethylcarbamate, 27a, Scheme 12 from 
1,2,3,4,5-Pentafluoro-6-styrylbenzene(17a). 
A mixture of 1,2,3,4,5-pentafluoro-6-styrylbenzene, 17a (27 mg, 0.1 mmol, 1.0 equiv), 
N-(tert-butoxycarbonyl)-L-cysteine methyl ester (21 µL, 0.1 mmol, 1.0 equiv) and TRIS 
(25 mg, 0.2 mmol, 2.0 equiv) in dry DMF (2.0 mL) was stirred for 4.5 h at room 
temperature under argon atmosphere in a 10 mL round bottom flask. After completion (as 
detected by TLC), the reaction mixture was poured into water (10 mL) and extracted with 
ethyl acetate (20 mL). The organic layer was washed with water (10 mL) and brine (10 
mL), dried over anhydrous Na2SO4 and the solvent was evaporated under reduced 
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pressure. The crude product was purified by column chromatography eluting with 
hexane/ethyl acetate (7:3) to afford the desired product as a white solid (41 mg, 84%), mp 
90-92 ºC. 
1
H  NMR (600 MHz, CDCl3): δ 7.56 (d, J = 7.2 Hz, 2H), 7.52 (d, J = 16.2 Hz, 
1H), 7.42 (t, J = 7.2 Hz, 2H), 7.36 (t, J = 7.2 Hz, 1H), 7.08 (d, J = 16.8 Hz, 1H), 5.39 (d, 
J = 6.6 Hz, 1H), 4.58-4.60 (m, 1H), 3.70 (s, 3H), 3.47 (dd, J = 14.4 Hz, 4.2 Hz, 1H), 3.38 
(dd, J = 14.4 Hz, 4.2 Hz, 1H), 1.41 (s, 9H); 
13
C{
1
H} NMR (150 MHz, CDCl3): δ 170.4, 
154.7, 147.1(dm, J = 243.0 Hz), 144.4 (dm, J = 250.5 Hz), 138.0 (t, J = 9.0 Hz), 136.4, 
129.1, 128.8, 127.0, 117.5 (t, J = 13.5 Hz), 113.5, 111.0 (t, J = 21.0 Hz), 80.3, 53.7, 52.6, 
36.6, 28.1; 
19
F NMR (470 MHz, CDCl3): δ -134.5 (m, 2F), -142.6 (m, 2F); IR (neat): υmax 
1739, 1706, 1472, 1342, 1160, 1063, 1015, 963, 754 cm
-1
; HRMS (EI, m/z) calcd. for 
C23H23NO4SF4 [M]
+
: 485.1284; found: 485.1287. 
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CHAPTER IV 
 
Palladium-Catalyzed Decarboxylative, Decarbonylative and 
Dehydrogenative C(sp
2
)-H Acylation at Room Temperature 
 
 
 
Abstract: Over the past decades, an impressive array of C-H activation methodology has 
been developed for organic synthesis. However, due to the inherent inertness of the C-H 
bonds (e. g. ~ 110 kcal/mol for the cleavage of C(aryl)-H bonds) harsh reaction 
conditions have been realized to overcome high energetic transition states resulting in 
limited substrate scope and functional group tolerance. Therefore, development of mild 
C-H functionalization protocols is in high demand to exploit the full potential of C-H 
activation strategy in the synthesis of complex molecular framework. Although, electron-
rich substrates undergo electrophilic metalation under relatively mild conditions, 
electron-deficient substrates proceed through a rate-limiting C-H insertion under forcing 
conditions at high temperature. In addition, stoichiometric amount of toxic silver salt is 
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frequently used in palladium catalysis to facilitate the C-H activation process which is not 
acceptable from environmental and industrial standpoint. We report herein, a Pd(II)-
catalyzed decarboxylative C-H acylation of 2-arylpyridines with α-ketocarboxylic acids 
under mild conditions. The present protocol does not require stoichiometric silver(I) salts 
as additives and proceeds smoothly at ambient temperature. A novel decarbonylative C-H 
acylation reaction has also been accomplished using aryl glyoxals as acyl surrogate. 
Finally, a practical C-H acylation via dehydrogenative pathway has been demonstrated 
using commercially available benzaldehydes and aqueous hydroperoxide. We also 
disclose that acetonitrile solvent is optimal for the acylation reaction at room temperature 
and has a prominent role on the reaction outcome. Control experiments suggest that the 
acylation reaction via decarboxylative, decarbonylative and dehydrogenative proceeds 
through radical pathway. Thus we disclose a practical protocol for the sp
2
 C-H acylation 
reaction. 
 
1. Hossian, A.; Manna, M. K.; Manna, K.; Jana, R. Org. Biomol. Chem. 2017, 15, 6592-
6603. 
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Palladium-Catalyzed Decarboxylative, Decarbonylative and 
Dehydrogenative C(sp
2
)-H Acylation at Room Temperature 
IV. 1. Introduction 
Owing to the prevalence of benzophenones in natural products, pharmaceuticals and 
functionalized materials, the synthesis of functionalized carbonyl compounds is a 
sustained exertion in organic synthesis (Figure 1).
1
 Typically, Lewis-acid promoted 
Friedel-Crafts acylation via electrophilic aromatic substitution generates isomeric 
mixtures and requires stoichiometric metal salts.
2
 The reaction of Weinreb amides with 
Grignard reagents yields the carbonyl compounds with limited functional group 
tolerance.
3
 Whereas, transition metal catalyzed cross-couplings are reported with 
relatively less nucleophilic organometallic reagents such as organozinc reagents and 
boronic acids.
4
 As an alternative to air and moisture sensitive acyl chlorides which 
generate stoichiometric metal halide waste, thioesters is used in palladium-catalyzed 
Liebeskind-Srogl cross-coupling.
5
 However, the reaction requires stoichiometric amount 
of copper complex as additive. Carbonylation of aryl halides with hazardous carbon 
monoxide requires special handling skills and laboratory set up.
6
 Therefore, considering 
the stringent environmental factors (E factors) in chemical processes there is an urgent 
need for the development of practical and environmentally benign acylation reactions. 
 
Figure 1. Some benzophenone containing drugs 
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Beyond typical cross-coupling approaches, the C-H activation strategy offers a 
unique opportunity to access carbonyl compounds without prefunctionalization steps 
(Scheme 1).
7
 Although an enormous effort has been dedicated to the development of C-H 
activation processes, significant challenges still remain unsolved. The harsh reaction 
conditions, use of stoichiometric toxic silver(I) salts, high reaction temperature etc. limits 
their application in the synthesis of complex molecular architecture and industrial 
processes. Thus, developments of mild acylation reaction via C-H activation processes is 
in high demand.
8
 In recent years, decarboxylative cross-coupling has been established as 
a modern strategy for C-C and C-heteroatom bond formation.
9
 Inexpensive and readily 
available carboxylic acids are used as an alternative to expensive organometallic reagents 
and halides. Combining the decarboxylative cross-coupling process and the C-H 
activation method, decarboxylative C-H functionalization has emerged as a fascinating 
field of research.
10
 However, like C-H insertion, decarboxylative metalation is also a high 
energetic process and proceeds at elevated temperatures.
11
 In this vein, α-oxocarboxylic 
acids undergo transition metal-catalyzed decarboxylation to provide acyl anion 
equivalent which been utilized in cross-coupling
12
 and C-H acylation reaction to provide 
diaryl ketones (Scheme 1).
13
 
 
Scheme 1. Synthesis of carbonyl compounds via C-H bond activation methods. 
IV. 2. Review 
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In their seminal work in 2010, the Ge group have developed a palladium catalyzed 
decarboxylative ortho C(sp
2
)-H acylation of acetanilides with α-ketocarboxylic acids at 
room temperature (Scheme 2).
14
 This reaction provides variety of aryl ketones with 
excellent yield and regioselectivity under mild conditions. Mechanistically, first ortho-
palladation of the acetanilides occurred through a facile electrophilic ortho metalation 
pathway and subsequent anion exchange with α-ketocarboxylates provided the 
intermediate II. Then palladium mediated decarboxylation followed by reductive 
elimination afforded the desired acylated product and palladium(II) catalyst is 
regenerated in the catalytic cycle via oxidation by oxidant (NH4)2S2O8.  
 
 Scheme 2. Palladium-catalyzed decarboxylative ortho acylation of acetanilides 
Very recently, a dual catalysis approach has been developed for the novel organic 
transformations via single electron transfer pathway under very mild reaction 
conditions.
15 
The dual catalysis strategy comprising the merging of visible light induced 
photoredox catalysis and transition metal catalysis system has also been successfully 
applied to the decarboxylative acylation reactions. In this vein, the Wang group have 
developed a dual catalyst system merging palladium catalysis and photoredox catalysis 
for the decarboxylative C(sp
2
)-H acylation of acetanilides (Scheme 3).
16b
 Interestingly, no 
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external stoichiometric oxidant is required for the catalytic turnover and molecular 
oxygen acts as an oxidant via superoxide radical anion formation in the reaction.  
 
Scheme 3. Decarboxylative ortho C(sp
2
)-H acylation of acetanilides using dual catalysis 
In 2016, the same group reported the decarboxylative C(sp
2
)-H acylation of azo- 
and azoxybenzenes with α-oxocarboxylic acids utilizing the dual catalysis approach 
through an acyl-radical intermediate (Scheme 4).
16a
 
 
Scheme 4. Decarboxylative ortho C(sp
2
)-H acylation of azobenzene using dual catalysis 
For the C(sp
2
)-H acylation reactions of electron deficient substrates, the Ge group 
have reported palladium-catalyzed decarboxylative C(sp
2
)-H acylation of 2-
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phenylpyridines
17
 (Scheme 5) and benzoic acids
18
 (Scheme 6) with α-oxocarboxylic 
acids. They adopted palladium/silver bimetallic catalytic system for this transformation 
where stoichiometric amount of silver salt was used as an oxidant as well as 
decarboxylation agent. These methods provided variety of aromatic ketones with 
excellent yields and regioselectivities. 
 
Scheme 5. Palladium-catalyzed decarboxylative ortho C(sp
2
)-H acylation of 2-
phenylpyridines 
 
Scheme 6. Palladium-catalyzed decarboxylative C(sp
2
)-H acylation of benzoic acids 
Recently, Zhang and coworkers reported a palladium-catalyzed decarboxylative 
ortho C-H acylation of 2-aryloxypyridines with α-oxocarboxylic acids (Scheme 7).19 In 
the reaction, they have also used stoichiometric amount of silver salt as an oxidant on 
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palladium for catalytic turnover. The advantage of the reaction is the easy removal of the 
pyridine moiety from the products to give the corresponding 2-hydroxy aryl ketones 
which are useful precursors for the preparation of oxygen containing heterocycles.
20
  
 
Scheme 7. Decarboxylative ortho C(sp
2
)-H acylation of 2-aryloxypyridines 
IV. 3. Present work 
The decarboxylative C-H acylation of electron rich aniline derivatives or oximes proceed 
at ambient temperature through a facile electrophilic ortho metalation,
21
 but electron-
deficient substrates require high temperature (110-140 
o
C) and stoichiometric silver(I) 
salt which is not acceptable from environmental and industrial viewpoint.
17,18
 To the best 
of our knowledge, silver free decarboxylative acylation of electron-deficient 2-
arylpyridine at room temperature has not been reported so far. As a part of our continuing 
research program for the development of cross-coupling reactions at mild conditions, we 
have reported decarboxylative Heck coupling at room temperature
22
 and divergent 
synthesis of 2-arylindol and indolines via C-H activation.
23
 Herein for the first time, we 
report a palladium-catalyzed decarboxylative C-H acylation of electron-deficient 2-
arylpyridines system at room temperature. The present protocol does not require 
stoichiometric silver(I) salt and  a dramatic influence of solvent was observed where 
acetonitrile was found to be optimal for this acylation reaction at ambient condition.
24
 
This room temperature acylation reaction was also demonstrated using phenylglyoxals 
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and aldehydes as acylating agent via decarbonylative and dehydrogenative manifolds 
respectively. 
 
Scheme 8. C(sp
2
)-H acylation reaction 
IV. 4. Results and discussion  
Initially, we started optimization for the decarboxylative acylation reaction at room 
temperature. A mixture of 2-phenylpyridine (6a) and phenylglyoxylic acid (2a) was 
stirred in the presence of 10 mol % palladium(II)acetate and 2.0 equiv of potassium 
persulfate (K2S2O8) in diglyme solvent.
10k
 The expected monoacylated product (7a) was 
obtained in 20% yield without any silver(I) salt added (entry 1, Table 1). Further 
screening of solvents showed that acetonitrile is superior to other solvents such as DMF, 
DMSO, toluene, acetic acid, 1,4-dioxane and DCE (entry 2-7, Table 1). Typically, silver 
salt is used in palladium catalysis for facile decarboxylation, carbonate or carboxylate 
anion source, halide scavenger and terminal oxidant for catalytic turnover.
25 
However, 
contrary to our expectations, no desired product was isolated using silver salts such as 
Ag2CO3, Ag2O etc. at room temperature although it is used as additive for this 
transformation at high temperature
18a
 (entry 9-10, Table 1). Other common oxidants such 
as ammonium persulfate, (diacetoxyiodo)benzene (PIDA), tert-butyl hydroperoxide (in 
decane) and also molecular oxygen etc. were found to be inferior for this coupling 
reaction (entry 11-14, Table 1). Owing to the facile electrophilic palladation of cationic 
palladium salts, several Pd-complexes, such as Pd(TFA)2, Pd(MeCN)2Cl2, 
Pd(MeCN)2(OTs)2, and Pd(MeCN)4(BF4)2 were examined but provided lower yield 
(entry 15-18, Table 1). We also observed that silver nitrate as a catalyst was inactive for 
this transformation (entry 19, Table 1). Finally, in combination of 10 mol % Pd(OAc)2 
and 2.0 equiv of K2S2O8 as oxidant using acetonitrile as a solvent provided excellent 
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yield after stirring 16 h at room temperature (entry 8, Table 1). It is important to note that 
both Pd(OAc)2 and K2S2O8 are essential for this coupling reaction since no desired 
product was isolated while they were used separately (entry 20-21, Table 1). The yield of 
the acylation product was decreased to some extent under air (entry 22, Table 1) and no 
product was formed with oxygen purging (entry 23, Table 1). During optimization, it was 
found that moisture has negative impact on the reaction outcome presumably due to the 
formation of decarboxylative protonation product from phenylglyoxylic acid. 
Table 1. Optimization of the reaction conditions
a,b
 
 
entry catalyst  
(10 mol %) 
oxidant  
(2.0 equiv) 
solvent yield 
(%)
b
 
1 Pd(OAc)2 K2S2O8  diglyme 20 
2 Pd(OAc)2 K2S2O8 DMF 50 
3 Pd(OAc)2 K2S2O8 DMSO 52 
4 Pd(OAc)2 K2S2O8 Toluene trace 
5 Pd(OAc)2 K2S2O8 AcOH 25 
6 Pd(OAc)2 K2S2O8 1,4-dioxane 14 
7 Pd(OAc)2 K2S2O8 DCE 40 
8 Pd(OAc)2 K2S2O8 MeCN 76 
9 Pd(OAc)2 Ag2CO3 MeCN 0 
10 Pd(OAc)2 Ag2O MeCN 0 
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11 Pd(OAc)2 (NH4)2S2O8 MeCN 50 
12 Pd(OAc)2 PIDA MeCN 26 
13 Pd(OAc)2 TBHP (in decane) MeCN 0 
14 Pd(OAc)2 O2 MeCN 0 
15 Pd(TFA)2 K2S2O8 MeCN 70 
16 
17  
18 
19  
20 
21 
22
c
 
23
d
 
Pd(MeCN)2Cl2 
Pd(MeCN)2(OTs)2 
Pd(MeCN)4(BF4)2 
AgNO3 
Pd(OAc)2 
- 
Pd(OAc)2 
Pd(OAc)2 
K2S2O8 
K2S2O8 
K2S2O8 
K2S2O8 
     - 
K2S2O8 
K2S2O8 
K2S2O8 
MeCN 
MeCN 
MeCN 
MeCN 
MeCN 
MeCN 
MeCN 
MeCN 
 8 
65 
57 
0 
0 
0 
67 
0 
a
All reactions were carried out in 0.1 mmol scale, 6a (1.0 equiv) and 2a (1.5 equiv). 
b
Yields refer to here are overall isolated yields. 
c
The reaction vessel was purged with air. 
d
The reaction vessel was purged with O2. 
Next we explored the substrate scope under the optimized reaction conditions. A 
wide variety of phenylglyoxylic acids having electron-withdrawing and electron-donating 
substituents underwent decarboxylative coupling providing high to excellent yield 
(Scheme 9). Besides methoxy, alkyl, and aryl groups, halogens such as bromo (7i, 7l, 7v, 
Scheme 9), chloro (7h, Scheme 9), and fluoro (7g, Scheme 9) were also well tolerated in 
the reaction condition which are useful for further cross-coupling reactions. A strong 
electron-withdrawing group on α-keto acid afforded the acylated product in good yield 
(7j, Scheme 9). Interestingly, the α-keto acid with a naphthyl moiety furnished the 
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Scheme 9. Substrate scope of 2-phenylpyridines and α-ketocarboxylic acids  
Note: The reaction was carried out in 0.2 mmol scale, 6 (1.0 equiv) and 2 (1.5-2.0 equiv). 
The yield referred to here is the average isolated yield of at least two experiments. 
a
Diacylation occurred. 
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desired product in good yield (7k, Scheme 9). The ortho substituted α-keto acid 
participated in the reaction with excellent yield (7l, Scheme 9). Disubstituted α-keto acids 
also participated in the reaction providing good yield (7m-7n, Scheme 9). No significant 
influence of the electronic nature of the substituents on α-keto acids was observed on the 
reaction outcome. Similarly, substitutions on the 2-phenylpyridine moiety such as alkyl 
(7o-7q, Scheme 9), methoxy (7s-7v, Scheme 9) were tolerated in the reaction condition. 
In addition, aliphatic α-oxocarboxylic acid also afforded the desired product in good yield 
(7w, Scheme 9). Unfortunately, electron deficient groups like acyl, trifluromethyl on 2-
phenylpyridine moiety did not furnish any acylated products. Other nitrogen directing 
groups like 2- phenoxypyridine, 1-phenyl-1H-pyrazole, acetophenone O-methyl oxime, 
and also 2-phenylbenzo[d]thiazole did not provide desired acylation products at room 
temperature. However, 2-phenylpyrimidine furnished a mixture of mono and diacylation 
product which was separated through column chromatography (mono:di = 2.5:1). To 
demonstrate the practical utility of this present protocol the reaction was performed in 
gram-scale providing the acylation product in comparable yields (7a, Scheme 9). 
In recent years, decarbonylative cross-coupling reaction from carbonyl or 
carboxylic acid derivatives has emerged as a promising strategy in organic synthesis.
26
 
Initially, the transition metal undergoes oxidative addition to the activated carboxylic acid 
derivatives such as acid chlorides,
27
 anhydrides,
28
 esters
29
 etc. to generate an acyl-metal 
species. Subsequently, aryl-metal species is formed through the extrusion of carbon 
monoxide. Unlike redox-neutral decarboxylative cross-coupling, no stoichiometric 
oxidant is required in the decarbonylative cross-coupling process. Although transition 
metal-catalyzed decarbonylative cross-coupling for arylation has been explored
30
 but 
decarbonylative C-H acylation is not known. We hypothesized that glyoxals can be 
utilized in palladium-catalyzed decarbonylative C-H acylation reaction. To test, a mixture 
of 2-phenylpyridine, (6a) and phenylglyoxal (8a) was subjected under the optimized 
reaction conditions of decarboxylative acylation. Gratifyingly, the corresponding 
acylation product was isolated in 70% yield (7a, Scheme 10). However, the reaction 
under oxygen did not furnish any acylation product although dioxygen-mediated 
generation of alkyl radical from corresponding aldehydes is known at elevated 
temperature.
31
 Other oxidants such as aq. TBHP or TBHP in decane even (NH4)2S2O8 
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were ineffective for this transformation. Surprisingly, a trace amount of acylation product 
was isolated in other solvents like DMSO, DMF, DCE and toluene. Therefore, we 
proceeded to examine the substrate scope under this condition. To our delight, a number 
of 2-phenylpyridine as well as phenylglyoxal with different substituents provided the 
corresponding acylated product with moderate to good yield (Scheme 10). It is 
noteworthy that halogenated and ortho-substituted 2-phynylpyridines also provided 
moderate yield of the acylation products which were ineffective under decarboxylative 
acylation protocol.  
 
Scheme 10. Substrate scope of 2-phenylpyridines and 2-oxo-2-phenylacetaldehydes 
Note: The reaction was carried out in 0.2 mmol scale, 6 (1.0 equiv) and 8 (1.5 equiv). The 
yield referred to here is the average isolated yield of at least two experiments.  
Next we turned our attention to achieve acylation reaction with commercially 
available and inexpensive aldehydes as acylation agent. From literature, palladium-
catalyzed C-H acylation of 2-phenylpyridine with aryl and alkyl aldehydes is known at 
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high temperature.
32
 However, aldehydes are converted to the corresponding acids by 
oxygen rapidly at high temperature and the yield is decreased.
32b,33
 In addition, the 
oxidant TBHP is explosive at high temperature particularly in industrial-scale.
24
 Keeping 
this in mind we intended to develop an acylation reaction with aldehydes at room 
temperature. Our initial trial reaction between 2-phenylpyridine (6a) and benzaldehyde 
(9a) under the previous optimized reaction conditions afforded acylated product in 35% 
yield (7a, Scheme 11). Considering the unique ability of tert-butylhydroperoxide (TBHP) 
to generate acyl radical from aldehydes,
35
 we decided to use TBHP as oxidant in lieu of 
K2S2O8. Surprisingly, the yield was improved to 55% with inexpensive aq. TBHP. 
Finally an excellent yield of the acylated product (7a) in 87% was isolated after stirring 
the reaction mixture for 36 h at room temperature with the combination of 10 mol % 
Pd(OAc)2 and 3.0 equiv of aq. TBHP from 1.0 equiv of 2-phenylpyridine (6a) and 1.5 
equiv of benzaldehyde (9a). However, 30% aq. H2O2 in lieu of aq. TBHP did not furnish 
any acylation product. To note, the reaction under air or oxygen provided lower (37%) or 
no yield thus the reaction vessel was purged with nitrogen. The reaction under neat 
condition also furnished inferior result (38%). 
Subsequently, we explored the substrate scope under the optimized reaction 
conditions. A wide variety of functional groups on 2-phenylpyridine as well as on 
aldehyde were found to be compatible under this mild reaction protocol. Besides 
methoxy, alkyl, and aryl groups, halogens such as chloro (7ah, Scheme 11), ester (7ad, 
Scheme 11), cyano (7ae, Scheme 11), nitro (7af, Scheme 11) remain intact which are 
useful for further organic transformation. Interestingly, the acyl group on aldehyde (7ac, 
Scheme 11) is well-tolerated under the reaction conditions which demonstrate the mild 
nature of the conditions. Interestingly, the aldehyde with a naphthyl moiety furnished the 
desired product in good yields (7ag, Scheme 11). The electron deficient group like acyl 
on 2-phenylpyridine afforded the moderate yield (7an, Scheme 11) which was inferior in 
the decarboxylative acylation reaction. The reaction with 2-phenylquinoline afforded the 
acylation product in moderate yield (7ao, Scheme 11). Interestingly, the heterocyclic 
aldehydes, such as furan-2-carbaldehyde and thiophene-3-carbaldehyde provided 
moderate yield of the desired product (7ap-7aq, Scheme 11). In addition, aliphatic 
aldehydes also afforded the acylation product in moderate to excellent yield (7w-7as,  
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Scheme 11. Substrate scope of 2-phenylpyridines and aldehydes  
Note: The reaction was carried out in 0.2 mmol scale, 6 (1.0 equiv) and 9 (1.5 equiv). The 
yield referred to here is the average isolated yield of at least two experiments. 
a
The 
reaction was run for 72 h. 
Scheme 11). It is important to note that, benzo[h]quinoline worked extremely well in the 
reaction conditions to give the corresponding acylation product in excellent yield (7at, 
Scheme 11). Although, 2-phenoxypyridine, 1-phenyl-1H-pyrazole provided lower yield 
and unreacted starting material was recovered (7au-7av, Scheme 11) but 2-
phenylpyrimidine furnished good yield (7x, Scheme 11) of the mono-acylation product. 
Finally, the reaction was reproduced in gram-scale providing comparable yield (7a, 
Scheme 11). Other in situ convertible acylating agents such as benzyl alcohol, benzyl 
amine, styrene and toluene did not furnish any acylated product with 2-phenylpyridine 
under the reaction conditions. 
IV. 5. Reaction mechanism  
To gain insight into the reaction mechanism, we performed several control experiments. 
To check whether decarboxylative acylation reaction with phenylglyoxylic acid proceeds 
through radical or anionic pathway, radical scavenger 2,2,6,6-tetramethylpiperidinyl-1-
oxy (TEMPO) experiment was performed. It was observed that the acylation reaction 
completely suppressed with 1.0 equiv of TEMPO. The TEMPO-acyl adduct, 2,2,6,6-
tetramethylpiperidin-1-yl benzoate (10a) was detected in electrospray ionization (ESI) 
mass spectrometry of the crude reaction mixture. Further, it was isolated in 74% yield 
and well-characterized by NMR and HRMS spectroscopy (Scheme 12a). Thus the 
decarboxylative acylation reaction may proceed through radical pathway and the acyl 
radical may generate from the corresponding phenylglyoxylic acids with K2S2O8 at room 
temperature. Similarly, acylation reaction with phenylglyoxal was also completely 
suppressed with 1.0 equiv of TEMPO and the TEMPO-acyl adduct (10a) was isolated in 
56% yield (Scheme 12a). In addition, phenylglyoxal did not oxidized to the 
phenylglyoxylic acid under the reaction condition and remained intact (Scheme 12b). 
Therefore, the possibility of oxidation to the corresponding acid followed by 
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decarboxylative acylation was ruled out rather an acyl radical may generate in the course 
of the reaction through decarbonylation of the arylglyoxal. Finally, dehydrogenative  
 
Scheme 12. Control experiments 
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acylation reaction with benzaldehyde was also supressed substantially with 1.0 and 1.5 
equiv of TEMPO and completely suppressed with 2.0 equiv of TEMPO. The TEMPO-
acyl adduct (10a) was also isolated in 71% yield for further confirmation (Scheme 12a). 
Thus, dehydrogenative acylation may also proceed through radical pathway and the acyl 
radical intermediate may form from the corresponding benzaldehyde via TBHP 
oxidation. In the absence of K2S2O8 no decarboxylative acylation product was isolated 
with 10 mol % or even with 1.0 equiv of Pd(OAc)2 indicating that combination of 
palladium and K2S2O8 is essential for the reaction to occur (Scheme 12c). Since 
palladium(II) acetate is known to form a dimeric complex with 2-phenylpyridine through 
C-H insertion,
36
 a palladium dimer complex (11a) was prepared separately and subjected 
to the reaction conditions (Scheme 12d). Only a trace amount of product was detected 
suggesting that dimeric palladium species with 2-phenylpyridine may not form under the 
present reaction conditions whereas a monomeric palladium species may be involved. 
 
Scheme 13. Plausible mechanism 
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From the control experiments and previous reported literatures,
35,37,38
 we propose 
the reaction mechanism which has shown in Scheme 13. The pyridine-assisted 
cyclopalladation with Pd(II) via electrophilic palladation may generates the 5-membered 
palladacycle intermediate A (Scheme 13), which undergoes oxidative addition with acyl 
radical to yield cyclopalladated Pd(III) intermediate B (Scheme 13). Under visible light 
photoredox and palladium dual catalysis condition this putative Pd(III) is further oxidized 
to Pd(IV) with photoredox catalyst and/or oxidant.
8e,21b,38c,d,39
 However in these catalytic 
systems, the role of K2S2O8 or TBHP in Pd(III)/Pd(IV) oxidation is not clear at this 
moment and warrants further investigation. The desired acylation product 3 may form 
through the facile reductive elimination of the intermediate B (Scheme 13) and the 
generation of Pd(II) catalyst for the subsequent runs. 
IV. 6. Conclusion 
In conclusions, we have developed a mild reaction protocol for Pd(II)-catalyzed C(sp
2
)-H 
acylation using α-ketocarboxylic acids, phenylglyoxals  and commercially available, 
inexpensive aldehydes via decarboxylative, decarbonylative and dehydrogenative 
manifolds respectively. The major advantages of the present protocol are- a) the reaction 
operates under mild conditions at room temperature; b) it does not require stoichiometric 
amount of toxic silver(I) salt for decarboxylation of the α-ketocarboxylic acid or as 
oxidant; c) acetonitrile was optimal for the acylation; d) gaseous CO2, CO or water is 
formed as by-products avoiding rigorous separation technique; e) the present acylation 
reaction proceeds through radical pathway to provide mono acylation product at the ortho 
position selectively. This room temperature acylation reaction is scalable, energy efficient 
and avoids the accidental hazard due to explosion of peroxides at elevated temperature. 
Thus, we anticipate that this mild C-H acylation protocol will find its place in industrial 
application. 
IV. 7. Experimental section 
General experimental procedure for the preparation of 2-phenylpyridines.
40
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To a solution of arylboronic acid (2.6 mmol, 1.3 equiv) in toluene (7.0 mL), ethanol (1.5 
mL) and H2O (7.0 mL) Na2CO3 (1.6 g, 15 mmol, 7.5 equiv) was added followed by 
Pd(PPh3)4 (69 mg, 0.060 mmol) and 2-bromopyridine (0.2 mL, 2.0 mmol, 1.0 equiv) 
were added in a 50 mL round bottom flask. The reaction mixture was evacuated and 
refilled with nitrogen three times and stirred at 110 
o
C for 18 h. After the completion of 
the reaction as indicated by TLC, the reaction mixture was cooled to room temperature. 
To the reaction mixture, aqueous NH4CL (15 mL) was added, extracted with ethyl acetate 
for three times, dried over Na2SO4 and evaporated in vacuum to afford the crude product. 
The crude product was purified by column chromatography on silica gel with using 
hexane/EtOAc (9/1) to afford pure 2-arylpyridines. 
General experimental procedure for the preparation of arylglyoxylic acids.
41 
A mixture of acetophenones (8.0 mmol, 1.0 equiv) and selenium dioxide (1.8 g, 16 mmol, 
2.0 equiv) in dry pyridine (4.0 mL) was stirred at 120 
o
C under N2 for 18 h. After 
completion of the reaction, as determined by TLC, the solution containing precipitated 
selenium was filtered using a Buckner funnel and the residue was washed with ethyl 
acetate (40 mL). The combined filtrate was treated with 1N HCl (60 mL), the organic 
layer was separated, and the remaining aqueous layer was extracted with ethyl acetate 
(2x20). The organic layers were combined and treated with 1N NaOH (2x50), and the 
aqueous layer was separated. Then the aqueous layer was acidified using 1N HCl to 
about pH 1.5. The mixture was extracted with ethyl acetate (3x40), and the combined 
organic layers were dried over Na2SO4 and evaporated in vacuum to afford the crude 
product. The crude product was purified by column chromatography on silica gel with 
using hexane/EtOAc (7/3) to give the pure corresponding arylglyoxylic acids. 
General experimental procedure for the preparation of phenylglyoxals.
42
 
To a 50 mL two-neck round bottom flask fitted with a condenser, was added 1,4-dioxane 
(13.0 mL), SeO2 (2.8 g, 25.0 mmol) and water (0.5 mL). The mixture was heated at 50-55 
o
C and stirred under N2 atmosphere until the solid was dissolved, then the corresponding 
acetophenone (25.0 mmol, 1.0 equiv) was added and the reaction mixture was stirred at 
110 
o
C for 4 h. Then the reaction mixture was cooled to room temperature. The solid was 
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removed by filtration; the filtrate was evaporated to afford a crude product. The crude 
product was purified by silica gel column chromatography (hexane:ethyl acetate/8:2) to 
give the product as a yellow liquid. This liquid was dissolved in hot water (10 mL) and 
allowed to crystallize to afford the desired products, arylglyoxal monohydrate as a white 
solid. 
Experimental procedure for the preparation of 2-phenylpyrimidine.
43
 
To a round-bottom flask was added 2-chloropyrimidine (229.0 mg, 2.0 mmol, 1.0 equiv), 
phenylboronic acid (293mg, 2.4 mmol, 1.2 equiv), Pd(PPh3)2Cl2 (28mg, 0.04 mmol, 0.02 
equiv) and Na2CO3 (2.0 M, 5.0 mL) in dioxane (5.0 mL). The reaction mixture was 
heated to 90 
o
C for 16 h under N2 atmosphere. After completion of the reaction (as 
indicated by TLC), the heterogeneous aqueous was concentrated under reduced pressure 
and the residue was extracted with EtOAc (30 mL), washed by H2O (30 mL) and brine 
(30 mL). The organic layer was dried over Na2SO4, concentrated and purified by column 
chromatography on silica gel using ethyl acetate/hexane as eluent to afford the desired 
product, 2-phenylpyrimidine as colorless oil.
 1
H NMR (300 MHz, CDCl3): δ 8.81 (d, J = 
4.8 Hz, 2H), 8.43-8.46 (m, 2H), 7.48-7.52 (m, 3H), 7.19 (t, J = 4.8 Hz, 1H). 
Experimental procedure for the preparation of 2-phenoxypyridine.
19
 
To an oven-dried 50 mL round bottomed flask, CuI (122.0 mg, 0.64 mmol, 0.1 equiv), 
picolinic acid (158 mg, 1.3 mmol, 0.2 equiv), phenol (715 mg, 7.6 mmol, 1.2 equiv) and 
K3PO4 (2.7 g, 12.8 mmol, 2.0 equiv) was added then the flask was evacuated and back-
filled with N2. To this reaction mixture, 2-bromopyridine (0.6 mL, 6.4 mmol, 1.0 equiv) 
and DMSO (12 mL) was added via syringe. The reaction mixture was stirred at 90 
o
C for 
24 h under N2. Then the reaction mixture was cooled to room temperature. The mixture 
was poured into water (30 mL) and extracted with ethyl acetate (30 mL). The organic 
layer was washed with water (20x2 mL) and brine (10 mL), dried over anhydrous 
Na2SO4 and the solvent was evaporated under reduced pressure. The crude product was 
purified by silica gel column chromatography using ethyl acetate/hexane as eluent to 
afford the desired product, 2-phenoxypyridine as a white solid. 
1
H NMR (300 MHz, 
CDCl3): δ 8.21 (dd, J = 4.8 Hz, 1.2 Hz, 1H), 7.65-7.71 (m, 1H), 7.41 (t, J = 7.8 Hz, 2H), 
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7.22 (d, J = 7.5 Hz, 1H), 7.15 (d, J = 7.8 Hz, 2H), 6.99 (dd, J = 5.1 Hz, 5.4 Hz, 1H), 6.91 
(d, J = 8.4 Hz, 1H). 
Experimental procedure for the preparation of 1-phenyl-1H-pyrazole.
44 
To a solution of Cu(OAc)2.H2O (6.0 mg, 0.03 mmol, 0.01 equiv) in DMF (6.0 mL) were 
added iodobenzene (0.4 mL, 3.6 mmol, 1.2 equiv), 1H-pyrazole (204 mg, 3.0 mmol, 1.0 
equiv), and Cs2CO3 (2.0 g, 6.0 mmol, 2.0 equiv) under N2. The mixture was stirred at 110 
o
C for 24 h. Then the reaction mixture was cooled to room temperature. The mixture was 
poured into water (20 mL) and extracted with ethyl acetate (30 mL). The organic layer 
was washed with water (10x2 mL) and brine (10 mL), dried over anhydrous Na2SO4 and 
the solvent was evaporated under reduced pressure. The crude product was purified by 
silica gel column chromatography using ethyl acetate/hexane as eluent to afford the 
desired product, 1-phenyl-1H-pyrazole as colorless oil.
 1
H NMR (300 MHz, CDCl3): δ 
7.94 (d, J = 2.1 Hz, 1H), 7.69-7.74 (m, 3H), 7.46 (t, J = 7.5 Hz, 2H), 7.29 (t, J = 7.2 Hz, 
1H), 6.48 (t, J = 1.8 Hz, 1H). 
Experimental procedure for the preparation of 2-phenylpyridine palladacycle dimer 
complex (11a).
36
 
To an oven-dried 50 mL round bottomed flask, 2-Phenylpyridine (155 mg, 1.0 mmol, 1.0 
equiv) was added to a solution of Pd(OAc)2 (225 mg, 1.0 mol, 1.0 equiv) in MeOH (16 
mL) and stirred at room temperature for 6 h under N2, during which time a yellow solid 
precipitated was formed in the solution. The precipitate was collected at the top of a plug 
of Celite, and the solids were washed with hexanes (3 x 10 mL). The yellow residue at 
the top of the celite plug was then washed through with CH2Cl2 (2 x 30 mL). The solvent 
was evaporated under reduced pressure, and the resulting solid was recrystallized from 
CH2Cl2/hexanes to afford the desired product as a yellow solid (82% yield).
 1
H NMR 
(300 MHz, CDCl3): δ 7.87 (d, J = 5.4 Hz, 2H), 7.38 (t, J = 7.8 Hz, 2H), 7.09 (d, J = 8.1 
Hz, 2H), 6.79-6.94 (m, 8H), 6.45 (t, J = 6.6 Hz, 2H), 2.29 (s, 6H). 
General experimental procedure for the decarboxylative acylation reaction between 
2-phenylpyridines and α-ketocarboxylic acids, Scheme 9. 
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To an oven-dried 10 mL sealed tube, a mixture of 2-phenylpyridines (0.2 mmol, 1.0 
equiv), α-ketocarboxylic acids (0.3-0.4 mmol, 1.5-2.0 equiv), potassium persulfate (108 
mg, 0.4 mmol, 2.0 equiv) and palladium(II)acetate (4.6 mg, 0.02 mmol, 0.1 equiv) was 
taken and dry MeCN (3.0 mL) was added to it. After flushing with nitrogen for 30 
seconds, immediately the vessel was sealed with a screw cap. The reaction mixture was 
allowed to stir for 16 h at room temperature. After that the reaction mixture was 
quenched with NaHCO3 to remove the unreacted acids. Then the reaction mixture was 
poured into water (40 mL) and extracted with ethyl acetate (40 mL). The organic layer 
was washed with water (10 mL) and brine (10 mL), dried over anhydrous Na2SO4 and the 
solvent was evaporated under reduced pressure. The crude product was purified by 
column chromatography using ethyl acetate/hexane as eluent to afford the desired 
product. 
To note: During optimization, it was found that α-ketocarboxylic acids are hygroscopic in 
nature thus water or moisture is detrimental to the reaction outcome. Therefore, so after 
flushing with nitrogen the reaction vessel was immediately sealed with a screw cap.  
Phenyl(2-(pyridin-2-yl)phenyl)methanone, 7a, Scheme 9.
7d
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 2-
oxo-2-phenylacetic acid (45 mg, 0.3 mmol, 1.5 equiv), potassium persulfate (108 mg, 0.4 
mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (39.5 mg, 76%), mp 105-107 
o
C. 
1
H NMR (600 MHz, CDCl3): δ 
8.36 (d, J = 4.2 Hz, 1H), 7.78 (d, J = 7.8 Hz, 1H), 7.70 (d, J = 7.8 Hz, 2H), 7.61 (t, J = 
7.2 Hz, 1H), 7.50-7.56 (m, 4H), 7.39 (t, J = 7.2 Hz, 1H), 7.27 (t, J = 7.2 Hz, 2H), 7.01 (t, 
J = 4.8 Hz, 1H); 
13
C NMR (150 MHz, CDCl3): δ 198.2, 156.7, 149.0, 139.6, 139.5, 137.9, 
136.3, 132.3, 130.2, 129.4, 129.1, 128.7, 128.5, 128.0, 122.6, 121.9; IR (neat): υmax 1665, 
1587, 1279, 929, 751, 703 cm
-1
; HRMS (EI, m/z) calcd. for C18H13NO [M]
+
: 259.0997; 
found: 259.0979. 
(2-(Pyridin-2-yl)phenyl)(p-tolyl)methanone, 7b, Scheme 9.
7d
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 2-
oxo-2-(p-tolyl)acetic acid (49 mg, 0.3 mmol, 1.5 equiv), potassium persulfate (108 mg, 
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0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (39.0 mg, 72%), mp 97-99 
o
C. 
1
H NMR (600 MHz, CDCl3): δ 
8.41 (d, J = 4.2 Hz, 1H), 7.78 (d, J = 7.2 Hz, 1H), 7.56-7.62 (m, 4H), 7.52 (d, J = 4.2 Hz, 
2H), 7.49 (d, J = 8.4 Hz, 1H), 7.09 (d, J = 7.8 Hz, 2H), 7.03-7.06 (m, 1H), 2.33 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 197.9, 156.9, 149.1, 143.1, 139.7, 139.5, 136.2, 135.3, 
130.0, 129.7, 128.92, 128.90, 128.8, 128.4, 122.8, 121.9, 21.6; IR (neat): υmax 1662, 1604, 
1433, 1284, 929, 751 cm
-1
; HRMS (ESI, m/z) calcd. for C19H15NONa [M + Na]
+
: 
296.1051; found: 296.1049. 
(4-(tert-Butyl)phenyl)(2-(pyridin-2-yl)phenyl)methanone, 7c, Scheme 9.
45
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(4-(tert-butyl)phenyl)-2-oxoacetic acid (62 mg, 0.3 mmol, 1.5 equiv), 
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 
0.02 mmol, 0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a yellowish oil (46.0 mg, 73%). 
1
H NMR (300 
MHz, CDCl3): δ 8.40 (d, J = 4.2 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.65 (d, J = 8.4 Hz, 
2H), 7.46-7.62 (m, 5H), 7.30 (d, J = 8.4 Hz, 2H), 7.00-7.04 (m, 1H), 1.27 (s, 9H); 
13
C 
NMR (150 MHz, CDCl3): δ 197.9, 157.0, 156.0, 149.1, 139.7, 139.6, 136.2, 135.1, 130.0, 
129.6, 129.0, 128.9, 128.2, 125.0, 122.9, 121.8, 35.0, 31.0; IR (neat): υmax 2961, 1666, 
1598, 1466, 1277, 753 cm
-1
; HRMS (ESI, m/z) calcd. for C22H21NONa [M + Na]
+
: 
338.1521; found: 338.1523. 
(4-isoButylphenyl)(2-(pyridin-2-yl)phenyl)methanone, 7d, Scheme 9. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(4-isobutylphenyl)-2-oxoacetic acid (62 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a colourless oil (45.0 mg, 71%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.39 (d, J = 4.2 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.51-7.62 (m, 6H), 7.45 (d, J 
= 7.8 Hz, 1H), 7.03 (d, J = 8.4 Hz, 2H), 7.00-7.02 (m, 1H), 2.43 (d, J = 7.2 H, 2H), 1.78-
1.85 (m,1H), 0.84 (d, J = 6.6 Hz, 6H); 
13
C NMR (150 MHz, CDCl3): δ 198.0, 157.0, 
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149.0, 146.8, 139.7, 139.6, 136.1, 135.5, 130.1, 129.5, 129.1, 128.9, 128.7, 128.4, 123.0, 
121.8, 45.3, 30.1, 22.2; IR (neat): υmax 2957, 1664, 1602, 1281, 930, 751 cm
-1
; HRMS 
(ESI, m/z) calcd. for C22H21NONa [M + Na]
+
: 338.1521; found: 338.1520. 
(4-Methoxyphenyl)(2-(pyridin-2-yl)phenyl)methanone, 7e, Scheme 9.
7d
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(4-methoxyphenyl)-2-oxoacetic acid (54 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (35.0 mg, 60%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.44 (d, J = 4.8 Hz, 1H), 7.78 (d, J = 7.8 Hz, 1H), 7.68-7.70 (m, 2H), 7.56-7.62 
(m, 2H), 7.52 (d, J = 4.2 Hz, 2H), 7.48 (d, J = 7.8 Hz, 1H), 7.05-7.07 (m, 1H), 6.76-6.79 
(m,2H), 3.81 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 197.0, 163.0, 157.0, 149.1, 139.6, 
139.5, 136.2, 131.9, 130.7, 129.9, 129.0, 128.8, 128.3, 123.0, 121.9, 113.3, 55.3; IR 
(neat): υmax 1658, 1597, 1464, 1256, 1027, 753 cm
-1
; HRMS (ESI, m/z) calcd. for 
C19H15NO2Na [M + Na]
+
: 312.1000; found: 312.0997. 
[1,1'-Biphenyl]-4-yl(2-(pyridin-2-yl)phenyl)methanone, 7f, Scheme 9.
17
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-([1,1'-biphenyl]-4-yl)-2-oxoacetic acid (68 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a light yellow oil (55.0 mg, 82%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.41-8.42 (m, 1H), 7.78-7.82 (m, 3H), 7.64 (td, J = 7.2 Hz, 1.2 Hz, 1H),7.52-
7.61 (m, 8H), 7.45 (t, J = 7.2, Hz, 2H), 7.38 (t, J = 7.2 Hz, 1H), 7.03-7.05 (m, 1H); 
13
C 
NMR (150 MHz, CDCl3): δ 197.8, 156.8, 149.1, 144.9, 139.9, 139.6, 139.5, 136.6, 136.3, 
130.2, 130.1, 129.0, 128.84, 128.82, 128.5, 128.0, 127.2, 126.7, 122.7, 122.0; IR (neat): 
υmax 1662, 1595, 1280, 926, 745 cm
-1
; HRMS (EI, m/z) calcd. for C24H17NO [M]
+
: 
335.1310; found: 335.1314. 
(4-Fluorophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7g, Scheme 9.
32b
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(4-fluorophenyl)-2-oxoacetic acid (51.5 mg, 0.3 mmol, 1.5 equiv), potassium 
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persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (44.0 mg, 80%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.38 (d, J = 4.8 Hz, 1H), 7.78 (d, J = 7.8 Hz, 1H), 7.70-7.73 (m, 2H), 7.59-7.65 
(m, 2H), 7.54 (d, J = 4.2 Hz, 2H), 7.52 (d, J = 7.8 Hz, 1H), 7.04-7.06 (m, 1H), 6.92-6.96 
(m, 2H); 
13
C NMR (150 MHz, CDCl3): δ 196.7, 165.1 (d, J = 252.0 Hz), 156.6, 149.0, 
139.4, 139.2, 136.4, 134.3 (d, J = 3.0 Hz), 131.9 (d, J = 9.0 Hz), 130.3, 129.0, 128.7, 
128.6, 122.6, 122.0, 115.1 (d, J = 21.0 Hz); IR (neat): υmax 1666, 1594, 1280, 1232, 1151, 
752 cm
-1
; HRMS (ESI, m/z) calcd. for C18H12FNONa [M + Na]
+
: 300.0801; found: 
300.0806. 
(4-Chlorophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7h, Scheme 9.
7d
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(4-chlorophenyl)-2-oxoacetic acid (55.5 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (37.5 mg, 64%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.35-8.36 (m, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.60-7.64 (m, 4H), 7.52-7.56 (m, 
3H), 7.24-7.28 (m, 2H), 7.05-7.07 (m, 1H); 
13
C NMR (75 MHz, CDCl3): δ 197.0, 156.4, 
149.0, 139.4, 139.1, 138.6, 136.45, 136.41, 130.7, 130.3, 129.0, 128.6, 128.3, 122.4, 
122.1; IR (neat): υmax 2925, 1669, 1587, 1280, 1089, 928, 750 cm
-1
; HRMS (ESI, m/z) 
calcd. for C18H12ClNONa [M + Na]
+
: 316.0505; found: 316.0503. 
(4-Bromophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7i, Scheme 9.
32b
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(4-bromophenyl)-2-oxoacetic acid (69 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish solid (54.5 mg, 81%), mp 102-104 
o
C. 
1
H 
NMR (600 MHz, CDCl3): δ 8.35-8.36 (m, 1H), 7.78 (d, J = 7.8 Hz, 1H), 7.60-7.64 (m, 
2H), 7.52-7.57 (m, 5H), 7.40-7.42 (m, 2H), 7.05-7.07 (m, 1H); 
13
C NMR (75 MHz, 
CDCl3): δ 196.9, 156.4, 148.9, 139.4, 139.0, 136.8, 136.5, 131.3, 130.8, 130.3, 129.0, 
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128.64, 128.58, 127.2, 122.4, 122.1; IR (neat): υmax 1670, 1584, 1279, 1067, 927, 750 cm
-
1
; HRMS (ESI, m/z) calcd. for C18H12BrNONa [M + Na]
+
: 360.0000; found: 360.0002. 
(2-(Pyridin-2-yl)phenyl)(4-(trifluoromethyl)phenyl)methanone, 7j, Scheme 9.
17
 The 
same general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-oxo-2-(4-(trifluoromethyl)phenyl)acetic acid (65.5 mg, 0.3 mmol, 1.5 equiv), 
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 
0.02 mmol, 0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a white solid (37.0 mg, 57%), mp 76-78 
o
C. 
1
H 
NMR (600 MHz, CDCl3): δ 8.30-8.31 (m, 1H), 7.78-7.81 (m, 3H), 7.54-7.66 (m, 5H), 
7.53 (d, J = 7.8 Hz, 2H), 7.02-7.04 (m, 1H); 
13
C NMR (150 MHz, CDCl3): δ 196.9, 
156.0, 148.8, 141.0, 139.4, 138.8, 136.6, 133.2 (q, J = 31.5 Hz), 130.5, 129.3, 129.1, 
128.8, 128.4, 125.0 (q, J = 3.0 Hz), 123.6 (q, J = 271.5 Hz), 122.2, 122.1; IR (neat): υmax 
1675, 1587, 1322, 1130, 753 cm
-1
; HRMS (EI, m/z) calcd. for C19H12F3NO [M]
+
: 
327.0871; found: 327.0867. 
Naphthalen-1-yl(2-(pyridin-2-yl)phenyl)methanone, 7k, Scheme 9.
32b 
The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(naphthalen-1-yl)-2-oxoacetic acid (60 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish solid (34.5 mg, 56%), mp 101-103 
o
C. 
1
H 
NMR (600 MHz, CDCl3): δ 8.93 (d, J = 8.4 Hz, 1H), 8.14 (d, J = 4.8 Hz, 1H), 7.75-7.78 
(m, 3H), 7.72 (d, J = 7.8 Hz, 1H), 7.63-7.66 (m, 2H), 7.56 (td, J = 7.8 Hz, 1.2 Hz, 1H), 
7.52 (t, J = 7.2 Hz, 1H), 7.35-7.43 (m, 3H), 7.17 (t, J = 7.8 Hz, 1H), 6.76-6.78 (m, 1H); 
13
C NMR (150 MHz, CDCl3): δ 199.6, 157.0, 148.9, 141.0, 140.2, 136.3, 136.0, 133.5, 
132.3, 131.0, 130.6, 130.1, 129.6, 128.8, 128.5, 128.0, 127.6, 126.5, 126.2, 123.7, 122.2, 
121.4; IR (neat): υmax 1662, 1586, 1432, 1279, 750 cm
-1
; HRMS (EI, m/z) calcd. for 
C22H15NO [M]
+
: 309.1154; found: 309.1133. 
(2-Bromophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7l, Scheme 9.
46
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(2-bromophenyl)-2-oxoacetic acid (69 mg, 0.3 mmol, 1.5 equiv), potassium 
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persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (54.0 mg, 80%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.52-8.54 (m, 1H), 7.70-7.71 (m, 1H), 7.61-7.66 (m, 2H), 7.57 (td, J = 7.8 Hz, 
1.8 Hz, 1H), 7.53 (td, J = 7.2 Hz, 1.2 Hz, 1H), 7.44-7.46 (m, 2H), 7.23-7.26 (m, 1H), 
7.06-7.09 (m, 2H), 7.01-7.03 (m, 1H); 
13
C NMR (150 MHz, CDCl3): δ 196.7, 157.1, 
149.1, 140.7, 139.4, 138.7, 136.2, 139.9, 131.6, 131.3, 131.2, 130.6, 129.3, 128.6, 126.5, 
122.8, 121.8, 121.4; IR (neat): υmax 1673, 1586, 1464, 1432, 1292, 928, 750 cm
-1
; HRMS 
(EI, m/z) calcd. for C18H12BrNO [M]
+
: 337.0102; found: 337.0101. 
(2,4-Dimethylphenyl)(2-(pyridin-2-yl)phenyl)methanone, 7m, Scheme 9. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(2,4-dimethylphenyl)-2-oxoacetic acid (53.5 mg, 0.3 mmol, 1.5 equiv), 
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 
0.02 mmol, 0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a light yellow oil (40.0 mg, 70%). 
1
H NMR (600 
MHz, CDCl3): δ 8.46-8.47 (m, 1H), 7.66-7.67 (m, 1H), 7.56-7.60 (m, 3H), 7.49-7.52 (m, 
1H), 7.42 (d, J = 7.8 Hz, 1H), 7.11 (d, J = 8.4 Hz, 1H), 7.03-7.05 (m, 1H), 6.92 (s, 1H), 
6.76 (d, J = 7.8 Hz, 1H), 2.56 (s, 3H), 2.24 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 
199.5, 157.4, 148.7, 141.5, 141.0, 139.8, 139.4, 136.3, 135.2, 132.1, 131.2, 130.3, 129.6, 
129.2, 128.4, 125.5, 122.8, 121.8, 21.3, 21.0; IR (neat): υmax 2924, 1663, 1601, 1436, 
1299, 753 cm
-1
; HRMS (EI, m/z) calcd. for C20H17NO [M]
+
: 287.1310; found: 287.1305. 
(3,5-Dimethoxyphenyl)(2-(pyridin-2-yl)phenyl)methanone, 7n, Scheme 9. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(3,5-dimethoxyphenyl)-2-oxoacetic acid (63 mg, 0.3 mmol, 1.5 equiv), 
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 
0.02 mmol, 0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a colourless oil (37.0 mg, 58%). 
1
H NMR (600 
MHz, CDCl3): δ 8.40 (d, J = 4.8 Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.58-7.61 (m, 2H), 
7.50-7.54 (m, 3H), 7.04-7.06 (m, 1H), 6.96 (d, J = 1.8 Hz, 2H), 6.50 (t, J = 2.4 Hz, 1H), 
3.73 (s, 6H); 
13
C NMR (150 MHz, CDCl3): δ 197.6, 160.3, 156.7, 149.0, 139.8, 139.5, 
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139.3, 136.3, 130.2, 129.1, 128.7, 128.4, 122.4, 122.0, 107.3, 105.0, 55.5; IR (neat): υmax 
1670, 1594, 1462, 1302, 1156, 1062, 753 cm
-1
; HRMS (ESI, m/z) calcd. for 
C20H17NO3Na [M + Na]
+
: 342.1106; found: 342.1007. 
(5-Methyl-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7o, Scheme 9.
37d
 The same 
general procedure was followed by using 2-(p-tolyl)pyridine (34.0 mg, 0.2 mmol, 1.0 
equiv), 2-oxo-2-phenylacetic acid (60 mg, 0.4 mmol, 2.0 equiv), potassium persulfate 
(108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (40.0 mg, 73%), mp 137-139 
o
C. 
1
H NMR (600 MHz, 
CDCl3): δ 8.35 (d, J = 4.8 Hz, 1H), 7.68-7.70 (m, 3 H), 7.55 (td, J = 7.8 Hz, 1.8 Hz, 1H), 
7.48 (d, J = 7.8 Hz, 1H), 7.42 (d, J = 7.8 Hz, 1H), 7.36-7.40 (m, 2H), 7.26-7.28 (m, 2H), 
6.98-7.00 (m, 1H), 2.47 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 198.4, 156.6, 148.9, 
139.4, 138.6, 137.9, 136.8, 136.2, 132.2, 130.9, 129.6, 129.4, 128.5, 127.9, 122.4, 121.6, 
21.2; IR (neat): υmax 1666, 1588, 1461, 1250, 698 cm
-1
; HRMS (ESI, m/z) calcd. for 
C19H15NONa [M + Na]
+
: 296.1051; found: 296.1051. 
(5-(tert-Butyl)-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7p, Scheme 9.
45
 The same 
general procedure was followed by using 2-(4-(tert-butyl)phenyl)pyridine (42.5 mg, 0.2 
mmol, 1.0 equiv), 2-oxo-2-phenylacetic acid (60 mg, 0.4 mmol, 2.0 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (38.0 mg, 60%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.35 (d, J = 4.2 Hz, 1H), 7.70-7.73 (m, 3H), 7.64 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 
7.53-7.56 (m, 2H), 7.48 (d, J = 7.8 Hz, 1H), 7.38 (t, J = 7.2 Hz, 1H), 7.26-7.28 (m, 2H), 
6.98-7.00 (m, 1H), 1.39 (s, 9H); 
13
C NMR (150 MHz, CDCl3): δ 198.7, 156.7, 151.8, 
148.9, 139.0, 138.0, 136.8, 136.2, 132.2, 129.4, 128.4, 127.9, 127.3, 126.0, 122.4, 121.6, 
34.8, 31.2; IR (neat): υmax 2962, 1667, 1590, 1467, 1249, 751 cm
-1
; HRMS (ESI, m/z) 
calcd. for C22H21NONa [M + Na]
+
: 338.1521; found: 338.1521. 
 (4-Methyl-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7q, Scheme 9.
32b
 The same 
general procedure was followed by using 2-(m-tolyl)pyridine (34.0 mg, 0.2 mmol, 1.0 
equiv), 2-oxo-2-phenylacetic acid (60 mg, 0.4 mmol, 2.0 equiv), potassium persulfate 
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(108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (38.0 mg, 70%), mp 106-108 
o
C. 
1
H NMR (600 MHz, 
CDCl3): δ 8.40 (d, J = 4.2 Hz, 1H), 7.68 (d, J = 7.2 Hz, 2H), 7.58 (s, 1H), 7.52-7.55 (m, 
1H), 7.47 (d, J = 7.8 Hz, 1H), 7.44 (d, J = 7.8 Hz, 1H), 7.38 (t, J = 7.2 Hz, 1H), 7.34 (d, J 
= 7.8 Hz, 1H), 7.24-7.28 (m, 2H), 7.00-7.02 (m, 1H), 2.51 (s, 3H); 
13
C NMR (150 MHz, 
CDCl3): δ 198.2, 157.1, 149.0, 140.6, 139.9, 138.0, 136.6, 136.1, 132.2, 129.6, 129.5, 
129.4, 129.1, 127.9, 123.0, 121.8, 21.5; IR (neat): υmax 1665, 1588, 1281, 932, 702 cm
-1
; 
HRMS (ESI, m/z) calcd. for C19H15NONa [M + Na]
+
: 296.1051; found: 296.1050. 
(2-(Pyridin-2-yl)phenyl)(m-tolyl)methanone, 7r, Scheme 9.
47
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 2-
oxo-2-(m-tolyl)acetic acid (49 mg, 0.3 mmol, 1.5 equiv), potassium persulfate (108 mg, 
0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a yellowish oil (38.0 mg, 70%). 
1
H NMR (600 MHz, CDCl3): δ 8.39 (d, J = 
4.8 Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.61 (td, J = 7.2 Hz, 2.4 Hz, 1H), 7.48-7.58 (m, 
6H), 7.22 (d, J = 7.2 Hz, 1H), 7.16 (t, J = 7.8 Hz, 1H), 7.02-7.04 (m, 1H), 2.29 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 198.4, 156.9, 149.0, 139.7, 139.6, 137.7, 136.2, 133.2, 
130.1, 129.9, 129.1, 128.8,128.4, 127.9, 127.0, 122.7, 121.9, 21.2; IR (neat): υmax 1666, 
1588, 1432, 1284, 752 cm
-1
; HRMS (EI, m/z) calcd. for C19H15NO [M]
+
: 273.1154; 
found: 273.1150. 
(5-Methoxy-2-(pyridin-2-yl)phenyl)(m-tolyl)methanone, 7s, Scheme 9. The same 
general procedure was followed by using 2-(4-methoxyphenyl)pyridine (37.0 mg, 0.2 
mmol, 1.0 equiv), 2-oxo-2-(m-tolyl)acetic acid (66 mg, 0.4 mmol, 2.0 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (42.5 mg, 70%). 
1
H NMR (600 MHz, 
CDCl3): δ 8.34 (d, J = 4.8 Hz, 1H), 7.72 (d, J = 8.4 Hz, 1H), 7.55 (s, 1H), 7.51-7.54 (m, 
1H), 7.48 (d, J = 7.2 Hz, 1H), 7.44 (d, J = 7.8 Hz, 1H), 7.20 (d, J = 7.8 Hz, 1H), 7.12-
7.16 (m, 2H), 7.05 (d, J = 2.4 Hz, 1H), 6.96-6.98 (m, 1H), 3.88 (s, 3H), 2.28 (s, 3H); 
13
C 
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NMR (150 MHz, CDCl3): δ 198.1, 159.7, 156.4, 148.8, 140.8, 137.7, 137.6, 136.1, 133.2, 
132.0, 130.0, 129.8, 127.9, 126.8, 122.1, 121.3, 116.0, 114.0, 55.5, 21.2; IR (neat): υmax 
1667, 1595, 1464, 1288, 1234, 753 cm
-1
; HRMS (ESI, m/z) calcd. for C20H17NO2Na [M + 
Na]
+
: 326.1157; found: 326.1161. 
(5-Methoxy-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7t, Scheme 9.
32b
 The same 
general procedure was followed by using 2-(4-methoxyphenyl)pyridine (37.0 mg, 0.2 
mmol, 1.0 equiv), 2-oxo-2-phenylacetic acid (60 mg, 0.4 mmol, 2.0 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a white solid (46.0 mg, 80%). mp 98-100 
o
C. 
1
H NMR 
(600 MHz, CDCl3): δ 8.32 (d, J = 4.8 Hz, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.70 (d, J = 7.2 
Hz, 2H), 7.53 (td, J = 7.8 Hz, 1.2 Hz, 1H), 7.45 (d, J = 7.8 Hz, 1H), 7.38 (t, J = 7.2 Hz, 
1H), 7.26-7.28 (m, 2H), 7.14 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.06 (d, J = 2.4 Hz, 1H), 6.95-
6.97 (m, 1H), 3.89 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 197.9, 159.8, 156.3, 148.8, 
140.8, 137.7, 136.2, 132.3, 132.0, 129.9, 129.3, 128.0, 122.0, 121.3, 116.1, 114.0, 55.6; 
IR (neat): υmax 1666, 1595, 1462, 1286, 1230, 741, 700 cm
-1
; HRMS (ESI, m/z) calcd. for 
C19H15NO2Na [M + Na]
+
: 312.1000; found: 312.1003. 
(4-Fluorophenyl)(5-methoxy-2-(pyridin-2 yl)phenyl)methanone, 7u, Scheme 9. The 
same general procedure was followed by using 2-(4-methoxyphenyl)pyridine (37.0 mg, 
0.2 mmol, 1.0 equiv), 2-(4-fluorophenyl)-2-oxoacetic acid (67 mg, 0.4 mmol, 2.0 equiv), 
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 
0.02 mmol, 0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a white solid (39.0 mg, 64%), mp 74-76 
o
C. 
1
H 
NMR (600 MHz, CDCl3): δ 8.31 (d, J = 4.8 Hz, 1H), 7.70-7.73 (m, 3H), 7.55 (td, J = 7.8 
Hz, 1.8 Hz, 1H), 7.46 (d, J = 7.8 Hz, 1H), 7.14 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.4 (d, J = 
2.4 Hz, 1H), 6.98 (dd, J = 7.2 Hz, 4.8 Hz,1H), 6.93 (t, J = 8.4 Hz, 2H), 3.89 (s, 3H); 
13
C 
NMR (150 MHz, CDCl3): δ 196.3, 165.1 (d, J = 252.0 Hz), 159.9, 156.1, 148.8, 140.5, 
136.3, 134.2 (d, J = 3.0 Hz), 131.8 (d, J = 9.0 Hz), 129.9, 121.9, 121.4, 116.1, 115.1 (d, J 
= 21.0 Hz), 113.9, 55.6; IR (neat): υmax 1668, 1596, 1464, 1289, 1230, 850 cm
-1
; HRMS 
(ESI, m/z) calcd. for C19H14FNO2Na [M + Na]
+
: 330.0906; found: 330.0872. 
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(4-Bromophenyl)(5-methoxy-2-(pyridin-2-yl)phenyl)methanone, 7v, Scheme 9. The 
same general procedure was followed by using 2-(4-methoxyphenyl)pyridine (37.0 mg, 
0.2 mmol, 1.0 equiv), 2-(4-bromophenyl)-2-oxoacetic acid (92 mg, 0.4 mmol, 2.0 equiv), 
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 
0.02 mmol, 0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a yellowish solid (49.0 mg, 67%), mp 107-109 
o
C. 
1
H NMR (600 MHz, CDCl3): δ 8.28 (d, J = 4.8 Hz, 1H), 7.72 (d, J = 8.4 Hz, 1H), 
7.55-7.57 (m, 3H), 7.48 (d, J = 7.8 Hz, 1H), 7.39 (d, J = 9.0 Hz, 2H), 7.13 (dd, J = 9.0 
Hz, 3.0 Hz, 1H), 7.03 (d, J = 3.0 Hz, 1H), 6.98 (dd, J = 7.2 Hz, 4.8 Hz, 1H), 3.88 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 196.8, 159.9, 155.8, 148.7, 140.3, 136.7, 136.4, 131.7, 
131.3, 130.7, 129.8, 127.2, 121.7, 121.5, 116.2, 113.9, 55.6; IR (neat): υmax 1669, 1586, 
1464, 1230, 841, 757 cm
-1
; HRMS (ESI, m/z) calcd. for C19H14BrNO2Na [M + Na]
+
: 
390.0106; found: 390.0104. 
3-Methyl-1-(2-(pyridin-2-yl)phenyl)butan-1-one, 7w, Scheme 9.
17
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 4-
methyl-2-oxopentanoic acid (52 mg, 0.4 mmol, 2.0 equiv), potassium persulfate (108 mg, 
0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a colourless oil (34.0 mg, 71%). 
1
H NMR (600 MHz, CDCl3): δ 8.62 (d, J = 
4.2 Hz, 1H), 7.76 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.61 (d, J = 7.2 Hz, 1H), 7.56 (d, J = 8.4 
Hz, 1H), 7.44-7.52 (m, 3H), 7.24-7.28 (m, 1H), 2.40 (d, J = 6.6 Hz, 2H), 2.09-2.16 (m, 
1H), 0.87 (d, J = 7.2 Hz, 6H); 
13
C NMR (150 MHz, CDCl3): δ 206.6, 157.6, 149.2, 142.0, 
138.6, 136.7, 130.0, 129.2, 128.5, 127.5, 122.6, 122.2, 51.7, 24.8, 22.6; IR (neat): υmax 
2956, 1693, 1587, 1465, 1208, 754 cm
-1
; HRMS (ESI, m/z) calcd. for C16H17NONa [M + 
Na]
+
: 262.1208; found: 262.1207. 
Phenyl(2-(pyrimidin-2-yl)phenyl)methanone, 7x, Scheme 9.
48
 The same general 
procedure was followed by using 2-phenylpyrimidine (31.5 mg, 0.2 mmol, 1.0 equiv), 2-
oxo-2-phenylacetic acid (45 mg, 0.4 mmol, 1.5 equiv), potassium persulfate (108 mg, 0.4 
mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
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product as a white solid (33 mg, 63%), mp 129-131 
o
C. 
1
H NMR (600 MHz, CDCl3): δ 
8.56 (d, J = 4.8 Hz, 2H), 8.38 (d, J = 7.2 Hz, 1H), 7.73 (d, J = 7.2 Hz, 2H), 7.66 (t, J = 7.8 
Hz, 1H), 7.61 (t, J = 7.8 Hz, 1H), 7.52 (d, J = 7.2 Hz, 1H), 7.42 (t, J = 7.8 Hz, 1H), 7.30 
(t, J = 7.8 Hz, 2H), 7.00 (t, J = 4.8 Hz, 1H);
 13
C NMR (150 MHz, CDCl3): δ 197.8, 163.9, 
156.6, 140.5, 138.1, 136.9, 132.2, 130.3, 129.9, 129.4, 129.0, 128.6, 128.1, 118.7; IR 
(neat): υmax 1664, 1557, 1413, 1281, 752 cm
-1
; HRMS (ESI, m/z) calcd. for C17H12N2ONa 
[M + Na]
+
: 283.0847; found: 283.0841. 
Decarboxylative acylation reaction in gram scale (Synthesis of phenyl(2-(pyridin-2-
yl)phenyl)methanone, 7a, Scheme 9). 
To an oven-dried 100 mL sealed tube, a mixture of 2-phenylpyridines (0.93 mL, 6.5 
mmol, 1.0 equiv), 2-oxo-2-phenylacetic acid (1.46g, 9.8 mmol, 1.5 equiv), potassium 
persulfate (3.51g, 13.0 mmol, 2.0 equiv) and palladium(II)acetate (146 mg, 0.65 mmol, 
0.1 equiv) was taken and dry MeCN (50 mL) was added to it. After flushing with 
nitrogen for 30 seconds, immediately the vessel was sealed with a screw cap. The 
reaction mixture was allowed to stir for 16 h at room temperature. After that the reaction 
mixture was quenched with NaHCO3 to remove the unreacted acids. Then the reaction 
mixture was poured into water (80 mL) and extracted with ethyl acetate (60x2 mL). The 
organic layer was washed with water (30x2 mL) and brine (30 mL), dried over anhydrous 
Na2SO4 and the solvent was evaporated under reduced pressure. The pure phenyl(2-
(pyridin-2-yl)phenyl)methanone (7a) was obtained as a white solid in 68% (1.15 g) yield 
after column chromatography of the crude reaction mixture using ethyl acetate/hexane 
(7:3) as eluent.  
General experimental procedure for the decarbonylative acylation reaction between 
2-phenylpyridines and phenylglyoxals, Scheme 10. 
To an oven-dried 10 mL sealed tube, a mixture of 2-phenylpyridines (0.2 mmol, 1.0 
equiv), phenylglyoxals (0.3 mmol, 1.5 equiv), potassium persulfate (108 mg, 0.4 mmol, 
2.0 equiv) and palladium(II)acetate (4.6 mg, 0.02 mmol, 0.1 equiv) was taken and dry 
MeCN (3.0 mL) was added to it. After flushing with nitrogen, immediately the vessel 
was sealed with a screw cap. The reaction mixture was allowed to stir for 16 h at room 
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temperature. After that the reaction mixture was quenched with NaHCO3. Then the 
reaction mixture was poured into water (40 mL) and extracted with ethyl acetate (40 mL). 
The organic layer was washed with water (10 mL) and brine (10 mL), dried over 
anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. The crude 
product was purified by column chromatography using ethyl acetate/hexane as eluent to 
afford the desired product. 
Phenyl(2-(pyridin-2-yl)phenyl)methanone, 7a, Scheme 10. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 2-
oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv), potassium persulfate (108 mg, 
0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (36.5 mg, 70%), mp 105-107 
o
C. The spectral data of compound 
7a is in decarboxylative acylation part. 
(2-(Pyridin-2-yl)phenyl)(p-tolyl)methanone, 7b, Scheme 10. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 2-
oxo-2-(p-tolyl)acetaldehyde (45 mg, 0.3 mmol, 1.5 equiv), potassium persulfate (108 mg, 
0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (26 mg, 48%), mp 97-99 
o
C. The spectral data of compound 7b is 
in decarboxylative acylation part. 
(4-Fluorophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7g, Scheme 10. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(4-fluorophenyl)-2-oxoacetaldehyde (46 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (31.0 mg, 56%). The spectral data of 
compound 7g is in decarboxylative acylation part. 
(4-Chlorophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7h, Scheme 10. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
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equiv), 2-(4-chlorophenyl)-2-oxoacetaldehyde (51.0 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (33.5 mg, 57%). The spectral data of 
compound 7h is in decarboxylative acylation part. 
 (2-Bromophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7l, Scheme 10. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), 2-(2-bromophenyl)-2-oxoacetaldehyde (64.0 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish oil (40.5 mg, 60%). The spectral data of 
compound 7l is in Scheme 9. 
(2-(Pyridin-2-yl)phenyl)(m-tolyl)methanone, 7r, Scheme 10. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 2-
oxo-2-(m-tolyl)acetaldehyde (45 mg, 0.3 mmol, 1.5 equiv), potassium persulfate (108 
mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a yellowish oil (26.0 mg, 47%). The spectral data of compound 7r is in 
Scheme 9. 
(5-fluoro-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7y, Scheme 10.
32b
 The same 
general procedure was followed by using 2-(4-fluorophenyl)pyridine (35.0 mg, 0.2 mmol, 
1.0 equiv), 2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a white solid (26.5 mg, 48%), mp 149-151 
o
C. 
1
H NMR 
(600 MHz, CDCl3): δ 8.36 (d, J = 4.8 Hz, 1H), 7.78 (dd, J = 8.4 Hz, 4.8 Hz, 1H), 7.69 (d, 
J = 7.8 Hz, 2H), 7.58 (td, J = 7.8 Hz, 1.2 Hz, 1H), 7.48 (d, J = 7.8 Hz, 1H), 7.42 (t, J = 
7.2 Hz, 1H), 7.25-7.33 (m, 4H), 7.03 (dd, J = 6.6 Hz, 5.4 Hz, 1H);
 13
C NMR (150 MHz, 
CDCl3): δ 196.4, 162.6 (d, J = 249.0 Hz), 155.6, 148.9, 141.4 (d, J = 4.5 Hz), 137.2, 
136.5, 135.5 (d, J = 1.5 Hz), 132.6, 130.6 (d, J = 7.5 Hz), 129.3, 128.1, 122.4, 122.0, 
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117.1 (d, J = 21.0 Hz), 116.1 (d, J = 22.5 Hz); IR (neat): υmax 1661, 1588, 1279, 846, 789 
cm
-1
; HRMS (ESI, m/z) calcd. for C18H12FNONa [M + Na]
+
: 300.0801; found: 300.0802. 
(5-chloro-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7z, Scheme 10.
17
 The same 
general procedure was followed by using 2-(4-chlorophenyl)pyridine (38.0 mg, 0.2 
mmol, 1.0 equiv), 2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a white solid (33.0 mg, 56%), mp 113-115 
o
C. 
1
H NMR 
(600 MHz, CDCl3): δ 8.36 (d, J = 4.2 Hz, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.69 (dd, J = 8.4 
Hz, 1.2 Hz, 2H), 7.57-7.61 (m, 2H), 7.52 (d, J = 1.8 Hz, 1H), 7.50 (d, J = 8.4 Hz, 1H), 
7.40-7.43 (m, 1H), 7.30 (t, J = 7.8 Hz, 2H), 7.04-7.06 (m, 1H);
 13
C NMR (150 MHz, 
CDCl3): δ 195.8, 155.4, 148.9, 141.0, 137.7, 137.2, 136.6, 134.9, 132.6, 130.2, 129.9, 
129.3, 129.0, 128.2, 122.4, 122.2; IR (neat): υmax 1688, 1588, 1458, 1276, 786 cm
-1
; 
HRMS (ESI, m/z) calcd. for C18H12ClNONa [M + Na]
+
: 316.0505; found: 316.0502. 
(5-bromo-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7aa, Scheme 10.
35a
 The same 
general procedure was followed by using 2-(4-bromophenyl)pyridine (47.0 mg, 0.2 
mmol, 1.0 equiv), 2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 
0.1 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) 
afforded the desired product as a white solid (28.5 mg, 42%), mp 109-111 
o
C. 
1
H NMR 
(600 MHz, CDCl3): δ 8.36 (d, J = 4.2 Hz, 1H), 7.74 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.66-
7.69 (m, 4H), 7.59 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.50 (d, J = 7.8 Hz, 1H), 7.42 (t, J = 7.2 
Hz, 1H), 7.30 (t, J = 7.8 Hz, 2H), 7.04 (dd, J = 6.6 Hz, 4.8 Hz, 1H);
 13
C NMR (150 MHz, 
CDCl3): δ 196.2, 155.5, 149.0, 141.1, 138.2, 137.2, 136.6, 133.1, 132.6, 131.8, 130.1, 
129.4, 128.2, 123.0, 122.4, 122.3; IR (neat): υmax 1668, 1587, 1458, 1275, 786 cm
-1
; 
HRMS (ESI, m/z) calcd. for C18H12BrNONa [M + Na]
+
: 360.0000, 361.9979; found: 
359.9971, 361.9979. 
(3-methyl-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 7ab, Scheme 10.
32b
 The same 
general procedure was followed by using 2-(o-tolyl)pyridine (34.0 mg, 0.2 mmol, 1.0 
equiv), 2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv), potassium persulfate 
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(108 mg, 0.4 mmol, 2.0 equiv) and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (27.0 mg, 50%). 
1
H NMR (600 MHz, CDCl3): δ 8.49 
(d, J = 4.2 Hz, 1H), 7.65 (d, J = 7.2 Hz, 2H), 7.60 (t, J = 7.2 Hz, 1H), 7.46 (d, J = 7.2 Hz, 
1H), 7.40-7.43 (m, 2H), 7.37 (d, J = 7.2 Hz, 1H), 7.28-7.31 (m, 3H), 7.08 (dd, J = 6.6 Hz, 
5.4 Hz, 1H), 2.30 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 198.2, 157.3, 148.7, 140.0, 
137.6, 136.8, 136.1, 132.6, 132.5, 129.9, 129.8, 128.0, 127.9, 126.2, 125.3, 121.9, 20.1; 
IR (neat): υmax 1666, 1589, 1282, 752, 707 cm
-1
; HRMS (ESI, m/z) calcd. for 
C19H15NONa [M + Na]
+
: 296.1051; found: 296.1062. 
General experimental procedure for the dehydrogenative acylation reaction 
between 2-phenylpyridines and aldehydes, Scheme 11. 
To an oven-dried 7 mL clear vial, a mixture of 2-phenylpyridines (0.2 mmol, 1.0 equiv) 
and palladium(II)acetate (4.6 mg, 0.02 mmol, 0.1 equiv) was taken and dry MeCN (3.0 
mL) was added to it. The corresponding aldehydes (0.3 mmol 1.5 equiv) were added to 
the reaction mixture. After flushing with nitrogen for 30 seconds, immediately the vessel 
was sealed with a screw cap. Then aq. TBHP (82 µL, 0.6 mmol, 3.0 equiv) was added to 
the reaction mixture via micro-litter syringe. The reaction mixture was allowed to stir for 
36 h at room temperature. After completion (as indicated by TLC), the reaction mixture 
was quenched with NaHCO3. Then the reaction mixture was poured into water (40 mL) 
and extracted with ethyl acetate (40 mL). The organic layer was washed with water (10 
mL) and brine (10 mL), dried over anhydrous Na2SO4 and the solvent was evaporated 
under reduced pressure. The crude product was purified by column chromatography 
using ethyl acetate/hexane as eluent to afford the desired product. 
Phenyl(2-(pyridin-2-yl)phenyl)methanone, 7a, Scheme 11. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), benzaldehyde (32 µL, 0.3 mmol, 
1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (45.0 mg, 87%), mp 105-107 
o
C. The spectral data of compound 
7a is in Scheme 9. 
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(2-(Pyridin-2-yl)phenyl)(p-tolyl)methanone, 7b, Scheme 11. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-methylbenzaldehyde (36 µL, 0.3 
mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (42.5 mg, 78%), 97-99 
o
C. The spectral data of 
compound 7b is in Scheme 9. 
(4-Methoxyphenyl)(2-(pyridin-2-yl)phenyl)methanone, 7e, Scheme 11. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-methoxybenzaldehyde 
(36.5 µL, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 
equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded 
the desired product as a yellowish oil (39.0 mg, 68%). The spectral data of compound 7e 
is in Scheme 9. 
1-(4-(2-(Pyridin-2-yl)benzoyl)phenyl)ethanone, 7ac, Scheme 11. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-acetylbenzaldehyde (44.5 mg, 0.3 
mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (44.0 mg, 73%), 80-82 
o
C. 
1
H NMR (600 MHz, CDCl3): 
δ 8.30 (d, J = 4.8 Hz, 1H), 7.83 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 7.8 Hz, 1H), 7.75 (d, J = 
8.4 Hz, 2H), 7.62-7.66 (m, 1H), 7.60 (td, J = 7.8 Hz, 1.2 Hz, 1H), 7.56-7.58 (m, 3H), 
7.00-7.02 (m, 1H), 2.57 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 197.6, 197.3, 156.1, 
148.8, 141.6, 139.3, 139.2, 139.0, 136.5, 130.5, 129.2, 129.1, 128.8, 128.4, 127.9, 122.2, 
122.1, 26.8; IR (neat): υmax 1682, 1433, 1259, 930, 753 cm
-1
; HRMS (EI, m/z) calcd. for 
C20H15NO2 [M]
+
: 301.1103; found: 301.1104. 
Methyl 4-(2-(pyridin-2-yl)benzoyl)benzoate, 7ad, Scheme 11.
37a
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), methyl 4-formylbenzoate (49 mg, 
0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
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Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (45.5 mg, 72%). mp 100-102 
o
C. 
1
H NMR (600 MHz, 
CDCl3): δ 8.28-8.29 (m, 1H), 7.91 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 7.2 Hz, 1H), 7.71 (d, J 
= 8.4 Hz, 2H), 7.61-7.64 (m, 1H), 7.54-7.59 (m, 4H), 6.98-7.00 (m, 1H), 3.89 (s, 3H); 
13
C 
NMR (150 MHz, CDCl3): δ 197.4, 166.3, 156.1, 148.8, 141.6, 139.4, 139.0, 136.5, 132.8, 
130.5, 129.2, 128.9, 128.8, 128.4, 122.2, 122.1, 52.3; IR (neat): υmax 1717, 1664, 1281, 
1107, 743 cm
-1
; HRMS (EI, m/z) calcd. for C20H15NO3 [M]
+
: 317.1052; found: 317.1053. 
4-(2-(Pyridin-2-yl)benzoyl)benzonitrile, 7ae, Scheme 11.
32b
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-formylbenzonitrile (40 mg, 0.3 
mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (26.5 mg, 47%), mp 106-108 
o
C. 
1
H NMR (600 MHz, 
CDCl3): δ 8.26 (d, J = 4.2 Hz, 1H), 7.81 (d, J = 7.2 Hz, 1H), 7.74-7.75 (m, 2H), 7.54-7.67 
(m, 7H), 7.02-7.04 (m, 1H); 
13
C NMR (150 MHz, CDCl3): δ 196.4, 155.7, 148.7, 141.6, 
139.2, 138.4, 136.7, 131.9, 130.7, 129.2, 129.0, 128.2, 122.3, 122.0, 118.2, 115.0; IR 
(neat): υmax 2225, 1671, 1285, 929, 744 cm
-1
; HRMS (EI, m/z) calcd. for C19H12N2O 
[M]
+
: 284.0950; found: 284.0958. 
(3-Nitrophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7af, Scheme 11.
32b
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 3-nitrobenzaldehyde (45 
mg, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (34.0 mg, 56%). 
1
H NMR (600 MHz, CDCl3): δ 8.44 
(s, 1H), 8.26 (d, J = 4.2 Hz, 1H), 8.22 (d, J = 7.8 Hz, 1H), 8.03 (d, J = 7.8 Hz, 1H), 7.83 
(d, J = 7.2 Hz, 1H), 7.58-7.69 (m, 5H), 7.47 (t, J = 7.8 Hz, 1H), 7.00-7.02 (m,1H); 
13
C 
NMR (150 MHz, CDCl3): δ 195.5, 155.8, 148.7, 147.9, 139.8, 139.3, 138.2, 136.8, 134.4, 
130.8, 129.20, 129.17, 129.0, 128.4, 126.2, 123.6, 122.2, 122.0; IR (neat): υmax 1674, 
1531, 1349, 1277, 753 cm
-1
; HRMS (ESI, m/z) calcd. for C18H12N2O3Na [M + Na]
+
: 
327.0746; found: 327.0752. 
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Naphthalen-2-yl(2-(pyridin-2-yl)phenyl)methanone, 7ag, Scheme 11.
17
 The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 2-naphthaldehyde (47 mg, 
0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (37.0 mg, 60%). 
1
H NMR (600 MHz, CDCl3): δ 8.33 
(d, J =4.8 Hz, 1H), 8.09 (s, 1H), 7.94 (dd, J = 9.0 Hz, 1.8 Hz, 1H), 7.83 (d, J = 7.2 Hz, 
1H), 7.77-7.81 (m, 3H), 7.65-7.67 (m, 1H), 7.62 (dd, J = 7.2 Hz, 1.2 Hz, 1H), 7.51-7.58 
(m, 4H), 7.46 (t, J = 7.2 Hz, 1H), 6.93-6.95 (m, 1H); 
13
C NMR (150 MHz, CDCl3): δ 
198.2, 156.7, 149.0, 139.7, 139.6, 136.3, 135.3, 135.2, 132.2, 131.5, 130.2, 129.4, 129.1, 
128.8, 128.5, 128.1, 128.0, 127.6, 126.4, 124.9, 122.5, 121.9; IR (neat): υmax 1662, 1588, 
1465, 1289, 753 cm
-1
; HRMS (EI, m/z) calcd. for C22H15NO [M]
+
: 309.1154; found: 
309.1150.  
 (3,4-Dichlorophenyl)(2-(pyridin-2-yl)phenyl)methanone, 7ah, Scheme 11. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 3,4-dichlorobenzaldehyde 
(52.5 mg, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 
equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded 
the desired product as a white solid (31.5 mg, 48%), mp 135-137 
o
C. 
1
H NMR (600 MHz, 
CDCl3): δ 8.33 (d, J = 4.2 Hz, 1H), 7.80 (d, J = 7.2 Hz, 1H), 7.78 (d, J = 1.8 Hz, 1H), 
7.63-7.66 (m, 2H), 7.59 (d, J = 7.8 Hz, 1H), 7.55 (t, J = 7.2 Hz, 1H), 7.49-7.53 (m, 2H), 
7.34 (d, J = 8.4 Hz, 1H), 7.06-7.08 (m, 1H); 
13
C NMR (150 MHz, CDCl3): δ 195.7, 
156.0, 148.8, 139.3, 138.5, 137.8, 136.6, 136.4, 132.5, 130.9, 130.6, 130.1, 129.0, 128.8, 
128.4, 128.2, 122.2, 122.1; IR (neat): υmax 1666, 1580, 1434, 1380, 1275, 955, 747 cm
-1
; 
HRMS (ESI, m/z) calcd. for C18H11Cl2NONa [M + Na]
+
: 350.0115; found: 350.0117. 
(3,4-Dimethoxyphenyl)(2-(pyridin-2-yl)phenyl)methanone, 7ai, Scheme 11. The same 
general procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 
equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 3,4-
dimethoxybenzaldehyde (50 mg, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide 
(82 µL, 0.6 mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 7:3 
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hexane/ethyl acetate) afforded the desired product as a white solid (48.0 mg, 75%). mp 
108-110 
o
C. 
1
H NMR (600 MHz, CDCl3): δ 8.42-8.43 (m, 1H), 7.77 (d, J = 7.8 Hz, 1H), 
7.58-7.60 (m, 1H), 7.56 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.49-7.52 (m, 2H), 7.46 (d, J = 7.8 
Hz, 1H), 7.44 (d, J = 1.8 Hz, 1H), 7.16 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.03-7.05 (m, 1H), 
6.66 (d, J = 8.4 Hz, 1H), 3.96 (s, 3H), 3.85 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 
197.0, 157.0, 152.7, 149.2, 148.6, 139.51, 139.48, 136.2, 130.8, 130.0, 129.0, 128.9, 
128.3, 125.2, 122.9, 121.9, 110.9, 109.6, 55.91, 55.89; IR (neat): υmax 1656, 1588, 1511, 
1269, 1128, 753 cm
-1
; HRMS (ESI, m/z) calcd. for C20H17NO3Na [M + Na]
+
: 342.1106; 
found: 342.1112. 
(4-Methyl-2-(pyridin-2-yl)phenyl)(p-tolyl)methanone, 7aj, Scheme 11. The same 
general procedure was followed by using 2-(m-tolyl)pyridine (34.0 mg, 0.2 mmol, 1.0 
equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-methylbenzaldehyde (36 
µL, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a white solid (46.0 mg, 80%), mp 128-130 
o
C. 
1
H NMR (600 MHz, 
CDCl3): δ 8.42 (d, J = 4.2 Hz, 1H), 7.58-7.61 (m, 3H), 7.53 (td, J = 7.8 Hz, 1.8 Hz, 1H), 
7.43 (t, J = 7.2 Hz, 2H), 7.32 (d, J = 7.8 Hz, 1H), 7.07 (d, J = 8.4 Hz, 2H), 7.01-7.03 (m, 
1H), 2.50 (s, 3H), 2.31 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 198.0, 157.2, 149.1, 
143.0, 140.3, 139.8, 136.8, 136.1, 135.4, 129.8, 129.7, 129.2, 129.0, 128.7, 123.1, 121.8, 
21.6, 21.4; IR (neat): υmax 1661, 1605, 1467, 1286, 931, 756 cm
-1
; HRMS (ESI, m/z) 
calcd. for C20H17NONa [M + Na]
+
: 310.1208; found: 310.1217. 
(4-Methoxy-2-(pyridin-2-yl)phenyl)(p-tolyl)methanone, 7ak, Scheme 11. The same 
general procedure was followed by using 2-(3-methoxyphenyl)pyridine (37.0 mg, 0.2 
mmol, 1.0 equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-
methylbenzaldehyde (36 µL, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 
µL, 0.6 mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a colourless oil (36.5 mg, 60%). 
1
H
 
NMR (600 
MHz, CDCl3): δ 8.43-8.44 (m, 1H), 7.58 (d, J = 8.4 Hz, 2H), 7.52-7.55 (m, 2H), 7.39 (d, 
J = 7.8 Hz, 1H), 7.27 (d, J = 7.8 Hz, 1H), 7.02-7.07 (m, 4H), 3.93 (s, 3H), 2.31 (s, 3H);
 
13
C NMR (150 MHz, CDCl3): δ 197.3, 161.0, 157.2, 149.1, 142.9, 142.1, 136.1, 135.6, 
 Chapter IV    
201 
 
132.0, 131.3, 129.8, 128.7, 123.4, 122.0, 114.6, 113.7, 55.5, 21.5; IR (neat): υmax 2926, 
1659, 1603, 1467, 1284, 1223, 1032, 758 cm
-1
; HRMS (EI, m/z) calcd. for C20H17NO2 
[M]
+
: 303.1259; found: 303.1256. 
(5-Methyl-2-(pyridin-2-yl)phenyl)(p-tolyl)methanone, 7al, Scheme 11.
47
 The same 
general procedure was followed by using 2-(p-tolyl)pyridine (34.0 mg, 0.2 mmol, 1.0 
equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-methylbenzaldehyde (36 
µL, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (40.0 mg, 70%). 
1
H
 
NMR (600 MHz, CDCl3): δ 8.37-
8.38 (m, 1H), 7.68 (d, J = 8.4 Hz, 1H), 7.61 (d, J = 8.4 Hz, 2H), 7.53-7.55 (m, 1H), 7.46 
(d, J = 7.8 Hz, 1H), 7.40 (d, J = 7.8 Hz, 1H), 7.32 (s, 1H), 7.07 (d, J = 8.4 Hz, 2H), 6.99-
7.01 (m, 1H), 2.45 (s, 3H), 2.32 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 198.2, 156.8, 
149.0, 143.0, 139.6, 138.5, 136.7, 136.1, 135.3, 130.7, 129.7, 129.4, 128.72, 128.70, 
122.6, 121.6, 21.6, 21.2; IR (neat): υmax 2923, 1663, 1603, 1463, 1290, 757 cm
-1
; HRMS 
(EI, m/z) calcd. for C20H17NO [M]
+
: 287.1310; found: 287.1316. 
(4-(Pyridin-2-yl)-[1,1'-biphenyl]-3-yl)(p-tolyl)methanone, 7am, Scheme 11. The same 
general procedure was followed by using 2-([1,1'-biphenyl]-4-yl)pyridine (46.5 mg, 0.2 
mmol, 1.0 equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-
methylbenzaldehyde (36 µL, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 
µL, 0.6 mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a white solid (38.5 mg, 55%), mp 145-147 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 8.42 (d, J = 4.2 Hz, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.84 (dd, J 
= 7.8 Hz, 1.8 Hz, 1H), 7.76 (d, J = 1.8 Hz, 1H), 7.67-7.69 (m, 4H), 7.59 (td, J = 7.8 Hz, 
1.8 Hz, 1H), 7.55 (d, J = 7.8 Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 7.39 (t, J = 7.2 Hz, 1H), 
7.11 (d, J = 7.8 Hz, 2H), 7.04-7.06 (m, 1H), 2.34 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 
197.9, 156.5, 149.1, 143.2, 141.2, 140.2, 139.7, 138.3, 136.3, 135.2, 129.8, 129.3, 128.9, 
128.8, 128.5, 127.9, 127.5, 127.1, 122.6, 121.9, 21.6; IR (neat): υmax 1662, 1596, 1462, 
1245, 758 cm
-1
; HRMS (ESI, m/z) calcd. for C25H19NONa [M + Na]
+
: 372.1364; found: 
372.1364. 
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1-(3-(4-Methylbenzoyl)-4-(pyridin-2-yl)phenyl)ethanone, 7an, Scheme 11. The same 
general procedure was followed by using 1-(4-(pyridin-2-yl)phenyl)ethanone (39.5 mg, 
0.2 mmol, 1.0 equiv), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 4-
methylbenzaldehyde (36 µL, 0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 
µL, 0.6 mmol, 3.0 equiv). Column chromatography (SiO2, eluting with 7:3 hexane/ethyl 
acetate) afforded the desired product as a white solid (28.0 mg, 45%), mp 89-91 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 8.41-8.42 (m, 1H), 8.19 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 8.07 (d, 
J = 1.8 Hz, 1H), 7.89 (d, J = 8.4 Hz, 1H), 7.59-7.64 (m, 3H), 7.55 (d, J = 7.8 Hz, 1H), 
7.08-7.11 (m, 3H), 2.66 (s, 3H), 2.34 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 197.1, 
197.0, 155.6, 149.2, 143.6, 143.5, 140.0, 136.6, 136.5, 134.8, 129.6, 129.5, 129.2, 128.9, 
122.9, 122.6, 26.8, 21.6; IR (neat): υmax 2925, 1682, 1599, 1300, 1243, 756 cm
-1
; HRMS 
(EI, m/z) calcd. for C21H17NO2 [M]
+
: 315.1259; found: 315.1248. 
Phenyl(2-(quinolin-2-yl)phenyl)methanone, 7ao, Scheme 11.
49
 The same general 
procedure was followed by using 2-phenylquinoline (41.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), benzaldehyde (32 µL, 0.3 mmol, 
1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (28.5 mg, 46%), mp 118-120 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 
8.07 (d, J = 8.4 Hz, 1H), 7.94 (d, J = 7.8 Hz, 1H), 7.76-7.77 (m, 2H), 7.65-7.74 (m, 4H), 
7.57-7.61 (m, 3H), 7.43 (d, J = 7.2 Hz, 1H), 7.31-7.33 (m, 1H), 7.23 (t, J = 7.8 Hz, 2H);
 
13
C NMR (150 MHz, CDCl3): δ 198.2, 156.1, 147.3, 140.3, 139.4, 138.2,136.6, 132.1, 
130.1, 129.5, 129.2, 129.04, 128.99, 128.82, 128.80, 127.9, 127.2, 126.54, 126.46, 119.9; 
IR (neat): υmax 1665, 1596, 1282, 931, 768 cm
-1
; HRMS (ESI, m/z) calcd. for 
C22H15NONa [M + Na]
+
: 332.1051; found: 332.1050. 
(2-(Pyridin-2-yl)phenyl)(thiophen-3-yl)methanone, 7ap, Scheme 11. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), thiophene-3-carbaldehyde (26 µL, 
0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (30.0 mg, 56%). 
1
H NMR (600 MHz, CDCl3): δ 8.46 
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(d, J = 4.2 Hz, 1H), 7.77 (d, J = 7.2 Hz, 1H), 7.58-7.62 (m, 4H), 7.52 (t, J = 7.2 Hz, 1H), 
7.49 (d, J = 7.8 Hz, 1H), 7.42 (d, J = 4.8 Hz, 1H), 7.15-7.16 (m, 1H), 7.07-7.09 (m, 1H); 
13
C NMR (150 MHz, CDCl3): δ 191.8, 157.0, 149.2, 142.8, 140.0, 139.4, 136.3, 133.9, 
130.3, 129.2, 128.7, 128.4, 127.6, 125.8, 122.9, 121.9; IR (neat): υmax 1656, 1586, 1428, 
1273, 858, 752 cm
-1
; HRMS (ESI, m/z) calcd. for C16H11NSONa [M + Na]
+
: 288.0459; 
found: 288.0460. 
Furan-2-yl(2-(pyridin-2-yl)phenyl)methanone, 7aq, Scheme 11.
50
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), furan-2-carbaldehyde (25 µL, 0.3 
mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (21.0 mg, 42%). 
1
H NMR (600 MHz, CDCl3): δ 8.49 
(d, J = 4.8 Hz, 1H), 7.78 (d, J = 7.8 Hz, 1H), 7.61-7.66 (m, 3H), 7.52-7.54 (m, 2H), 7.43 
(s, 1H), 7.10-7.12 (m, 1H), 6.82 (d, J = 3.0 Hz, 1H), 6.34-6.35 (m, 1H); 
13
C NMR (150 
MHz, CDCl3): δ 185.4, 157.1, 152.8, 149.2, 146.5, 139.8, 138.3, 136.4, 130.6, 129.1, 
129.0, 128.4, 122.7, 121.9, 119.3, 111.9; IR (neat): υmax 1656, 1566, 1465, 1301, 1019, 
753 cm
-1
; HRMS (ESI, m/z) calcd. for C16H11NO2Na [M + Na]
+
: 272.0687; found: 
272.0634.  
3-Methyl-1-(2-(pyridin-2-yl)phenyl)butan-1-one, 7w, Scheme 11. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 3-methylbutanal (33 µL, 0.3 mmol, 
1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a colourless oil (31.0 mg, 65%). The spectral data of compound 3w is in 
decarboxylative acylation part. 
Cyclohexyl(2-(pyridin-2-yl)phenyl)methanone, 7ar, Scheme 11.
32a
 The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), cyclohexanecarbaldehyde (36.5 µL, 
0.3 mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
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desired product as a white solid (46.5 mg, 88%), mp 86-88 
o
C. 
1
H
 
NMR (600 MHz, 
CDCl3): δ 8.64 (d, J = 4.2 Hz, 1H), 7.76 (t, J = 7.2 Hz, 1H), 7.68 (d, J = 7.8 Hz, 1H), 7.60 
(d, J = 7.8 Hz, 1H), 7.51 (t, J = 7.8 Hz, 1H), 7.44 (t, J = 7.8 Hz, 1H), 7.41 (d, J = 7.2 Hz, 
1H), 7.23-7.25 (m, 1H), 2.18-2.23 (m, 1H), 1.73 (d, J = 13.2 Hz, 2H), 1.66-1.69 (m, 2H), 
1.55 (d, J = 13.2 Hz, 1H), 1.35-1.42 (m, 2H), 1.10-1.17 (m, 1H), 0.94-1.02 (m, 2H);
 13
C 
NMR (150 MHz, CDCl3): δ 210.8, 157.2, 149.3, 141.3, 138.1, 136.8, 129.8, 128.7, 128.6, 
128.1, 122.3, 122.3, 50.8, 29.1, 25.9, 25.8; IR (neat): υmax  2928, 1687, 1586, 1438, 976, 
750 cm
-1
; HRMS (ESI, m/z) calcd. for C18H19NONa [M + Na]
+
: 288.1364; found: 
288.1361. 
3-Methyl-1-(2-(pyridin-2-yl)phenyl)but-2-en-1-one, 7as, Scheme 11. The same general 
procedure was followed by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), 3-methylbut-2-enal (29 µL, 0.3 
mmol, 1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). 
Column chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the 
desired product as a colourless oil (15.0 mg, 76%). 
1
H
 
NMR (600 MHz, CDCl3): δ 8.64 
(d, J = 4.8 Hz, 1H), 7.72 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.62 (d, J = 7.2 Hz, 1H), 7.58 (d, J 
= 7.8 Hz, 1H), 7.52-7.54 (m, 1H), 7.46-7.48 (m, 2H), 7.22-7.24 (m, 1H), 6.03 (s, 1H), 
2.08 (s, 3H), 1.72 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 196.0, 158.1, 154.8, 149.2, 
142.1, 139.4, 136.1, 130.1, 129.5, 128.4, 128.1, 125.3, 123.5, 122.0, 27.5, 20.7; IR (neat): 
υmax 2926, 1666, 1615, 1434, 1236, 1012, 752 cm
-1
; HRMS (ESI, m/z) calcd. for 
C16H15NONa [M + Na]
+
: 260.1051; found: 260.1057. 
Benzo[h]quinolin-10-yl(phenyl)methanone, 7at, Scheme 11.
32b
 The same general 
procedure was followed by using benzo[h]quinoline (36.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), benzaldehyde (32 µL, 0.3 mmol, 
1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (51.5 mg, 91%), mp 148-150 
o
C. 
1
H NMR (600 MHz, CDCl3): δ 
8.51 (d, J = 4.2 Hz, 1.8 Hz, 1H), 8.04-8.07 (m, 2H), 7.88 (d, J = 8.4 Hz, 1H), 7.77-7,80 
(m, 3H), 7.72 (d, J = 9.0 Hz, 1H), 7.65 (dd, J = 7.2 Hz, 1.2 Hz, 1H), 7.40-7.43 (m, 1H), 
7.29-7.32 (m, 3H); 
13
C NMR (150 MHz, CDCl3): δ 198.6, 147.0, 144.6, 139.2, 138.9, 
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135.3, 133.8, 131.7, 129.2, 129.0, 128.7, 128.1, 127.8, 127.7, 127.0, 126.4, 126.1, 121.6; 
IR (neat): υmax 1672, 1417, 1272, 841, 708 cm
-1
; HRMS (EI, m/z) calcd. for C20H13NO 
[M]
+
: 283.0997; found: 283.0993. 
Phenyl(2-(pyrimidin-2-yl)phenyl)methanone, 7x, Scheme 11. The same general 
procedure was followed by using 2-phenylpyrimidine (31.5 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), benzaldehyde (32 µL, 0.3 mmol, 
1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (34.0 mg, 65%), mp 129-131 
o
C. The spectral data of compound 
7x is in decarboxylative acylation part. 
Phenyl(2-(pyridin-2-yloxy)phenyl)methanone, 7au, Scheme 11.
51
 The same general 
procedure was followed except the reaction was run for 72 hours  by using 2-
phenoxypyridine (34.0 mg, 0.2 mmol, 1.0 equiv), palladium(II) acetate (4.5 mg, 0.02 
mmol, 0.1 equiv), benzaldehyde (32 µL, 0.3 mmol, 1.5 equiv), and aq. tert-butyl 
hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). Column chromatography (SiO2, eluting 
with 7:3 hexane/ethyl acetate) afforded the desired product as a colourless oil (12.0 mg, 
22%). 
1
H
 
NMR (600 MHz, CDCl3): δ 8.00-8.02 (m, 1H), 7.76 (d, J = 8.4 Hz, 2H), 7.56-
7.59 (m, 2H), 7.46-7.52 (m, 2H), 7.30-7.34 (m, 3H), 7.27 (d, J = 8.4 Hz, 1H), 6.86-6.88 
(m, 1H), 6.60 (d, J = 8.4 Hz, 1H); 
13
C NMR (150 MHz, CDCl3): δ 195.3, 163.0, 151.6, 
147.0, 139.3, 137.5, 132.8, 132.22, 132.15, 130.3, 129.8, 128.0, 124.7, 122.8, 118.5, 
111.5, IR (neat): υmax 1666, 1590, 1432, 1250, 766 cm
-1
; HRMS (ESI, m/z) calcd. for 
C18H13NO2Na [M + Na]
+
: 298.0844; found: 298.0861. 
(2-(1H-Pyrazol-1-yl)phenyl)(phenyl)methanone, 7av, Scheme 11.
51
 The same general 
procedure was followed by using 1-phenyl-1H-pyrazole (29.0 mg, 0.2 mmol, 1.0 equiv), 
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv), benzaldehyde (32 µL, 0.3 mmol, 
1.5 equiv), and aq. tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv). Column 
chromatography (SiO2, eluting with 7:3 hexane/ethyl acetate) afforded the desired 
product as a white solid (16.0 mg, 32%), mp 82-84 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 
7.58-7.66 (m, 6H), 7.50 (td, J = 7.2 Hz, 1.2 Hz, 1H), 7.43-7.46 (m, 1H), 7.41 (d, J = 1.8 
Hz, 1H), 7.30 (t, J = 8.4 Hz, 2H), 6.19 (t, J = 1.8 Hz, 1H);
 13
C NMR (150 MHz, CDCl3): δ 
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195.8, 141.2, 138.6, 136.7, 133.8, 132.9, 131.2, 129.8, 129.6, 129.0, 128.1, 127.5, 123.2, 
107.6; IR (neat): υmax 1669, 1590, 1264, 931, 762 cm
-1
; HRMS (EI, m/z) calcd. for 
C16H12N2O [M]
+
: 248.0950; found: 248.0947. 
Dehydrogenative acylation reaction in gram scale (Synthesis of phenyl(2-(pyridin-2-
yl)phenyl)methanone, 7a, Scheme 11). 
To an oven-dried 100 mL sealed tube, a mixture of 2-phenylpyridines (0.93 mL, 6.5 
mmol, 1.0 equiv) and palladium(II)acetate (146 mg, 0. 65 mmol, 0.1 equiv) was taken 
and dry MeCN (50 mL) was added to it. Then benzaldehyde (1.0 mL, 9.8 mmol 1.5 
equiv) was added to the reaction mixture. After few seconds flushing with nitrogen, 
immediately 70% aq. TBHP (2.6 mL, 19.5 mmol, 3.0 equiv) was added to the reaction 
mixture via syringe. The vessel was sealed with a screw cap. The reaction mixture was 
allowed to stir for 36 h at room temperature. After completion (as indicated by TLC), the 
reaction mixture was quenched with NaHCO3. Then the reaction mixture was poured into 
water (80 mL) and extracted with ethyl acetate (60x2 mL). The organic layer was washed 
with water (30x2 mL) and brine (30 mL), dried over anhydrous Na2SO4 and the solvent 
was evaporated under reduced pressure. The pure phenyl(2-(pyridin-2-
yl)phenyl)methanone (7a) was obtained as a white solid in 72% (1.21 g) yield after 
column chromatography of the crude reaction mixture using ethyl acetate/hexane (7:3) as 
eluent. 
Control experiments, Scheme 12. 
The standard decarboxylative acylation reaction with radical scavenger (2,2,6,6-
Tetramethylpiperidin-1-yl)oxyl (TEMPO), Scheme 12a. 
To an oven-dried 10 mL sealed tube, a mixture of 2-phenylpyridine (31.5 mg, 0.2 mmol, 
1.0 equiv), 2-oxo-2-phenylacetic acid (45 mg, 0.3 mmol, 1.5 equiv), potassium persulfate 
(108 mg, 0.4 mmol, 2.0 equiv), palladium(II)acetate (4.6 mg, 0.02 mmol, 0.1 equiv) and 
(2,2,6,6-Tetramethylpiperidin-1-yl)oxyl (TEMPO) (31.5 mg, 0.2 mmol, 1.0 equiv) was 
taken and dry MeCN (3.0 mL) was added to it. After few seconds flushing with nitrogen, 
the vessel was sealed with a screw cap. The reaction mixture was allowed to stir for 16 h 
at room temperature. After that the reaction mixture was quenched with NaHCO3. We did 
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not detect any desired acylation product (7a) by TLC. However, we isolated TEMPO-
acyl adduct, 2,2,6,6-tetramethylpiperidin-1-yl benzoate (10a) in 74% yield as a white 
solid from the reaction mixture. 
This control experiment suggested that the reaction may proceed via radical pathway and 
the acyl radical intermediate may form from the corresponding 2-oxo-2-phenylacetic 
acids. 
2,2,6,6-Tetramethylpiperidin-1-yl benzoate 10a, Scheme 12a.
16a
 Column 
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired 
product as a white solid (39.0 mg, 74%), mp 85-87 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 
8.08-8.10 (m, 2H), 7.59 (t, J = 7.2 Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 1.77-1.82 (m, 2H), 
1.67-1.74 (m, 1H), 1.59-1.62 (m, 2H), 1.46-1.49 (m, 1H), 1.29 (s, 6H), 1.13 (s, 6H); 
13
C 
NMR (150 MHz, CDCl3): δ 166.4, 132.8, 129.7, 129.5, 128.4, 60.4, 39.0, 31.9, 20.8, 
17.0; IR (neat): υmax 2932, 1742, 1452, 1248, 1067, 712 cm
-1
; HRMS (ESI, m/z) calcd. for 
C16H23NO2Na [M + Na]
+
: 284.1626; found: 284.1628. 
The standard decarbonylative acylation reaction with radical scavenger (2,2,6,6-
Tetramethylpiperidin-1-yl)oxyl (TEMPO), Scheme 12a. 
To an oven-dried 10 mL sealed tube, a mixture of 2-phenylpyridine (31.5 mg, 0.2 mmol, 
1.0 equiv), 2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv), potassium 
persulfate (108 mg, 0.4 mmol, 2.0 equiv), palladium(II)acetate (4.6 mg, 0.02 mmol, 0.1 
equiv) and (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl (TEMPO) (31.5 mg, 0.2 mmol, 1.0 
equiv) was taken and dry MeCN (3.0 mL) was added to it. After few seconds flushing 
with nitrogen, the vessel was sealed with a screw cap. The reaction mixture was allowed 
to stir for 16 h at room temperature. After that the reaction mixture was quenched with 
NaHCO3. We did not detect any desired acylation product (7a) as indicated by TLC. But 
we isolated TEMPO-acyl adduct, 2,2,6,6-tetramethylpiperidin-1-yl benzoate (10a) in 
56% as a white solid from the reaction mixture.  
This control experiment suggested that the reaction may proceed via radical pathway and 
the acyl radical intermediate may form from the corresponding arylglyoxals. 
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The standard dehydrogenative acylation reaction with radical scavenger (2,2,6,6-
Tetramethylpiperidin-1-yl)oxyl (TEMPO), Scheme 12a. 
To an oven-dried 7 mL clear vial, a mixture of 2-phenylpyridine (31.5 mg, 0.2 mmol, 1.0 
equiv) and palladium(II)acetate (4.6 mg, 0.02 mmol, 0.1 equiv) was taken and dry MeCN 
(3.0 mL) was added to it. Then benzaldehyde (32.0 µL, 0.3 mmol 1.5 equiv) and (2,2,6,6-
Tetramethylpiperidin-1-yl)oxyl (TEMPO) (63.0 mg, 0.4 mmol, 2.0 equiv)  was added to 
the reaction mixture. After flushing with nitrogen, immediately the vessel was sealed 
with a screw cap.  Then aq. TBHP (82 µL, 0.6 mmol, 3.0 equiv) was added to the 
reaction mixture via micro-litter syringe. The reaction mixture was allowed to stir for 36 
h at room temperature. After that the reaction mixture was quenched with NaHCO3. We 
did not detect any desired acylation product (7a) as indicated by TLC. But we isolated 
TEMPO-acyl adduct, 2,2,6,6-tetramethylpiperidin-1-yl benzoate (10a) in 71% as a white 
solid from the reaction mixture. 
When the same experiment was performed with 1.0 equiv of 2,2,6,6-
Tetramethylpiperidin-1-yl)oxyl (TEMPO) (31.5 mg, 0.2 mmol), we isolated the desired 
acylation product (7a) in 28% yield and also TEMPO-acyl adduct, 2,2,6,6-
tetramethylpiperidin-1-yl benzoate (10a) in 90% as a white solid from the reaction 
mixture. In addition, when the same experiment was performed with 1.5 equiv of 
(2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) (47.0 mg, 0.3 mmol), we isolated the 
desired acylation product (7a) in 12% yield and also TEMPO-acyl adduct, 2,2,6,6-
tetramethylpiperidin-1-yl benzoate (10a) in 75% as a white solid from the reaction 
mixture. This control experiment suggested that the reaction may proceed via radical 
pathway and the acyl radical intermediate may form from the corresponding aldehydes. 
 
IV. 8. 
1
H and 
13
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CHAPTER V 
 
Cu
I
/Ag
I
-Promoted Decarboxylative Alkynylation of ortho-Nitro Benzoic 
Acids 
 
 
 
Abstract: We report herein, a novel copper-silver-promoted alkynylation of ortho-
nitrobenzoic acids with arylacetylenic acids through a double decarboxylation. The 
present cross-coupling is extremely challanging due to sluggish decarboxylation of arene 
carboxylates and deleterious oxidative Glaser-Hay type homocoupling of terminal 
alkynes. Mechanistically, this sp
2
-sp cross-coupling may proceed through a silver-
assisted decarboxylation of 2-nitrobenzoic acids followed by transmetalation with 
copper-acetylide and reductive elimination. The ortho-nitroacetylenic product is an 
important precursor for the synthesis of functionalized indoles. 
 
1. Hossian, A.; Manna, K.; Das, P.; Jana, R. ChemistrySelect 2018, 3, 4315-4318. 
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Cu
I
/Ag
I
-Promoted Decarboxylative Alkynylation of ortho-Nitro Benzoic 
Acids 
V. 1. Introduction 
Owing to their unique reactivity as nucleophile as well as electrophile, alkynes are used 
as one of the most versatile functional groups in organic synthesis and represent an 
impressive array of utilities in the fuel industry, advanced materials, chemical biology 
and drug development.
1
 However, installation of the alkyne moiety into the organic 
backbone is heavily dependent on the Sonogashira cross-coupling between vinyl/aryl 
halides and terminal acetylenes in the presence of palladium/copper(I) bimetallic 
catalyst.
2
 Therefore, development of novel methodology for the synthesis of structurally 
diverse alkynes is highly desirable. In fact, the direct alkynylation through C-H bonds 
activation has been investigated in the last decade.
3
 But installation of the directing 
groups to control site-selectivity and their subsequent removal prevents the synthetic 
fidelity.
4
 As an alternative to conventional cross-coupling or C-H functionalization 
reactions, decarboxylative cross-coupling has emerged as a modern strategy using readily 
available and inexpensive; air and moisture stable carboxylic acids as coupling partner
5
 
and have also been successfully accomplished in the alkynylation reactions (Scheme 1). 
 
Scheme 1. Alkynylation reactions 
V. 2. Review 
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Although, the decarboxylative biaryl and Heck-type cross-coupling have been well-
explored but decarboxylative alkynylation remain underdeveloped.
6
 In this vein, the Lee 
group have successfully developed an efficient method for the decarboxylative 
alkynylation reactions using aryl/vinyl halides and triflates as electrophiles and propiolic 
acids (Scheme 2).
7
 For this transformation, they adopted a palladium/silver bimetallic 
catalyst system to get synthetically useful yields. Mechanistically, propiolic acids 
undergo decarboxylation in the presence of silver salt producing silver-acetylides species 
which may transmetalates with the aryl-Pd(II) intermediate which is formed via oxidative 
addition of Pd(0) to aryl halides. Finally, the reductive elimination of alkynyl-aryl Pd(II) 
species provided the desired alkynylated product, regenerating the Pd(0) for next catalytic 
cycle. 
 
Scheme 2. Palladium-catalyzed Decarboxylative alkynylation reaction 
In 2015, Wang and coworkers have reported hypervalent iodine catalyzed 
sunlight-driven metal free decarboxylative alkynylation of α-keto acids with 
bromoacetylenes to provide variety of ynones with excellent yields (Scheme 3).
8
 The 
sunlight acts as photocatalyst for this transformation and the reaction proceed through 
acyl radical intermediate formed from the corresponding α-oxocarboxylic acids. 
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Scheme 3. Decarboxylative ynone synthesis 
 
Scheme 4. Nickel-catalyzed decarboxylative alkynylation reaction 
 
Scheme 5. Decarboxylative allylation of propiolic acids 
Owing to the prevalence of nickel catalysts towards the decarboxylative cross-
coupling reactions,
9
 the Baran group has successfully developed a nickel catalyzed 
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decarboxylative alkynylation reaction using redox-active carboxylic esters and alkynyl 
zinc reagents (Scheme 4).
10 
Interestingly, this method is also applicable to unnatural 
amino acids and provided a variety of synthetically useful alkyne products. 
The Tunge group has also reported palladium catalyzed decarboxylative allylation 
of propiolic acids derivatives (Scheme 5).
11
 The propiolic acids are readily decarboxylate 
in the presence of palladium catalyst generating palladium-acetylides species which can 
be coupled with π-allyl electrophiles to furnish 1,4-enynes via reductive elimination. 
V. 3. Present Work 
The three different classes of carboxylic acids have been explored for decarboxylative 
alkynylation reactions- 1) the propiolic acids undergo decarboxylative metalation to form 
metal-acetylides for subsequent arylation and heterodiarylation
12
 allylation and 
benzylation;
13
 2) α-oxocarboxylic acids serve as an excellent acyl radical equivalent 
which have also been utilized in the decarboxylative ynone synthesis
14
 and recently, 3) 
alkyl carboxylic acids have showcased tremendous potential in decarboxylative 
alkynylation reactions under radical conditions.
15
 To the best of our knowledge, there is 
no report of decarboxylative sp
2
-sp cross-coupling using arene carboxylic acids. This 
might be ascribed due to sluggish decarboxylation of arene carboxylates and deleterious 
oxidative Glaser-Hay type homocoupling of terminal alkynes. For the first time, we 
report herein a copper(I)/silver(I)-promoted decarboxylative sp
2
-sp cross-coupling 
between 2-nitrobenzoic acid derivatives and alkyne carboxylic acids via double 
decarboxylation. 2-Alkynylated nitroarene product obtained in this protocol is crucial 
precursor for the synthesis of a plethora of N-heterocycles especially functionalized 
indoles.
16 
 
 
Scheme 6. Decarboxylative sp
2
-sp alkynylation of ortho nitrobenzoic acids 
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V. 4. Results and discussion  
Initially, 2-nitrobenzoic acid (12a, Table 1) and phenyl acetylene were chosen as model 
substrate for the optimization of decarboxylative alkynylation reaction. However, no 
desired alkynylation product was obtained except oxidative homocoupling of phenyl 
acetylene with catalytic palladium(0)/copper(I)iodide. We realized that decarboxylative 
metalation of nitrobenzoic acid is a slower process compared to copper-assisted 
homocoupling of phenyl acetylene. To circumvent, we chose phenylpropiolic acid (2a, 
Table 1) to induce parity in decarboxylation steps of two cross-coupling partners.
17
 Since 
palladium did not afford the desired product and silver is known to accelerate 
decarboxylation process, we decided to use silver(I)/copper(I) bimetallic system which 
was originally developed by the Goossen’s group.18 Subsequent trials with catalytic 
copper(I) iodide (20 mol %), in presence of silver(I) carbonate (1.0 equiv) and cesium 
carbonate (1.0 equiv) afforded decarboxylative protonation of 2-nitrobenzoic acid and 
20% of alkyne homocoupling product 13a (entry 1, Table 1). We hypothesized that 
sufficient copper-acetylide is essential for the transmetalation with aryl-silver species 
which is formed through decarboxylation. As expected, increasing the amount of 
copper(I)iodide to 0.5 and 1.0 equiv the yield of the desired product was increased to 
10% and 28% respectively (entry 2 and 3, Table 1). We examined several ligands such as 
triphenylphosphine, 1,10-phenanthroline, dtbpy etc. with  catalytic copper(I) catalyst but 
did not improved the yield further (entry 4, Table 1). Other copper catalysts such as 
copper(I) bromide, copper(I) chloride, copper(II) chlorides, copper(II) acetates etc. also 
afforded interior results (entry 6,7, 20 Table 1). Among the bases screened, potassium-
tert-butoxide was found to be superior to other bases such as K2CO3, NEt3, piperidine, 
pyrrolidine etc. and obtained 40% yield of alkynylation product (3a) along with 45% of 
13a (entry 9-12, Table 1). Other solvents such as DMA, DMSO, NMP, CH3CN, etc. and 
additives provided inferior results (for details see the Supplementary Information). Other 
several additives were also screened but provided lower yield (entry 13-15, Table 1). 
Interestingly, the yield of desired alkynylation product (3a) was increased to 52% using 
1.2 equiv of copper(I) iodide under air (entry 16, Table 1). To accelerate the rate of 
decarboxylation of 2-nitrobenzoic acid, 2.0 equiv of silver(I) carbonate was necessary 
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(entry 17, Table 1). Finally heating the reaction mixture at 130 
o
C for 24 h in a 
combination of 1.2 equiv of copper(I) iodide, 2.0 equiv of silver(I) carbonate and 1.0 
equiv of potassium-tert-butoxide, the alkynylation product (3a) was isolated in 64% yield 
along with 52% of alkyne homocoupling product (13a) (entry 18,  Table 1). Interestingly, 
aerial oxygen was necessary and sufficient for the transformation whereas purging with 
excess oxygen found to be detrimental (entry 19, Table 1). However, we were unable to 
suppress alkyne homocoupling product formation even after rigorous screening. 
Table 1. Optimization of the reaction conditions
a
 
 
entry     catalyst 
 
additive 
 
base yield (%)b 
 3a   13ac 
1d CuI (0.2 equiv) Ag2CO3 Cs2CO3  0       20 
2 CuI (0.5 equiv) Ag2CO3 Cs2CO3  10     48     
3 CuI (1.0 equiv) Ag2CO3 Cs2CO3  28     42        
4e CuI (1.0 equiv) Ag2CO3 Cs2CO3  0       45 
5f CuI (1.0 equiv) Ag2CO3 Cs2CO3  nd     35 
6 CuCl (1.0 equiv) Ag2CO3 Cs2CO3  20     44 
7 CuBr (1.0 equiv) Ag2CO3 Cs2CO3  18     40 
8 Pd(tfa)2 (0.2 equiv) Ag2CO3 Cs2CO3  0        7 
9 CuI (1.0 equiv) Ag2CO3 K2CO3  20     41 
10 CuI (1.0 equiv) Ag2CO3 pyrrolidine  30     50   
11 CuI (1.0 equiv) Ag2CO3 
tBuOK  40     45   
12 
13 
CuI (1.0 equiv) 
CuI (1.0 equiv) 
Ag2CO3 
Ag2O 
NEt3 
tBuOK 
 0       52 
 27     62 
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14 
15 
16g 
17g,h 
18g,h,i 
19h,i,j 
20g,h,i 
21g,h,i 
CuI (1.0 equiv) 
CuI (1.0 equiv) 
CuI (1.2 equiv) 
CuI (1.2 equiv) 
CuI (1.2 equiv) 
CuI (1.2 equiv) 
CuCl2 (1.2 equiv) 
CuI (1.0 equiv) 
AgOAc 
K2S2O8 
Ag2CO3 
Ag2CO3 
Ag2CO3 
Ag2CO3 
Ag2CO3 
Ag2CO3 
tBuOK 
tBuOK 
tBuOK 
tBuOK 
tBuOK 
tBuOK 
tBuOK 
    - 
 5       38 
 0       60 
 52     57 
 60     54 
 64     52 
 32     55 
 30     65   
 0       75 
a
All reactions were carried out in 0.2 mmol scale using 12a (1.0 equiv) and 2a (2.5 
equiv). 
b
Yields refer to here are isolated yields. 
c
% of yield for 13a based on total 
amount of 2a was taken. 
d
1.5 equiv of 2a was used. 
e
1.0 equiv of PPh3 or 1,10-
phenanthroline ligand was used. 
f
0.2 equiv of Ag2CO3 was used. 
g
Reaction was run 
under air. 
h
2.0 equiv of Ag2CO3 was used. 
i
The reaction was heated at 130 
o
C. 
j
Reaction was run under O2. 
A wide variety of substituents such as alkyl, alkoxyl, chloro on 2-
nitrobenzoic acid underwent decarboxylative coupling providing moderate to good 
yield under the optimized reaction conditions (Scheme 7). To compare, several 
reactions were also performed with arylacetylenes to furnish the corresponding 
alkynylation product (Scheme 7). Various substituents on phenylacetylene and/or 
phenylacetylynic acid such as alkyl (3g-3i, 3m, 3o, 3q, 3r, Scheme 7), aryl (3j, 
Scheme 7), methoxy (3n, 3p, Scheme 7), chloro (3k, 3t, Scheme 7), bromo (3s, 
Scheme 7), fluoro (3l, Scheme 7), trifluoromethoxy (3u, Scheme 7) were well-
tolerated under the reaction conditions. The ortho substituted phenylpropiolic acids 
also took part in the reaction providing high to good yield (3g, 3o, 3q, Scheme 7). 
However, other benzoic acids such as ortho-methoxybenzoic acid, 
pentafluorobenzoic acid, para-nitrobenzoic acid and heteroaryl carboxylic acids 
and also alkylated propiolic acids did not furnish any desired product. It was found 
that the nitro group at ortho position of arene carboxylic acids is essential to the 
desired cross-coupling presumably due the strong inductive effect and coordinating 
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Scheme 7. Substrate scope of decarboxylative alkynylation reaction
  
Note: The reactions was carried out in 0.2 mmol scale using 12 (1.0 equiv) and 2 
(2.5 equiv). Yields refer to the average of isolated yields of at least two 
experiments. 
c
In every cases 40-50% yield of 13 was separated with respect to total 
amount of 2 was taken. 
ability of the nitro group that may stabilizes the incipient anion which is formed 
after the decarboxylation. Ortho nitrobenzoic acids with another electron-deficient 
substituent such as 2,4-dinitrobenzoic acid resulted in decarboxylative protonation 
product only. This indicates that electron withdrawing substituents may facilitate 
the decarboxylation but they decrease the ability of the aryl anion to serve as a σ-
donor for the copper(II)-acetylide. The same observation was also found in our 
previous work of decarboxylative allylation of ortho nitrobenzoic esters.
19
 
Selective reduction of nitro group followed by cyclization leads to the formation of 
2-phenylindole from 3a (procedure in experimental section). 
V. 5. Reaction mechanism 
Next, we performed few control experiments to gain insight of the reaction 
mechanism. The standard reaction without copper salt did not furnish any desired 
alkynylation product (3a) instead nitrobenzene was formed predominantly through 
decarboxylative protonation and a trace amount of alkyne homocoupling product 
(13a) (Scheme 8a). Furthermore, in the absence of silver salt alkyne homocoupling  
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 Scheme 8. Control experiments 
Product (13a) was favored (80%) along with the formation of nitrobenzene (12%) 
(Scheme 8b). Therefore, copper is involved in the formation of copper-acetylide 
via decarboxylation of propiolic acids and silver is participating in the formation of 
aryl-Ag species via decarboxylation of the nitrobenzoic acids.  
 Based on these control experiments and previous literature on copper/silver 
bimetallic system,
18
 it is speculated that initially a silver carboxylate forms 
followed by aryl-silver species, 12a’’ (Scheme 9) through the extrusion of CO2. 
On the other hand, a copper(I)-acetylide, 2a’’ (Scheme 9) is formed either via 
decarboxylative metalation of arylpropiolic carboxylate which is form through 
base mediated deprotonation of arylpropiolic acid or direct deprotonation of the 
phenylacetylene by base which is converted to copper(II)-acetylide, 2a’’’ (Scheme 
9) under the oxidative conditions here aerial oxygen or silver may acts as an 
oxidant. Subsequently, a transmetalation between aryl-silver and copper(II)-
acetylide may leads to the aryl, alkyne-copper intermediate, 3a’ (Scheme 9). There 
is a possibility of disproportionation to generate copper(III) species for facile 
reductive elimination at this step and generate a copper(I) species for subsequent 
runs.
20
 However, under the stoichiometric copper catalysis direct reductive 
elimination from the copper(II) intermediate to furnish the alkynylation product is 
also plausible. However, the exact mechanism is unclear at this moment  
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Scheme 9. Plausible mechanism 
and warrants further studies. 
V. 6. Conclusion 
In conclusion, we have developed a novel Cu
I
/Ag
I
-promoted alkynylation of 
nitroarenes through a double decarboxylation. This present approach of using two 
decarboxylations in an oxidative alkynylation is an excellent strategy to address 
challenging alkynylations. The 2-alkynyl nitroarenes serve as an important 
precursor for the synthesis of a plethora of N-heterocycles especially 
functionalized indoles. 
V. 7. Experimental section 
General experimental procedure for the preparation of arylalkynecarboxylic 
acids.
21 
Propiolic acid (193.0 mg, 2.75 mmol, 1.1 equiv) was diluted with DMSO (1.5 
mL). The solution was added to a mixture of Pd(PPh3)4 (144.5 mg, 0.125 mmol, 
0.05 equiv), aryl bromide (2.5 mmol, 1.0 equiv), DBU (0.82 mL, 5.5 mmol, 2.2 
equiv), and DMSO (3.5 mL) in a small round-bottom flask. The resulting mixture 
was stirred at 35 °C for 24 h. After that, the reaction mixture was poured into ethyl 
acetate (30.0 mL), and extracted with saturated aqueous NaHCO3 solution. The 
aqueous layer was separated and acidified to pH 2.0 by adding cold HCl (1.0 N), 
and finally extracted with CH2Cl2. The organic layer was washed with water (10 
mL x 2) and brine (10 mL), dried over anhydrous Na2SO4 and the solvent was 
evaporated under reduced pressure. The crude product was purified by column 
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) to afford the 
desired product as a white solid. 
General experimental procedure for copper(I)/silver(I)-promoted 
decarboxylative alkynylation of ortho nitrobenzoic acids. 
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To an oven-dried 15 mL sealed tube, a mixture of 2-nitrobenzoic acids (0.2 mmol, 
1.0 equiv), phenylpropiolic acids and/or phenyl acetylenes (0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv) was 
taken. Then dry DMF (3.0 mL) and DMSO (0.15 mL) were added to it and the 
vessel was sealed with a screw cap. The reaction mixture was allowed to stir for 24 
h at 130 
o
C. After completion (as detected by TLC), the reaction mixture was 
poured into water (20 mL) and extracted with ethyl acetate (30 mL). The organic 
layer was washed with cold water (15 mL x 2) and brine (10 mL), dried over 
anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. The 
crude product was purified by column chromatography using ethyl acetate/hexane 
as eluent to afford the desired product. 
1-Nitro-2-(phenylethynyl)benzene, 3a, Scheme 7.
22 
The same general procedure 
was followed by using 2-nitrobenzoic acid (33.5 mg, 0.2 mmol, 1.0 equiv), 3-
phenylpropiolic acid (73.0 mg, 0.5 mmol, 2.5 equiv), copper(I) iodide (46.0 mg, 
0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 2.0 equiv) and 
potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column chromatography 
(SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired product as a 
yellow oil, (28.5 mg, 64%). When the same experiment was performed with using 
ethynylbenzene (55.0 µL, 0.5 mmol, 2.5 equiv) instead of  3-phenylpropiolic acid  
provided the desired product as a yellow oil (27.0 mg, 60%). 
1
H
 
NMR (300 MHz, 
CDCl3): δ 8.08 (dd, J = 8.1 Hz, 0.9 Hz, 1H), 7.72 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 
7.57-7.63 (m, 3H), 7.46 (td, J = 8.1 Hz, 1.5 Hz, 1H), 7.37-7.39 (m, 3H); 
13
C NMR 
(75 MHz, CDCl3): δ 149.6, 134.6, 132.8, 132.0, 129.2, 128.5, 128.4, 124.7, 122.4, 
118.8, 97.1, 84.8; IR (neat): υmax 2218, 1606, 1526, 1345, 751 cm
-1
; HRMS (EI, 
m/z) calcd. for C14H9NO2 [M]
+
: 223.0633; found: 223.0633. 
4-Methoxy-2-nitro-1-(phenylethynyl)benzene, 3b, Scheme 7.
23
 The same 
general procedure was followed by using 4-methoxy-2-nitrobenzoic acid (39.5 mg, 
0.2 mmol, 1.0 equiv), 3-phenylpropiolic acid (73.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
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mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded 
the desired product as a yellow oil, (30.0 mg, 60%). When the same experiment 
was performed with using ethynylbenzene (55.0 µL, 0.5 mmol, 2.5 equiv) instead 
of 3-phenylpropiolic acid provided the desired product as yellow oil (29.0 mg, 
58%).  
1
H
 
NMR (300 MHz, CDCl3): δ 7.56-7.63 (m, 4H), 7.35-7.37 (m, 3H), 7.14 
(dd, J = 8.7 Hz, 2.7 Hz, 1H), 3.90 (s, 3H);
 13
C NMR (75 MHz, CDCl3): δ 159.4, 
150.4, 135.5, 131.8, 128.8, 128.4, 122.7, 119.8, 110.8, 109.3, 95.2, 84.7, 56.0. 
4-Methyl-2-nitro-1-(phenylethynyl)benzene, 3c, Scheme 7.
24
 The same general 
procedure was followed by using 4-methyl-2-nitrobenzoic acid (36.2 mg, 0.2 
mmol, 1.0 equiv), 3-phenylpropiolic acid (73.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded 
the desired product as a yellow oil (24.5 mg, 52%). 
1
H
 
NMR (600 MHz, CDCl3): δ 
7.90 (s, 1H), 7.59-7.62 (m, 3H), 7.41 (d, J = 7.8 Hz, 1H), 7.38-7.39 (m, 3H), 2.47 
(s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 149.4, 139.5, 134.3, 133.7, 131.9, 129.0, 
128.4, 125.0, 122.5, 115.8, 96.1, 84.8, 21.2. 
1-Methyl-3-nitro-2-(phenylethynyl)benzene, 3d, Scheme 7. The same general 
procedure was followed by using 2-methyl-6-nitrobenzoic acid (36.2 mg, 0.2 
mmol, 1.0 equiv), 3-phenylpropiolic acid (73.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded 
the desired product as a yellow oil (28.5 mg, 60%). 
1
H
 
NMR (300 MHz, CDCl3): δ 
7.85 (d, J = 8.1 Hz, 1H), 7.58-7.61 (m, 2H), 7.51 (d, J = 7.5 Hz, 1H), 7.31-7.39 (m, 
4H), 2.62 (s, 3H); 
13
C NMR (150 MHz, CDCl3): δ 150.6, 143.3, 134.0, 132.0, 
129.3, 128.6, 127.9, 122.7, 122.2, 118.2, 101.9, 83.3, 21.5; IR (neat): υmax 2925, 
2212, 1528, 1347, 750 cm
-1
; HRMS (ESI, m/z) calcd. for C15H11NO2Na [M + Na]
+
: 
260.0687; found: 260.0688. 
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4-Methoxy-1-nitro-2-(phenylethynyl)benzene, 3e, Scheme 7. The same general 
procedure was followed by using 5-methoxy-2-nitrobenzoic acid (39.5 mg, 0.2 
mmol, 1.0 equiv), 3-phenylpropiolic acid (73.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded 
the desired product as a white solid (32.0 mg, 63%), mp 76-78 
o
C. 
1
H
 
NMR (600 
MHz, CDCl3): δ 8.15 (d, J = 9.0 Hz, 1H), 7.62-7.64 (m, 2H), 7.38-7.40 (m, 3H), 
7.15 (d, J = 2.4 Hz, 1H), 6.94 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 3.93 (s, 3H);
 13
C NMR 
(150 MHz, CDCl3): δ 162.8, 142.6, 132.0, 129.2, 128.4, 127.2, 122.4, 121.0, 
118.4, 114.6, 97.0, 85.4, 56.0; IR (neat): υmax 2207, 1583, 1499, 1331, 1232, 756 
cm
-1
; HRMS (EI, m/z) calcd. for C15H11NO3 [M]
+
: 253.0739; found: 253.0742. 
4-Chloro-2-nitro-1-(phenylethynyl)benzene, 3f, Scheme 7. The same general 
procedure was followed by using 4-chloro-2-nitrobenzoic acid (40.5 mg, 0.2 
mmol, 1.0 equiv), 3-phenylpropiolic acid (73.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 99:1 hexane/ethyl acetate) afforded 
the desired product as a yellowish solid (33.0 mg, 64%), mp 67-69 
o
C. 
1
H
 
NMR 
(600 MHz, CDCl3): δ 8.10 (d, J = 1.8 Hz, 1H), 7.67 (d, J = 8.4 Hz, 1H), 7.58-7.61 
(m, 3H), 7.38-7.43 (m, 3H);
 13
C NMR (150 MHz, CDCl3): δ 149.7, 135.4, 134.3, 
133.1, 132.0, 129.4, 128.5, 125.0, 122.0, 117.3, 98.2, 83.9; IR (neat): υmax 2924, 
2216, 1538, 1344, 1107, 757 cm
-1
; HRMS (ESI, m/z) calcd. for C14H8ClNO2Na [M 
+ Na]
+
: 280.0141; found: 280.0139. 
1-Methyl-2-((2-nitrophenyl)ethynyl)benzene, 3g, Scheme 7. The same general 
procedure was followed by using 2-nitrobenzoic acid (33.5 mg, 0.2 mmol, 1.0 
equiv), 3-(o-tolyl)propiolic acid (80.0 mg, 0.5 mmol, 2.5 equiv), copper(I) iodide 
(46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 2.0 
equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column 
chromatography (SiO2, eluting with 99:1 hexane/ethyl acetate) afforded the desired 
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product as a yellow oil (30.0 mg, 64%). 
1
H
 
NMR (600 MHz, CDCl3): δ 8.11 (d, J 
= 7.8 Hz, 1H), 7.75 (d, J = 7.8 Hz, 1H), 7.62 (t, J = 7.2 Hz, 1H), 7.58 (d, J = 7.2 
Hz, 1H), 7.48 (t, J = 7.2 Hz, 1H), 7.30 (t, J = 7.2 Hz, 1H), 7.27 (d, J = 7.2 Hz, 1H), 
7.21 (t, J = 7.8 Hz, 1H), 2.59 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 149.2, 141.0, 
134.7, 132.8, 132.5, 129.6, 129.3, 128.4, 125.6, 124.7, 122.1, 119.0, 96.3, 88.4, 
20.7; IR (neat): υmax 2924, 2213, 1525, 1344, 751 cm
-1
; HRMS (ESI, m/z) calcd. 
for C15H11NO2Na [M + Na]
+
: 260.0687; found: 260.0688. 
1-Nitro-2-(p-tolylethynyl)benzene, 3h, Scheme 7.
24
 The same general procedure 
was followed by using 2-nitrobenzoic acid (33.5 mg, 0.2 mmol, 1.0 equiv), 3-(p-
tolyl)propiolic acid (80.0 mg, 0.5 mmol, 2.5 equiv), copper(I) iodide (46.0 mg, 
0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 2.0 equiv) and 
potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column chromatography 
(SiO2, eluting with 99:1 hexane/ethyl acetate) afforded the desired product as a 
white solid, (27.5 mg, 58%). When the same experiment was performed with using 
1-ethynyl-4-methylbenzene (63.5 µL, 0.5 mmol, 2.5 equiv) instead of 3-(p-
tolyl)propiolic acid provided the desired product as a white solid (29.5 mg, 62%), 
mp 96-98 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 8.09 (d, J = 7.8 Hz, 1H), 7.72 (d, J = 
7.2 Hz, 1H), 7.60 (t, J = 7.2 Hz, 1H), 7.51 (d, J = 7.8 Hz, 2H), 7.46 (t, J = 7.8 Hz, 
1H), 7.20 (d, J = 7.2 Hz, 2H), 2.40 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 149.5, 
139.6, 134.5, 132.8, 131.9, 129.2, 128.3, 124.7, 119.3, 119.0, 97.5, 84.2, 21.6. 
1-Nitro-2-(m-tolylethynyl)benzene, 3i, Scheme 7. The same general procedure 
was followed by using 2-nitrobenzoic acid (33.5 mg, 0.2 mmol, 1.0 equiv), 3-(m-
tolyl)propiolic acid (80.0 mg, 0.5 mmol, 2.5 equiv), copper(I) iodide (46.0 mg, 
0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 2.0 equiv) and 
potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column chromatography 
(SiO2, eluting with 99:1 hexane/ethyl acetate) afforded the desired product as a 
yellowish oil (31.5 mg, 67%). 
1
H
 
NMR (600 MHz, CDCl3): δ 8.10 (dd, J = 8.4 Hz, 
0.6 Hz, 1H), 7.73 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 7.61 (td, J = 7.8 Hz, 1.2 Hz, 1H), 
7.48 (td, J = 8.4 Hz, 1.2 Hz, 1H), 7.44 (s, 1H), 7.42 (d, J = 7.8 Hz, 1H), 7.28 (t, J = 
7.2 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 2.38 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 
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149.6, 138.2, 134.5, 132.8, 132.6, 130.1, 129.1, 128.4, 128.3, 124.7, 122.1, 118.9, 
97.4, 84.4, 21.2; IR (neat): υmax 2924, 2208, 1525, 1344, 784 cm
-1
; HRMS (ESI, 
m/z) calcd. for C15H11NO2Na [M + Na]
+
: 260.0687; found: 260.0682. 
4-((2-Nitrophenyl)ethynyl)-1,1'-biphenyl, 3j, Scheme 7. The same general 
procedure was followed by using 2-nitrobenzoic acid (33.5 mg, 0.2 mmol, 1.0 
equiv), 4-ethynyl-1,1'-biphenyl (89.0 mg, 0.5 mmol, 2.5 equiv), copper(I) iodide 
(46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 2.0 
equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column 
chromatography (SiO2, eluting with 99:1 hexane/ethyl acetate) afforded the desired 
product as a yellowish solid (28.5 mg, 48%), mp 114-116 
o
C. 
1
H
 
NMR (600 MHz, 
CDCl3): δ 8.12 (d, J = 7.8 Hz, 1H), 7.76 (d, J = 7.2 Hz, 1H), 7.69 (d, J = 7.8 Hz, 
2H), 7.61-7.64 (m, 5H), 7.47-7.50 (m, 3H), 7.40 (t, J = 7.8 Hz, 1H);
 13
C NMR (150 
MHz, CDCl3): δ 149.5, 141.9, 140.1, 134.6, 132.8, 132.5, 128.9, 128.5, 127.8, 
127.1, 127.0, 124.8, 121.2, 118.8, 97.1, 85.5; IR (neat): υmax 2922, 2215, 1521, 
1335, 755 cm
-1
; HRMS (EI, m/z) calcd. for C20H13NO2 [M]
+
: 299.0946; found: 
299.0948. 
1-((4-Chlorophenyl)ethynyl)-2-nitrobenzene, 3k, Scheme 7. The same general 
procedure was followed by using 2-nitrobenzoic acid (33.5 mg, 0.2 mmol, 1.0 
equiv), 1-chloro-4-ethynylbenzene (68.0 mg, 0.5 mmol, 2.5 equiv), copper(I) 
iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 
2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column 
chromatography (SiO2, eluting with 99:1 hexane/ethyl acetate) afforded the desired 
product as a yellowish solid (23.0 mg, 45%), mp 94-96 
o
C. 
1
H
 
NMR (600 MHz, 
CDCl3): δ 8.11 (d, J = 8.4 Hz, 1H), 7.72 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 7.63 (td, J = 
7.2 Hz, 1.2 Hz, 1H), 7.54 (d, J = 8.4 Hz, 2H), 7.50 (td, J = 8.4 Hz, 1.2 Hz, 1H), 
7.37 (d, J = 8.4 Hz, 2H);
 13
C NMR (150 MHz, CDCl3): δ 149.5, 135.4, 134.5, 
133.2, 132.9, 128.8, 128.7, 124.8, 120.8, 118.4, 95.8, 85.6; IR (neat): υmax 2212, 
1516, 1338, 1082, 823 cm
-1
; HRMS (EI, m/z) calcd. for C14H8ClNO2 [M]
+
: 
257.0244; found: 257.0246. 
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1-((4-Fluorophenyl)ethynyl)-2-nitrobenzene, 3l, Scheme 7.
24
 The same general 
procedure was followed by using 2-nitrobenzoic acid (33.5 mg, 0.2 mmol, 1.0 
equiv), 3-(4-fluorophenyl)propiolic acid (82.0 mg, 0.5 mmol, 2.5 equiv), copper(I) 
iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 
2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column 
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate) afforded the desired 
product as a yellowish solid (22.0 mg, 46%), mp 83-85 
o
C. 
1
H
 
NMR (600 MHz, 
CDCl3): δ 8.10 (dd, J = 8.4 Hz, 1.2 Hz, 1H), 7.72 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 
7.58-7.64 (m, 3H), 7.49 (t, J = 8.4 Hz, 1.2 Hz, 1H), 7.07-7.11 (m, 2H);
 13
C NMR 
(150 MHz, CDCl3): δ 163.0 (d, J = 250.5 Hz), 149.5, 134.4, 134.0 (d, J = 9.0 Hz), 
132.8, 128.6, 124.8, 118.6, 118.5 (d, J = 4.5 Hz), 115.8 (d, J = 22.5 Hz), 96.0, 
84.5. 
4-Methoxy-2-nitro-1-(p-tolylethynyl)benzene, 3m, Scheme 7.
25
 The same 
general procedure was followed by using 4-methoxy-2-nitrobenzoic acid (39.5 mg, 
0.2 mmol, 1.0 equiv), 3-(p-tolyl)propiolic acid (80.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded 
the desired product as a yellowish solid (21.0 mg, 40%), mp 64-66 
o
C. 
1
H
 
NMR 
(600 MHz, CDCl3): δ 7.62 (d, J = 9.0 Hz, 1H), 7.60 (d, J = 2.4 Hz, 1H), 7.48 (d, J 
= 7.8 Hz, 2H), 7.19 (d, J = 7.8 Hz, 2H), 7.15 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 3.92 (s, 
3H), 2.39 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 159.2, 150.3, 139.1, 135.4, 
131.7, 129.2, 119.9, 119.6, 111.2, 109.2, 95.6, 84.2, 56.0, 21.6. 
4-Methoxy-1-((4-methoxyphenyl)ethynyl)-2-nitrobenzene, 3n, Scheme 7. The 
same general procedure was followed by using 4-methoxy-2-nitrobenzoic acid 
(39.5 mg, 0.2 mmol, 1.0 equiv), 3-(4-methoxyphenyl)propiolic acid (88.0 mg, 0.5 
mmol, 2.5 equiv), copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) 
carbonate (110 mg, 0.4 mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 
0.2 mmol, 1.0 equiv). Column chromatography (SiO2, eluting with 9:1 
hexane/ethyl acetate) afforded the desired product as a yellowish solid (35.0 mg, 
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62%), mp 99-101 
o
C. 
1
H
 
NMR (300 MHz, CDCl3): δ 7.59 (d, J = 6.6 Hz, 1H), 7.58 
(s, 1H), 7.49-7.53 (m, 2H), 7.13 (dd, J = 8.7 Hz, 2.7 Hz, 1H), 6.89 (d, J = 9.0 Hz, 
2H), 3.90 (s, 3H), 3.84 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 160.1, 159.0, 
150.2, 135.3, 133.4, 119.9, 114.8, 114.0, 111.4, 109.2, 95.5, 83.7, 56.0, 55.3; IR 
(neat): υmax 2211, 1523, 1245, 1028, 831 cm
-1
; HRMS (EI, m/z) calcd. for 
C16H13NO4 [M]
+
: 283.0845; found: 283.0842. 
4-Methoxy-1-nitro-2-(o-tolylethynyl)benzene, 3o, Scheme 7. The same general 
procedure was followed by using 5-methoxy-2-nitrobenzoic acid (39.5 mg, 0.2 
mmol, 1.0 equiv), 3-(o-tolyl)propiolic acid (80.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded 
the desired product as a white solid (22.0 mg, 42%), mp 62-64 
o
C. 
1
H
 
NMR (600 
MHz, CDCl3): δ 8.17 (d, J = 9.0 Hz, 1H), 7.59 (d, J = 7.8 Hz, 1H), 7.30 (td, J = 7.8 
Hz, 1.2 Hz, 1H), 7.27 (d, J = 6.6 Hz, 1H), 7.21 (t, J = 7.2 Hz, 1H), 7.16 (d, J = 3.0 
Hz, 1H), 6.94 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 3.94 (s, 3H), 2.60 (s, 3H);
 13
C NMR 
(150 MHz, CDCl3): δ 162.8, 142.3, 141.2, 132.6, 129.6, 129.3, 127.3, 125.6, 
122.1, 121.4, 118.6, 114.4, 96.2, 89.0, 56.0, 20.8; IR (neat): υmax 2934, 2208, 1577, 
1515, 1337, 1235, 1077, 759 cm
-1
; HRMS (EI, m/z) calcd. for C16H13NO3 [M]
+
: 
267.0895; found: 267.0884. 
4-Chloro-1-((4-methoxyphenyl)ethynyl)-2-nitrobenzene, 3p, Scheme 7. The 
same general procedure was followed by using 4-chloro-2-nitrobenzoic acid (40.5 
mg, 0.2 mmol, 1.0 equiv), 3-(4-methoxyphenyl)propiolic acid (88.0 mg, 0.5 mmol, 
2.5 equiv), copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate 
(110 mg, 0.4 mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 
1.0 equiv). Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) 
afforded the desired product as a yellowish solid (25.0 mg, 44%), mp 108-110 
o
C. 
1
H
 
NMR (300 MHz, CDCl3): δ 8.07 (d, J = 1.8 Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 
7.51-7.56 (m, 3H), 6.90 (d, J = 8.7 Hz, 2H), 3.84 (s, 3H);
 13
C NMR (150 MHz, 
CDCl3): δ 160.6, 149.5, 135.2, 133.74, 133.69, 133.0, 125.0, 117.7, 114.2, 114.1, 
 Chapter V    
244 
 
98.8, 83.1, 55.4; IR (neat): υmax 2207, 1516, 1339, 1248, 825 cm
-1
; HRMS (EI, 
m/z) calcd. for C15H10ClNO3 [M]
+
: 287.0349; found: 287.0341. 
4-Methoxy-2-nitro-1-(o-tolylethynyl)benzene, 3q, Scheme 7. The same general 
procedure was followed by using 4-methoxy-2-nitrobenzoic acid (39.5 mg, 0.2 
mmol, 1.0 equiv), 3-(o-tolyl)propiolic acid (80.0 mg, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded 
the desired product as a yellowish oil (28.0 mg, 53%). 
1
H
 
NMR (600 MHz, 
CDCl3): δ 7.64 (d, J = 9.0 Hz, 1H), 7.61 (d, J = 3.0 Hz, 1H), 7.55 (d, J = 7.2 Hz, 
1H), 7.25-7.29 (m, 2H), 7.20 (td, J = 7.2 Hz, 1.8 Hz, 1H), 7.16 (dd, J = 9.0 Hz, 2.4 
Hz, 1H), 3.92 (s, 3H), 2.57 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 159.3, 150.0, 
140.8, 135.6, 132.3, 129.6, 128.9, 125.6, 122.5, 119.9, 111.2, 109.2, 94.4, 88.4, 
56.0, 20.7; IR (neat): υmax 2929, 2211, 1524, 1283, 1030, 758 cm
-1
; HRMS (EI, 
m/z) calcd. for C16H13NO3 [M]
+
: 267.0895; found: 267.0898. 
4-Methoxy-1-nitro-2-(p-tolylethynyl)benzene, 3r, Scheme 7. The same general 
procedure was followed by using 5-methoxy-2-nitrobenzoic acid (39.5 mg, 0.2 
mmol, 1.0 equiv), 1-ethynyl-4-methylbenzene (63.5 µL, 0.5 mmol, 2.5 equiv), 
copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 
mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). 
Column chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded 
the desired product as a white solid (20.0 mg, 38%), mp 91-93 
o
C. 
1
H
 
NMR (600 
MHz, CDCl3): δ 8.15 (d, J = 9.0 Hz, 1H), 7.52 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 7.8 
Hz, 2H), 7.14 (d, J = 3.0 Hz, 1H), 6.92 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 3.93 (s, 3H), 
2.40 (s, 3H);
 13
C NMR (150 MHz, CDCl3): δ 162.8, 142.6, 139.6, 132.0, 129.2, 
127.2, 121.3, 119.3, 118.2, 114.5, 97.4, 85.0, 56.0, 21.6; IR (neat): υmax 2918, 
2202, 1570, 1502, 1304, 1075, 752 cm
-1
; HRMS (EI, m/z) calcd. for C16H13NO3 
[M]
+
: 267.0895; found: 267.0886. 
1-((4-Bromophenyl)ethynyl)-4-methoxy-2-nitrobenzene, 3s, Scheme 7. The 
same general procedure was followed by using 4-methoxy-2-nitrobenzoic acid 
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(39.5 mg, 0.2 mmol, 1.0 equiv), 1-bromo-4-ethynylbenzene (90.0 mg, 0.5 mmol, 
2.5 equiv), copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate 
(110 mg, 0.4 mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 
1.0 equiv). Column chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish solid (40.0 mg, 60%), mp 93-95 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 7.61-7.63 (m, 2H), 7.51 (d, J = 8.4 Hz, 2H), 7.44 (d, J 
= 8.4 Hz, 2H), 7.16 (dd, J = 9.0 Hz, 3.0 Hz, 1H), 3.92 (s, 3H);
 13
C NMR (150 
MHz, CDCl3): δ 159.6, 150.4, 135.4, 133.2, 131.7, 123.2, 121.7, 119.9, 110.5, 
109.4, 94.0, 85.9, 56.0; IR (neat): υmax 2925, 2214, 1528, 1291, 1067, 816 cm
-1
; 
HRMS (ESI, m/z) calcd. for C15H10BrNO3Na [M + Na]
+
: 355.9721; found: 
355.9719. 
1-((4-Chlorophenyl)ethynyl)-4-methoxy-2-nitrobenzene, 3t, Scheme 7. The 
same general procedure was followed by using 4-methoxy-2-nitrobenzoic acid 
(39.5 mg, 0.2 mmol, 1.0 equiv), 1-chloro-4-ethynylbenzene (68.0 mg, 0.5 mmol, 
2.5 equiv), copper(I) iodide (46.0 mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate 
(110 mg, 0.4 mmol, 2.0 equiv) and potassium-tert-butoxide (22.5 mg, 0.2 mmol, 
1.0 equiv). Column chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate) 
afforded the desired product as a yellowish solid (32.0 mg, 56%), mp 76-78 
o
C. 
1
H
 
NMR (600 MHz, CDCl3): δ 7.62 (d, J = 9.0 Hz, 2H), 7.51 (d, J = 7.8 Hz, 2H), 7.35 
(d, J = 8.4 Hz, 2H), 7.16 (dd, J = 8.4 Hz, 1.8 Hz, 1H), 3.92 (s, 3H);
 13
C NMR (150 
MHz, CDCl3): δ 159.6, 150.4, 135.4, 134.9, 133.0, 128.8, 121.2, 119.9, 110.5, 
109.4, 94.0, 85.7, 56.0; IR (neat): υmax 2923, 2215, 1530, 1279, 1082, 821 cm
-1
; 
HRMS (EI, m/z) calcd. for C15H10ClNO3 [M]
+
: 287.0349; found: 287.0346. 
4-Methoxy-2-nitro-1-((4-(trifluoromethoxy)phenyl)ethynyl)benzene, 3u, 
Scheme 7. The same general procedure was followed by using 4-methoxy-2-
nitrobenzoic acid (39.5 mg, 0.2 mmol, 1.0 equiv), 1-ethynyl-4-
(trifluoromethoxy)benzene (77.0 µL, 0.5 mmol, 2.5 equiv), copper(I) iodide (46.0 
mg, 0.24 mmol, 1.2 equiv), silver (I) carbonate (110 mg, 0.4 mmol, 2.0 equiv) and 
potassium-tert-butoxide (22.5 mg, 0.2 mmol, 1.0 equiv). Column chromatography 
(SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired product as a 
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yellow oil (25.5 mg, 38%). 
1
H
 
NMR (600 MHz, CDCl3): δ 7.60-7.63 (m, 4H), 7.22 
(d, J = 8.4 Hz, 2H), 7.15-7.17 (m, 1H), 3.92 (s, 3H);
 13
C NMR (150 MHz, CDCl3): 
δ 159.6, 150.5, 149.2, 135.5, 133.3, 121.5, 120.3 (q, J = 256.5 Hz), 120.9, 119.9, 
110.4, 109.4, 93.6, 85.6, 56.0; IR (neat): υmax 2931, 2219, 1525, 1261, 1029, 839 
cm
-1
; HRMS (EI, m/z) calcd. for C16H10F3NO4 [M]
+
: 337.0562; found: 337.0568. 
1,4-Diphenylbuta-1,3-diyne, 13a, Scheme 7.
26
 Column chromatography (SiO2, 
eluting with 99:1 hexane/ethyl acetate) afforded the desired product as a white 
solid (40.0 mg, 80%). 
1
H
 
NMR (600 MHz, CDCl3): δ 7.55-7.56 (m, 4H), 7.35-7.41 
(m, 6H); 
13
C NMR (150 MHz, CDCl3): δ 132.5, 129.2, 128.4, 121.7, 81.5, 73.9. 
Preparation of 2-(phenylethynyl)aniline (14a) from 1-nitro-2-
(phenylethynyl)benzene (3a) via selective reduction of nitro group. The 
compound (14a) was synthesized according to the literature procedure.
27
 
To a 10 mL round bottom flask, a mixture of 1-nitro-2-(phenylethynyl)benzene 
(67.0 mg, 0.3 mmol, 1.0 equiv), indium (III) chloride (27.0 mg, 0.12 mmol, 0.4 
equiv) and indium powder (138.0 mg, 1.2 mmol, 4.0 equiv) was taken. Then THF 
(3.0 mL) and H2O (0.6 mL) were added to it and the vessel was sealed with a 
screw cap. The reaction mixture was allowed to stir for 5 h at 50 
o
C. After 
completion (as detected by TLC), the reaction mixture was poured into water (30 
mL) and extracted with ethyl acetate (30 mL). The organic layer was washed with 
water (15 mL) and brine (10 mL), dried over anhydrous Na2SO4 and the solvent 
was evaporated under reduced pressure. The crude product was purified by column 
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate) afforded the desired 
product, 2-(phenylethynyl)aniline (14a)
24
 as a pale yellowish solid (43.0 mg, 
75%).
 1
H NMR (600 MHz, CDCl3): δ 7.55-7.56 (m, 2H), 7.34-7.40 (m, 4H), 7.16 
(t, J = 7.8 Hz, 1H), 6.74-6.76 (m, 2H), 4.17 (brs, 2H);
 13
C NMR (150 MHz, 
CDCl3): δ 147.6, 132.1, 131.4, 129.7, 128.4, 128.2, 123.3, 118.0, 114.4, 108.0, 
94.7, 85.8. 
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Direct synthesis of 2-phenylindole (15a) from 1-nitro-2-
(phenylethynyl)benzene(3a). The compound (15a) was synthesized according 
to the literature procedure.
28
 
A solution of 1-nitro-2-(phenylethynyl)benzene (89.0 mg, 0.4 mmol, 1.0 equiv) in 
pyrrolidine (0.7 mL, 8.0 mmol, 20.0 equiv) was stirred in a 10 mL round bottom 
flask at 80 °C for 1 h. After removal of pyrrolidine on a rotary evaporator, the 
residue was dissolved in EtOH (1.0 mL), to which was added Pd/C (4.2 mg, 0.04 
mmol, 0.1 equiv). Then the reaction mixture was allowed to stir at 60 
o
C for 10 h 
under a hydrogen atmosphere. After completion (as detected by TLC), the reaction 
mixture was filtered through a pad of celite, and concentrated. The crude reaction 
mixture was purified by column chromatography (SiO2, eluting with 95:5 
hexane/ethyl acetate) afforded the desired product, 2-phenylindole (15a)
24
 as a 
white solid (46.0 mg, 60%).
 1
H NMR (600 MHz, CDCl3): δ 8.35 (brs, 1H), 7.69 (d, 
J = 7.8 Hz, 2H), 7.67 (d, J = 7.8 Hz, 1H), 7.47 (t, J = 7.2 Hz, 2H), 7.43 (d, J = 7.8 
Hz, 1H), 7.36 (t, J = 7.8 Hz, 1H), 7.23 (t, J = 7.8 Hz, 1H), 7.16 (t, J = 7.8 Hz, 1H), 
6.86 (s, 1H);
 13
C NMR (150 MHz, CDCl3): δ 137.8, 136.8, 132.3, 129.2, 129.0, 
127.7, 125.1, 122.3, 120.6, 120.3, 110.9, 100.0. 
 
V. 8. 
1
H and 
13
C NMR spectra 
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Palladium(0)-Catalyzed Intramolecular Decarboxylative Allylation of
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ABSTRACT: A Pd/Ag bimetallic system has been developed for the
decarboxylative allylation of ortho-nitrobenzoic esters in an intramolecular
fashion. In contrast to the typical sp2−sp3 cross-coupling approach which
requires air and moisture sensitive preformed organometallic reagents, we
provide an alternative route to the synthesis of ortho-allyl nitroarenes from the
corresponding ortho-nitrobenzoic acid derivatives. The reaction proceeds
through a mechanistically distinct decarboxylative metalation pathway. A
cooperative reactivity of palladium and silver is crucial for the reaction outcome.
Aromatic nitro compounds are useful intermediates for thesynthesis of agrochemicals, pharmaceuticals, dyes, photo-
reactive compounds, high energetic materials, radiopharma-
ceutical tracers, etc.1 A facile reduction of the aromatic nitro
groups to their corresponding anilines provides common
starting materials for the syntheses of a plethora of N-
heterocycles and natural products.2 Despite their interesting
properties, access to ortho-substituted nitroarenes is limited due
to inherent incompatibility with some organometallic reagents.3
To overcome this problem the Knochel group introduced an
elegant approach for the generation of nitro-containing
organometallics via I−Mg exchange.4 However, this protocol
suﬀers from serious limitations such as the use of air and
moisture sensitive preformed organometallic reagents, highly
toxic copper(I)cyanide, and expensive organohalides. There-
fore, alternative routes to the synthesis of ortho-functionalized
nitroarenes using inexpensive, air and moisture stable starting
materials are in high demand.
Recently, increasing use of nitrobenzoic acid derivatives in
palladium-catalyzed decarboxylative cross-coupling reactions5
has also motivated us to explore the ortho-allylation reaction.
Although palladium-catalyzed decarboxylative sp3−sp3 allylic
alkylation has been widely explored,6 decarboxylative sp2−sp3
allylation is less studied.7 In this vein, an activated coumarin
moiety furnished moderate to good yields of allylation product
and preferred sp3−sp3 allylation6i over the sp2−sp3 allylation.7a
Decarboxylative allylation of electron-rich arenes also provided
poor yields of the desired products.7b Decarboxylative allylation
of α-oxocarboxylates resulted in α,β-unsaturated ketones
through alkene isomerization.7c The diﬃculty in decarbox-
ylative sp2−sp3 allylation arises due to the fact that, in sp3−sp3
allylation, the incipient anion after decarboxylation is stabilized
by the proximal electron-withdrawing groups such as keto,8
ester,9 nitro,10 cyano,11 sulfone,12 etc. Whereas, in the case of
sp2−sp3 allylation, the anion on the sp2-carbon is highly
unstable and exhibits a high propensity toward protonation.
Therefore, selective sp2−sp3 decarboxylative allylation in high
yields is an extremely challenging task to achieve. To our
surprise, decarboxylative sp2−sp3 allylation of electron-deﬁcient
arenes especially nitroarenes is not known. We hypothesized
that the nitro group at the ortho position could be beneﬁcial in
decarboxylative allylation as it can stabilize the aryl anion which
is formed after decarboxylation.
We started optimization of the reaction conditions by heating
a mixture of ortho-nitrobenzoic acid and allyl bromide and a
catalytic amount of Pd(0) at 160 °C, but no allylation product
was formed. Switching to allyl acetate from allyl bromide
resulted in a trace amount of allylation product along with
nitrobenzene as a major product. We realized that the
carboxylic acid proton could be detrimental for the allylation
product formation and may lead to the undesired protonation
product. Therefore, the potassium salt of the corresponding
nitrobenzoic acid was employed, but unfortunately, no
allylation product was observed. Next, an allyl ester of the
corresponding acid was prepared and subjected to the
intramolecular decarboxylative allylation (Table 1). Interest-
ingly, all starting material was consumed and a mixture of
corresponding allyl and styrenyl products was isolated in
slightly improved yield (entry 18, Table 1). Still, the undesired
ortho-nitrobenzoic acid and nitrobenzene were formed
predominantly. The poor mass balance toward the allylation
product can be attributed due to decomposition of the π-allyl-
Pd species13 and double bond isomerization at elevated
temperature to generate the undesired styrenyl product.
Therefore, we decided to use the silver(I) salt as an additive
since it is known to promote decarboxylation at lower
temperature14 and decreases double bond isomerization.15
Gratifyingly, yield was improved to 55% with the addition of
only 10 mol % of the silver carbonate (entry 5, Table 1). After a
rigorous study varying the catalyst, ligand, solvent, and the
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amount of additive, the allylation product was isolated in
excellent yields using a combination of 5 mol % Pd2dba3, 10
mol % dppp with 1.5 equiv of Ag2CO3 in DMA at 110 °C.
Under the optimized reaction conditions, we explored the
substrate scope for the decarboxylative allylation reaction
(Scheme 1). A variety of substituted nitroarenes allow the
formation of allylation products in good to excellent yields. A
careful study revealed that electron-donating substituents such
as p-OMe on o-nitrobenzoate favor allylation product formation
(2b, 2m, 2q, 2r, 2v, Scheme 1) and two m-OMe groups which
are electron-withdrawing in nature lower the yields to some
extent (2i, 2n, 2w, Scheme 1). However, yields of the allylation
products are decreased drastically with a substitution of three
adjacent −OMe groups due to low conversion, substantial
amounts of protonation product, and carboxylic acid formation
(2j, 2o, 2u, Scheme 1). Substrates with an electron-deﬁcient
substituent, e.g. 2,4-dinitro benzoic ester, resulted in a
decarboxylative protonation product only. Therefore, electron-
withdrawing substituents on the o-nitro-benzoate facilitate
decarboxylation but they decrease the ability of the aryl anion
to serve as a σ-donor for the Pd(II)allyl cation. Halogen
substituents, such as Br, Cl, are compatible with the reaction
conditions (2d, 2e, Scheme 1) which may undergo further
cross-coupling reactions. In addition to the cross-couplings of
unsubstituted allyl esters, a variety of substituted and
functionalized allyl esters also underwent couplings to provide
allylation products (2k−2q, Scheme 1). Allyl esters from the
corresponding cinnamyl alcohols and its derivatives produced
the linear product selectively (2r−2w, Scheme 1). However,
allyl esters that possess β-hydrogens such as crotyl, prenyl, 2-
cyclohexenyl esters preferentially formed conjugated dienes via
β-hydrogen elimination and a protonation product6g (see
Supporting Information, Scheme 1). A selective reduction of
the nitro group aﬀorded o-allyl aniline in excellent yields
(Supporting Information, Scheme 2).
Subsequently, several heteroaromatic carboxylic esters were
tested under the reaction conditions. Unfortunately, nitrogen-
containing heterocycles such as indole and pyridine-2-
carboxylic esters did not furnish any desired product. However,
benzofuran-2-carboxylic esters furnished an allylation product
in good to moderate yields (Scheme 2).
Table 1. Optimization of the Reaction Conditionsa
entry Pd cat. ligand x yield (%)b 2a:2a′:2a″b
1c Pd(PPh3)4 − 0 0 −
2c Pd(PPh3)4 − 0.2 30 70:10:20
3c Pd(OAc)2 − 0.2 0 −
4c Pd(tfa)2 − 1.5 0 −
5 Pd2dba3 xantphos 0.1 55 80:7:13
6 Pd2dba3 dppf 0.1 50 75:10:15
7 Pd2dba3 rac-BINAP 0.1 63 73:7:20
8 Pd2dba3 dppp 0.1 68 82:10:8
9 Pd2dba3 dppp 0.5 72 85:6:9
10 Pd2dba3 dppp 1.0 80 85:5:10
11 Pd2dba3 dppp 1.5 90 94:0:6
12 Pd2dba3 dppp 2.0 88 92:0:8
13 Pd2dba3 dppe 1.5 40 78:13:9
14 Pd2dba3 dppb 1.5 50 80:12:8
15 Pd2dba3 PCy3 1.5 45 82:10:8
16 Pd2dba3 xphos 1.5 60 77:13:10
17d Pd2dba3 dppp 0 0 −
18e Pd2dba3 dppp 0 55 30:43:27
19 Pd(tfa)2 dppp 1.5 48 63:27:10
20f Pd(tfa)2 − 3.0 7 −
aAll reactions were carried out in 0.1 mmol scale, in DMA 0.06 M.
bYields refered to here are overall isolated yields, and product
distributions were determined by 1H NMR of the crude product. c10
mol % of the Pd cat. was used. d100 mol % of the Pd2dba3 and 200
mol % of the dppp were used. eThe reaction was heated at 160 °C; a
mixture of allyl and styrenyl product was isolated. f20 mol % of
Pd(tfa)2, DMF/DMSO (19:1), 120 °C.
Scheme 1. Substrate Scope of Decarboxylative Allylationa,b
aAll reactions were carried out in 0.3 mmol scale. b Yields refer to the
average of isolated yields of at least two experiments.
Scheme 2. Decarboxylative Allylations of Benzofuran-2-
Carboxylates
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Next, we turned our attention toward gaining insight into the
reaction mechanism. After oxidative addition of palladium(0) to
the allyl ester 1a the reaction may proceed in three distinct
pathways. In path a, the solvent-separated ion pair may
undergo decarboxylation via a two-electron process16 followed
by carbopalladation to generate 1a″ which is converted to the
desired product after reductive elimination. Whereas, in path b,
a silver-assisted decarboxylation via an anionic route can
generate the arylsilver species 1a′ which can undergo
transmetalation with palladium followed by reductive elimi-
nation to furnish an allylation product. Alternatively, this silver-
assisted decarboxylation may proceed via a Hunsdiecker-type
free radical pathway as depicted in path c (Scheme 3). The
ortho-nitro group can stabilize to either the organosilver(I) or
organopalladium(II) prior to and after decarboxylation through
coordination.
To elucidate, several control experiments were performed.
Heating the reaction mixture at 110 °C without any silver salt
resulted in only nitrobenzoic acid. Even a stoichiometric
amount of palladium also failed to promote decarboxylation at
this temperature (entry 17, Table 1), whereas heating the
reaction mixture at 160 °C with a catalytic amount of palladium
aﬀorded the desired product albeit in low yield (entry 18, Table
1). On the other hand, when ortho-nitro benzoic acid was
heated at 110 °C only with the silver carbonate the
nitrobenzene was formed indicating silver-assisted decarbox-
ylation. To elucidate further, the reaction was carried out under
the standard reaction conditions in the presence of 1.0 equiv of
TEMPO, a radical scavenger. Almost the same yield of 2a as
under the standard conditions (84%) was obtained, which rules
out the radical mechanism as shown in path c. When Pd(II)/
Ag(I) was used in lieu of Pd(0)/Ag(I), only starting material
was recovered which indicates that Pd(0) is essential to initiate
the reaction (entry 20, Table 1). An extensive crossover was
also observed between two structurally disparate allyl esters,
which is supportive evidence that the solvent-separated ion
pairs are formed and undergo all possible combinations to
provide the crossover products (Scheme 4).
Based on these observations, we presumed that the reaction
may proceed through path a at an elevated temperature vs path
b under a Pd/Ag bimetallic system at a lower temperature.
Initially, palladium(0) undergoes an oxidative addition to the
allyl ester 1a to form a π-allyl-Pd complex and an ortho-
nitrobenzoate anion. Subsequently, a silver salt of the
corresponding ortho-nitrobenzoic acid may form and undergo
Ag(I)-assisted decarboxylation to aﬀord the corresponding aryl-
Ag species 1a′. A transmetalation between an aryl-Ag and π-
allyl-Pd complex generates an aryl-Pd species 1a″. Finally,
reductive elimination yields the desired allylation product and
the Pd(0) to complete the catalytic cycle (Scheme 5).
Finally, to demonstrate the role of the nitro group in
decarboxylative allylation, we synthesized diallyl ester 3a where
both ester groups are ortho to the nitro group and its
corresponding regioisomer 3b where one allyl ester group is at
the ortho position and the other one is at the meta position.
Under slightly modiﬁed reaction conditions, 3a aﬀorded a
diallylation product in good yield via double decarboxylative
allylations, whereas 3b aﬀorded the monoallylation along with
the decarboxylative protonation product at the ortho position
leaving the meta allyl ester intact (Scheme 6). Similarly, para-
nitro benzoic ester was inactive under the reaction conditions.
Presumably, the nitro group at the ortho position has a dual role
in decarboxylation. First, it can coordinate to either the Ag(I)
or Pd(II) prior to and after decarboxylation. This is particularly
important for “post-decarboxylation” acting as a C/O bidentate
Scheme 3. Possible Mechanistic Pathways
Scheme 4. Crossover Experiment
Scheme 5. Plausible Catalytic Cycle for the Decarboxylative
Allylation
Scheme 6. Selective Decarboxylative Allylation of Nitro
Benzoic Esters
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ligand to form a relatively stable 5-membered palladacycle.
Second, it imparts a strong inductive eﬀect that stabilizes the
incipient anion which leads to rapid decarboxylation followed
by allylation.
In conclusion, we have developed a Pd/Ag bimetallic system
for the decarboxylative sp2−sp3 allylation of ortho-nitrobenzoic
esters in an intramolecular fashion. A synergistic eﬀect of
palladium and silver was observed in this decarboxylative
allylation. Mechanistic studies suggest that silver-assisted
decarboxylation occurs in an anionic pathway at the presented
reaction conditions which lead to an allylation product via
transmetalation and reductive elimination.
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ABSTRACT: We report herein a Pd(II)-catalyzed Heck-type
coupling between arene carboxylic acids and alkenes at room
temperature. Mechanistically, the reaction proceeds in two distinct
pathways where electron-rich substrates undergo a palladium(II)-
catalyzed decarboxylation and electron-deﬁcient substrates proceed
through silver(I)-assisted decarboxylation. Dimethyl sulfoxide
(DMSO) or sulﬁde ligands have positive and negative roles in the
reaction outcome, respectively. The present protocol is combined for
the peptide modiﬁcation under mild reaction conditions.
■ INTRODUCTION
The decarboxylative cross-coupling of arene carboxylic acids
with oleﬁns and aryl electrophiles provides an attractive
approach for the alkene functionalization and biaryl synthesis.1
Inexpensive and readily available carboxylic acid as nucleophilic
coupling partner is a user-friendly alternative to the air and
moisture sensitive organometallic reagents. In a seminal report
in 2002, Myers and co-workers reported a decarboxylative
Heck-type oleﬁnation of arene carboxylic acids.2 However, one
of the major pitfalls in decarboxylative cross-coupling is the
requirement of high reaction temperature (120−190 °C) which
restricts its application in the synthesis of complex molecular
frameworks. Because of the prevalence of stilbenes in numerous
natural product, bioactive molecules and high tech materials
(Figure 1),3 we were particularly interested to the development
of decarboxylative Heck-type coupling at room temperature.
Although, palladium-catalyzed decarboxylative coupling of
nitroalkanes4 and α-ketocarboxylic acids5 at room temperature
is known, there is no report of decarboxylative cross-coupling of
arene carboxylates at room temperature. We report here for the
ﬁrst time a palladium-catalyzed decarboxylative Heck-type
coupling at room temperature (Scheme 1). We also report
the substrate-dependent mechanistic variation and distinct role
of dimethyl sulfoxide/sulﬁde ligands in the present trans-
formation.
■ RESULTS AND DISCUSSION
From literature it was evident that o,o′-disubstitution facilitates
carbon dioxide extrusion.6 In addition, from our previous
experience with the decarboxylative allylation of ortho-nitro-
benzoic acids, we realized that the incipient anion which is
generated after decarboxylation needs to be stabilized for
further cross-couplings.7 Thus, we rationalized that either 2,6-
dimethoxy benzoic acid or pentaﬂuorobenzoic acid could be
model substrates to study room temperature decarboxylative
cross-coupling which will be a major advancement in this ﬁeld.
Initially, we started screening for decarboxylative Heck
reaction between 2,6-dimethoxybenzoic acid and styrene
under the Myers’s original conditions. But a trace amount of
corresponding Heck product was isolated at room temperature.
However, a good yield of the coupling product was isolated
after 36 h stirring. In search for alternative oxidants to
stoichiometric silver carbonate, 1,4-benzoquinone (BQ) was
found to be suitable.8 Finally, an excellent yield of the stilbene
product was obtained after stirring the reaction mixture for 36 h
Received: January 15, 2016
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Figure 1. Representative example of some important stilbenes.
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at room temperature with 10 mol % palladium catalyst and 2.0
equiv of 1,4-benzoquinone.
Being encouraged, several alkene partners were examined. A
wide variety of styrenes having electron-withdrawing and
electron-donating substituents underwent decarboxylative
coupling providing high to excellent yields (Scheme 2).
Fluoro-, chloro-, bromo-, (3c−3e, 3t, 3ae, Scheme 2) and
remarkably acetoxy- (3g, 3af, Scheme 2) groups were intact
under the reaction conditions demonstrating the mild nature of
this present protocol. Besides styrenes, activated alkenes such as
acrylonitrile, (3n, Scheme 2) acrylates (3o−3r, 3ag, Scheme 2)
also provided the corresponding cross-coupling products.
Interestingly, unactivated allylbenzenes (3s−3u, Scheme 2),
allyl acetate (3v, Scheme 2), allyl malonate (3x, 3ah, Scheme
2), and unactivated terminal alkene (3y, Scheme 2) also
aﬀorded the corresponding coupling products in good to
moderate yields and good styrenyl selective products under
slightly higher catalyst loading. The Heck coupling with an allyl
alcohol (3w, Scheme 2) provided the corresponding ketone
product via selective β-hydride elimination in moderate yield.6b
Remarkably, 1,4-divinylbenzene provided the double cross-
coupling product in one stroke (3m, Scheme 2). 2,6-Diethoxy-
(3z, Scheme 2) and 2,6-dibenzyloxy (3aa, Scheme 2) benzoic
acid also provided the corresponding coupling products in
excellent yields. However, benzoic acid, mesitylenecarboxylic
acid, 2-methoxy benzoic acid, and heteroaryl carboxylic acids
such as pyridine-2-carboxylic acid, and benzofuran-2-carboxylic
acid did not furnish any desired product. It was found that o,o-
dialkoxy substitution is essential for decarboxylative coupling at
room temperature presumably due to coordination between
oxygen and arylpalladium species.
Next we turned our attention to the pentaﬂuoroarenes as
they exhibit distinct chemical and physical properties to their
hydrocarbon counterpart.9 Also an increasing use of perﬂuori-
nated compounds in material science, biomedical and
bioanalytical research, defense, refrigeration, and domestic
appliances has been observed.10 Therefore, introduction of
perﬂuorinated moiety into the organic backbone has become a
fascinating ﬁeld of research in the last years.11 However, the
metal-catalyzed cross-coupling reaction with this highly
electron-deﬁcient arenes poses a great challenge, due to poor
coordination with the metal center and reluctance to undergo
cross-coupling. A seminal work of palladium-catalyzed Heck
coupling between pentaﬂuorohalobenzene (X = I, Br) and
styrenes was reported by the Espinet and Milstein groups.12
Recently, an oxidative Heck coupling between pentaﬂuor-
obenzene and styrenes were reported by the Zhang group,13a
and a decarboxylative allylation of pentaﬂuorobenzoates was
reported by the Gooβen group at 120 and 110 °C
respectively.13b Direct oxidative cross-coupling with perﬂuor-
oarenes also an emerging ﬁeld of research.14
To examine decarboxylative Heck coupling with electron-
deﬁcient substrates, pentaﬂuorobenzoic acid was employed
under the optimized reaction conditions but no product was
formed. Since PdII/AgI combination is essential for the
Scheme 1. Decarboxylative Heck-Arylation with Oleﬁns Scheme 2. Substrate Scope with Electron-Rich Carboxylic
Acidsa,b,c
aConditions: The reaction was carried out in 0.2 mmol scale, 0.06 M.
bYield referred to here is the average of at least two experiments.
cUnless otherwise stated E/Z ratio of the Heck products are >20:1 as
determined by 1H NMR. d20 mol % Pd(TFA)2 and 3.0 equiv BQ were
used. eReaction time 48 h.
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decarboxylative coupling of electron-deﬁcient substrates,15
benzoquinone was replaced by silver carbonate. Still no Heck
product was isolated. Surprisingly, the reaction in pure DMF
provided the Heck product at room temperature. This is in
sharp contrast to the earlier reports where addition of 5%
dimethyl sulfoxide (DMSO) in dimethylformamide (DMF)
was found to improve the yield at elevated temperature. Finally,
the desired Heck-products were obtained with 10 mol %
Pd(tfa)2 and 2.0 equiv of Ag2CO3 in good yields after 16 h
stirring at room temperature.
With this optimized reaction conditions we explored the
substrate scope. A wide variety of substituted styrenes provided
the Heck product in high yields. Besides alkyl substituents,
halogens (6b−6d, 6k−6m, Scheme 3), labile acetoxy (6i, 6t,
Scheme 3) and tert-butyldimethylsilyloxy (6j, Scheme 3)
groups were compatible under these mild reaction conditions.
The reaction was also reproduced in gram scale in comparable
yield. However, 2,3,4,5-tetraﬂuoro and 2,6-diﬂuoro benzoic
acids provided the coupling product at 120 °C (6u, 6v, Scheme
3). Interestingly, the reaction with allylbenzene at 120 °C
provided the corresponding allylation product in high yield and
selectivity (6w, Scheme 3). Activated alkenes such as methyl
acrylate aﬀorded only a trace amount of Heck product under
the same reaction conditions.
Reaction Mechanism. In their report, the Myers group
applied a general reaction conditions for electron-rich and
electron-deﬁcient carboxylic acids. In addition, experimental
and theoretical mechanistic investigation was performed
exclusively based on the electron-rich substrates.16 In their
study with catalytic and stoichiometric palladium(II)-
triﬂuoroacetate, it was observed that decarboxylation occurs
by palladium salt where silver salt acts as an oxidant for catalytic
turnover.16b However, the mechanism for electron-deﬁcient
substrate was illusive. In this present study, we have also
observed that electron-rich 2,6-dimethoxybenzoic acid under-
goes decarboxylative Heck reaction by a catalytic amount of
palladium(II) triﬂuoroacetate where silver(I) carbonate was
replaced by benzoquinone for practical applications. A
stoichiometric palladium salt also reproduced the same result
in the absence of benzoquinone (Scheme 4a). Additionally, a
control experiment suggests that even a superstoichiometric
amount of silver(I) carbonate (2 equiv) did not furnish
decarboxylation of the 2,6-dimethoxybenzoic acid in the
absence of palladium at room temperature (Scheme 4b).
However, exclusive decarboxylative protonation product was
observed by the Larrosa group with 10 mol % Silver(I)
carbonate at 120 °C.17 In sharp contrast, in the absence of silver
salt the reaction with electron-deﬁcient pentaﬂuorobenzoic acid
did not proceed even with stoichiometric amount of palladium-
(II) triﬂuoroacetate (Scheme 4c). However, either stoichio-
metric (2 equiv) or a catalytic amount (20 mol %) of silver(I)
carbonate resulted in decarboxylative protonation product
exclusively (Scheme 4d). Additionally, a catalytic amount of
silver(I) carbonate (20 mol %), palladium(II) triﬂuoroacetate
(10 mol %), and benzoquinone (2.0 equiv) aﬀorded the
corresponding Heck product from the pentaﬂuorobenzoic acid
and styrene albeit in low yield (35%) (Scheme 4e). Therefore,
electron-deﬁcient substrates may follow a distinct pathway for
Scheme 3. Substrate Scope with Perﬂuorobenzoic Acidsa,b,c
aConditions: The reaction was carried out in 0.2 mmol scale, 0.06 M.
bYield referred to here is the average of at least two experiments. cE/Z
ratio of the Heck products are >20:1 as determined by 1H NMR. d120
°C was used. e20 mol % Pd(TFA)2, 3.0 equiv Ag2CO3 and 5%
DMSO−DMF were used, reaction time 4 h.
Scheme 4. Control Experiments
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the decarboxylative Heck reaction from electron-rich substrates
at room temperature. A similar observation was also observed
by the Su group where 2,4-dimethoxybenzoic acid underwent
decarboxylative protonation with stoichiometric palladium(II)-
triﬂuoroacetate at 80 °C but 2-nitrobenzoic acid was unreactive.
On the other hand, electron-deﬁcient 2-nitrobenzoic acid
aﬀorded decarboxylative protonation exclusively with super-
stoichiometric amount of silver(I) carbonate (3.0 equiv) only.
Ultimately, a Pd/Ag bimetallic system was applied for the C-3
selective arylation of indoles with electron-deﬁcient nitro-
benzoic acids.15,18
Interestingly, in the earlier reports dimethyl sulfoxide
(DMSO) or other sulﬁde ligands exhibited a prominent role
in decarboxylative, direct alkenylation or allylic C−H
activations where addition of 5% DMSO as a cosolvent was
found to improve yields and catalytic eﬃciency.2,16,19 From
NMR and crystal structure studies, the Myers group has also
shown that DMSO acts as a ligand on the arylpalladium species
in decarboxylative Heck-type coupling.16b In sharp contrast, for
the ﬁrst time we have observed that DMSO or sulﬁde ligand
exhibit a negative role in the decarboxylative alkenylation
reaction between pentaﬂuorobenzoic acid and styrene at room
temperature. A careful study revealed that the yield of the
alkenylation product was decreased successively with the
increase of DMSO (Figure 2) with respect to the
pentaﬂuorobenzoic acid. In lieu of pure DMF (Scheme 4d),
5% DMSO−DMF also furnished the decarboxylative proto-
nation product exclusively suggesting that DMSO has no role
in siver-mediated decarboxylation. Therefore, DMSO may act
as a ligand on the palladium and inﬂuence negatively for the
subsequent cross-coupling processes with electron-deﬁcient
carboxylic acids. The same trend was also observed with phenyl
methyl sulﬁde. Although, the exact reason for this negative
eﬀect of DMSO is not clear at this moment but this room
temperature decarboxylation will leads to the development of
new cross-coupling reactions under mild conditions.
On the basis of earlier reports and the present study it is
speculated that depending of the electronic nature of the
carboxylic acids a mechanistic divergence is observed in the
decarboxylative Heck coupling reaction. The electron-rich
substrates may follow a palladium-catalyzed decarboxylation
where dimethyl sulfoxide acts as a ligand and benzoquinone
plays as an oxidant for catalytic turnover as shown in path a,
Scheme 5.1h Whereas, pentaﬂuorobenzoic acid may undergo a
silver-assisted decarboxylation which forms a arylpalladium
species after transmetalation as depicted in path b, Scheme 5.
Subsequently, the arylpalladium species undergoes migratory
alkene insertion and β-hydride elimination to provide the Heck
product and palladium(0). Finally, the palladium(0) is oxidized
either by silver(I) salt or benzoquinone in path a and path b
respectively to complete the catalytic cycle.
Next we turned our attention to utilize the decarboxylative
Heck product for further useful transformations. Under basic
conditions, the pentaﬂuoroarene moiety, 6a undergoes an
activated aromatic nucleophilic substitution (SNAr) with indole
selectively at the para-position to aﬀord (7, Scheme 6). The
remaining ﬂuorenes are further substituted by excess pyrazoles
to provide (8, Scheme 6).20 Development of novel synthetic
methods for the postsynthetic modiﬁcation of peptide is an
attractive research ﬁeld.21 In this vein, we have applied the
decarboxylative Heck product for the arylation with cysteine.
Figure 2. Negative role of sulfoxide or sulﬁde ligand in the heck
reaction between pentaﬂuorobenzoic acid and styrene at room
temperature.
Scheme 5. Plausible Mechanism
Scheme 6. Product Derivatization
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To demonstrate with the sulfur nucleophiles, the Heck product
6a was reacted with benzyl mercaptan to aﬀord (9, Scheme 6)
in excellent yield. Similarly, it also underwent activated aromatic
nucleophilic substitution (SNAr) with the protected cysteine
selectively at the para-position to provide (10, Scheme 6).
■ CONCLUSION
In conclusion, we have developed a decarboxylative Heck-type
coupling between arene carboxylic acids and alkenes at room
temperature. A substrate-dependent mechanistic divergence
was observed where electron-rich arene carboxylic acids
undergo palladium-catalyzed decarboxylation and electron-
deﬁcient arene carboxylic acids undergo silver-assisted decar-
boxylation. Similarly, dimethyl sulfoxide or other sulﬁde ligands
exhibit positive and negative roles respectively in the present
transformation. The pentaﬂuoroarene moiety obtained from
the cross-coupling was further derivatized via activated aromatic
nucleophilic substitution (SNAr) with nitrogen and sulfur
nucleophiles. Therefore, this room temperature reaction
sequence is useful for peptide modiﬁcation under mild reaction
conditions.
■ EXPERIMENTAL SECTION
General Information. Melting points were determined in open
end-capillary tubes and are uncorrected. TLC was performed on silica
gel plates (Merck silica gel 60, f254), and the spots were visualized
with UV light (254 and 365 nm) and KMnO4 stain.
1H and 13C{1H}
NMR spectra were recorded in CDCl3 using TMS as the internal
standard. The 19F NMR spectra were recorded in CDCl3 solvent using
hexaﬂuorobenzene as the internal standard. HRMS (m/z) were
measured using EI (magnetic sector, positive ion) and ESI (Q-TOF,
positive ion) techniques. Infrared (IR) spectra were recorded on
Fourier transform infrared spectroscopy; only intense peaks were
reported.
General Experimental Procedure for the Decarboxylative
Heck Reaction between Electron-Rich Carboxylic Acids and
Alkenes. To an oven-dried 15 mL sealed tube, a mixture of carboxylic
acids (0.20 mmol, 1.0 equiv), palladium(II) triﬂuoroacetate (6.7 mg,
0.02 mmol, 0.1 equiv) and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0
equiv) was taken. Then dry DMF (3.0 mL) and DMSO (0.15 mL)
were added to it. After purging the reaction vessel with nitrogen, the
corresponding alkene (0.30 mmol, 1.5 equiv) was added to the
reaction mixture via microliter syringe and the vessel was sealed with a
screw cap. The reaction mixture was allowed to stir for 36 h at room
temperature. After completion (as detected by TLC), the reaction
mixture was poured into water (20 mL) and extracted with ethyl
acetate (30 mL). The organic layer was washed with aqueous NaOH
solution (2 N, 10 mL), water (10 mL), and brine solution (10 mL),
dried over anhydrous Na2SO4 and the solvent was evaporated under
reduced pressure. The crude product was puriﬁed by column
chromatography using ethyl acetate/hexane as eluent to aﬀord the
desired product.
1-(2,6-Dimethoxystyryl)benzene, 3a, Scheme 2.22 The same
general procedure was followed by using 2,6-dimethoxybenzoic acid
(36.5 mg, 0.2 mmol, 1.0 equiv), styrene (35 μL, 0.3 mmol, 1.5 equiv),
palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-
benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column chromatography
(SiO2, eluting with 96:4 hexane/ethyl acetate) aﬀorded the desired
product as a colorless oil, (45 mg, 94%). 1H NMR (300 MHz, CDCl3)
δ 7.61 (d, J = 6.8 Hz, 1H), 7.57 (d, J = 7.8 Hz, 2H), 7.49 (d, J = 16.5
Hz, 1H), 7.37 (t, J = 7.2 Hz, 2H), 7.24 (t, J = 7.5 Hz, 1H), 7.19 (t, J =
8.4 Hz, 1H), 6.62 (d, J = 8.4 Hz, 2H), 3.92 (s, 6H); 13C{1H} NMR
(75 MHz, CDCl3) δ 158.5, 139.2, 132.2, 128.4, 128.0, 126.8, 126.3,
119.8, 114.6, 103.9, 55.7; IR (neat) υmax 2934, 1584, 1470, 1248, 1106,
976, 749 cm−1; HRMS (EI, m/z) calcd. for C16H16O2 [M]
+ 240.1150,
found 240.1157.
1-(2,6-Dimethoxystyryl)-4-tert-butylbenzene, 3b, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-tert-butylstyrene (55 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 96:4 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (56 mg,
94%), mp 98−100 °C. 1H NMR (300 MHz, CDCl3) δ 7.54 (d, J =
16.8 Hz, 1H), 7.42−7.48 (m, 3H), 7.35 (d, J = 8.4 Hz, 2H), 7.14 (t, J =
8.4 Hz, 1H), 6.58 (d, J = 8.1 Hz, 2H), 3.87 (s, 6H), 1.33 (s, 9H);
13C{1H} NMR (75 MHz, CDCl3) δ 158.6, 149.9, 136.6, 132.2, 127.8,
126.1, 125.4, 119.2, 115.1, 104.0, 55.8, 34.5, 31.3; IR (neat) υmax 2958,
1581, 1470, 1252, 1108, 770 cm−1; HRMS (ESI, m/z) calcd. for
C20H24O2Na [M + Na]
+ 319.1674, found 319.1694.
1-(2,6-Dimethoxystyryl)-4-ﬂuorobenzene, 3c, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-ﬂuorostyrene (36 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate)
aﬀorded the desired product as a colorless oil, (45 mg, 87%). 1H
NMR (600 MHz, CDCl3) δ 7.57 (d, J = 16.8 Hz, 1H), 7.51−7.54 (m,
2H), 7.40 (d, J = 16.8 Hz, 1H), 7.20 (t, J = 8.4 Hz, 1H), 7.05 (t, J = 8.4
Hz, 2H), 6.62 (d, J = 8.4 Hz, 2H), 3.92 (s, 6H); 13C{1H} NMR (150
MHz, CDCl3) δ 162.0 (d, J = 244.5 Hz), 158.6, 135.4 (d, J = 3.0 Hz),
131.1, 128.1, 127.8 (d, J = 7.5 Hz), 119.6 (d, J = 1.5 Hz), 115.3 (d, J =
2.1 Hz), 114.6, 104.0, 55.8; 19F NMR (470 MHz, CDCl3) δ −119.0 (s,
1F); IR (neat) υmax 2935, 1590, 1506, 1470, 1246, 1106, 775 cm
−1;
HRMS (ESI, m/z) calcd. for C16H15FO2Na [M + Na]
+ 281.0954,
found 281.0929.
1-(2,6-Dimethoxystyryl)-4-chlorobenzene, 3d, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-chlorostyrene (38 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 96:4 hexane/ethyl
acetate) aﬀorded the desired product as a colorless oil, (45 mg,
82%). 1H NMR (300 MHz, CDCl3) δ 7.54 (d, J = 16.8 Hz, 1H),
7.41−7.48 (m, 3H), 7.30 (d, J = 8.4 Hz, 2H), 7.18 (t, J = 8.1 Hz, 1H),
6.60 (d, J = 8.4 Hz, 2H), 3.90 (s, 6H); 13C{1H} NMR (75 MHz,
CDCl3) δ 158.6, 137.8, 132.4, 130.9, 128.6, 128.4, 127.6, 120.5, 114.4,
103.9, 55.8; IR (neat) υmax 2935, 1585, 1484, 1249, 1109, 975, 774
cm−1; HRMS (ESI, m/z) calcd. for C16H15ClO2Na [M + Na]
+
297.0658, found 297.0681.
1-(2,6-Dimethoxystyryl)-4-bromobenzene, 3e, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-bromostyrene (40 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 96:4 hexane/ethyl
acetate) aﬀorded the desired product as a colorless oil, (47 mg,
74%). 1H NMR (600 MHz, CDCl3) δ 7.53 (d, J = 16.8 Hz, 1H),
7.46−7.48 (m, 3H), 7.42 (d, J = 8.4 Hz, 2H), 7.20 (t, J = 8.4 Hz, 1H),
6.61 (d, J = 8.4 Hz, 2H), 3.91 (s, 6H); 13C{1H} NMR (150 MHz,
CDCl3) δ 158.6, 138.3, 131.5, 130.9, 128.4, 127.9, 120.6, 120.5, 114.4,
103.9, 55.8; IR (neat) υmax 2935, 1584, 1475, 1249, 1106, 772 cm
−1;
HRMS (ESI, m/z) calcd. for C16H15BrO2Na [M + Na]
+ 341.0153,
found 341.0155.
2-(4-Methoxystyryl)-1,3-dimethoxybenzene, 3f, Scheme 2.23 The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-vinylanisole (40 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (32 mg, 60%), mp
71−73 °C. 1H NMR (300 MHz, CDCl3) δ 7.54 (d, J = 16.5 Hz, 1H),
7.49 (d, J = 8.7 Hz, 2H), 7.33 (d, J = 16.5 Hz, 1H), 7.16 (t, J = 8.4 Hz,
1H), 6.90 (d, J = 8.7 Hz, 2H), 6.60 (d, J = 8.4 Hz, 2H), 3.90 (s, 6H),
3.84 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 158.8, 158.4, 132.0,
131.8, 127.6, 127.5, 117.8, 114.9, 113.8, 103.9, 55.7, 55.2; IR (neat)
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υmax 2937, 1601, 1581, 1469, 1249, 1106, 1033, 773 cm
−1; HRMS (EI,
m/z) calcd. for C17H18O3 [M]
+ 270.1256, found 270.1257.
4-(2,6-Dimethoxystyryl)phenyl acetate, 3g, Scheme 2. The same
general procedure was followed by using 2,6-dimethoxybenzoic acid
(36.5 mg, 0.2 mmol, 1.0 equiv), 4-acetoxystyrene (46 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate)
aﬀorded the desired product as a colorless oil, (57 mg, 95%). 1H
NMR (300 MHz, CDCl3) δ 7.54−7.60 (m, 3H), 7.42 (d, J = 16.5 Hz,
1H), 7.19 (t, J = 8.4 Hz, 1H), 7.08 (d, J = 8.4 Hz, 2H), 6.61 (d, J = 8.4
Hz, 2H), 3.91 (s, 6H), 2.32 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3)
δ 171.3, 160.1, 151.3, 138.9, 133.0, 129.9, 129.0, 123.3, 122.0, 116.3,
105.7, 57.5, 22.9; IR (neat) υmax 2937, 1760, 1584, 1504, 1195, 1105,
772 cm−1; HRMS (ESI, m/z) calcd. for C18H18O4Na [M + Na]
+
321.1103, found 321.1115.
1-(2,6-Dimethoxystyryl)-3-nitrobenzene, 3h, Scheme 2. The same
general procedure was followed by using 2,6-dimethoxybenzoic acid
(36.5 mg, 0.2 mmol, 1.0 equiv), 3-nitrostyrene (42 μL, 0.3 mmol, 1.5
equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv),
and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 95:5 hexane/ethyl acetate)
aﬀorded the desired product as a yellow solid, (53 mg, 93%), mp
116−118 °C. 1H NMR (600 MHz, CDCl3) δ 8.37 (s, 1H), 8.04−8.06
(m, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.59−7.66 (m, 2H), 7.49 (t, J = 8.4
Hz, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.62 (d, J = 8.4 Hz, 2H), 3.93 (s,
3H); 13C{1H} NMR (150 MHz, CDCl3) δ 158.8, 148.6, 141.2, 132.0,
129.6, 129.2, 129.1, 122.9, 121.3, 120.9, 113.7, 103.9, 55.8; IR (neat)
υmax 1527, 1473, 1343, 1107, 737 cm
−1; HRMS (EI, m/z) calcd. for
C16H15NO4 [M]
+ 285.1001, found 285.1013.
(E)-1-(2,6-Dimethoxyphenyl)-2-(3,5-dimethoxyphenyl)ethene, 3i,
Scheme 2. The same general procedure was followed by using 2,6-
dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 3,5-
dimethoxystyrene (49 mg, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone
(50 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2, eluting
with 9:1 hexane/ethyl acetate) aﬀorded the desired product as a
colorless oil, (45 mg, 84%). 1H NMR (600 MHz, CDCl3) δ 7.53 (d, J
= 16.8 Hz, 1H), 7.46 (d, J = 16.8 Hz, 1H), 7.19 (t, J = 8.4 Hz, 1H),
6.73 (d, J = 1.8 Hz, 2H), 6.61 (d, J = 8.4 Hz, 2H), 6.40 (t, J = 2.4 Hz,
1H), 3.91 (s, 6H), 3.86 (s, 6H); 13C{1H} NMR (150 MHz, CDCl3) δ
160.8, 158.6, 141.4, 132.3, 128.2, 120.4, 114.6, 104.5, 104.0, 99.4, 55.8,
55.3; IR (neat) υmax 2937, 2838, 1587, 1472, 1153, 773 cm
−1; HRMS
(ESI, m/z) calcd. for C18H20O4Na [M + Na]
+ 323.1259, found
323.1278.
2-(2,6-Dimethoxystyryl)naphthalene, 3j, Scheme 2. The same
general procedure was followed by using 2,6-dimethoxybenzoic acid
(36.5 mg, 0.2 mmol, 1.0 equiv), 2-vinylnaphthalene (46 mg, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (50 mg, 86%), mp
136−138 °C. 1H NMR (300 MHz, CDCl3) δ 7.75−7.87 (m, 6H), 7.62
(d, J = 16.8 Hz, 1H), 7.40−7.49 (m, 2H), 7.20 (t, J = 8.4 Hz, 1H), 6.63
(d, J = 8.4 Hz, 2H), 3.94 (s, 6H); 13C{1H} NMR (75 MHz, CDCl3) δ
158.7, 136.9, 133.9, 132.9, 132.4, 128.2, 128.0, 127.96, 127.7, 126.2,
126.1, 125.4, 123.8, 120.4, 114.9, 104.1, 55.8; IR (neat) υmax 1583,
1470, 1242, 1105, 772 cm−1; HRMS (EI, m/z) calcd. for C20H18O2
[M]+ 290.1307, found 290.1310.
1-(2,6-Dimethoxystyryl)-2,3,4,5,6-pentaﬂuorobenzene, 3k,
Scheme 2. The same general procedure was followed by using 2,6-
dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), pentaﬂuor-
ostyrene (42 μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate
(6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4
mmol, 2.0 equiv). Column chromatography (SiO2, eluting with 96:4
hexane/ethyl acetate) aﬀorded the desired product as a white solid,
(56 mg, 85%), mp 146−148 °C. 1H NMR (600 MHz, CDCl3) δ 7.75
(d, J = 17.4 Hz, 1H), 7.47 (d, J = 16.8 Hz, 1H), 7.24 (t, J = 8.4 Hz,
1H), 6.61 (d, J = 8.4 Hz, 2H), 3.92 (s, 6H); 13C{1H} NMR (150 MHz,
CDCl3) δ 158.9, 144.6 (dm, J = 249.0 Hz), 139.1, (dm, J = 250.5 Hz),
137.7 (dm, J = 247.5 Hz), 129.6, 128.6 (t, J = 9.0 Hz), 116.2, 114.2
(td, J = 13.5 Hz, 4.5 Hz), 113.8, 103.8, 55.8 (d, J = 3.0 Hz); 19F NMR
(470 MHz, CDCl3) δ −144.6 (dd, J = 26.8 Hz, 8.9 Hz, 2F), −159.5 (t,
J = 26.3 Hz, 1F), −165.0 (td, J = 26.3 Hz, 8.9 Hz, 2F); IR (neat) υmax
1585, 1496, 1245, 1108, 1000, 774 cm−1; HRMS (EI, m/z) calcd. for
C16H11F5O2 [M]
+ 330.0679, found 330.0665.
2-(2-Methoxystyryl)-1,3-dimethoxybenzene, 3l, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), 2-vinylanisole (40 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 96:4 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (41 mg, 76%), mp
66−68 °C. 1H NMR (300 MHz, CDCl3) δ 7.87 (d, J = 16.8 Hz, 1H),
7.64 (dd, J = 7.5 Hz, 0.9 Hz, 1H), 7.39 (d, J = 16.8 Hz, 1H), 7.11−7.25
(m, 2H), 6.96 (t, J = 7.5 Hz, 1H), 6.87 (d, J = 8.1 Hz, 1H), 6.58 (d, J =
8.4 Hz, 2H), 3.88 (s, 6H), 3.86 (s, 3H); 13C{1H} NMR (75 MHz,
CDCl3) δ 158.6, 156.7, 128.6, 128.0, 127.8, 127.2, 126.2, 120.7, 120.4,
115.4, 110.8, 104.0, 55.8, 55.6; IR (neat) υmax 2935, 2837, 1586, 1468,
1243, 1106, 746 cm−1; HRMS (ESI, m/z) calcd. for C17H18O3Na [M +
Na]+ 293.1154, found 293.1147.
1,4-Bis(2,6-dimethoxystyryl)benzene, 3m, Scheme 2. The same
general procedure was followed by using 2,6-dimethoxybenzoic acid
(36.5 mg, 0.2 mmol, 1.0 equiv), 1,4-divinylbenzene (22 μL, 0.15
mmol, 0.75 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate)
aﬀorded the desired product as a yellow solid, (29 mg, 72%), mp 180−
182 °C. 1H NMR (600 MHz, CDCl3) δ 7.61 (d, J = 16.2 Hz, 2H),
7.54 (s, 4H), 7.50 (d, J = 16.8 Hz, 2H), 7.18 (t, J = 8.4 Hz, 2H), 6.62
(d, J = 8.4 Hz, 4H), 3.93 (s, 12H); 13C{1H} NMR (150 MHz, CDCl3)
δ 158.6, 138.0, 132.2, 127.9, 126.5, 119.3, 115.0, 104.0, 55.8; IR (neat)
υmax 1582, 1472, 1251, 1105, 770 cm
−1; HRMS (EI, m/z) calcd. for
C26H26O4 [M]
+ 402.1831, found 402.1833.
(E)-3-(2,6-Dimethoxyphenyl)acrylonitrile, 3n, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), acrylonitrile (20 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) aﬀorded
the desired product as a colorless oil, (24 mg, 64%). 1H NMR (600
MHz, CDCl3) δ 7.82 (d, J = 16.8 Hz, 1H), 7.28−7.34 (m, 2H), 7.22
(d, J = 12.0 Hz, 1H), 6.59 (d, J = 8.4 Hz, 2H), 6.57 (d, J = 8.4 Hz,
2H), 6.42 (d, J = 16.8 Hz, 1H), 5.58 (d, J = 12.0 Hz, 1H), 3.89 (s,
12H); 13C{1H} NMR (150 MHz, CDCl3) δ 158.8, 158.2, 141.4, 141.0,
132.0, 131.6, 120.2, 117.3, 111.9, 111.6, 103.7, 103.6, 99.9, 98.4, 55.8,
55.4; IR (neat) υmax 2936, 2210, 1696, 1601, 1475, 1249, 1112, 777
cm−1; HRMS (ESI, m/z) calcd. for C11H11NO2Na [M + Na]
+
212.0687, found 212.0691.
(E)-Methyl 3-(2,6-dimethoxyphenyl)acrylate, 3o, Scheme 2.1h
The same general procedure was followed by using 2,6-dimethox-
ybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), methyl acrylate (27 μL,
0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0
equiv). Column chromatography (SiO2, eluting with 9:1 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (36 mg, 81%),
mp 70−72 °C. 1H NMR (300 MHz, CDCl3) δ 8.14 (d, J = 16.2 Hz,
1H), 7.26 (t, J = 8.4 Hz, 1H), 6.88 (d, J = 16.2 Hz, 1H), 6.55 (d, J =
8.4 Hz, 2H), 3.87 (s, 6H), 3.79 (s, 3H); 13C{1H} NMR (75 MHz,
CDCl3) δ 169.0, 160.0, 135.6, 131.2, 120.2, 112.1, 103.6, 55.7, 51.4; IR
(neat) υmax 2942, 1703, 1618, 1255, 1161, 1104, 748 cm
−1; HRMS (EI,
m/z) calcd. for C12H14O4 [M]
+ 222.0892, found 222.0902.
(E)-Butyl 3-(2,6-dimethoxyphenyl)acrylate, 3p, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), butyl acrylate (43 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) aﬀorded
the desired product as a colorless oil, (39 mg, 74%). 1H NMR (300
MHz, CDCl3) δ 8.14 (d, J = 16.2 Hz, 1H), 7.26 (t, J = 8.4 Hz, 1H),
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6.88 (d, J = 16.5 Hz, 1H), 6.55 (d, J = 8.4 Hz, 2H), 4.20 (t, J = 6.6 Hz,
2H), 3.88 (s, 6H), 1.64−1.74 (m, 2H), 1.38−1.50 (m, 2H), 0.96 (t, J =
7.5 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 168.6, 159.8, 135.2,
131.0, 120.5, 112.1, 103.5, 63.9, 55.6, 30.8, 19.1, 13.7; IR (neat) υmax
2959, 1706, 1623, 1587, 1474, 1255, 1109, 744 cm−1; HRMS (EI, m/
z) calcd. for C15H20O4 [M]
+ 264.1362, found 264.1346.
(E)-Phenyl 3-(2,6-dimethoxyphenyl)acrylate, 3q, Scheme 2. The
same general procedure was followed by using 2,6-dimethoxybenzoic
acid (36.5 mg, 0.2 mmol, 1.0 equiv), phenyl acrylate (45 mg, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (41.5 mg, 73%), mp
106−108 °C. 1H NMR (300 MHz, CDCl3) δ 8.36 (d, J = 16.2 Hz,
1H), 7.42 (t, J = 7.8 Hz, 2H), 7.33 (t, J = 8.4 Hz, 1H), 7.26 (d, J = 8.1
Hz, 1H), 7.20 (d, J = 7.5 Hz, 2H), 7.11 (d, J = 16.2 Hz, 1H), 6.61 (d, J
= 8.4 Hz, 2H), 3.93 (s, 6H); 13C{1H} NMR (75 MHz, CDCl3) δ
167.0, 160.2, 151.2, 137.4, 131.8, 129.4, 125.5, 121.9, 119.6, 112.1,
103.7, 55.8; IR (neat) υmax 1735, 1619, 1478, 1254, 1131, 738 cm
−1;
HRMS (ESI, m/z) calcd. for C17H16O4Na [M + Na]
+ 307.0946, found
307.0957.
(E)-Methyl 3-(2,6-dimethoxyphenyl)-2-methyl acrylate, 3r,
Scheme 2.24 The same general procedure was followed by using
2,6-dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), methyl
methacrylate (32 μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuor-
oacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43
mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2, eluting
with 9:1 hexane/ethyl acetate) aﬀorded the desired product as a
colorless oil, (19 mg, 40%). 1H NMR (600 MHz, CDCl3) δ 7.54 (s,
1H), 7.28 (t, J = 8.4 Hz, 1H), 6.59 (d, J = 8.4 Hz, 2H), 3.83 (s, 6H),
3.81 (s, 3H), 1.79 (d, J = 1.2 Hz, 3H); 13C{1H} NMR (150 MHz,
CDCl3) δ 168.7, 157.7, 131.9, 130.9, 129.7, 113.4, 103.5, 55.6, 51.8,
15.2; IR (neat) υmax 2950, 2840, 1710, 1587, 1470, 1253, 1105, 745
cm−1; HRMS (ESI, m/z) calcd. for C13H16O4Na [M + Na]
+ 259.0946,
found 259.0934.
1-((E)-3-(2,6-Dimethoxyphenyl)prop-1-enyl)benzene, 3s, Scheme
2. The same general procedure was followed by using 2,6-
dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), allylbenzene
(40 μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (13.4 mg,
0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.4 mmol, 3.0
equiv). Column chromatography (SiO2, eluting with 95:5 hexane/
ethyl acetate) aﬀorded the desired product as a colorless oil, (28 mg,
55%). 1H NMR (600 MHz, CDCl3) δ 7.33 (d, J = 7.2 Hz, 2H), 7.25−
7.28 (m, 2H), 7.13−7.20 (m, 2H), 7.09 (d, J = 8.4 Hz, 2H), 6.32−6.41
(m, 2H), 3.85 (s, 6H), 3.58 (d, J = 6.0 Hz, 2H); 13C{1H} NMR (150
MHz, CDCl3) δ 158.2, 138.1, 129.4, 129.0, 128.3, 127.1, 126.5, 126.0,
116.5, 103.8, 55.8, 26.4; IR (neat) υmax 2927, 1728, 1593, 1469, 1254,
1110, 729 cm−1; HRMS (ESI, m/z) calcd. for C17H18O2Na [M + Na]
+
277.1204, found 277.1179.
1-Fluoro-4-((E)-3-(2,6-dimethoxyphenyl)prop-1-enyl)benzene, 3t,
Scheme 2. The same general procedure was followed by using 2,6-
dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-
ﬂuoroallylbenzene (41 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv), and 1,4-
benzoquinone (65 mg, 0.4 mmol, 3.0 equiv). Column chromatography
(SiO2, eluting with 95:5 hexane/ethyl acetate) aﬀorded the desired
product as a white solid, (31 mg, 57%), mp 68−70 °C. 1H NMR (600
MHz, CDCl3) δ 7.28−7.31 (m, 2H), 7.19 (t, J = 8.4 Hz, 1H), 6.96 (t, J
= 8.4 Hz, 2H), 6.60 (d, J = 8.4 Hz, 2H), 6.36 (d, J = 15.6 Hz, 1H),
6.25−6.30 (m, 1H), 3.86 (s, 6H), 3.58 (d, J = 6.0 Hz, 2H); 13C{1H}
NMR (150 MHz, CDCl3) δ 161.7 (d, J = 243.0 Hz), 158.2, 134.2 (d, J
= 3.0 Hz), 128.7 (d, J = 3.0 Hz), 128.3, 127.3 (d, J = 7.5 Hz), 127.2,
116.4, 115.1 (d, J = 21.0 Hz), 103.8, 55.8, 26.4; 19F NMR (470 MHz,
CDCl3) δ −119.6 (s, 1F); IR (neat) υmax 2929, 1592, 1470, 1255,
1107, 839 cm−1; HRMS (EI, m/z) calcd. for C17H17FO2 [M]
+
272.1213, found 272.1208.
2-(4-Methoxycinnamyl)-1,3-dimethoxybenzene, 3u, Scheme 2.8
The same general procedure was followed by using 2,6-dimethox-
ybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-methoxyallylbenzene
(46 μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (13.4 mg,
0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.4 mmol, 3.0
equiv). Column chromatography (SiO2, eluting with 95:5 hexane/
ethyl acetate) aﬀorded the desired product as a white solid, (24 mg,
42%), mp 70−72 °C. 1H NMR (600 MHz, CDCl3) δ 7.26 (d, J = 9.0
Hz, 2H), 7.17 (t, J = 8.4 Hz, 1H), 6.81 (d, J = 8.4 Hz, 2H), 6.58 (d, J =
8.4 Hz, 2H), 6.34 (d, J = 15.6 Hz, 1H), 6.18−6.23 (m, 1H), 3.85 (s,
6H), 3.79 (s, 3H), 3.55 (d, J = 6.6 Hz, 2H); 13C{1H} NMR (150 MHz,
CDCl3) δ 158.4, 158.2, 131.1, 128.8, 127.05, 127.02, 126.8, 116.8,
113.7, 103.8, 55.8, 55.2, 26.4; IR (neat) υmax 2930, 1597, 1510, 1469,
1250, 1111, 833 cm−1; HRMS (EI, m/z) calcd. for C18H20O3 [M]
+
284.1412, found 284.1408.
2,6-Dimethoxycinnamyl acetate, 3v, Scheme 2.8 The same
general procedure was followed by using 2,6-dimethoxybenzoic acid
(36.5 mg, 0.2 mmol, 1.0 equiv), allylacetate (33 μL, 0.3 mmol, 1.5
equiv), palladium(II) triﬂuoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv),
and 1,4-benzoquinone (65 mg, 0.6 mmol, 3.0 equiv). Column
chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate) aﬀorded
the desired product as a colorless oil, (32 mg, 67%). 1H NMR (600
MHz, CDCl3) δ 7.18 (t, J = 8.4 Hz, 1H), 6.99 (d, J = 16.2 Hz, 1H),
6.71−6.76 (m, 1H), 6.56 (d, J = 8.4 Hz, 2H), 4.75 (dd, J = 6.6 Hz, 0.6
Hz, 2H), 3.86 (s, 6H), 2.11 (s, 3H); 13C{1H} NMR (150 MHz,
CDCl3) δ 171.0, 158.6, 128.6, 126.8, 125.0, 113.3, 103.8, 67.1, 55.7,
21.1; IR (neat) υmax 2938, 1737, 1587, 1472, 1247, 772 cm
−1; HRMS
(ESI, m/z) calcd. for C13H16O4Na [M + Na]
+ 259.0946, found
259.0923.
3-(2,6-Dimethoxyphenyl)-1-phenylpropan-1-one, 3w, Scheme
2.6b The same general procedure was followed by using 2,6-
dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 1-phenyl-
prop-2-en-1-ol (40 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone
(43 mg, 0.4 mmol, 2.0 equiv) except the reaction was run for 48 h.
Column chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (20.5 mg, 38%), mp 88−
90 °C. 1H NMR (600 MHz, CDCl3) δ 8.02 (dd, J = 8.4 Hz, 1.2 Hz,
2H), 7.54−7.57 (m, 1H), 7.45−7.47 (m, 2H), 7.18 (t, J = 8.4 Hz, 1H),
6.57 (d, J = 8.4 Hz, 2H), 3.81 (s, 6H), 3.14−3.17 (m, 2H), 3.08−3.11
(m, 2H); 13C{1H} NMR (150 MHz, CDCl3) δ 200.6, 158.2, 137.0,
132.7, 128.4, 128.2, 127.1, 117.4, 103.5, 55.6, 38.3, 18.5; IR (neat) υmax
2937, 1682, 1593, 1471, 1254, 1107, 778, 693 cm−1; HRMS (ESI, m/
z) calcd. for C17H18O3Na [M + Na]
+ 293.1154, found 293.1130.
Diethyl 2-(2,6-dimethoxycinnamyl)malonate, 3x, Scheme 2.8
The same general procedure was followed by using 2,6-dimethox-
ybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), diethyl 2-allylmalonate
(60 μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (13.4 mg,
0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.6 mmol, 3.0
equiv). Column chromatography (SiO2, eluting with 9:1 hexane/ethyl
acetate) aﬀorded the desired product as a colorless oil, (44 mg, 65%).
1H NMR (600 MHz, CDCl3) δ 7.12 (t, J = 8.4 Hz, 1H), 6.74 (t, J =
16.2 Hz, 1H), 6.51−6.58 (m, 3H), 4.19−4.26 (m, 4H), 3.82 (s, 6H),
3.51 (t, J = 7.8 Hz, 1H), 2.83 (td, J = 7.8 Hz, 1.2 Hz, 2H), 1.28 (t, J =
6.6 Hz, 6H); 13C{1H} NMR (150 MHz, CDCl3) δ 169.1, 158.2, 129.7,
127.7, 123.0, 114.4, 103.9, 61.3, 55.6, 52.5, 34.0, 14.0; IR (neat) υmax
2981, 1732, 1585, 1472, 1251, 1113, 772 cm−1; HRMS (ESI, m/z)
calcd. for C18H24O6Na [M + Na]
+ 359.1471, found 359.1468.
(E)-4-Methoxybenzyl 5-(2,6-dimethoxyphenyl)pent-4-enoate, 3y,
Scheme 2. The same general procedure was followed by using 2,6-
dimethoxybenzoic acid (36.5 mg, 0.2 mmol, 1.0 equiv), 4-
methoxybenzyl pent-4-enoate (66 mg, 0.3 mmol, 1.5 equiv),
palladium(II) triﬂuoroacetate (13.4 mg, 0.04 mmol, 0.1 equiv), and
1,4-benzoquinone (65 mg, 0.6 mmol, 3.0 equiv). Column chromatog-
raphy (SiO2, eluting with 8:2 hexane/ethyl acetate) aﬀorded the
desired product as colorless oil, (28.5 mg, 40%). 1H NMR (600 MHz,
CDCl3) δ 7.31 (d, J = 8.4 Hz, 2H), 7.13 (t, J = 8.4 Hz, 1H), 6.88 (d, J
= 8.4 Hz, 2H), 6.70 (d, J = 16.2 Hz, 1H), 6.57−6.62 (m, 1H), 6.56 (d,
J = 8.4 Hz, 2H), 5.08 (s, 2H), 3.83 (s, 6H), 3.82 (s, 3H), 2.58−2.61
(m, 2H), 2.53−2.56 (m, 2H); 13C{1H} NMR (150 MHz, CDCl3) δ
173.2, 159.5, 158.2, 132.7, 130.0, 128.2, 127.5, 121.2, 114.6, 113.9,
103.9, 65.9, 55.7, 55.2, 34.5, 30.0; IR (neat) υmax 2928, 1732, 1586,
1514, 1469, 1248, 1111, 823 cm−1; HRMS (ESI, m/z) calcd. for
C21H24O5Na [M + Na]
+ 379.1521, found 379.1530.
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1-(2,6-Diethoxystyryl)benzene, 3z, Scheme 2. The same general
procedure was followed by using 2,6-diethoxybenzoic acid (42 mg, 0.2
mmol, 1.0 equiv), styrene (35 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone
(43 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2, eluting
with 95:5 hexane/ethyl acetate) aﬀorded the desired product as a
white solid, (48 mg, 90%), mp 55−57 °C. 1H NMR (300 MHz,
CDCl3) δ 7.72 (d, J = 16.5 Hz, 1H), 7.50−7.56 (m, 3H), 7.36 (t, J =
7.5 Hz, 2H), 7.21−7.26 (m, 1H), 7.13 (t, J = 8.4 Hz, 1H), 6.57 (d, J =
8.4 Hz, 2H), 4.12 (q, J = 6.9 Hz, 4H), 1.51 (t, J = 7.2 Hz, 6H);
13C{1H} NMR (75 MHz, CDCl3) δ 158.1, 139.5, 132.1, 128.4, 128.0,
126.8, 126.3, 120.2, 114.8, 104.9, 64.2, 14.9; IR (neat) υmax 2978, 1582,
1458, 1247, 1116, 1083, 748 cm−1; HRMS (ESI, m/z) calcd. for
C18H20O2Na [M + Na]
+ 291.1361, found 291.1352.
1-((3-(Benzyloxy)-2-styrylphenoxy)methyl)benzene, 3aa, Scheme
2. The same general procedure was followed by using 2,6-
dibenzyloxybenzoic acid (67 mg, 0.2 mmol, 1.0 equiv), styrene (35
μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02
mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0
equiv). Column chromatography (SiO2, eluting with 95:5 hexane/
ethyl acetate) aﬀorded the desired product as a white solid, (59 mg,
75%), mp 88−90 °C. 1H NMR (600 MHz, CDCl3) δ 7.70 (d, J = 16.8
Hz, 1H), 7.62 (d, J = 16.8 Hz, 1H), 7.51 (d, J = 7.8 Hz, 4H), 7.41−
7.43 (m, 6H), 7.36 (t, J = 7.8 Hz, 2H), 7.32 (t, J = 7.8 Hz, 2H), 7.21 (t,
J = 7.2 Hz, 1H), 7.14 (t, J = 7.8 Hz, 1H), 6.68 (d, J = 8.4 Hz, 2H), 5.19
(s, 4H); 13C{1H} NMR (150 MHz, CDCl3) δ 157.8, 139.2, 137.1,
132.7, 128.5, 128.4, 127.9, 127.8, 127.2, 126.9, 126.3, 119.7, 115.8,
105.9, 70.8; IR (neat) υmax 2926, 1728, 1582, 1452, 1254, 1104, 741
cm−1; HRMS (ESI, m/z) calcd. for C28H24O2Na [M + Na]
+ 415.1674,
found 415.1674.
1,3,5-Trimethoxy-2-styrylbenzene, 3ab, Scheme 2.25 The same
general procedure was followed by using 2,4,6-trimethoxybenzoic acid
(42.5 mg, 0.2 mmol, 1.0 equiv), styrene (35 μL, 0.3 mmol, 1.5 equiv),
palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-
benzoquinone (43 mg, 0.4 mmol, 2.0 equiv). Column chromatography
(SiO2, eluting with 9:1 hexane/ethyl acetate) aﬀorded the desired
product as a colorless oil, (50 mg, 93%). 1H NMR (600 MHz, CDCl3)
δ 7.55 (d, J = 7.8 Hz, 2H), 7.50 (d, J = 16.2 Hz, 1H), 7.44 (d, J = 16.2
Hz, 1H), 7.36 (t, J = 7.8 Hz, 2H), 7.22 (t, J = 7.2 Hz, 1H), 6.20 (s,
2H), 3.91 (s, 6H), 3.86 (s, 3H); 13C{1H} NMR (150 MHz, CDCl3) δ
160.2, 159.5, 139.7, 129.9, 128.4, 126.5, 126.1, 119.8, 108.1, 90.8, 55.8,
55.3; IR (neat) υmax 2938, 1597, 1461, 1328, 1210, 1119, 813 cm
−1;
HRMS (ESI, m/z) calcd. for C17H18O3Na [M + Na]
+ 293.1154, found
293.1140.
2-(4-Phenylstyryl)-1,3,5-trimethoxybenzene, 3ac, Scheme 2. The
same general procedure was followed by using 2,4,6-trimethoxyben-
zoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), 4-vinylbiphenyl (54 mg, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 9:1 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (57 mg, 82%), mp 150−
152 °C. 1H NMR (600 MHz, CDCl3) δ 7.64−7.66 (m, 2H), 7.59−
7.62 (m, 4H), 7.53 (d, J = 16.8 Hz, 1H), 7.45−7.49 (m, 3H), 7.35 (t, J
= 7.2 Hz, 1H), 6.21 (s, 2H), 3.92 (s, 6H), 3.87 (s, 3H); 13C{1H} NMR
(150 MHz, CDCl3) δ 160.3, 159.6, 141.0, 139.1, 138.8, 129.3, 128.7,
127.1, 127.0, 126.8, 126.6, 120.0, 108.2, 90.8, 55.8, 55.3; IR (neat) υmax
1592, 1458, 1326, 1218, 1153, 1119, 766 cm−1; HRMS (ESI, m/z)
calcd. for C23H22O3Na [M + Na]
+ 369.1467, found 369.1467.
2-(2-Methylstyryl)-1,3,5-trimethoxybenzene, 3ad, Scheme 2.26
The same general procedure was followed by using 2,4,6-
trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), 2-
methylstyrene (39 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone
(43 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2, eluting
with 9:1 hexane/ethyl acetate) aﬀorded the desired product as a white
solid, (51 mg, 90%), mp 86−88 °C. 1H NMR (300 MHz, CDCl3) δ
7.62−7.69 (m, 2H), 7.24 (d, J = 16.5 Hz, 1H), 7.08−7.19 (m, 3H),
6.17 (s, 2H), 3.87 (s, 6H), 3.84 (s, 3H), 2.39 (s, 3H); 13C{1H} NMR
(150 MHz, CDCl3) δ 160.2, 159.4, 138.7, 135.3, 130.1, 128.0, 126.5,
126.0, 124.9, 120.8, 108.6, 90.8, 55.8, 55.3, 20.0; IR (neat) υmax 2936,
1586, 1460, 1198, 1118, 809 cm−1; HRMS (ESI, m/z) calcd. for
C18H20O3Na [M + Na]
+ 307.1310, found 307.1308.
2-(3-Chlorostyryl)-1,3,5-trimethoxybenzene, 3ae, Scheme 2.26
The same general procedure was followed by using 2,4,6-
trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), 3-
chlorostyrene (38 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone
(43 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2, eluting
with 9:1 hexane/ethyl acetate) aﬀorded the desired product as a white
solid, (55 mg, 91%), mp 80−82 °C. 1H NMR (600 MHz, CDCl3) δ
7.51 (t, J = 1.8 Hz, 1H), 7.42 (d, J = 1.8 Hz, 2H), 7.38 (d, J = 7.8 Hz,
1H), 7.25 (t, J = 7.8 Hz, 1H), 7.15−7.17 (m, 1H), 6.19 (s, 2H), 3.90
(s, 6H), 3.86 (s, 3H); 13C{1H} NMR (150 MHz, CDCl3) δ 160.5,
159.6, 141.7, 134.3, 129.5, 128.2, 126.2, 125.9, 124.3, 121.2, 107.6,
90.7, 55.7, 55.3; IR (neat) υmax 2961, 1586, 1462, 1326, 1220, 1117,
962, 796 cm−1; HRMS (ESI, m/z) calcd. for C17H17ClO3Na [M +
Na]+ 327.0764, found 327.0783.
4-(2,4,6-Trimethoxystyryl)-2-methoxyphenyl acetate, 3af,
Scheme 2. The same general procedure was followed by using
2,4,6-trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), 4-
acetoxy-3-methoxystyrene (57 mg, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and 1,4-benzoquinone
(43 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2, eluting
with 8:2 hexane/ethyl acetate) aﬀorded the desired product as a white
solid, (61 mg, 85%), mp 105−107 °C. 1H NMR (600 MHz, CDCl3) δ
7.43 (d, J = 16.8 Hz, 1H), 7.33 (d, J = 16.2 Hz, 1H), 7.10−7.11 (m,
2H), 7.00 (d, J = 8.4 Hz, 1H), 6.19 (s, 2H), 3.898 (s, 3H), 3.896 (s,
6H), 3.86 (s, 3H), 2.33 (s, 3H); 13C{1H} NMR (150 MHz, CDCl3) δ
169.2, 160.3, 159.5, 150.9, 138.9, 138.4, 129.3, 122.6, 120.2, 118.6,
110.0, 107.9, 90.8, 55.9, 55.8, 55.3, 20.7; IR (neat) υmax 2933, 1761,
1598, 1460, 1118, 817 cm−1; HRMS (ESI, m/z) calcd. for
C20H22O6Na [M + Na]
+ 381.1314, found 381.1336.
(E)-Butyl 3-(2,4,6-trimethoxyphenyl)acrylate, 3ag, Scheme 2.27
The same general procedure was followed by using 2,4,6-
trimethoxybenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), butyl acrylate
(43 μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg,
0.02 mmol, 0.1 equiv), and 1,4-benzoquinone (43 mg, 0.4 mmol, 2.0
equiv). Column chromatography (SiO2, eluting with 8:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (41 mg, 70%),
mp 79−81 °C. 1H NMR (300 MHz, CDCl3) δ 8.09 (d, J = 16.2 Hz,
1H), 6.75 (d, J = 16.2 Hz, 1H), 6.11 (s, 2H), 4.19 (t, J = 6.6 Hz, 2H),
3.87 (s, 6H), 3.84 (s, 3H), 1.64−1.73 (m, 2H), 1.37−1.50 (m, 2H),
0.96 (t, J = 7.5 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 169.1,
162.6, 161.1, 135.4, 117.4, 105.7, 90.3, 63.8, 55.6, 55.3, 30.9, 19.2, 13.8;
IR (neat) υmax 2939, 1699, 1602, 1461, 1156, 1119, 815 cm
−1; HRMS
(ESI, m/z) calcd. for C16H22O5Na [M + Na]
+ 317.1365, found
317.1360.
Diethyl 2-(2,4,6-trimethoxycinnamyl)malonate, 3ah, Scheme 2.
The same general procedure was followed by using 2,4,6-
trimethoxybenzoic acid (42.5 mg, 0.2 mmol), diethyl 2-allylmalonate
(60 μL, 0.3 mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (13.4 mg,
0.04 mmol, 0.1 equiv), and 1,4-benzoquinone (65 mg, 0.6 mmol, 3.0
equiv). Column chromatography (SiO2, eluting with 8:2 hexane/ethyl
acetate) aﬀorded the desired product as a colorless oil, (45 mg, 62%).
1H NMR (600 MHz, CDCl3) δ 6.66 (d, J = 16.2 Hz, 1H), 6.38−6.43
(m, 1H), 6.12 (s, 2H), 4.18−4.23 (m, 4H), 3.81 (s, 3H), 3.80 (s, 6H),
3.48 (t, J = 7.8 Hz, 1H), 2.80 (t, J = 7.8 Hz, 2H), 1.27 (t, J = 7.2 Hz,
6H); 13C{1H} NMR (150 MHz, CDCl3) δ 169.2, 159.8, 159.0, 127.2,
122.8, 107.7, 90.6, 61.2, 55.6, 55.2, 52.6, 34.0, 14.0; IR (neat) υmax
2939, 1729, 1604, 1462, 1124, 1036, 814 cm−1; HRMS (ESI, m/z)
calcd. for C19H26O7Na [M + Na]
+ 389.1576, found 389.1563.
General Experimental Procedure for the Decarboxylative
Heck Reaction between Electron-Deﬁcient Carboxylic Acids
and Vinyl Arenes. To an oven-dried 15 mL sealed tube, a mixture of
pentaﬂuorobenzoic acid (0.20−0.24 mmol, 1.0−1.2 equiv), palladium-
(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver
carbonate (110 mg, 0.4 mmol, 2.0 equiv) was taken then dry DMF
(3.0 mL) was added to it. After purging with nitrogen, the
corresponding styrenes (0.20−0.30 mmol, 1.0−1.5 equiv) were
added via microliter syringe and the vessel was sealed with a screw
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cap. The reaction mixture was allowed to stir for 16 h at room
temperature. After completion (as detected by TLC), the reaction
mixture was poured into water (20 mL) and extracted with ethyl
acetate (30 mL). The organic layer was washed with water (10 mL ×
2) and brine (10 mL), dried over anhydrous Na2SO4 and the solvent
was evaporated under reduced pressure. The crude product was
puriﬁed by column chromatography using ethyl acetate/hexane as
eluent to aﬀord the desired product.
1,2,3,4,5-Pentaﬂuoro-6-styrylbenzene, 6a, Scheme 3.19 The same
general procedure was followed by using pentaﬂuorobenzoic acid
(42.5 mg, 0.2 mmol, 1.0 equiv), styrene (35 μL, 0.3 mmol, 1.5 equiv),
palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and
silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (36 mg, 66%), mp
132−134 °C. 1H NMR (300 MHz, CDCl3) δ 7.53 (d, J = 7.5 Hz, 2H),
7.31−7.47 (m, 4H), 6.98 (d, J = 16.8 Hz, 1H); 13C{1H} NMR (150
MHz, CDCl3) δ 144.8 (dm, J = 248.8 Hz), 139.7 (dm, J = 252.8 Hz),
137.7 (dm, J = 248.2 Hz), 137.1 (td, J = 8.2 Hz, 2.6 Hz), 136.4, 128.9,
128.8, 126.8 112.6 (d, J = 2.4 Hz), 112.4 (td, J = 13.6 Hz, 4.2 Hz); 19F
NMR (470 MHz, CDCl3) δ −146.0 (dd, J = 21.6 Hz, 7.0 Hz, 2F),
−159.8 (t, J = 20.7 Hz, 1F), −166.2 (td, J = 20.7 Hz, 7.0 Hz, 2F); IR
(neat) υmax 1523, 1493, 1000, 959, 754 cm
−1; HRMS (EI, m/z) calcd.
for C14H7F5 [M]
+ 270.0468, found 270.0448.
1-(4-Fluorostyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6b, Scheme 3.19
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 4-ﬂuorostyrene (36 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (36 mg, 62%), mp
110−112 °C. 1H NMR (600 MHz, CDCl3) δ 7.51 (dd, J = 8.4 Hz, 5.4
Hz, 2H), 7.39 (d, J = 16.8 Hz, 1H), 7.09 (t, J = 8.4 Hz, 2H), 6.89 (d, J
= 16.8 Hz, 1H); 13C{1H} NMR (150 MHz, CDCl3) δ 163.1 (d, J =
248.0 Hz), 144.8 (dm, J = 249.0 Hz), 139.7 (dm, J = 253.5 Hz), 137.7
(dm, J = 249.0 Hz), 135.9 (td, J = 9.0 Hz, 1.5 Hz), 132.6 (d, J = 3.0
Hz), 128.5 (d, J = 7.5 Hz), 115.9 (d, J = 22.5 Hz), 112.4, 112.2 (td, J =
13.5 Hz, 4.5 Hz); 19F NMR (470 MHz, CDCl3) δ −115.2 (s, 1F),
−146.1 (dd, J = 21.2 Hz, 7.5 Hz, 2F), −159.6 (t, J = 20.7 Hz, 1F),
−166.1 (td, J = 21.2 Hz, 7.5 Hz, 2F); IR (neat) υmax 1519, 1492, 1240,
1003, 958 cm−1; HRMS (EI, m/z) calcd. for C14H6F6 [M]
+ 288.0374,
found 288.0365.
1-(4-Chlorostyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6c, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 4-chlorostyrene (38 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (44 mg,
73%), mp 98−100 °C. 1H NMR (600 MHz, CDCl3) δ 7.47 (d, J = 8.4
Hz, 2H), 7.37−7.41 (m, 3H), 6.96 (d, J = 16.8 Hz, 1H); 13C{1H}
NMR (150 MHz, CDCl3) δ 144.8 (dm, J = 249.2 Hz), 139.8 (dm, J =
253.5 Hz), 137.8 (dm, J = 249.2 Hz), 135.7 (td, J = 9.0 Hz, 3.0 Hz),
134.9, 134.7, 129.0, 128.0, 113.2 (d, J = 1.5 Hz), 112.0 (td, J = 13.5 Hz,
4.5 Hz); 19F NMR (470 MHz, CDCl3) δ −142.6 (dd, J = 22.1 Hz, 7.0
Hz, 2F), −156.0 (t, J = 20.7 Hz, 1F), −162.8 (td, J = 20.7 Hz, 6.6 Hz,
2F) ; IR (neat) υmax 1520, 1490, 1004, 958, 811 cm
−1; HRMS (EI, m/
z) calcd. for C14H6ClF5 [M]
+ 304.0078, found 304.0061.
1-(4-Bromostyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6d, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 4-bromostyrene (39 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (47 mg,
67%), mp 99−101 °C. 1H NMR (CDCl3, 300 MHz) δ 7.52 (d, J = 8.1
Hz, 2H), 7.34−7.41 (m, 3H), 6.97 (d, J = 16.8 Hz, 1H); 13C{1H}
NMR (CDCl3, 75 MHz) δ 144.7 (dm, J = 248.9 Hz), 139.8 (dm, J =
252.8 Hz), 137.7 (dm, J = 249.8 Hz), 135.8 (td, J = 9.0 Hz, 1.5 Hz),
135.3, 132.0, 128.2, 122.9, 113.3 (d, J = 3.0 Hz), 112.0 (td, J = 13.5 Hz,
4.5 Hz); 19F NMR (470 MHz, CDCl3) δ −142.6 (dd, J = 21.2 Hz, 6.6
Hz, 2F), −155.9 (t, J = 21.6 Hz, 1F), −162.7 (td, J = 21.6 Hz, 7.0 Hz,
2F); IR (neat) υmax 1519, 1492, 1002, 961, 810 cm
−1; HRMS (EI, m/
z) calcd. for C14H6BrF5 [M]
+ 347.9573, 349.9553, found 347.9570,
349.9529.
1-(4-Methylstyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6e, Scheme
3.13a The same general procedure was followed by using
pentaﬂuorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), 4-
methylstyrene (40 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver carbonate
(110 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2,
eluting with 97:3 hexane/ethyl acetate) aﬀorded the desired product as
a white solid, (41 mg, 73%), mp 142−144 °C. 1H NMR (300 MHz,
CDCl3) δ 7.38−7.44 (m, 3H), 7.20 (d, J = 8.1 Hz, 2H), 6.93 (d, J =
16.8 Hz, 1H), 2.38 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 144.7
(dm, J = 248.3 Hz), 139.5 (dm, J = 252.8 Hz), 139.1, 137.7 (dm, J =
250.5 Hz), 137.1 (td, J = 8.2 Hz, 2.2 Hz), 133.7, 129.5, 126.8, 112.6
(td, J = 13.5 Hz, 4.5 Hz), 111.6 (d, J = 2.2 Hz), 21.3; 19F NMR (470
MHz, CDCl3) −143.0 (dd, J = 22.6 Hz, 6.1 Hz, 2F), −157.1 (t, J =
20.7 Hz, 1F), −163.2 (td, J = 20.7 Hz, 6.1 Hz, 2F); IR (neat) υmax
2924, 1519, 1492, 1001, 958, 804 cm−1; HRMS (EI, m/z) calcd. for
C15H9F5 [M]
+ 284.0624, found 284.0615.
1-(4-Ethylstyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6f, Scheme 3. The
same general procedure was followed by using pentaﬂuorobenzoic acid
(42.5 mg, 0.2 mmol, 1.0 equiv), 4-ethylstyrene (44 μL, 0.3 mmol, 1.5
equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv),
and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (33 mg, 56%), mp
134−136 °C. 1H NMR (300 MHz, CDCl3) δ 7.39−7.47 (m, 3H), 7.32
(d, J = 8.1 Hz, 2H), 6.94 (d, J = 16.5 Hz, 1H), 2.67 (q, J = 7.5 Hz,
2H), 1.26 (t, J = 7.5 Hz, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ
144.7 (dm, J = 248.4 Hz), 145.5, 139.5 (dm, J = 252.0 Hz), 137.8 (dm,
J = 249.2 Hz), 137.1 (t, J = 8.2 Hz), 134.0, 128.4, 126.9, 112.6 (td, J =
13.5 Hz, 3.8 Hz), 111.7 (d, J = 1.5 Hz), 28.7, 15.4; 19F NMR (470
MHz, CDCl3) δ −143.0 (dd, J = 20.2 Hz, 5.2 Hz, 2F), −157.1 (t, J =
20.7 Hz, 1F), −163.2 (td, J = 20.7 Hz, 5.6 Hz, 2F); IR (neat) υmax
2925, 1522, 1491, 1001, 959, 819 cm−1; HRMS (EI, m/z) calcd. for
C16H11F5 [M]
+ 298.0781, found 298.0784.
1-(4-tert-Butylstyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6g, Scheme
3. The same general procedure was followed by using pentaﬂuor-
obenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 4-tert-butylstyrene (37
μL, 0.2 mmol, 1.0 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02
mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (46 mg,
70%), mp 100−102 °C. 1H NMR (300 MHz, CDCl3) δ 7.35−7.49
(m, 5H), 6.94 (d, J = 16.8 Hz, 1H), 1.34 (s, 9H); 13C{1H} NMR (75
MHz, CDCl3) δ 152.4, 144.7 (dm, J = 248.2 Hz), 139.5 (dm, J = 252.0
Hz), 137.8 (dm, J = 249.0 Hz), 137.0 (t, J = 8.2 Hz), 133.7, 126.6,
125.8, 122.6 (td, J = 13.5 Hz, 3.8 Hz), 111.8, 34.8, 31.2; 19F NMR
(470 MHz, CDCl3) −142.9 (dd, J = 21.6 Hz, 6.6 Hz, 2F), −157.0 (t, J
= 20.7 Hz, 1F), −163.2 (td, J = 21.2 Hz, 6.6 Hz, 2F); IR (neat) υmax
2971, 1520, 1498, 1003, 960, 822 cm−1; HRMS (EI, m/z) calcd. for
C18H15F5 [M]
+ 326.1094, found 326.1081.
1-(4-Methoxystyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6h, Scheme
3.19 The same general procedure was followed by using penta-
ﬂuorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 4-vinylanisole (27
μL, 0.2 mmol, 1.0 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02
mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 97:3 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (43 mg,
72%), mp 128−130 °C. 1H NMR (600 MHz, CDCl3) δ 7.47 (d, J =
9.0 Hz, 2H), 7.38 (d, J = 16.8 Hz, 1H), 6.92 (d, J = 9.0, 2H), 6.83 (d, J
= 16.8 Hz, 1H), 3.85 (s, 3H); 13C{1H} NMR (150 MHz, CDCl3) δ
160.3, 144.6 (dm, J = 247.5 Hz), 139.3 (dm, J = 252.0 Hz), 137.8 (dm,
J = 247.5 Hz), 136.6 (td, J = 9.0 Hz, 1.5 Hz), 129.2, 128.2, 114.2, 112.7
(td, J = 13.5 Hz, 4.5 Hz), 110.3 (d, J = 3.0 Hz), 55.3; 19F NMR (470
MHz, CDCl3) δ −143.2 (dd, J = 21.2 Hz, 5.2 Hz, 2F), −157.5 (t, J =
20.7 Hz, 1F), −163.3 (td, J = 20.7 Hz, 5.6 Hz, 2F); IR (neat) υmax
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2926, 1603, 1519, 1492, 1255, 1001, 956, 816 cm−1; HRMS (EI, m/z)
calcd. for C15H9OF5 [M]
+ 300.0574, found 300.0561.
4-(Perﬂuorostyryl)phenyl acetate, 6i, Scheme 3. The same general
procedure was followed by using pentaﬂuorobenzoic acid (51 mg, 0.24
mmol, 1.2 equiv), 4-acetoxystyrene (30 μL, 0.2 mmol, 1.0 equiv),
palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and
silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). In this case little bit
unreacted styrene was there with the same polarity desired products.
To purify the desired products high pressure vacuum pump was used
to remove the unreacted styrene. Column chromatography (SiO2,
eluting with 97:3 hexane/ethyl acetate) aﬀorded the desired product as
a white solid, (38 mg, 58%), mp 130−132 °C. 1H NMR (600 MHz,
CDCl3) δ 7.54 (d, J = 8.4 Hz, 2H), 7.41, (d, J = 16.8 Hz, 1H), 7.13 (d,
J = 8.4 Hz, 2H), 6.93 (d, J = 16.8 Hz, 1H), 2.3 (s, 3H); 13C{1H} NMR
(150 MHz, CDCl3) δ 169.3, 151.0, 144.8 (dm, J = 249.0 Hz), 139.7
(dm, J = 252.0 Hz), 137.7 (dm, J = 250.5 Hz), 136.0 (td, J = 9.0 Hz,
3.0 Hz), 134.2, 127.9, 122.0, 112.8 (d, J = 1.5 Hz), 112.2 (td, J = 13.5
Hz, 3.0 Hz), 21.1; 19F NMR (470 MHz, CDCl3) δ −142.7 (dd, J =
21.6 Hz, 6.1 Hz, 2F), −156.4 (t, J = 20.7 Hz, 1F), −162.9 (td, J = 20.2
Hz, 5.6 Hz, 2F); IR (neat) υmax 2925, 1761, 1518, 1497, 1197, 1007,
957 cm−1; HRMS (EI, m/z) calcd. for C16H9O2F5 [M]
+ 328.0523,
found 328.0525.
(4-(Perﬂuorostyryl)phenoxy)(tert-butyl)dimethylsilane, 6j,
Scheme 3. The same general procedure was followed by using
pentaﬂuorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 4-(tert-
butyldimethylsiloxy)styrene (47 μL, 0.2 mmol, 1.0 equiv), palladium-
(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver
carbonate (110 mg, 0.4 mmol, 2.0 equiv). Here little bit unreacted
styrene was there with the same polarity desired products. To purify
the desired products high pressure vacuum pump was used to remove
the unreacted styrene. Column chromatography (SiO2, eluting with
97:3 hexane/ethyl acetate) aﬀorded the desired product as a white
solid, (54 mg, 68%), mp 116−118 °C. 1H NMR (600 MHz, CDCl3) δ
7.42 (d, J = 8.4 Hz, 2H), 7.37 (d, J = 16.8 Hz, 1H), 6.86 (d, J = 9.0 Hz,
2H), 6.84 (d, J = 16.8 Hz, 1H), 1.01 (s, 9H), 0.24 (s, 6H); 13C{1H}
NMR (150 MHz, CDCl3) δ 156.6, 144.6 (dm, J = 248.1 Hz), 139.3
(dm, J = 252.0 Hz), 137.7 (dm, J = 248.7 Hz), 136.8 (td, J = 9.0 Hz,
1.5 Hz), 129.8, 128.2, 120.5, 112.7 (td, J = 13.5 Hz, 4.5 Hz), 110.5 (d,
J = 1.5 Hz), 25.6, 18.2, −4.4; 19F NMR (470 MHz, CDCl3) δ −143.2
(dd, J = 22.6 Hz, 6.1 Hz, 2F), −157.5 (t, J = 20.7 Hz, 1F), −163.3 (td,
J = 20.7 Hz, 6.6 Hz, 2F); IR (neat) υmax 2858, 1600, 1521, 1492, 1276,
1003, 960, 916 cm−1; HRMS (EI, m/z) calcd. for C20H21OSiF5 [M]
+
400.1282, found 400.1278.
1-(3-Fluorostyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6k, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 3-ﬂuorostyrene (36 μL, 0.3 mmol,
1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 98:2 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (35 mg, 61%), mp
82−84 °C. 1H NMR (600 MHz, CDCl3) δ 7.39 (d, J = 16.2 Hz, 1H),
7.34−7.37 (m, 1H), 7.29 (d, J = 7.8 Hz, 1H), 7.22−7.24 (m, 1H), 7.04
(td, J = 8.4 Hz, 1.8 Hz, 1H), 6.98 (d, J = 16.8 Hz, 1H); 13C{1H} NMR
(150 MHz, CDCl3) δ 163.1 (d, J = 246.0 Hz), 144.8 (dm, J = 249.0
Hz), 139.9 (dm, J = 253.5 Hz), 138.7 (d, J = 7.5 Hz), 137.8 (dm, J =
247.5 Hz), 135.8 (t, J = 7.5 Hz), 130.3 (d, J = 9.0 Hz), 122.8 (d, J = 3.0
Hz), 115.8 (d, J = 21.0 Hz), 114.0 (d, J = 3.0 Hz), 113.2 (d, J = 22.5
Hz), 111.9 (td, J = 13.5 Hz, 3.0 Hz); 19F NMR (470 MHz, CDCl3) δ
−112.8 (s, 1F), −142.4 (dd, J = 20.7 Hz, 5.2 Hz, 2F), −155.7 (t, J =
20.7 Hz, 1F), −162.7 (m, 2F); IR (neat) υmax 1521, 1494, 1004, 955,
680 cm−1; HRMS (EI, m/z) calcd. for C14H6F6 [M]
+ 288.0374, found
288.0365.
1-(3-Chlorostyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6l, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 3-chlorostyrene (38 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (43 mg,
71%), mp 74−76 °C. 1H NMR (300 MHz, CDCl3) δ 7.51 (s, 1H),
7.31−7.42 (m, 4H), 6.98 (d, J = 16.8 Hz, 1H); 13C{1H} NMR (75
MHz, CDCl3) δ 144.9 (dm, J = 246.8 Hz), 140.0 (dm, J = 256.5 Hz),
138.3, 137.8 (dm, J = 251.2 Hz), 135.6 (t, J = 8.2 Hz), 134.9, 130.0,
128.8, 126.7, 125.1, 114.1, 111.9 (td, J = 13.5 Hz, 4.5 Hz); 19F NMR
(470 MHz, CDCl3) δ −142.4 (dd, J = 21.2 Hz, 5.6 Hz, 2F), −155.6 (t,
J = 20.7 Hz, 1F), 162.6 (td, J = 21.6 Hz, 7.0 Hz, 2F); IR (neat) υmax
1519, 1497, 1003, 964, 782 cm−1; HRMS (EI, m/z) calcd. for
C14H6ClF5 [M]
+ 304.0078, found 304.0075.
1-(3-Bromostyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6m, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 3-bromostyrene (39 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Here
little bit unreacted styrene was there with the same polarity desired
products. To purify the desired products high pressure vacuum pump
was used to remove the unreacted styrene. Column chromatography
(SiO2, eluting with 98:2 hexane/ethyl acetate) aﬀorded the desired
product as a white solid, (42 mg, 60%), mp 76−78 °C. 1H NMR (300
MHz, CDCl3) δ 7.67−7.68 (m, 1H), 7.43−7.48 (m, 2H), 7.36 (d, J =
16.8 Hz, 1H), 7.24−7.29 (m, 1H), 6.97 (d, J = 16.8 Hz, 1H);
13C{1H}NMR (75 MHz, CDCl3) δ 144.9 (dm, J = 249.4 Hz), 140.0
(dm, J = 253.6 Hz), 138.6, 137.8 (dm, J = 250.5 Hz), 135.5 (t, J = 8.2
Hz), 131.8, 130.3, 129.6, 125.5, 123.0, 114.1, 111.9 (td, J = 13.5 Hz,
3.8 Hz); 19F NMR (470 MHz, CDCl3) δ −145.6 (dd, J = 20.7 Hz, 7.0
Hz, 2F), −158.8 (t, J = 20.7 Hz, 1F), −165.9 (td, J = 20.7 Hz, 7.0 Hz,
2F); IR (neat) υmax 1521, 1496, 1002, 964, 780 cm
−1; HRMS (EI, m/
z) calcd. for C14H6BrF5 [M]
+ 347.9573, 349.9553, found 347.9573,
349.9541.
1-(3-Methylstyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6n, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 3-methylstyrene (32 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (37 mg,
65%), mp 104−106 °C. 1H NMR (600 MHz CDCl3) δ 7.40 (d, J =
16.8 Hz, 1H), 7.33−7.34 (m, 2H), 7.29 (t, J = 7.2 Hz, 1H), 7.16 (d, J =
7.2 Hz, 1H), 6.97 (d, J = 16.8 Hz, 1H), 2.40 (s, 3H); 13C{1H} NMR
(150 MHz, CDCl3) δ 144.8 (dm, J = 249.0 Hz), 139.6 (dm, J = 253.5
Hz), 138.5, 137.7 (dm, J = 249.0 Hz), 137.3 (td, J = 9.0 Hz, 3.0 Hz),
136.4, 129.8, 128.7, 127.5, 124.0, 112.43 (td, J = 13.5 Hz, 3.0 Hz),
112.40 (d, J = 3.0 Hz), 21.4; 19F NMR (470 MHz, CDCl3) δ −142.8
(dd, J = 21.6 Hz, 7.0 Hz, 2F), −156.8 (t, J = 20.7 Hz, 1F), −163.1 (m,
2F); IR (neat) υmax 2924, 1521, 1493, 1000, 962, 783 cm
−1; HRMS
(EI, m/z) calcd. for C15H9F5 [M]
+ 284.0624, found 284.0598.
1-(3-Methoxystyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6o, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (51 mg, 0.24 mmol, 1.2 equiv), 3-vinylanisole (28 μL, 0.2 mmol,
1.0 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1
equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv). Column
chromatography (SiO2, eluting with 97:3 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (45 mg, 75%), mp
140−142 °C. 1H NMR (600 MHz, CDCl3) δ 7.40 (d, J = 16.8 Hz,
1H), 7.31 (t, J = 7.8 Hz, 1H), 7.13 (d, J = 7.8 Hz, 1H), 7.05 (d, J = 1.8
Hz, 1H), 6.97 (d, J = 16.8 Hz, 1H), 6.90 (dd, J = 7.8 Hz, 1.8 Hz, 1H),
3.86 (s, 3H); 13C{1H} NMR (150 MHz, CDCl3) δ 159.9, 144.8 (dm, J
= 249.0 Hz), 139.7 (dm, J = 252.0 Hz), 137.8, 137.7 (dm, J = 247.5
Hz), 137.0 (td, J = 9.0 Hz, 3.0 Hz), 129.8, 119.5, 114.6, 113.0 (d, J =
3.0 Hz), 112.3 (td, J = 13.5 Hz, 3.0 Hz), 112.1, 55.3; 19F NMR (470
MHz, CDCl3) δ −142.7 (dd, J = 22.1 Hz, 6.1 Hz, 2F), −156.5 (t, J =
20.7 Hz, 1F), −163.0 (td, J = 21.2 Hz, 6.1 Hz, 2F); IR (neat) υmax
1578, 1522, 1495, 1268, 1045, 1002, 965, 778 cm−1; HRMS (EI, m/z)
calcd. for C15H9OF5 [M]
+ 300.0574, found 300.0564.
1-(3-(Triﬂuoromethyl)styryl)-2,3,4,5,6-pentaﬂuorobenzene, 6p,
Scheme 3. The same general procedure was followed by using
pentaﬂuorobenzoic acid (42.5 mg, 0.2 mmol, 1.0 equiv), 3-
triﬂuoromethylstyrene (45 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver carbonate
(110 mg, 0.4 mmol, 2.0 equiv). Column chromatography (SiO2,
eluting with 98:2 hexane/ethyl acetate) aﬀorded the desired product as
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a white solid, (45 mg, 67%), mp 76−78 °C. 1H NMR (600 MHz,
CDCl3) δ 7.76 (s, 1H), 7.71 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 7.8 Hz,
1H), 7.52 (t, J = 7.8 Hz, 1H), 7.46 (d, J = 16.2 Hz, 1H), 7.05 (d, J =
16.8 Hz, 1H); 13C{1H} NMR (150 MHz, CDCl3) δ 144.9 (dm, J =
249.0 Hz), 140.1 (dm, J = 255.0 Hz), 137.2, 137.8 (dm, J = 251.7 Hz),
135.5 (td, J = 9.0 Hz, 1.5 Hz), 131.4 (q, J = 33.0 Hz), 129.8, 129.3,
123.9 (q, J = 271.5 Hz), 125.4 (q, J = 4.5 Hz), 123.6 (q, J = 3.0 Hz),
114.6 (d, J = 3.0 Hz), 111.7 (td, J = 13.5 Hz, 4.5 Hz); 19F NMR (470
MHz, CDCl3) δ −66.1 (s, 1F), −145.6 (dd, J = 21.2 Hz, 7.5 Hz, 2F),
−158.6 (t, J = 20.7 Hz, 1F), −165.8 (td, J = 21.2 Hz, 7.5 Hz, 2F); IR
(neat) υmax 2924, 1520, 1497, 1331, 1128, 1004, 961, 695 cm
−1;
HRMS (EI, m/z) calcd. for C15H6F8 [M]
+ 338.0342, found 338.0343.
1-(2-Methylstyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6q, Scheme 3.
The same general procedure was followed by using pentaﬂuorobenzoic
acid (42.5 mg, 0.2 mmol, 1.0 equiv), 2-methylstyrene (31 μL, 0.3
mmol, 1.5 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (34 mg,
60%), mp 112−114 °C. 1H NMR (300 MHz, CDCl3) δ 7.68 (d, J =
16.8 Hz, 1H), 7.57−7.61 (m, 1H), 7.19−7.28 (m, 3H), 6.86 (d, J =
16.5 Hz, 1H), 2.42 (s, 3H); 13C{1H} NMR (75 MHz, CDCl3) δ 144.8
(dm, J = 248.2 Hz), 139.7 (dm, J = 252.8 Hz), 137.8 (dm, J = 249.8
Hz), 136.4, 135.7, 135.2 (td, J = 8.2 Hz, 3.0 Hz), 130.6, 128.8, 126.4,
125.3, 113.8 (d, J = 3.0 Hz), 112.6 (td, J = 13.5 Hz, 4.5 Hz), 19.7; 19F
NMR (470 MHz, CDCl3) δ −143.0 (dd, J = 20.2 Hz, 7.5 Hz, 2F),
−156.7 (t, J = 20.7 Hz, 1F), −163.0 (td, J = 21.2 Hz, 7.0 Hz, 2F); IR
(neat) υmax 2924, 1522, 1494, 1000, 962, 754 cm
−1; HRMS (EI, m/z)
calcd. for C15H9F5 [M]
+ 284.0624, found 284.0620.
1,3-Dimethoxy-5-(perﬂuorostyryl)benzene, 6r, Scheme 3. The
same general procedure was followed by using pentaﬂuorobenzoic acid
(51 mg, 0.24 mmol, 1.2 equiv), 3,5-dimethoxystyrene (33 μL, 0.2
mmol, 1.0 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol,
0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 97:3 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (46 mg,
69%), mp 103−105 °C. 1H NMR (300 MHz, CDCl3) δ 7.36 (d, J =
16.5 Hz, 1H), 6.95 (d, J = 16.8 Hz, 1H), 6.67 (d, J = 2.1 Hz, 2H), 6.46
(t, J = 2.1 Hz, 1H), 3.84 (s, 6H); 13C{1H} NMR (75 MHz, CDCl3) δ
161.1, 144.8 (dm, J = 249.2 Hz), 139.7 (dm, J = 253.0 Hz), 137.7 (dm,
J = 249.8 Hz), 138.4, 137.1 (td, J = 8.2 Hz, 1.5 Hz), 113.1 (d, J = 2.2
Hz), 112.2 (td, J = 13.5 Hz, 4.5 Hz), 104.9, 101.1, 55.4; 19F NMR (470
MHz, CDCl3) δ −142.6 (dd, J = 20.7 Hz, 5.6 Hz, 2F), −156.4 (t, J =
20.7 Hz, 1F), −163.0 (m, 2F); IR (neat) υmax 1593, 1522, 1494, 1296,
1155, 1061, 1005 cm−1; HRMS (EI, m/z) calcd. for C16H11O2F5 [M]
+
330.0679, found 330.0678.
1-(3,4-Dimethoxystyryl)-2,3,4,5,6-pentaﬂuorobenzene, 6s,
Scheme 3. The same general procedure was followed by using
pentaﬂuorobenzoic acid (51 mg, 0.24 mmol, 1.2 equiv), 3,4-
dimethoxystyrene (30 μL, 0.2 mmol, 1.0 equiv), palladium(II)
triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv), and silver carbonate
(110 mg, 0.4 mmol, 2.0 equiv). Here little bit unreacted styrene was
there with the same polarity desired products. To purify the desired
products high pressure vacuum pump was used to remove the
unreacted styrene. Column chromatography (SiO2, eluting with 97:3
hexane/ethyl acetate) aﬀorded the desired product as a white solid,
(45 mg, 68%), mp 131−133 °C. 1H NMR (600 MHz, CDCl3) δ 7.36
(d, J = 16.2 Hz, 1H), 7.08 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.04 (d, J = 1.8
Hz, 1H), 6.87 (d, J = 7.8 Hz, 1H), 6.82 (d, J = 16.8 Hz, 1H), 3.95 (s,
3H), 3.92 (s, 3H); 13C{1H} NMR (150 MHz, CDCl3) δ 149.6, 149.2,
144.6 (dm, J = 247.5 Hz), 139.4 (dm, J = 247.5 Hz), 137.7 (dm, J =
247.5 Hz), 136.9 (td, J = 9.0 Hz, 1.5 Hz), 120.6, 112.6 (td, J = 13.5 Hz,
4.5 Hz), 111.1, 110.5 (d, J = 3.0 Hz), 108.8, 55.92, 55.90; 19F NMR
(470 MHz, CDCl3) δ −143.2 (dd, J = 20.7 Hz, 5.2 Hz, 2F), −157.3 (t,
J = 20.7 Hz, 1F), −163.2 (td, J = 20.7 Hz, 5.2 Hz, 2F); IR (neat) υmax
1520, 1494, 1262, 1022, 961 cm−1; HRMS (ESI, m/z) calcd. for
C16H11O2F5Na [M + Na]
+ 353.0577, found 353.0577.
2-Methoxy-4-(perﬂuorostyryl)phenyl acetate, 6t, Scheme 3. The
same general procedure was followed by using pentaﬂuorobenzoic acid
(51 mg, 0.24 mmol, 1.2 equiv), 4-acetoxy-3-methoxystyrene (38 μL,
0.2 mmol, 1.0 equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02
mmol, 0.1 equiv), and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv).
Column chromatography (SiO2, eluting with 97:3 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (44 mg,
62%), mp 149−151 °C. 1H NMR (600 MHz, CDCl3) δ 7.40 (d, J =
16.8 Hz, 1H), 7.12 (dd, J = 8.4 Hz, 1.8 Hz, 1H), 7.09 (s, 1H), 7.06 (d,
J = 7.8 Hz, 1H), 6.91 (d, J = 16.8 Hz, 1H), 3.90 (s, 3H), 2.53 (s, 3H);
13C{1H} NMR (150 MHz, CDCl3) δ 168.9, 151.3, 144.8 (dm, J =
249.0 Hz), 140.3, 139.7 (dm, J = 252.6 Hz), 137.7 (dm, J = 250.5 Hz),
136.4 (td, J = 9.0 Hz, 1.5 Hz), 135.4, 123.1, 119.6, 112.9 (d, J = 1.5
Hz), 112.2 (td, J = 13.5 Hz, 3.0 Hz), 110.4, 55.9, 20.6; 19F NMR (470
MHz, CDCl3) δ −142.7 (dd, J = 20.7 Hz, 5.6 Hz, 2F), −156.3 (t, J =
20.7 Hz, 1F), −162.9 (m, 2F); IR (neat) υmax 1764, 1517, 1496, 1204,
1004, 968 cm−1; HRMS (ESI, m/z) calcd. for C17H11O3F5Na [M +
Na]+ 381.0526, found 381.0534.
1,2,3,4-Tetraﬂuoro-5-styrylbenzene, 6u, Scheme 3.13a The same
general procedure was followed by using 1,2,3,4-tetraﬂuorobenzoic
acid (39 mg, 0.2 mmol, 1.0 equiv), styrene (35 μL, 0.3 mmol, 1.5
equiv), palladium(II) triﬂuoroacetate (13.4 mg, 0.04 mmol, 0.2 equiv),
and silver carbonate (165 mg, 0.6 mmol, 3.0 equiv). 5% DMSO was
used as a co solvent and the reaction was run for 4 h at 120 °C.
Column chromatography (SiO2, eluting with 98:2 hexane/ethyl
acetate) aﬀorded the desired product as a white solid, (30 mg,
60%), mp 86−88 °C. 1H NMR (600 MHz, CDCl3) δ 7.52 (d, J = 7.8
Hz, 2H), 7.39 (t, J = 7.8 Hz, 2H), 7.33 (t, J = 7.8 Hz, 1H), 7.18−7.22
(m, 1H), 7.08−7.15 (m, 2H); 13C{1H} NMR (150 MHz, CDCl3) δ
147.3 (dm, J = 244.8 Hz), 145.3 (dm, J = 248.4 Hz), 141.0 (dm, J =
250.0 Hz), 139.6 (dm, J = 252.9 Hz), 136.1, 132.9 (t, J = 3.0 Hz),
128.8, 128.7, 126.8, 121.7 (m), 117.9 (t, J = 3.0 Hz), 107.4 (dt, J =
21.0 Hz, 3.0 Hz); 19F NMR (470 MHz, CDCl3) δ −139.8 (dd, J = 21.2
Hz, 11.3 Hz, 1F), −144.1 (dd, J = 20.7 Hz, 10.8 Hz, 1F) −156.0 (t, J =
19.3 Hz, 1F), −157.0 (t, J = 20.7 Hz, 1F); IR (neat) υmax 1527, 1477,
1039, 942, 756, 693 cm−1; HRMS (EI, m/z) calcd. for C14H8F4 [M]
+
252.0562, found 252.0556.
1-(2,6-Diﬂuorostyryl)benzene, 6v, Scheme 3.13a The same general
procedure was followed by using 2,6-diﬂuorobenzoic acid (32 mg, 0.2
mmol, 1.0 equiv), styrene (35 μL, 0.3 mmol, 1.5 equiv), palladium(II)
triﬂuoroacetate (13.4 mg, 0.04 mmol, 0.2 equiv), and silver carbonate
(165 mg, 0.4 mmol, 3.0 equiv). 5% DMSO was used as a co solvent
and the reaction was run for 4 h at 120 °C. Column chromatography
(SiO2, eluting with 98:2 hexane/ethyl acetate) aﬀorded the desired
product as a white solid, (30 mg, 70%), mp 65−67 °C. 1H NMR (300
MHz, CDCl3) δ 7.54 (d, J = 7.2 Hz, 2H), 7.25−7.42 (m, 4H), 7.11−
7.18 (m, 2H), 6.91 (t, J = 8.4 Hz, 2H); 13C{1H} NMR (75 MHz,
CDCl3) δ 161.0 (dm, J = 249.8 Hz), 137.4, 135.1 (t, J = 8.1 Hz),
128.7, 128.2, 127.8 (t, J = 10.5 Hz), 126.7, 115.2, 114.8 (t, J = 15.0
Hz), 111.5 (m); 19F NMR (470 MHz, CDCl3) δ −113.0 (s, 2F); IR
(neat) υmax 1565, 1463, 1210, 993, 748 cm
−1.
1-Cinnamyl-2,3,4,5,6-pentaﬂuorobenzene, 6w, Scheme 3.28 The
same general procedure was followed by using pentaﬂuorobenzoic acid
(42.5 mg, 0.2 mmol, 1.0 equiv), allylbenzene (40 μL, 0.3 mmol, 1.5
equiv), palladium(II) triﬂuoroacetate (6.7 mg, 0.02 mmol, 0.1 equiv),
and silver carbonate (110 mg, 0.4 mmol, 2.0 equiv) except the reaction
was run at 120 °C. Column chromatography (SiO2, eluting with 98:2
hexane/ethyl acetate) aﬀorded the desired product as a colorless
liquid, (42 mg, 74%). 1H NMR (600 MHz, CDCl3) δ 7.23−7.36 (m,
5H), 6.50 (d, J = 15.6 Hz, 1H), 6.21−6.26 (m, 1H), 3.62 (dd, J = 6.6
Hz, 0.6 Hz, 2H); 13C{1H} NMR (150 MHz, CDCl3) δ 145.0 (dm, J =
244.5 Hz), 139.8 (dm, J = 250.5 Hz), 137.5 (dm, J = 249.0 Hz), 136.5,
132.4, 128.6, 127.6, 126.2, 124.2, 113.2 (td, J = 19.5 Hz, 4.5 Hz), 25.6;
19F NMR (470 MHz, CDCl3) δ −143.9 (dd, J = 21.6 Hz, 7.0 Hz, 2F),
−157.3 (t, J = 20.7 Hz, 1F), −162.5 (td, J = 20.7 Hz, 7.0 Hz, 2F); IR
(neat) υmax 1498, 1118, 990, 963, 911, 754, 694 cm
−1; HRMS (EI, m/
z) calcd. for C15H9F5 [M]
+ 284.0624, found 284.0608.
Gram Scale Reaction: (Synthesis of 1,2,3,4,5-Pentaﬂuoro-6-
styrylbenzene, Scheme 3, 6a). To an oven-dried 250 mL round-
bottom ﬂask, a mixture of pentaﬂuorobenzoic acid (1.0 g, 4.7 mmol,
1.0 equiv), palladium(II) triﬂuoroacetate (156 mg, 0.47 mmol, 0.1
equiv), and silver carbonate (2.6 g, 9.4 mmol, 2.0 equiv) was taken
then dry DMF (80 mL) was added to it under nitrogen atmosphere.
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To this reaction mixture styrene (0.8 mL, 7.05 mmol,) was added via
syringe. The reaction mixture was allowed to stir for 16 h at room
temperature under nitrogen atmosphere. After completion (as
detected by TLC), the reaction mixture was poured into water (60
mL) and extracted with ethyl acetate (80 mL). The organic layer was
washed with water (30 mL) and brine (20 mL), dried over anhydrous
Na2SO4 and the solvent was evaporated under reduced pressure. The
pure 1,2,3,4,5-pentaﬂuoro-6-styrylbenzene (6a) was obtained as a
white solid in 61% (775 mg) yield after column chromatography of the
crude reaction mixture using ethyl acetate/hexane (98:2) as eluent.
Experimental Procedure for the Preparation of 1-(2,3,5,6-
Tetraﬂuoro-4-styrylphenyl)-1H-indole, 7, Scheme 6 from 1,2,3,4,5-
Pentaﬂuoro-6-styrylbenzene (6a). Sodium tert-butoxide (53 mg, 0.55
mmol, 1.1 equiv) was added to a glass vial containing indole (59 mg,
0.5 mmol, 1.0 equiv) in dry DMA (3.0 mL). The mixture was stirred at
room temperature for 1.0 min. The mixture was cooled and added to a
cooled solution of 1,2,3,4,5-pentaﬂuoro-6-styrylbenzene (162 mg, 0.6
mmol,1.2 equiv) in dry DMA (3.0 mL) under stirring in a 10 mL
round-bottom ﬂask. After 15 min the cooling bath was removed and
the reaction mixture was allowed to stir for 1 h at room temperature
under nitrogen atmosphere. After completion (as detected by TLC),
the reaction mixture was mixed with sat. NH4Cl (aq.) (5.0 mL) and
water (10 mL) then extracted with ethyl acetate (20 mL) The organic
layer was washed with water (10 mL) and brine (10 mL), dried over
anhydrous Na2SO4 and the solvent was evaporated under reduced
pressure. The crude product was puriﬁed by column chromatography
eluting with hexane/ethyl acetate (8:2) aﬀorded the desired product as
a white solid, (156 mg, 85%), mp 130−132 °C. 1H NMR (600 MHz,
CDCl3) δ 7.75 (d, J = 7.8 Hz, 1H), 7.61−7.64 (m, 3H), 7.46 (t, J = 7.8
Hz, 2H), 7.40 (t, J = 7.2 Hz, 1H), 7.33 (td, J = 8.4 Hz, 1.2 Hz, 1H),
7.28 (td, J = 7.8 Hz, 1.2 Hz, 1H), 7.23−7.26 (m, 2H), 7.18 (d, J = 16.8
Hz, 1H), 6.83 (d, J = 3.6 Hz, 1H); 13C{1H} NMR (150 MHz, CDCl3)
δ 145.0 (dm, J = 249.2 Hz), 142.8 (dm, J = 250.0 Hz), 138.0 (t, J = 9.0
Hz), 136.4, 136.3, 129.2, 128.9, 128.7, 128.3, 127.1, 123.1, 121.2 (d, J
= 3.0 Hz), 116.6 (m), 116.2 (t, J = 13.5 Hz), 113.2, 110.6, 105.5; 19F
NMR (470 MHz, CDCl3) δ −145.6 (m, 2F), −150.7 (m, 2F); IR
(neat) υmax 1519, 1487, 1204, 971, 748, 693 cm
−1; HRMS (FAB, m/z)
calcd. for C22H14NF4 [M + H]
+ 368.1062, found 368.1062.
Experimental Procedure for the Preparation of 1-(2,3,5,6-
Tetra(1H-pyrazol-1-yl)-4-styrylphenyl)-1H-indole, 8, Scheme 6
from 1-(2,3,5,6-Tetraﬂuoro-4-styrylphenyl)-1H-indole (7). Sodium
tert-butoxide (48 mg, 0.5 mmol, 5.0 equiv) was added to a glass vial
containing pyrazole (34 mg, 0.5 mmol, 5.0 equiv) in dry DMA (1.0
mL). The mixture was stirred at room temperature for 1.0 min. The
mixture was cooled and added to a cooled solution of 1-(2,3,5,6-
tetraﬂuoro-4-styrylphenyl)-1H-indole (37 mg, 0.1 mmol, 1.0 equiv) in
dry DMA (1.0 mL) under stirring in a 10 mL round-bottom ﬂask.
After 15 min the cooling bath was removed and the reaction mixture
was allowed to stir for 1 h at room temperature under nitrogen
atmosphere. After completion (as detected by TLC), the reaction
mixture was quenched with sat. NH4Cl (aq.) (1.0 mL) then extracted
with ethyl acetate (20 mL) and water (10 mL). The organic layer was
washed with water (10 mL) and brine (10 mL), dried over anhydrous
Na2SO4 and the solvent was evaporated under reduced pressure. The
crude product was puriﬁed by column chromatography eluting with
hexane/ethyl acetate (7:3) aﬀorded the desired product as a white
solid, (55 mg, 98%), mp 280−282 °C. 1H NMR (600 MHz, CDCl3) δ
7.66 (d, J = 1.8 Hz, 2H), 7.53 (d, J = 2.4 Hz, 2H), 7.42−7.43 (m, 1H),
7.27−7.28 (m, 2H), 7.23−7.24 (m, 3H), 7.00−7.05 (m, 7H), 6.84 (d, J
= 3.0 Hz, 1H), 6.41 (d, J = 3.0 Hz, 1H), 6.38 (d, J = 16.8 Hz, 1H), 6.35
(t, J = 1.8 Hz, 2H), 5.90 (t, J = 1.8 Hz, 2H), 5.86 (d, J = 16.8 Hz, 1H);
13C{1H} NMR (150 MHz, CDCl3) δ 141.12, 141.10, 138.4, 137.17,
137.16, 136.9, 136.33, 136.28, 132.7, 132.5, 131.3, 128.8, 128.6, 128.3,
127.9, 126.8, 122.4, 120.5, 117.7, 109.6, 107.2, 106.8, 104.8; IR (neat)
υmax 2923, 1519, 1480, 1389, 1037, 950, 756 cm
−1; HRMS (EI, m/z)
calcd. for C34H25N9 [M]
+ 559.2233, found 559.2235.
Experimental Procedure for the Preparation of Benzyl(2,3,5,6-
tetraﬂuoro-4-styrylphenyl)sulfane, 9, Scheme 6 from 1,2,3,4,5-
Pentaﬂuoro-6-styrylbenzene (6a). A mixture of 1,2,3,4,5-penta-
ﬂuoro-6-styrylbenzene (27 mg, 0.1 mmol, 1.0 equiv), phenyl-
methanethiol (14 μL, 0.12 mmol, 1.2 equiv) and TRIS (145 mg, 1.2
mmol, 12 equiv) in dry DMF (2.0 mL) was stirred for 12 h at room
temperature under argon atmosphere in a 10 mL round-bottom ﬂask.
After completion (as detected by TLC), the reaction mixture was
poured into water (10 mL) and extracted with ethyl acetate (20 mL).
The organic layer was washed with water (10 mL) and brine (10 mL),
dried over anhydrous Na2SO4 and the solvent was evaporated under
reduced pressure. The crude product was puriﬁed by column
chromatography eluting with hexane/ethyl acetate (8:2) to aﬀord
the desired product as a white solid, (34 mg, 90%), mp 108−110 °C.
1H NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.8 Hz, 2H), 7.50 (d, J =
16.8 Hz, 1H), 7.42 (t, J = 7.2 Hz, 2H), 7.36 (t, J = 7.8 Hz, 1H), 7.25−
7.31 (m, 5H), 7.06 (d, J = 16.8 Hz, 1H), 4.16 (s, 2H); 13C{1H} NMR
(150 MHz, CDCl3) δ 147.1 (dm, J = 242.8 Hz), 144.4 (dm, J = 250.2
Hz), 137.6 (t, J = 9.0 Hz), 136.5 (d, J = 1.5 Hz), 129.0, 128.83, 128.78,
128.6, 127.7, 127.0, 117.0 (t, J = 13.5 Hz), 113.7, 111.4 (t, J = 21.0
Hz), 39.0 (t, J = 3.0 Hz); 19F NMR (470 MHz, CDCl3) δ −138.4 (dd,
J = 22.6 Hz, 11.3 Hz, 2F), −146.2 (dd, J = 22.6 Hz, 11.3 Hz, 2F); IR
(neat) υmax 1468, 1064, 959, 752, 693 cm
−1; HRMS (EI, m/z) calcd.
for C21H14SF4 [M]
+ 374.0752, found 374.0734.
Experimental Procedure for the Preparation of tert-Butyl (S)-1-
(methoxycarbonyl)-2-(2,3,5,6-tetraﬂuoro-4-styrylphenylthio)-
ethylcarbamate, 10, Scheme 6 from 1,2,3,4,5-Pentaﬂuoro-6-
styrylbenzene (6a). A mixture of 1,2,3,4,5-pentaﬂuoro-6-styrylben-
zene, 6a (27 mg, 0.1 mmol, 1.0 equiv), N-(tert-butoxycarbonyl)-L-
cysteine methyl ester (21 μL, 0.1 mmol, 1.0 equiv) and TRIS (25 mg,
0.2 mmol, 2.0 equiv) in dry DMF (2.0 mL) was stirred for 4.5 h at
room temperature under argon atmosphere in a 10 mL round-bottom
ﬂask. After completion (as detected by TLC), the reaction mixture was
poured into water (10 mL) and extracted with ethyl acetate (20 mL).
The organic layer was washed with water (10 mL) and brine (10 mL),
dried over anhydrous Na2SO4 and the solvent was evaporated under
reduced pressure. The crude product was puriﬁed by column
chromatography eluting with hexane/ethyl acetate (7:3) to aﬀord
the desired product as a white solid, (41 mg, 84%), mp 90−92 °C. 1H
NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.2 Hz, 2H), 7.52 (d, J = 16.2
Hz, 1H), 7.42 (t, J = 7.2 Hz, 2H), 7.36 (t, J = 7.2 Hz, 1H), 7.08 (d, J =
16.8 Hz, 1H), 5.39 (d, J = 6.6 Hz, 1H), 4.58−4.60 (m, 1H), 3.70 (s,
3H), 3.47 (dd, J = 14.4 Hz, 4.2 Hz, 1H), 3.38 (dd, J = 14.4 Hz, 4.2 Hz,
1H), 1.41 (s, 9H); 13C{1H} NMR (150 MHz, CDCl3) δ 170.4, 154.7,
147.1(dm, J = 243.0 Hz), 144.4 (dm, J = 250.5 Hz), 138.0 (t, J = 9.0
Hz), 136.4, 129.1, 128.8, 127.0, 117.5 (t, J = 13.5 Hz), 113.5, 111.0 (t,
J = 21.0 Hz), 80.3, 53.7, 52.6, 36.6, 28.1; 19F NMR (470 MHz, CDCl3)
δ −134.5 (m, 2F), −142.6 (m, 2F); IR (neat) υmax 1739, 1706, 1472,
1342, 1160, 1063, 1015, 963, 754 cm−1; HRMS (EI, m/z) calcd. for
C23H23NO4SF4 [M]
+ 485.1284, found 485.1287.
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Palladium-catalyzed decarboxylative,
decarbonylative and dehydrogenative C(sp2)–H
acylation at room temperature†
Asik Hossian,a,b Manash Kumar Manna,a,b Kartic Mannaa,b and Ranjan Jana *a,b
Over the past few decades, an impressive array of C–H activation methodology has been developed for
organic synthesis. However, due to the inherent inertness of the C–H bonds (e.g. ∼110 kcal mol−1 for the
cleavage of C(aryl)–H bonds) harsh reaction conditions have been realized to overcome high energetic
transition states resulting in a limited substrate scope and functional group tolerance. Therefore, the
development of mild C–H functionalization protocols is in high demand to exploit the full potential of the
C–H activation strategy in the synthesis of a complex molecular framework. Although, electron-rich sub-
strates undergo electrophilic metalation under relatively mild conditions, electron-deﬁcient substrates
proceed through a rate-limiting C–H insertion under forcing conditions at high temperature. In addition,
a stoichiometric amount of toxic silver salt is frequently used in palladium catalysis to facilitate the C–H
activation process which is not acceptable from the environmental and industrial standpoint. We report
herein, a Pd(II)-catalyzed decarboxylative C–H acylation of 2-arylpyridines with α-ketocarboxylic acids
under mild conditions. The present protocol does not require stoichiometric silver(I) salts as additives and
proceeds smoothly at ambient temperature. A novel decarbonylative C–H acylation reaction has also
been accomplished using aryl glyoxals as acyl surrogates. Finally, a practical C–H acylation via a dehydro-
genative pathway has been demonstrated using commercially available benzaldehydes and aqueous
hydroperoxides. We also disclose that acetonitrile solvent is optimal for the acylation reaction at room
temperature and has a prominent role in the reaction outcome. Control experiments suggest that the
acylation reaction via decarboxylative, decarbonylative and dehydrogenative proceeds through a radical
pathway. Thus we disclose a practical protocol for the sp2 C–H acylation reaction.
Introduction
Owing to the prevalence of benzophenones in natural pro-
ducts, pharmaceuticals and functionalized materials, the syn-
thesis of functionalized carbonyl compounds is a sustained
exertion in organic synthesis (Fig. 1).1 Typically, Lewis-acid
promoted Friedel–Crafts acylation via electrophilic aromatic
substitution generates isomeric mixtures and requires
stoichiometric metal salts.2 The reaction of Weinreb amides
with Grignard reagents yields the carbonyl compounds with
limited functional group tolerance,3 whereas transition metal
catalyzed cross-couplings are reported with relatively less
nucleophilic organometallic reagents such as organozinc
reagents and boronic acids.4 As an alternative to air and moist-
ure sensitive acyl chlorides which generate stoichiometric
metal halide waste, thioesters are used in palladium-catalyzed
Liebeskind–Srogl cross-coupling.5 However, the reaction
requires a stoichiometric amount of copper complex as an
additive. Carbonylation of aryl halides with hazardous carbon
Fig. 1 Some benzophenone containing drugs.
†Electronic supplementary information (ESI) available: Starting materials prepa-
ration, control experiments, 1H and 13C NMR spectra for all synthesized com-
pounds. See DOI: 10.1039/c7ob01466j
aOrganic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical
Biology, 4 Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, West Bengal, India.
E-mail: rjana@iicb.res.in
bAcademy of Scientific and Innovative Research (AcSIR), Kolkata-700032,
West Bengal, India
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monoxide requires special handling skills and laboratory set
up.6 Therefore, considering the stringent environmental
factors (E factors) in chemical processes there is an urgent
need for the development of practical and environmentally
benign acylation reactions.
Beyond typical cross-coupling approaches, the C–H acti-
vation strategy oﬀers a unique opportunity to access carbonyl
compounds without prefunctionalization steps.7 Although an
enormous eﬀort has been dedicated for the development of
C–H activation processes, significant challenges still remain
unsolved. The harsh reaction conditions, use of stoichiometric
toxic silver(I) salts, high reaction temperature etc. limit their
application in the synthesis of complex molecular architecture
and industrial processes. Thus, the development of mild acyl-
ation reaction via C–H activation processes is in high demand.8
In recent years, decarboxylative cross-coupling has also
been established as a modern strategy for C–C and C–hetero-
atom bond formation.9 Inexpensive and readily available car-
boxylic acids are used as an alternative to expensive organo-
metallic reagents and halides. Combining these two promising
technologies, decarboxylative C–H functionalization has
emerged as a fascinating field of research.10 However, like C–H
insertion, decarboxylative metalation is also a high
energetic process and proceeds at elevated temperatures.11
α-Oxocarboxylic acids undergo transition metal-catalyzed de-
carboxylation to provide an acyl anion equivalent which has
been utilized in cross-coupling12 and C–H acylation reaction to
provide diaryl ketones.13 Although decarboxylative C–H acyl-
ation of electron rich aniline derivatives or oximes proceeds at
ambient temperature through a facile electrophilic ortho metal-
ation,14 electron-deficient substrates require high temperature
(110–140 °C) and stoichiometric silver(I) salt which is not
acceptable from the environmental and industrial viewpoint.15
To the best of our knowledge, silver free decarboxylative acyl-
ation of electron-deficient 2-arylpyridine at room temperature
has not been reported so far. As a part of our continuing
research program for the development of cross-coupling reac-
tions under mild conditions, we have reported decarboxylative
Heck coupling at room temperature16 and divergent synthesis
of 2-arylindoles and indolines via C–H activation.17 Herein for
the first time, we report a palladium-catalyzed decarboxylative
C–H acylation of an electron-deficient 2-arylpyridine system at
room temperature. The present protocol does not require stoi-
chiometric silver(I) salt and a dramatic influence of the solvent
was observed where acetonitrile was found to be optimal for
this acylation reaction under ambient conditions.18 This room
temperature acylation reaction was also demonstrated using
phenylglyoxals and aldehydes as acylating agents via decarbo-
nylative and dehydrogenative manifolds respectively
(Scheme 1).
Results and discussion
Initially, we started optimization for the decarboxylative acyl-
ation reaction at room temperature. A mixture of 2-phenylpyri-
dine (1a) and phenylglyoxylic acid (2a) was stirred in the pres-
ence of 10 mol% palladium(II)acetate and 2.0 equiv. of potas-
sium persulfate (K2S2O8) in diglyme solvent.
10k The expected
monoacylated product (3a) was obtained in 20% yield without
any silver(I) salt added (entry 1, Table 1). Further screening of
solvents showed that acetonitrile is superior to other solvents
such as DMF, DMSO, toluene, acetic acid, 1,4-dioxane
and DCE (entries 2–7, Table 1). Typically, silver salt is used in
Table 1 Optimization of the reaction conditionsa,b
Entry
Catalyst
(10 mol%)
Oxidant
(2.0 equiv.) Solvent
Yieldb
(%)
1 Pd(OAc)2 K2S2O8 Diglyme 20
2 Pd(OAc)2 K2S2O8 DMF 50
3 Pd(OAc)2 K2S2O8 DMSO 52
4 Pd(OAc)2 K2S2O8 Toluene Trace
5 Pd(OAc)2 K2S2O8 AcOH 25
6 Pd(OAc)2 K2S2O8 1,4-Dioxane 14
7 Pd(OAc)2 K2S2O8 DCE 40
8 Pd(OAc)2 K2S2O8 MeCN 76
9 Pd(OAc)2 Ag2CO3 MeCN 0
10 Pd(OAc)2 Ag2O MeCN 0
11 Pd(OAc)2 (NH4)2S2O8 MeCN 50
12 Pd(OAc)2 PIDA MeCN 26
13 Pd(OAc)2 TBHP (in decane) MeCN 0
14 Pd(OAc)2 O2 MeCN 0
15 Pd(TFA)2 K2S2O8 MeCN 70
16 Pd(MeCN)2Cl2 K2S2O8 MeCN 8
17 Pd(MeCN)2(OTs)2 K2S2O8 MeCN 65
18 Pd(MeCN)4(BF4)2 K2S2O8 MeCN 57
19 AgNO3 K2S2O8 MeCN 0
20 Pd(OAc)2 — MeCN 0
21 — K2S2O8 MeCN 0
22c Pd(OAc)2 K2S2O8 MeCN 67
23d Pd(OAc)2 K2S2O8 MeCN 0
a All reactions were carried out on a 0.1 mmol scale, using 1a
(1.0 equiv.) and 2a (1.5 equiv.). b Yields referred to here are overall iso-
lated yields. c Reaction was run in air. d Reaction was run under O2.Scheme 1 C(sp2)–H acylation reaction.
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palladium catalysis for facile decarboxylation, and as a carbon-
ate or carboxylate anion source, halide scavenger and terminal
oxidant for catalytic turnover.19 However, contrary to our expec-
tations, no desired product was isolated using silver salts such
as Ag2CO3, Ag2O etc. at room temperature although it is used
as an additive for this transformation at high temperature15a
(entries 9 and 10, Table 1). Other common oxidants such
as ammonium persulfate, (diacetoxyiodo)benzene (PIDA),
tert-butyl hydroperoxide (in decane) and also molecular
oxygen were found to be inferior for this coupling reaction
(entries 11–14, Table 1). Owing to the facile electrophilic
palladation of cationic palladium salts, several Pd-complexes,
such as Pd(TFA)2, Pd(MeCN)2Cl2, Pd(MeCN)2(OTs)2, and
Pd(MeCN)4(BF4)2 were examined but provided a lower yield
(entries 15–18, Table 1). We also observed that silver nitrate as
a catalyst was inactive for this transformation (entry 19,
Table 1). Finally, in combination of 10 mol% Pd(OAc)2 and
2.0 equiv. of K2S2O8 as the oxidant using acetonitrile as a
solvent provided excellent yield after stirring for 16 h at room
temperature (entry 8, Table 1). It is important to note that both
Pd(OAc)2 and K2S2O8 are essential for this coupling reaction
since no desired product was isolated while they were used
separately (entries 20 and 21, Table 1). The yield of the acyl-
ation product was decreased to some extent in air (entry 22,
Table 1) and no product was formed with oxygen purging
(entry 23, Table 1). During optimization, it was found that
moisture has a negative impact on the reaction outcome pre-
sumably due to the formation of a decarboxylative protonation
product from phenylglyoxylic acid.
Next we explored the substrate scope under the optimized
reaction conditions. A wide variety of phenylglyoxylic acids
having electron-withdrawing and electron-donating substitu-
ents underwent decarboxylative coupling providing high to
excellent yields (Scheme 2). Besides methoxy, alkyl, and aryl
groups, halogens such as bromo (3i, 3l, 3v, Scheme 2), chloro
(3h, Scheme 2), and fluoro (3g, Scheme 2) were also well toler-
ated under the reaction conditions which are useful for further
cross-coupling reactions. A strong electron-withdrawing group
on α-keto acid aﬀorded the acylated product in good yield (3j,
Scheme 3). Interestingly, the α-keto acid with a naphthyl
moiety furnished the desired product in good yield (3k,
Scheme 2). The ortho substituted α-keto acid participated in
the reaction with excellent yield (3l, Scheme 2). Disubstituted
α-keto acids also participated in the reaction providing good
yields (3m–3n, Scheme 2). No significant influence of the elec-
tronic nature of the substituents on α-keto acids was observed
on the reaction outcome. Similarly, substitutions on the
2-phenylpyridine moiety such as alkyl (3o–3q, Scheme 2) and
methoxy (3s–3v, Scheme 2) were tolerated under the reaction
conditions. In addition, aliphatic α-oxocarboxylic acid also
aﬀorded the desired product in good yield (3w, Scheme 2).
Unfortunately, electron deficient groups like acyl and trifluoro-
methyl on the 2-phenylpyridine moiety did not furnish any
acylated products. Other nitrogen directing groups like 2-phe-
noxypyridine, 1-phenyl-1H-pyrazole, acetophenone O-methyl
oxime, and also 2-phenylbenzo[d]thiazole did not provide the
desired acylation products at room temperature. However,
2-phenylpyrimidine furnished a mixture of mono and diacyl-
ation products which was separated through column chromato-
graphy (mono : di = 2.5 : 1). To demonstrate the practical utility
of this present protocol the reaction was performed on a gram-
scale providing the acylation product in comparable yields (3a,
Scheme 2).
In recent years, decarbonylative cross-coupling reaction
from carbonyl or carboxylic acid derivatives has emerged as a
promising strategy in organic synthesis.20 Initially, the tran-
sition metal undergoes oxidative addition to the activated
carboxylic acid derivatives such as acid chlorides,21 anhydrides,22
esters23 etc. to generate an acyl-metal species. Subsequently,
aryl-metal species is formed through the extrusion of carbon
monoxide. Unlike redox-neutral decarboxylative cross-coupling,
no stoichiometric oxidant is required in the decarbonylative
cross-coupling process. Although transition metal-catalyzed
Scheme 2 Substrate scope of 2-phenylpyridines and α-ketocarboxylic
acids. The reaction was carried out on a 0.2 mmol scale, using 1
(1.0 equiv.) and 2 (1.5–2.0 equiv.). The yield referred to here is the average
isolated yield of at least two experiments. aDiacylation occurred.
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decarbonylative cross-coupling for arylation has been
explored,24 decarbonylative C–H acylation is not known. We
hypothesized that glyoxals can be utilized in palladium-
catalyzed decarbonylative C–H acylation reaction. To test, a
mixture of 2-phenylpyridine (1a) and phenylglyoxal (4a) was
subjected under the optimized reaction conditions of decarb-
oxylative acylation. Gratifyingly, the corresponding acylation
product was isolated in 70% yield (3a, Scheme 3). However, the
reaction under oxygen did not furnish any acylation product
although dioxygen-mediated generation of an alkyl radical
from the corresponding aldehydes is known at elevated temp-
erature.25 Other oxidants such as aq. TBHP or TBHP in decane
and even (NH4)2S2O8 were ineﬀective for this transformation.
Surprisingly, a trace amount of the acylation product was iso-
lated in other solvents like DMSO, DMF, DCE and toluene.
Therefore, we proceeded to examine the substrate scope under
these conditions. To our delight, a number of 2-phenylpyri-
dines as well as phenylglyoxals with diﬀerent substituents pro-
vided the corresponding acylated products with moderate to
good yields (Scheme 3). It is noteworthy that halogenated and
ortho-substituted 2-phynylpyridines also provided a moderate
yield of the acylation products which were ineﬀective under a
decarboxylative acylation protocol.
Next we turned our attention to achieve acylation reaction
with commercially available and inexpensive aldehydes as acyl-
ation agents. From the literature, palladium-catalyzed C–H
acylation of 2-phenylpyridine with aryl and alkyl aldehydes is
known at high temperature.26 However, aldehydes are con-
verted into the corresponding acids by oxygen rapidly at high
temperature and the yield is decreased.26b,27 In addition, the
oxidant TBHP is explosive at high temperature particularly at
the industrial-scale.28 Keeping this in mind we intended to
develop an acylation reaction with aldehydes at room tempera-
ture. Our initial trial reaction between 2-phenylpyridine (1a)
and benzaldehyde (5a) under the previous optimized reaction
conditions aﬀorded the acylated product in 35% yield (3a,
Scheme 4). Considering the unique ability of tert-butylhydro-
peroxide (TBHP) to generate the acyl radical from aldehydes,29
Scheme 3 Substrate scope of 2-phenylpyridines and 2-oxo-2-phenyl-
acetaldehydes. The reaction was carried out on a 0.2 mmol scale, using
1 (1.0 equiv.) and 4 (1.5 equiv.). The yield referred to here is the average
isolated yield of at least two experiments.
Scheme 4 Substrate scope of 2-phenylpyridines and aldehydes. The
reaction was carried out on a 0.2 mmol scale, using 1 (1.0 equiv.) and 5
(1.5 equiv.). The yield referred to here is the average isolated yield of at
least two experiments. a The reaction was run for 72 h.
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we decided to use TBHP as the oxidant in lieu of K2S208.
Surprisingly, the yield was improved to 55% with inexpensive
aq. TBHP. Finally an excellent yield of the acylated product
(3a) in 87% was isolated after stirring the reaction mixture for
36 h at room temperature with the combination of 10 mol%
Pd(OAc)2 and 3.0 equiv. of aq. TBHP from 1.0 equiv. of
2-phenylpyridine (1a) and 1.5 equiv. of benzaldehyde (5a).
However, 30% aq. H2O2 in lieu of aq. TBHP did not furnish
any acylation product. Of note, the reaction in air or under
oxygen provided lower (37%) or no yield and thus the reaction
vessel was purged with nitrogen. The reaction under neat
conditions also furnished an inferior result (38%).
Subsequently, we explored the substrate scope under the
optimized reaction conditions. A wide variety of functional
groups on 2-phenylpyridine as well as on aldehydes were
found to be compatible under this mild reaction protocol.
Besides methoxy, alkyl and aryl groups, halogens such as
chloro (3ah, Scheme 4), ester (3ad, Scheme 4), cyano (3ae,
Scheme 4), and nitro (3af, Scheme 4) remain intact which are
useful for further organic transformation. Interestingly, the
acyl group on the aldehyde (3ac, Scheme 4) is well-tolerated
under the reaction conditions which demonstrate the mild
nature of the conditions. Interestingly, the aldehyde with a
naphthyl moiety furnished the desired product in good yields
(3ag, Scheme 4). The electron deficient group like acyl on
2-phenylpyridine aﬀorded the moderate yield (3an, Scheme 4)
which was inferior in the decarboxylative acylation reaction.
The reaction with 2-phenylquinoline aﬀorded the acylation
product in moderate yield (3ao, Scheme 4). Interestingly, the
heterocyclic aldehydes, such as furan-2-carbaldehyde and thio-
phene-3-carbaldehyde provided moderate yields of the desired
products (3ap–3aq, Scheme 4). In addition, aliphatic aldehydes
also aﬀorded the acylation product in moderate to excellent
yields (3w–3as, Scheme 4). It is important to note that, benzo
[h]quinoline worked extremely well under the reaction con-
ditions to give the corresponding acylation product in excellent
yield (3at, Scheme 4). Although, 2-phenoxypyridine, 1-phenyl-
1H-pyrazole provided a lower yield and the unreacted starting
material was recovered (3au–3av, Scheme 4) 2-phenylpyrimi-
dine furnished good yield (3x, Scheme 4) of the mono-acyl-
ation product. Finally, the reaction was reproduced on the
gram-scale providing a comparable yield (3a, Scheme 4). Other
in situ convertible acylating agents such as benzyl alcohol,
benzyl amine, styrene and toluene did not furnish any acylated
product with 2-phenylpyridine under the reaction conditions.
Investigation of the reaction
mechanism
To gain insight into the reaction mechanism, we performed
several control experiments. To check whether decarboxylative
acylation reaction with phenylglyoxylic acid proceeds through
a radical or anionic pathway, radical scavenger 2,2,6,6-tetra-
methylpiperidinyl-1-oxy (TEMPO) experiment was performed.
It was observed that the acylation reaction was completely sup-
pressed with 1.0 equiv. of TEMPO. The TEMPO-acyl adduct,
2,2,6,6-tetramethylpiperidin-1-yl benzoate (6a), was detected in
electrospray ionization (ESI) mass spectrometry of the crude
reaction mixture. Furthermore, it was isolated in 74% yield
and well-characterized by NMR and HRMS spectroscopy
(Scheme 5a) (see the ESI†). Thus the decarboxylative acylation
reaction may proceed through the radical pathway and the acyl
radical may generate from the corresponding phenylglyoxylic
acids with K2S2O8 at room temperature. Similarly, acylation
reaction with phenylglyoxal was also completely suppressed
with 1.0 equiv. of TEMPO and the TEMPO-acyl adduct (6a) was
isolated in 56% yield (Scheme 5a). In addition, phenylglyoxal
did not oxidize to the phenylglyoxylic acid under the reaction
conditions and remained intact (Scheme 5b). Therefore, the
possibility of oxidation to the corresponding acid followed by
decarboxylative acylation was ruled out and rather an acyl
radical may generate in the course of the reaction through
decarbonylation of the arylglyoxal. Finally, dehydrogenative
Scheme 5 Control experiments.
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acylation reaction with benzaldehyde was also suppressed sub-
stantially with 1.0 and 1.5 equiv. of TEMPO and completely
suppressed with 2.0 equiv. of TEMPO. The TEMPO-acyl adduct
(6a) was also isolated in 71% yield for further confirmation
(Scheme 5a). Thus, dehydrogenative acylation may also
proceed through the radical pathway and the acyl radical inter-
mediate may form from the corresponding benzaldehyde via
TBHP oxidation. In the absence of K2S2O8 no decarboxylative
acylation product was isolated with 10 mol% or even with
1.0 equiv. of Pd(OAc)2 indicating that the combination of
palladium and K2S2O8 is essential for the reaction to occur
(Scheme 5c). Since palladium(II) acetate is known to form a
dimeric complex with 2-phenylpyridine through C–H inser-
tion,30 a palladium dimer complex (7a) was prepared separ-
ately and subjected to the reaction conditions (Scheme 5d).
Only a trace amount of the product was detected suggesting
that dimeric palladium species with 2-phenylpyridine may not
form under the present reaction conditions whereas a mono-
meric palladium species may be involved.
From the control experiments and previous reported litera-
ture,29,31,32 we propose the reaction mechanism which is
shown in Scheme 6. The pyridine-assisted cyclopalladation
with Pd(II) via electrophilic palladation may generate the
5-membered palladacycle intermediate A (Scheme 6), which
undergoes oxidative addition with the acyl radical to yield
cyclopalladated Pd(III) intermediate B (Scheme 6). Under
visible light photoredox and palladium dual catalysis con-
ditions this putative Pd(III) is further oxidized to Pd(IV) with a
photoredox catalyst and/or an oxidant.8f,14b,32c,d,33 However in
these catalytic systems, the role of K2S2O8 or TBHP in Pd(III)/
Pd(IV) oxidation is not clear at this moment and warrants
further investigation. The desired acylation product 3 may
form through the facile reductive elimination of the intermedi-
ate B (Scheme 6) and the generation of the Pd(II) catalyst for
subsequent runs.
Conclusions
In conclusion, we have developed a mild reaction protocol for
Pd(II)-catalyzed C(sp2)–H acylation using α-ketocarboxylic
acids, phenylglyoxals and commercially available, inexpensive
aldehydes via decarboxylative, decarbonylative and dehydro-
genative manifolds respectively. The major advantages of the
present protocol are – (a) the reaction operates under mild con-
ditions at room temperature; (b) it does not require a stoichio-
metric amount of toxic silver(I) salt for decarboxylation of the
α-ketocarboxylic acid or as the oxidant; (c) acetonitrile was
optimal for the acylation; (d) gaseous CO2, CO or water is
formed as by-products avoiding rigorous separation tech-
niques; and (e) the present acylation reaction proceeds
through the radical pathway to provide a monoacylation
product at the ortho position selectively. This room tempera-
ture acylation reaction is scalable, energy eﬃcient and avoids
the accidental hazard due to explosion of peroxides at elevated
temperature. Thus, we anticipate that this mild C–H acylation
protocol will find its place in industrial application.
Experimental section
General information
Melting points were determined in open end-capillary tubes
and are uncorrected. TLC was performed on silica gel plates
(silica gel 60, f254), and the spots were visualized with UV light
(254 and 365 nm) and KMnO4 stain.
1H and 13C NMR spectra
were recorded in CDCl3 using TMS as the internal standard.
HRMS (m/z) were recorded using EI (magnetic sector, positive
ion) and ESI (Q-TOF, positive ion) techniques. Infrared (IR)
spectra were recorded using Fourier transform infrared
spectroscopy; only intense peaks were reported.
General experimental procedure for the decarboxylative
acylation reaction between 2-phenylpyridines and
α-ketocarboxylic acids, Scheme 2
To an oven-dried 10 mL sealed tube was added a mixture of
2-phenylpyridines (0.2 mmol, 1.0 equiv.), α-ketocarboxylic
acids (0.3–0.4 mmol, 1.5–2.0 equiv.), potassium persulfate
(108 mg, 0.4 mmol, 2.0 equiv.) and palladium(II) acetate
(4.6 mg, 0.02 mmol, 0.1 equiv.) and then dry MeCN (3.0 mL)
was added to it. After flushing with nitrogen for 30 seconds,
the vessel was immediately sealed with a screw cap. The reac-
tion mixture was allowed to stir for 16 h at room temperature.
After that the reaction mixture was quenched with NaHCO3 to
remove the unreacted acids. Then the reaction mixture was
poured into water (40 mL) and extracted with ethyl acetateScheme 6 Plausible mechanism of C(sp2)–H acylation.
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(40 mL). The organic layer was washed with water (10 mL) and
brine (10 mL), dried over anhydrous Na2SO4 and the solvent
was evaporated under reduced pressure. The crude product
was purified by column chromatography using ethyl acetate/
hexane as the eluent to aﬀord the desired product.
Of note, during optimization, it was found that
α-ketocarboxylic acids are hygroscopic in nature and thus
water or moisture is detrimental to the reaction outcome.
Therefore, after flushing with nitrogen the reaction vessel was
immediately sealed with a screw cap.
Phenyl(2-(pyridin-2-yl)phenyl)methanone, 3a, Scheme 2 .7d
The same general procedure was followed by using 2-phenyl-
pyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), 2-oxo-2-phenylacetic
acid (45 mg, 0.3 mmol, 1.5 equiv.), potassium persulfate
(108 mg, 0.4 mmol, 2.0 equiv.) and palladium(II) acetate
(4.5 mg, 0.02 mmol, 0.1 equiv.). Column chromatography
(SiO2, eluting with 7 : 3 hexane/ethyl acetate) aﬀorded the
desired product as a white solid, (39.5 mg, 76%), mp
105–107 °C. 1H NMR (600 MHz, CDCl3): δ 8.36 (d, J = 4.2 Hz,
1H), 7.78 (d, J = 7.8 Hz, 1H), 7.70 (d, J = 7.8 Hz, 2H), 7.61 (t, J =
7.2 Hz, 1H), 7.50–7.56 (m, 4H), 7.39 (t, J = 7.2 Hz, 1H), 7.27 (t,
J = 7.2 Hz, 2H), 7.01 (t, J = 4.8 Hz, 1H); 13C NMR (150 MHz,
CDCl3): δ 198.2, 156.7, 149.0, 139.6, 139.5, 137.9, 136.3, 132.3,
130.2, 129.4, 129.1, 128.7, 128.5, 128.0, 122.6, 121.9; IR (neat):
νmax 1665, 1587, 1279, 929, 751, 703 cm
−1; HRMS (EI, m/z)
calcd for C18H13NO [M]
+: 259.0997; found: 259.0979.
(2-(Pyridin-2-yl)phenyl)(p-tolyl)methanone, 3b, Scheme 2 .7d
The same general procedure was followed by using 2-phenyl-
pyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), 2-oxo-2-(p-tolyl)acetic
acid (49 mg, 0.3 mmol, 1.5 equiv.), potassium persulfate
(108 mg, 0.4 mmol, 2.0 equiv.) and palladium(II) acetate
(4.5 mg, 0.02 mmol, 0.1 equiv.). Column chromatography
(SiO2, eluting with 7 : 3 hexane/ethyl acetate) aﬀorded the
desired product as a white solid, (39.0 mg, 72%), mp 97–99 °C.
1H NMR (600 MHz, CDCl3): δ 8.41 (d, J = 4.2 Hz, 1H), 7.78 (d,
J = 7.2 Hz, 1H), 7.56–7.62 (m, 4H), 7.52 (d, J = 4.2 Hz, 2H), 7.49
(d, J = 8.4 Hz, 1H), 7.09 (d, J = 7.8 Hz, 2H), 7.03–7.06 (m, 1H),
2.33 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 197.9, 156.9, 149.1,
143.1, 139.7, 139.5, 136.2, 135.3, 130.0, 129.7, 128.92, 128.90,
128.8, 128.4, 122.8, 121.9, 21.6; IR (neat): νmax 1662, 1604,
1433, 1284, 929, 751 cm−1; HRMS (ESI, m/z) calcd for
C19H15NONa [M + Na]
+: 296.1051; found: 296.1049.
(4-(tert-Butyl)phenyl)(2-(pyridin-2-yl)phenyl)methanone, 3c,
Scheme 2 .34 The same general procedure was followed
by using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.),
2-(4-(tert-butyl)phenyl)-2-oxoacetic acid (62 mg, 0.3 mmol,
1.5 equiv.), potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv.)
and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.).
Column chromatography (SiO2, eluting with 7 : 3 hexane/ethyl
acetate) aﬀorded the desired product as a yellowish oil,
(46.0 mg, 73%). 1H NMR (300 MHz, CDCl3): δ 8.40 (d, J =
4.2 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.65 (d, J = 8.4 Hz, 2H),
7.46–7.62 (m, 5H), 7.30 (d, J = 8.4 Hz, 2H), 7.00–7.04 (m, 1H),
1.27 (s, 9H); 13C NMR (150 MHz, CDCl3): δ 197.9, 157.0, 156.0,
149.1, 139.7, 139.6, 136.2, 135.1, 130.0, 129.6, 129.0, 128.9,
128.2, 125.0, 122.9, 121.8, 35.0, 31.0; IR (neat): νmax 2961,
1666, 1598, 1466, 1277, 753 cm−1; HRMS (ESI, m/z) calcd for
C22H21NONa [M + Na]
+: 338.1521; found: 338.1523.
(4-Isobutylphenyl)(2-(pyridin-2-yl)phenyl)methanone, 3d,
Scheme 2. The same general procedure was followed by using
2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), 2-(4-isobutyl-
phenyl)-2-oxoacetic acid (62 mg, 0.3 mmol, 1.5 equiv.), potass-
ium persulfate (108 mg, 0.4 mmol, 2.0 equiv.) and palladium(II)
acetate (4.5 mg, 0.02 mmol, 0.1 equiv.). Column chromato-
graphy (SiO2, eluting with 7 : 3 hexane/ethyl acetate) aﬀorded
the desired product as a colourless oil, (45.0 mg, 71%).
1H NMR (600 MHz, CDCl3): δ 8.39 (d, J = 4.2 Hz, 1H), 7.76 (d,
J = 7.8 Hz, 1H), 7.51–7.62 (m, 6H), 7.45 (d, J = 7.8 Hz, 1H), 7.03
(d, J = 8.4 Hz, 2H), 7.00–7.02 (m, 1H), 2.43 (d, J = 7.2 Hz, 2H),
1.78–1.85 (m, 1H), 0.84 (d, J = 6.6 Hz, 6H); 13C NMR (150 MHz,
CDCl3): δ 198.0, 157.0, 149.0, 146.8, 139.7, 139.6, 136.1, 135.5,
130.1, 129.5, 129.1, 128.9, 128.7, 128.4, 123.0, 121.8, 45.3, 30.1,
22.2; IR (neat): νmax 2957, 1664, 1602, 1281, 930, 751 cm
−1;
HRMS (ESI, m/z) calcd for C22H21NONa [M + Na]
+: 338.1521;
found: 338.1520.
(4-Methoxyphenyl)(2-(pyridin-2-yl)phenyl)methanone, 3e,
Scheme 2 .7d The same general procedure was followed by
using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), 2-(4-
methoxyphenyl)-2-oxoacetic acid (54 mg, 0.3 mmol, 1.5 equiv.),
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv.) and palla-
dium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.). Column
chromatography (SiO2, eluting with 7 : 3 hexane/ethyl acetate)
aﬀorded the desired product as a yellowish oil, (35.0 mg, 60%).
1H NMR (600 MHz, CDCl3): δ 8.44 (d, J = 4.8 Hz, 1H), 7.78 (d,
J = 7.8 Hz, 1H), 7.68–7.70 (m, 2H), 7.56–7.62 (m, 2H), 7.52 (d,
J = 4.2 Hz, 2H), 7.48 (d, J = 7.8 Hz, 1H), 7.05–7.07 (m, 1H),
6.76–6.79 (m, 2H), 3.81 (s, 3H); 13C NMR (150 MHz, CDCl3):
δ 197.0, 163.0, 157.0, 149.1, 139.6, 139.5, 136.2, 131.9, 130.7,
129.9, 129.0, 128.8, 128.3, 123.0, 121.9, 113.3, 55.3; IR (neat):
νmax 1658, 1597, 1464, 1256, 1027, 753 cm
−1; HRMS (ESI, m/z)
calcd for C19H15NO2Na [M + Na]
+: 312.1000; found: 312.0997.
(2,4-Dimethylphenyl)(2-(pyridin-2-yl)phenyl)methanone, 3m,
Scheme 2. The same general procedure was followed by using
2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), 2-(2,4-di-
methylphenyl)-2-oxoacetic acid (53.5 mg, 0.3 mmol, 1.5 equiv.),
potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv.) and
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.).
Column chromatography (SiO2, eluting with 7 : 3 hexane/ethyl
acetate) aﬀorded the desired product as a light yellow oil,
(40.0 mg, 70%). 1H NMR (600 MHz, CDCl3): δ 8.46–8.47 (m,
1H), 7.66–7.67 (m, 1H), 7.56–7.60 (m, 3H), 7.49–7.52 (m, 1H),
7.42 (d, J = 7.8 Hz, 1H), 7.11 (d, J = 8.4 Hz, 1H), 7.03–7.05 (m,
1H), 6.92 (s, 1H), 6.76 (d, J = 7.8 Hz, 1H), 2.56 (s, 3H), 2.24 (s,
3H); 13C NMR (150 MHz, CDCl3): δ 199.5, 157.4, 148.7, 141.5,
141.0, 139.8, 139.4, 136.3, 135.2, 132.1, 131.2, 130.3, 129.6,
129.2, 128.4, 125.5, 122.8, 121.8, 21.3, 21.0; IR (neat):
νmax 2924, 1663, 1601, 1436, 1299, 753 cm
−1; HRMS (EI, m/z)
calcd for C20H17NO [M]
+: 287.1310; found: 287.1305.
(3,5-Dimethoxyphenyl)(2-(pyridin-2-yl)phenyl)methanone, 3n,
Scheme 2. The same general procedure was followed by
using 2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), 2-(3,5-
dimethoxyphenyl)-2-oxoacetic acid (63 mg, 0.3 mmol,
Paper Organic & Biomolecular Chemistry
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1.5 equiv.), potassium persulfate (108 mg, 0.4 mmol,
2.0 equiv.) and palladium(II) acetate (4.5 mg, 0.02 mmol,
0.1 equiv.). Column chromatography (SiO2, eluting with
7 : 3 hexane/ethyl acetate) aﬀorded the desired product as a col-
ourless oil, (37.0 mg, 58%). 1H NMR (600 MHz, CDCl3): δ 8.40
(d, J = 4.8 Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.58–7.61 (m, 2H),
7.50–7.54 (m, 3H), 7.04–7.06 (m, 1H), 6.96 (d, J = 1.8 Hz, 2H),
6.50 (t, J = 2.4 Hz, 1H), 3.73 (s, 6H); 13C NMR (150 MHz,
CDCl3): δ 197.6, 160.3, 156.7, 149.0, 139.8, 139.5, 139.3, 136.3,
130.2, 129.1, 128.7, 128.4, 122.4, 122.0, 107.3, 105.0, 55.5;
IR (neat): νmax 1670, 1594, 1462, 1302, 1156, 1062, 753 cm
−1;
HRMS (ESI, m/z) calcd for C20H17NO3Na [M + Na]
+: 342.1106;
found: 342.1007.
(5-Methoxy-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 3t,
Scheme 2 .26b The same general procedure was followed by
using 2-(4-methoxyphenyl)pyridine (37.0 mg, 0.2 mmol,
1.0 equiv.), 2-oxo-2-phenylacetic acid (60 mg, 0.4 mmol,
2.0 equiv.), potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv.)
and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.).
Column chromatography (SiO2, eluting with 7 : 3 hexane/ethyl
acetate) aﬀorded the desired product as a white solid,
(46.0 mg, 80%), mp 98–100 °C. 1H NMR (600 MHz, CDCl3):
δ 8.32 (d, J = 4.8 Hz, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.70 (d, J =
7.2 Hz, 2H), 7.53 (td, J = 7.8 Hz, 1.2 Hz, 1H), 7.45 (d, J = 7.8 Hz,
1H), 7.38 (t, J = 7.2 Hz, 1H), 7.26–7.28 (m, 2H), 7.14 (dd, J =
8.4 Hz, 2.4 Hz, 1H), 7.06 (d, J = 2.4 Hz, 1H), 6.95–6.97 (m, 1H),
3.89 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 197.9, 159.8, 156.3,
148.8, 140.8, 137.7, 136.2, 132.3, 132.0, 129.9, 129.3, 128.0,
122.0, 121.3, 116.1, 114.0, 55.6; IR (neat): νmax 1666, 1595,
1462, 1286, 1230, 741, 700 cm−1; HRMS (ESI, m/z) calcd for
C19H15NO2Na [M + Na]
+: 312.1000; found: 312.1003.
(4-Fluorophenyl)(5-methoxy-2-(pyridin-2-yl)phenyl)methanone,
3u, Scheme 2. The same general procedure was followed by
using 2-(4-methoxyphenyl)pyridine (37.0 mg, 0.2 mmol,
1.0 equiv.), 2-(4-fluorophenyl)-2-oxoacetic acid (67 mg,
0.4 mmol, 2.0 equiv.), potassium persulfate (108 mg,
0.4 mmol, 2.0 equiv.) and palladium(II) acetate (4.5 mg,
0.02 mmol, 0.1 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane/ethyl acetate) aﬀorded the desired product as
a white solid, (39.0 mg, 64%), mp 74–76 °C. 1H NMR
(600 MHz, CDCl3): δ 8.31 (d, J = 4.8 Hz, 1H), 7.70–7.73 (m, 3H),
7.55 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.46 (d, J = 7.8 Hz, 1H), 7.14
(dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.4 (d, J = 2.4 Hz, 1H), 6.98 (dd, J =
7.2 Hz, 4.8 Hz, 1H), 6.93 (t, J = 8.4 Hz, 2H), 3.89 (s, 3H);
13C NMR (150 MHz, CDCl3): δ 196.3, 165.1 (d, J = 252.0 Hz),
159.9, 156.1, 148.8, 140.5, 136.3, 134.2 (d, J = 3.0 Hz), 131.8 (d,
J = 9.0 Hz), 129.9, 121.9, 121.4, 116.1, 115.1 (d, J = 21.0 Hz),
113.9, 55.6; IR (neat): νmax 1668, 1596, 1464, 1289, 1230,
850 cm−1; HRMS (ESI, m/z) calcd for C19H14FNO2Na [M + Na]
+:
330.0906; found: 330.0872.
(4-Bromophenyl)(5-methoxy-2-(pyridin-2-yl)phenyl)methanone,
3v, Scheme 2. The same general procedure was followed by
using 2-(4-methoxyphenyl)pyridine (37.0 mg, 0.2 mmol,
1.0 equiv.), 2-(4-bromophenyl)-2-oxoacetic acid (92 mg,
0.4 mmol, 2.0 equiv.), potassium persulfate (108 mg,
0.4 mmol, 2.0 equiv.) and palladium(II) acetate (4.5 mg,
0.02 mmol, 0.1 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane/ethyl acetate) aﬀorded the desired product as
a yellowish solid, (49.0 mg, 67%), mp 107–109 °C. 1H NMR
(600 MHz, CDCl3): δ 8.28 (d, J = 4.8 Hz, 1H), 7.72 (d, J = 8.4 Hz,
1H), 7.55–7.57 (m, 3H), 7.48 (d, J = 7.8 Hz, 1H), 7.39 (d, J =
9.0 Hz, 2H), 7.13 (dd, J = 9.0 Hz, 3.0 Hz, 1H), 7.03 (d, J =
3.0 Hz, 1H), 6.98 (dd, J = 7.2 Hz, 4.8 Hz, 1H), 3.88 (s, 3H);
13C NMR (150 MHz, CDCl3): δ 196.8, 159.9, 155.8, 148.7, 140.3,
136.7, 136.4, 131.7, 131.3, 130.7, 129.8, 127.2, 121.7, 121.5,
116.2, 113.9, 55.6; IR (neat): νmax 1669, 1586, 1464, 1230,
841, 757 cm−1; HRMS (ESI, m/z) calcd for C19H14BrNO2Na
[M + Na]+: 390.0106; found: 390.0104.
For the spectroscopy data of compounds 3f, 3g, 3h, 3i, 3j,
3k, 3l, 3o, 3p, 3q, 3r, 3s, 3w and 3x, see the ESI.†
General experimental procedure for the decarbonylative
acylation reaction between 2-phenylpyridines and
phenylglyoxals, Scheme 3
To an oven-dried 10 mL sealed tube was added a mixture of
2-phenylpyridines (0.2 mmol, 1.0 equiv.), phenylglyoxals
(0.3 mmol, 1.5 equiv.), potassium persulfate (108 mg,
0.4 mmol, 2.0 equiv.) and palladium(II) acetate (4.6 mg,
0.02 mmol, 0.1 equiv.) and then dry MeCN (3.0 mL) was added
to it. After flushing with nitrogen, the vessel was immediately
sealed with a screw cap. The reaction mixture was allowed to
stir for 16 h at room temperature. After that the reaction
mixture was quenched with NaHCO3. Then the reaction
mixture was poured into water (40 mL) and extracted with
ethyl acetate (40 mL). The organic layer was washed with water
(10 mL) and brine (10 mL), dried over anhydrous Na2SO4 and
the solvent was evaporated under reduced pressure. The crude
product was purified by column chromatography using ethyl
acetate/hexane as the eluent to aﬀord the desired product.
(5-Fluoro-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 3y,
Scheme 3 .26b The same general procedure was followed by
using 2-(4-fluorophenyl)pyridine (35.0 mg, 0.2 mmol,
1.0 equiv.), 2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol,
1.5 equiv.), potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv.)
and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.).
Column chromatography (SiO2, eluting with 7 : 3 hexane/ethyl
acetate) aﬀorded the desired product as a white solid,
(26.5 mg, 48%), mp 149–151 °C. 1H NMR (600 MHz, CDCl3):
δ 8.36 (d, J = 4.8 Hz, 1H), 7.78 (dd, J = 8.4 Hz, 4.8 Hz, 1H), 7.69
(d, J = 7.8 Hz, 2H), 7.58 (td, J = 7.8 Hz, 1.2 Hz, 1H), 7.48 (d, J =
7.8 Hz, 1H), 7.42 (t, J = 7.2 Hz, 1H), 7.25–7.33 (m, 4H), 7.03
(dd, J = 6.6 Hz, 5.4 Hz, 1H); 13C NMR (150 MHz, CDCl3):
δ 196.4, 162.6 (d, J = 249.0 Hz), 155.6, 148.9, 141.4 (d, J = 4.5 Hz),
137.2, 136.5, 135.5 (d, J = 1.5 Hz), 132.6, 130.6 (d, J = 7.5 Hz),
129.3, 128.1, 122.4, 122.0, 117.1 (d, J = 21.0 Hz), 116.1 (d, J =
22.5 Hz); IR (neat): νmax 1661, 1588, 1279, 846, 789 cm
−1; HRMS
(ESI, m/z) calcd for C18H12FNONa [M + Na]
+: 300.0801; found:
300.0802.
(5-Chloro-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 3z,
Scheme 3 .15b The same general procedure was followed by
using 2-(4-chlorophenyl)pyridine (38.0 mg, 0.2 mmol, 1.0 equiv.),
2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv.),
Organic & Biomolecular Chemistry Paper
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potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv.) and
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.). Column
chromatography (SiO2, eluting with 7 : 3 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (33.0 mg, 56%),
mp 113–115 °C. 1H NMR (600 MHz, CDCl3): δ 8.36 (d, J =
4.2 Hz, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.69 (dd, J = 8.4 Hz,
1.2 Hz, 2H), 7.57–7.61 (m, 2H), 7.52 (d, J = 1.8 Hz, 1H), 7.50 (d,
J = 8.4 Hz, 1H), 7.40–7.43 (m, 1H), 7.30 (t, J = 7.8 Hz, 2H),
7.04–7.06 (m, 1H); 13C NMR (150 MHz, CDCl3): δ 195.8, 155.4,
148.9, 141.0, 137.7, 137.2, 136.6, 134.9, 132.6, 130.2, 129.9,
129.3, 129.0, 128.2, 122.4, 122.2; IR (neat): νmax 1688, 1588,
1458, 1276, 786 cm−1; HRMS (ESI, m/z) calcd for
C18H12ClNONa [M + Na]
+: 316.0505; found: 316.0502.
(5-Bromo-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 3aa,
Scheme 3 .29a The same general procedure was followed by
using 2-(4-bromophenyl)pyridine (47.0 mg, 0.2 mmol,
1.0 equiv.), 2-oxo-2-phenylacetaldehyde (40 mg, 0.3 mmol,
1.5 equiv.), potassium persulfate (108 mg, 0.4 mmol, 2.0 equiv.)
and palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.).
Column chromatography (SiO2, eluting with 7 : 3 hexane/ethyl
acetate) aﬀorded the desired product as a white solid,
(28.5 mg, 42%), mp 109–111 °C. 1H NMR (600 MHz, CDCl3):
δ 8.36 (d, J = 4.2 Hz, 1H), 7.74 (dd, J = 7.8 Hz, 1.8 Hz, 1H),
7.66–7.69 (m, 4H), 7.59 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.50 (d, J =
7.8 Hz, 1H), 7.42 (t, J = 7.2 Hz, 1H), 7.30 (t, J = 7.8 Hz, 2H), 7.04
(dd, J = 6.6 Hz, 4.8 Hz, 1H); 13C NMR (150 MHz, CDCl3):
δ 196.2, 155.5, 149.0, 141.1, 138.2, 137.2, 136.6, 133.1, 132.6,
131.8, 130.1, 129.4, 128.2, 123.0, 122.4, 122.3; IR (neat):
νmax 1668, 1587, 1458, 1275, 786 cm
−1; HRMS (ESI, m/z) calcd
for C18H12BrNONa [M + Na]
+: 360.0000, 361.9979; found:
359.9971, 361.9979.
(3-Methyl-2-(pyridin-2-yl)phenyl)(phenyl)methanone, 3ab,
Scheme 3 .26b The same general procedure was followed by
using 2-(o-tolyl)pyridine (34.0 mg, 0.2 mmol, 1.0 equiv.), 2-oxo-
2-phenylacetaldehyde (40 mg, 0.3 mmol, 1.5 equiv.), potassium
persulfate (108 mg, 0.4 mmol, 2.0 equiv.) and palladium(II)
acetate (4.5 mg, 0.02 mmol, 0.1 equiv.). Column chromato-
graphy (SiO2, eluting with 7 : 3 hexane/ethyl acetate) aﬀorded
the desired product as a colourless oil, (27.0 mg, 50%).
1H NMR (600 MHz, CDCl3): δ 8.49 (d, J = 4.2 Hz, 1H), 7.65 (d,
J = 7.2 Hz, 2H), 7.60 (t, J = 7.2 Hz, 1H), 7.46 (d, J = 7.2 Hz, 1H),
7.40–7.43 (m, 2H), 7.37 (d, J = 7.2 Hz, 1H), 7.28–7.31 (m, 3H),
7.08 (dd, J = 6.6 Hz, 5.4 Hz, 1H), 2.30 (s, 3H); 13C NMR
(150 MHz, CDCl3): δ 198.2, 157.3, 148.7, 140.0, 137.6, 136.8,
136.1, 132.6, 132.5, 129.9, 129.8, 128.0, 127.9, 126.2, 125.3,
121.9, 20.1; IR (neat): νmax 1666, 1589, 1282, 752, 707 cm
−1;
HRMS (ESI, m/z) calcd for C19H15NONa [M + Na]
+: 296.1051;
found: 296.1062.
General experimental procedure for the dehydrogenative
acylation reaction between 2-phenylpyridines and aldehydes,
Scheme 4
To an oven-dried 7 mL clear vial was added a mixture of 2-phenyl-
pyridines (0.2 mmol, 1.0 equiv.) and palladium(II) acetate
(4.6 mg, 0.02 mmol, 0.1 equiv.) and then dry MeCN (3.0 mL)
was added to it. The corresponding aldehydes (0.3 mmol,
1.5 equiv.) were added to the reaction mixture. After flushing
with nitrogen for 30 seconds, the vessel was immediately
sealed with a screw cap. Then aq. TBHP (82 µL, 0.6 mmol,
3.0 equiv.) was added to the reaction mixture via micro-liter
syringe. The reaction mixture was allowed to stir for 36 h at
room temperature. After completion (as indicated by TLC), the
reaction mixture was quenched with NaHCO3. Then the reac-
tion mixture was poured into water (40 mL) and extracted with
ethyl acetate (40 mL). The organic layer was washed with water
(10 mL) and brine (10 mL), dried over anhydrous Na2SO4 and
the solvent was evaporated under reduced pressure. The
crude product was purified by column chromatography using
ethyl acetate/hexane as the eluent to aﬀord the desired
product.
Methyl 4-(2-(pyridin-2-yl)benzoyl)benzoate, 3ad, Scheme 4 .31a
The same general procedure was followed by using 2-phenyl-
pyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), palladium(II) acetate
(4.5 mg, 0.02 mmol, 0.1 equiv.), methyl 4-formylbenzoate
(49 mg, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl hydroperoxide
(82 µL, 0.6 mmol, 3.0 equiv.). Column chromatography (SiO2,
eluting with 7 : 3 hexane/ethyl acetate) aﬀorded the desired
product as a white solid, (45.5 mg, 72%), mp 100–102 °C.
1H NMR (600 MHz, CDCl3): δ 8.28–8.29 (m, 1H), 7.91 (d, J =
8.4 Hz, 2H), 7.78 (d, J = 7.2 Hz, 1H), 7.71 (d, J = 8.4 Hz, 2H),
7.61–7.64 (m, 1H), 7.54–7.59 (m, 4H), 6.98–7.00 (m, 1H), 3.89
(s, 3H); 13C NMR (150 MHz, CDCl3): δ 197.4, 166.3, 156.1,
148.8, 141.6, 139.4, 139.0, 136.5, 132.8, 130.5, 129.2, 128.9,
128.8, 128.4, 122.2, 122.1, 52.3; IR (neat): νmax 1717, 1664,
1281, 1107, 743 cm−1; HRMS (EI, m/z) calcd for C20H15NO3
[M]+: 317.1052; found: 317.1053.
(3,4-Dichlorophenyl)(2-(pyridin-2-yl)phenyl)methanone, 3ah,
Scheme 4. The same general procedure was followed by using
2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), palladium(II)
acetate (4.5 mg, 0.02 mmol, 0.1 equiv.), 3,4-dichlorobenzalde-
hyde (52.5 mg, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl hydro-
peroxide (82 µL, 0.6 mmol, 3.0 equiv.). Column chromato-
graphy (SiO2, eluting with 7 : 3 hexane/ethyl acetate) aﬀorded
the desired product as a white solid, (31.5 mg, 48%), mp
135–137 °C. 1H NMR (600 MHz, CDCl3): δ 8.33 (d, J = 4.2 Hz,
1H), 7.80 (d, J = 7.2 Hz, 1H), 7.78 (d, J = 1.8 Hz, 1H), 7.63–7.66
(m, 2H), 7.59 (d, J = 7.8 Hz, 1H), 7.55 (t, J = 7.2 Hz, 1H),
7.49–7.53 (m, 2H), 7.34 (d, J = 8.4 Hz, 1H), 7.06–7.08 (m, 1H);
13C NMR (150 MHz, CDCl3): δ 195.7, 156.0, 148.8, 139.3, 138.5,
137.8, 136.6, 136.4, 132.5, 130.9, 130.6, 130.1, 129.0, 128.8,
128.4, 128.2, 122.2, 122.1; IR (neat): νmax 1666, 1580, 1434,
1380, 1275, 955, 747 cm−1; HRMS (ESI, m/z) calcd for
C18H11Cl2NONa [M + Na]
+: 350.0115; found: 350.0117.
(3,4-Dimethoxyphenyl)(2-(pyridin-2-yl)phenyl)methanone, 3ai,
Scheme 4. The same general procedure was followed by using
2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), palladium(II)
acetate (4.5 mg, 0.02 mmol, 0.1 equiv.), 3,4-dimethoxybenz-
aldehyde (50 mg, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl
hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv.). Column
chromatography (SiO2, eluting with 7 : 3 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (48.0 mg, 75%),
mp 108–110 °C. 1H NMR (600 MHz, CDCl3): δ 8.42–8.43
Paper Organic & Biomolecular Chemistry
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(m, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.58–7.60 (m, 1H), 7.56 (td, J =
7.8 Hz, 1.8 Hz, 1H), 7.49–7.52 (m, 2H), 7.46 (d, J = 7.8 Hz, 1H),
7.44 (d, J = 1.8 Hz, 1H), 7.16 (dd, J = 8.4 Hz, 2.4 Hz, 1H),
7.03–7.05 (m, 1H), 6.66 (d, J = 8.4 Hz, 1H), 3.96 (s, 3H), 3.85 (s,
3H); 13C NMR (150 MHz, CDCl3): δ 197.0, 157.0, 152.7, 149.2,
148.6, 139.51, 139.48, 136.2, 130.8, 130.0, 129.0, 128.9, 128.3,
125.2, 122.9, 121.9, 110.9, 109.6, 55.91, 55.89; IR (neat):
νmax 1656, 1588, 1511, 1269, 1128, 753 cm
−1; HRMS (ESI, m/z)
calcd for C20H17NO3Na [M + Na]
+: 342.1106; found: 342.1112.
(4-Methyl-2-(pyridin-2-yl)phenyl)(p-tolyl)methanone, 3aj,
Scheme 4. The same general procedure was followed by using
2-(m-tolyl)pyridine (34.0 mg, 0.2 mmol, 1.0 equiv.), palladium
(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.), 4-methyl-
benzaldehyde (36 µL, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl
hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv.). Column
chromatography (SiO2, eluting with 7 : 3 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (46.0 mg, 80%),
mp 128–130 °C. 1H NMR (600 MHz, CDCl3): δ 8.42 (d, J =
4.2 Hz, 1H), 7.58–7.61 (m, 3H), 7.53 (td, J = 7.8 Hz, 1.8 Hz, 1H),
7.43 (t, J = 7.2 Hz, 2H), 7.32 (d, J = 7.8 Hz, 1H), 7.07 (d, J =
8.4 Hz, 2H), 7.01–7.03 (m, 1H), 2.50 (s, 3H), 2.31 (s, 3H);
13C NMR (150 MHz, CDCl3): δ 198.0, 157.2, 149.1, 143.0, 140.3,
139.8, 136.8, 136.1, 135.4, 129.8, 129.7, 129.2, 129.0, 128.7,
123.1, 121.8, 21.6, 21.4; IR (neat): νmax 1661, 1605, 1467, 1286,
931, 756 cm−1; HRMS (ESI, m/z) calcd for C20H17NONa
[M + Na]+: 310.1208; found: 310.1217.
(4-Methoxy-2-(pyridin-2-yl)phenyl)(p-tolyl)methanone, 3ak,
Scheme 4. The same general procedure was followed by using
2-(3-methoxyphenyl)pyridine (37.0 mg, 0.2 mmol, 1.0 equiv.),
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.), 4-methyl-
benzaldehyde (36 µL, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl
hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv.). Column
chromatography (SiO2, eluting with 7 : 3 hexane/ethyl acetate)
aﬀorded the desired product as a colourless oil, (36.5 mg,
60%). 1H NMR (600 MHz, CDCl3): δ 8.43–8.44 (m, 1H), 7.58 (d,
J = 8.4 Hz, 2H), 7.52–7.55 (m, 2H), 7.39 (d, J = 7.8 Hz, 1H), 7.27
(d, J = 7.8 Hz, 1H), 7.02–7.07 (m, 4H), 3.93 (s, 3H), 2.31 (s, 3H);
13C NMR (150 MHz, CDCl3): δ 197.3, 161.0, 157.2, 149.1, 142.9,
142.1, 136.1, 135.6, 132.0, 131.3, 129.8, 128.7, 123.4, 122.0,
114.6, 113.7, 55.5, 21.5; IR (neat): νmax 2926, 1659, 1603, 1467,
1284, 1223, 1032, 758 cm−1; HRMS (EI, m/z) calcd for
C20H17NO2 [M]
+: 303.1259; found: 303.1256.
(4-(Pyridin-2-yl)-[1,1′-biphenyl]-3-yl)(p-tolyl)methanone, 3am,
Scheme 4. The same general procedure was followed by using
2-([1,1′-biphenyl]-4-yl)pyridine (46.5 mg, 0.2 mmol, 1.0 equiv.),
palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.), 4-methyl-
benzaldehyde (36 µL, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl
hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv.). Column chrom-
atography (SiO2, eluting with 7 : 3 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (38.5 mg, 55%),
mp 145–147 °C. 1H NMR (600 MHz, CDCl3): δ 8.42 (d, J =
4.2 Hz, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.84 (dd, J = 7.8 Hz,
1.8 Hz, 1H), 7.76 (d, J = 1.8 Hz, 1H), 7.67–7.69 (m, 4H), 7.59
(td, J = 7.8 Hz, 1.8 Hz, 1H), 7.55 (d, J = 7.8 Hz, 1H), 7.47 (t, J =
7.8 Hz, 2H), 7.39 (t, J = 7.2 Hz, 1H), 7.11 (d, J = 7.8 Hz, 2H),
7.04–7.06 (m, 1H), 2.34 (s, 3H); 13C NMR (150 MHz, CDCl3):
δ 197.9, 156.5, 149.1, 143.2, 141.2, 140.2, 139.7, 138.3, 136.3,
135.2, 129.8, 129.3, 128.9, 128.8, 128.5, 127.9, 127.5, 127.1,
122.6, 121.9, 21.6; IR (neat): νmax 1662, 1596, 1462, 1245,
758 cm−1; HRMS (ESI, m/z) calcd for C25H19NONa [M + Na]
+:
372.1364; found: 372.1364.
1-(3-(4-Methylbenzoyl)-4-(pyridin-2-yl)phenyl)ethanone, 3an,
Scheme 4. The same general procedure was followed by using
1-(4-(pyridin-2-yl)phenyl)ethanone (39.5 mg, 0.2 mmol,
1.0 equiv.), palladium(II) acetate (4.5 mg, 0.02 mmol, 0.1 equiv.),
4-methylbenzaldehyde (36 µL, 0.3 mmol, 1.5 equiv.), and aq.
tert-butyl hydroperoxide (82 µL, 0.6 mmol, 3.0 equiv.). Column
chromatography (SiO2, eluting with 7 : 3 hexane/ethyl acetate)
aﬀorded the desired product as a white solid, (28.0 mg, 45%),
mp 89–91 °C. 1H NMR (600 MHz, CDCl3): δ 8.41–8.42 (m, 1H),
8.19 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 8.07 (d, J = 1.8 Hz, 1H), 7.89
(d, J = 8.4 Hz, 1H), 7.59–7.64 (m, 3H), 7.55 (d, J = 7.8 Hz, 1H),
7.08–7.11 (m, 3H), 2.66 (s, 3H), 2.34 (s, 3H); 13C NMR
(150 MHz, CDCl3): δ 197.1, 197.0, 155.6, 149.2, 143.6, 143.5,
140.0, 136.6, 136.5, 134.8, 129.6, 129.5, 129.2, 128.9, 122.9,
122.6, 26.8, 21.6; IR (neat): νmax 2925, 1682, 1599, 1300, 1243,
756 cm−1; HRMS (EI, m/z) calcd for C21H17NO2 [M]
+: 315.1259;
found: 315.1248.
(2-(Pyridin-2-yl)phenyl)(thiophen-3-yl)methanone, 3ap,
Scheme 4. The same general procedure was followed by using
2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), palladium(II)
acetate (4.5 mg, 0.02 mmol, 0.1 equiv.), thiophene-3-carbalde-
hyde (26 µL, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl hydro-
peroxide (82 µL, 0.6 mmol, 3.0 equiv.). Column chromato-
graphy (SiO2, eluting with 7 : 3 hexane/ethyl acetate) aﬀorded
the desired product as a colourless oil, (30.0 mg, 56%).
1H NMR (600 MHz, CDCl3): δ 8.46 (d, J = 4.2 Hz, 1H), 7.77 (d,
J = 7.2 Hz, 1H), 7.58–7.62 (m, 4H), 7.52 (t, J = 7.2 Hz, 1H), 7.49
(d, J = 7.8 Hz, 1H), 7.42 (d, J = 4.8 Hz, 1H), 7.15–7.16 (m, 1H),
7.07–7.09 (m, 1H); 13C NMR (150 MHz, CDCl3): δ 191.8, 157.0,
149.2, 142.8, 140.0, 139.4, 136.3, 133.9, 130.3, 129.2, 128.7,
128.4, 127.6, 125.8, 122.9, 121.9; IR (neat): νmax 1656, 1586,
1428, 1273, 858, 752 cm−1; HRMS (ESI, m/z) calcd for
C16H11NSONa [M + Na]
+: 288.0459; found: 288.0460.
3-Methyl-1-(2-(pyridin-2-yl)phenyl)but-2-en-1-one, 3as,
Scheme 4. The same general procedure was followed by using
2-phenylpyridine (31.0 mg, 0.2 mmol, 1.0 equiv.), palladium(II)
acetate (4.5 mg, 0.02 mmol, 0.1 equiv.), 3-methylbut-2-enal
(29 µL, 0.3 mmol, 1.5 equiv.), and aq. tert-butyl hydroperoxide
(82 µL, 0.6 mmol, 3.0 equiv.). Column chromatography (SiO2,
eluting with 7 : 3 hexane/ethyl acetate) aﬀorded the desired
product as a colourless oil, (15.0 mg, 76%). 1H NMR (600 MHz,
CDCl3): δ 8.64 (d, J = 4.8 Hz, 1H), 7.72 (td, J = 7.8 Hz, 1.8 Hz,
1H), 7.62 (d, J = 7.2 Hz, 1H), 7.58 (d, J = 7.8 Hz, 1H), 7.52–7.54
(m, 1H), 7.46–7.48 (m, 2H), 7.22–7.24 (m, 1H), 6.03 (s, 1H),
2.08 (s, 3H), 1.72 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 196.0,
158.1, 154.8, 149.2, 142.1, 139.4, 136.1, 130.1, 129.5, 128.4,
128.1, 125.3, 123.5, 122.0, 27.5, 20.7; IR (neat): νmax 2926,
1666, 1615, 1434, 1236, 1012, 752 cm−1; HRMS (ESI, m/z) calcd
for C16H15NONa [M + Na]
+: 260.1051; found: 260.1057.
For the spectroscopy data of compounds 3ac, 3ae, 3af, 3ag,
3al, 3ao, 3aq, 3ar, 3at, 3au and 3av, see the ESI.†
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CuI/AgI-Promoted Decarboxylative Alkynylation of
ortho-Nitro Benzoic Acids
Asik Hossian,[a, b] Kartic Manna,[a, b] Pritha Das,[a, b] and Ranjan Jana*[a, b]
We report herein, a novel copper-silver-promoted alkynylation
of ortho-nitrobenzoic acids with arylacetylenic acids through a
double decarboxylation. The present cross-coupling is ex-
tremely challanging due to sluggish decarboxylation of arene
carboxylates and deleterious oxidative Glaser-Hay type homo-
coupling of terminal alkynes. Mechanistically, this sp2-sp cross-
coupling may proceed through a silver-assisted decarboxyla-
tion of 2-nitrobenzoic acids followed by transmetalation with
copper-acetylide and reductive elimination. The ortho-nitro-
acetylenic product is an important precursor for the synthesis
of functionalized indoles.
Introduction
Owing to their unique reactivity as nucleophile as well as
electrophile, alkynes are used as one of the most versatile
functional groups in organic synthesis and represent an
impressive array of utilities in the fuel industry, advanced
materials, chemical biology and drug development.[1] However,
installation of the alkyne moiety into the organic backbone is
heavily dependent on the Sonogashira cross-coupling between
vinyl/aryl halides and terminal acetylenes in the presence of
palladium/copper(I) bimetallic catalyst.[2] Therefore, develop-
ment of novel methodology for the synthesis of structurally
diverse alkynes is highly desirable. In fact, the direct alkynyla-
tion through CH bonds activation has been investigated in
the last decade.[3] But installation of the directing groups to
control site-selectivity and their subsequent removal precludes
the synthetic fidelity.[4]
As an alternative to conventional cross-coupling or CH
functionalization reactions, decarboxylative cross-coupling has
emerged as a modern strategy using readily available and
inexpensive; air and moisture stable carboxylic acids as
coupling partner.[5] In this case, a mechanistically distinct
decarboxylative metalation occurs through the extrusion of
CO2. Although decarboxylative biaryl and Heck-type cross-
coupling has been well-explored, decarboxylative alkynylation
remain underdeveloped.[6] In this vein, three different classes of
carboxylic acids have been explored- 1) the propiolic acids
undergo decarboxylative metalation to form metal-acetylides
for subsequent arylation and heterodiarylation,[7] allylation and
benzylation;[8] 2) a-oxocarboxylic acids serve as an excellent
acyl radical equivalent which have also been utilized in the
decarboxylative ynone synthesis[9] and recently, 3) alkyl carbox-
ylic acids have showcased tremendous potential in decarbox-
ylative alkynylation reactions under radical conditions.[10] To the
best of our knowledge, there is no report of decarboxylative
sp2-sp cross-coupling using arene carboxylic acids. This might
be ascribed due to sluggish decarboxylation of arene carbox-
ylates and deleterious oxidative Glaser-Hay type homocoupling
of terminal alkynes. For the first time, we report herein a
copper(I)/silver(I)-promoted decarboxylative sp2-sp cross-cou-
pling between 2-nitrobenzoic acid derivatives and alkyne
carboxylic acids via double decarboxylation. 2-Alkynylated nitro-
arene product obtained in this protocol is a crucial precursor
for the synthesis of a plethora of N-heterocycles especially
functionalized indoles.[11]
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Results and Discussion
Initially, 2-nitrobenzoic acid (1a, Table 1) and phenyl acetylene
were chosen as model substrates for the optimization of
decarboxylative alkynylation reaction. However, no desired
alkynylation product was obtained except oxidative homocou-
pling of phenyl acetylene with catalytic palladium(0)/copper(I)
iodide. We realized that decarboxylative metalation of nitro-
benzoic acid is a slower process compared to copper-assisted
homocoupling of phenyl acetylene. To circumvent, we chose
phenylpropiolic acid (2a, Table 1) to induce parity in decarbox-
ylation steps of two cross-coupling partners.[6b,12] Since palla-
dium did not afford the desired product and silver is known to
accelerate decarboxylation process, we decided to use silver(I)/
copper(I) bimetallic system which was originally developed by
the Gooßen’s group.[13] Subsequent trials with catalytic copper
(I) iodide (20 mol %), in presence of silver(I) carbonate
(1.0 equiv) and cesium carbonate (1.0 equiv) afforded decarbox-
ylative protonation of 2-nitrobenzoic acid and 20% of alkyne
homocoupling product 4a (entry 1, Table 1). We hypothesized
that sufficient copper-acetylide is essential for the transmetala-
tion with aryl-silver species which is formed through decarbox-
ylation. As expected, increasing the amount of copper(I)iodide
to 0.5 and 1.0 equiv. the yield of the desired product was
increased to 10% and 28% respectively (entry 2 and 3, Table 1).
We examined several ligands such as triphenylphosphine, 1,10-
phenanthroline, 2-methylpyridine etc. with catalytic as well as
stoichiometric amount of copper(I) catalyst but did not
improved the yield further (entry 4, Table 1). Only dtbpy (30%)
ligand is provided albeit in low yield (28%) with catalytic
amount of copper (30%) (entry 21, Table 1). But unfortunately,
after screening several parameters we did not get the improved
yield under the catalytic conditions. Other copper catalysts
such as copper(I) bromide, copper(I) chloride, copper(II)
chlorides, copper(II) acetates etc. also afforded interior results
(entry 6,7, 19 Table 1). Among the bases screened, potassium
tert-butoxide was found to be superior to other bases such as
K2CO3, NEt3, piperidine, pyrrolidine etc. and obtained 40% yield
of alkynylation product (3a) along with 45% of 4a (entry 8–11,
Table 1). Other solvents such as DMA, DMSO, NMP, CH3CN, etc.
provided inferior results (for details see the Supporting
Information). Other several additives were also screened but
provided lower yield (entry 12–14, Table 1). Interestingly, the
yield of desired alkynylation product (3a) was increased to 52%
using 1.2 equiv. of copper(I) iodide under air (entry 15, Table 1).
To accelerate the rate of decarboxylation of 2-nitrobenzoic acid,
2.0 equiv. of silver(I) carbonate was necessary (entry 16, Table 1).
Finally heating the reaction mixture at 130 oC for 24 h in a
combination of 1.2 equiv. of copper(I) iodide, 2.0 equiv. of silver
(I) carbonate and 1.0 equiv. of potassium tert-butoxide, the
alkynylation product (3a) was isolated in 64% yield along with
52% of alkyne homocoupling product (4a) (entry 17, Table 1).
Interestingly, aerial oxygen was necessary and sufficient for the
transformation whereas purging with excess oxygen found to
be detrimental (entry 18, Table 1). However, we were unable to
suppress alkyne homocoupling product formation even after
rigorous screening.
A wide variety of substituents such as alkyl, alkoxyl, chloro
on 2-nitrobenzoic acid underwent decarboxylative coupling
providing moderate to good yield under the optimized reaction
conditions (Table 2). To compare, several reactions were also
performed with arylacetylenes to furnish the corresponding
alkynylation product (Table 2). Various substituents on phenyl-
acetylene and/or phenylacetylynic acid such as alkyl (3g-3 i,
3m, 3o, 3q, 3r, Table 2), aryl (3 j, Table 2), methoxy (3n, 3p,
Table 2), chloro (3k, 3t, Table 2), bromo (3s, Table 2), fluoro (3 l,
Table 2), trifluoromethoxy (3u, Table 2) were well-tolerated
under the reaction conditions. The ortho substituted phenyl-
propiolic acids also took part in the reaction providing high to
good yield (3g, 3o, 3q, Table 2). However, other benzoic acids
such as ortho-methoxybenzoic acid, pentafluorobenzoic acid,
para-nitrobenzoic acid and heteroaryl carboxylic acids and also
alkylated propiolic acids did not furnish any desired product. It
was found that the nitro group at ortho position of arene
carboxylic acids is essential to the desired cross-coupling
presumable due the strong inductive effect and coordinating
ability of the nitro group that may stabilizes the incipient anion
which is formed after decarboxylation. Ortho nitrobenzoic acids
with another electron-deficient substituent such as 2,4-dinitro-
Table 1. Optimization of the Reaction Conditions[a]
entry Copper (I) additive base yield (%)[b] [3a 4a[c]]
1[d] CuI (0.2 equiv) Ag2CO3 Cs2CO3 0 20
2 CuI (0.5 equiv) Ag2CO3 Cs2CO3 10 48
3 CuI (1.0 equiv) Ag2CO3 Cs2CO3 28 42
4[e] CuI (1.0 equiv) Ag2CO3 Cs2CO3 0 45
5[f] CuI (1.0 equiv) Ag2CO3 Cs2CO3 nd 35
6 CuCl (1.0 equiv) Ag2CO3 Cs2CO3 20 44
7 CuBr(1.0 equiv) Ag2CO3 Cs2CO3 18 40
8 CuI (1.0 equiv) Ag2CO3 K2CO3 20 41
9 CuI (1.0 equiv) Ag2CO3 pyrrolidine 30 50
10 CuI (1.0 equiv) Ag2CO3
tBuOK 40 45
11 CuI (1.0 equiv) Ag2CO3 NEt3 0 52
12 CuI (1.0 equiv) Ag2O
tBuOK 27 62
13 CuI (1.0 equiv) AgOAc tBuOK 5 38
14 CuI (1.0 equiv) K2S2O8
tBuOK 0 60
15[g] CuI (1.2 equiv) Ag2CO3
tBuOK 52 57
16[g,h] CuI (1.2 equiv) Ag2CO3
tBuOK 60 54
17[g,h,i] CuI (1.2 equiv) Ag2CO3
tBuOK 64 52
18[h,i,j] CuI (1.2 equiv) Ag2CO3
tBuOK 32 55
19[g,h,i] CuCl2 (1.2 equiv) Ag2CO3
tBuOK 30 65
20[g,h,i] CuI (1.0 equiv) Ag2CO3 - 0 75
21[g,h,i,k] CuI (0.3 equiv) Ag2CO3
tBuOK 28 37
[a]All reactions were carried out in 0.2 mmol scale using 1a (1.0 equiv) and
2a (2.5 equiv). [b]Yields refer to here are isolated yields. [c]% of yield for 4a
based on total amount of 2a was taken. [d]1.5 equiv. of 2a was used. [e]1.0
equiv. of PPh3 or 1,10-phenanthroline ligand or 2-methylpyridine was used.
[f]0.2 equiv. of Ag2CO3 was used.
[g]Reaction was run under air. [h]2.0 equiv. of
Ag2CO3 was used.
[i]The reaction was heated at 130 oC. [j]Reaction was run
under O2.
[k]30% dtbpy ligand was used.
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benzoic acid resulted in decarboxylative protonation product
only. This indicates that electron withdrawing substituents may
facilitate the decarboxylation but they decrease the ability of
the aryl anion to serve as a s-donor for the copper(II)-acetylide.
The same observation was also found in our previous work of
decarboxylative allylation of ortho nitrobenzoic esters.[14] Selec-
tive reduction of nitro group followed by cyclization leads to
the formation of 2-phenylindole from 3a (see the Supporting
Information).
Reaction Mechanism
Next, we performed few control experiments to gain insight of
the reaction mechanism. The standard reaction without copper
salt did not furnish any desired alkynylation product (3a)
instead nitrobenzene (4a“) was formed predominantly through
decarboxylative protonation and a trace amount of alkyne
homocoupling product (4a) (Scheme 2). Furthermore, in the
absence of silver salt alkyne homocoupling product (4a) was
favored (80%) along with the formation of nitrobenzene (4a‘‘)
(12%) (Scheme 2). Therefore, copper is involved in the
formation of copper-acetylide via decarboxylation of propiolic
acids and silver is participating in the formation of aryl-Ag
species via decarboxylation of the nitrobenzoic acids.
Based on these control experiments and previous literature
on copper/silver bimetallic system,[13] it is speculated that
initially a silver carboxylate forms followed by aryl-silver species,
1a’’ (Scheme 3) through the extrusion of CO2. On the other
hand, a copper(I)-acetylide, 2a’’ is formed either via decarbox-
ylative metalation of arylpropiolic carboxylate which is form
through base mediated deprotonation of arylpropiolic acid or
direct deprotonation of the phenylacetylene by base which is
converted to copper(II)-acetylide, 2a’’’ (Scheme 3) under the
oxidative conditions here aerial oxygen or silver may acts as an
oxidant. Subsequently, a transmetalation between aryl-silver
Table 2. Substrate Scope of Decarboxylative Alkynylation[a],[b]
[a]All reactions were carried out in 0.2 mmol scale using 1 (1.0 equiv) and 2
(2.5 equiv).[b]Yields refer to the average of isolated yields of at least two
experiments.[c]In every cases 40–50% yield of 4 was separated with respect
to total amount of 2 was taken.
Scheme 2. Control Experiments
Scheme 3. Plausible Mechanism
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and copper(II)-acetylide may leads to the aryl,alkyne-copper
intermediate, 3a’ (Scheme 3). There is a possibility of dispro-
portionation to generate copper(III) species for facile reductive
elimination at this step and generate a copper(I) species for
subsequent runs.[15] However, under the stoichiometric copper
salt catalysis direct reductive elimination from the copper(II)
intermediate to furnish the alkynylation product is also
plausible. However, the exact mechanism is unclear at this
moment and warrants further studies.
Conclusions
In conclusion, we have developed a novel CuI/AgI-promoted
alkynylation of nitroarenes through a double decarboxylation.
This present approach of using two decarboxylations in an
oxidative alkynylation is an excellent strategy to address
challenging alkynylations. The 2-alkynyl nitroarenes serve as an
important precursor for the synthesis of a plethora of N-
heterocycles especially functionalized indoles.
Supporting Information Summary
The Supporting Information contains optimization details,
experimental procedures, all the spectroscopic data, 1H and
13CNMR spectra for all synthesized compounds.
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Carboxyl radical-assisted 1,5-aryl migration
through Smiles rearrangement†
Asik Hossiana,b and Ranjan Jana*a,b
We report herein, a silver(I)-catalyzed Smiles rearrangement of 2-aryloxy- or 2-(arylthio)benzoic acids to
provide aryl-2-hydroxybenzoate or aryl-2-mercaptobenzoate dimer, respectively, through 1,5-aryl
migration from oxygen or sulfur to carboxylate oxygen. Mechanistically, the aryl ether moiety undergoes
an intramolecular ipso attack by the carboxyl radical followed by a C–O or C–S bond cleavage. Aryl-2-
mercaptobenzoates undergo oxidative dimerization through a thiol moiety in situ.
Introduction
The rearrangement reactions provide concise routes to atom-
economic synthesis in organic chemistry.1 In this vein, the
Smiles rearrangement oﬀers a unique opportunity to the syn-
thesis of privileged medicinal scaﬀolds originally through an
intramolecular nucleophilic aromatic substitution.2 Varieties
of Smiles rearrangement such as Truce–Smiles,3 Ugi–Smiles4
have been explored for multicomponent reactions (MCR) in
medicinal chemistry. However, the potential of radical-Smiles
rearrangement has been realized recently.5 Notably, the Zard
group explored a peroxide-mediated radical-Smiles rearrange-
ment to access aryl- or pyridylacetic acid derivatives from
N-(α-xanthyl)acetanilides or N-(α-xanthyl)acetylaminopyri-
dines, respectively.6 Recently, a photoredox-catalyzed synthesis
of a difluoro-substituted spirocyclic ORL-1 antagonist through
radical-Smiles rearrangement was reported by the Stephenson
group which provides an alternative and practical route with
easily available starting materials at industrially relevant scale
and catalyst loading.7
Carboxylic acids have been explored as inexpensive, readily
available, air- and moisture-stable cross-coupling partners.8
The Glorius group reported a palladium-catalyzed decarboxyla-
tive intramolecular C–H arylation to aﬀord dibenzofuran using
2-aryloxybenzoic acids.9 Alternatively, silver(I)-catalyzed decar-
boxylative Pschorr-type cyclization to aﬀord fluorenone was
reported by the Greaney group.10 The Baran group also
employed this Ag(I)/K2S2O8 catalytic system for the generation
of aryl radicals from a boronate counterpart which has been
trapped intra- and intermolecularly.11 Recently, a similar cata-
lytic system has been utilized for the decarboxylative Minisci-
type arylation with benzoic acid derivatives.12 Intrigued by
these earlier reports we were interested to develop a silver-cata-
lyzed decarboxylative dibenzofuran synthesis from 2-aryloxy-
benzoic acids in an intramolecular fashion. Interestingly, we
observed 1,5-aryl migration through Smile-type rearrangement
in lieu of the expected decarboxylative dibenzofuran formation
(Scheme 1). Since radical aryl migration is a useful tool in
organic synthesis,13 we were interested to develop this
rearrangement reaction. From literature, a persulfate-mediated
uncontrolled 1,5-aryl migration/oxidative dimerization cascade
in water was reported.14 Surprisingly, in our present study, the
1,5-aryl migratory product formed predominantly and a trace
amount (<5%) of dimerization product was observed in elec-
trospray ionization (ESI) mass spectrometry of the crude reac-
tion mixture (see the ESI†). A copper-catalyzed domino aryl
Scheme 1 Divergent syntheses from ortho-substituted benzoic acids.
†Electronic supplementary information (ESI) available: Starting materials prepa-
ration, control experiments, optimization details, 1H, 13C NMR spectra for all
synthesized compounds, and crystallographic data of 2t. CCDC 1498919. For ESI
and crystallographic data in CIF or other electronic format see DOI: 10.1039/
c6ob01758d
aOrganic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical
Biology, 4 Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, West Bengal, India
bAcademy of Scientific and Innovative Research (AcSIR), Kolkata-700032,
West Bengal, India. E-mail: rjana@iicb.res.in
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migration/C–O/C–N bond formation for the synthesis of di-
benzoxazepinones,15 and a base-promoted 1,5-aryl migration
through Smiles rearrangement were reported.16 However, the
latter protocol is limited to the nicotinamides only where the
phenolic hydroxyl group is stabilized by the ortho pyridinyl
nitrogen. We report herein, a silver(I)-catalyzed 1,5-aryl
migration of 2-aryloxybenzoic acids via C–O/C–S bond cleavage
and C–O bond formation cascade. The corresponding
thioethers provided the rearranged product with disulfide
bond formation under this oxidative condition.
Results and discussion
To optimize the reaction conditions, 2-phenoxybenzoic acid
was chosen as a model substrate. Initially, a catalytic amount
of silver(I) nitrate in the presence of 3.0 equiv. of K2S2O8
aﬀorded the Smiles rearrangement product in 34% yield.
Decreasing the amount of oxidant to 1.5 equiv., the yield was
further improved. However, other common oxidants such as
aq. tert-butyl hydroperoxide, (diacetoxyiodo)benzene (PIDA),
benzoyl peroxide or even ammonium persulfate were not
eﬀective for this transformation. Similarly, other silver salts,
palladium(II) triflate, tris(acetylacetonato)iron(III) , nickel(II) tri-
flate, copper(II) acetate and tetrabutylammonium iodide were
proved to be inferior catalysts compared to silver(I) nitrate.
Gratifyingly, the yield was improved with the addition of
sodium trifluoroacetate as a base. After screening several
bases, ultimately potassium trifluoroacetate provided the
migratory product in good yields (for details see the ESI†).
Acetonitrile was the solvent of choice since other solvents such
as dichloroethane, N,N-dimethylformamide, toluene etc.
aﬀorded no or inferior yields. A substantial amount of
decomposition product formation was observed which we
could not eliminate even after rigorous optimization.
Interestingly, salicylic acid formation through hydrolysis of the
Smiles rearrangement product was not observed under the
reaction condition.
Next we explored the substrate scope under the optimized
reaction conditions. The starting materials were synthesized
through a copper-catalyzed cross-coupling of 2-halobenzoic
acid and phenol or thiophenol derivatives. A wide range of
substrates underwent Smiles rearrangement to provide 1,5-aryl
migratory products. Several substituents on the phenol com-
ponent such as alkyl (2g, 2k, 2p, Scheme 2), aryl (2h,
Scheme 2), alkoxyl (2e, 2f, 2l, 2n, Scheme 2), chloro (2c, 2m,
2u, Scheme 2), bromo (2d, Scheme 2) and fluoro (2b,
Scheme 2), were well tolerated under the reaction conditions.
Scheme 2 Substrate scope with diaryl ethers. The reaction was carried
out in 0.1 mmol scale, 0.05 M. The yield referred to here is the average
isolated yield of at least two experiments. a The reaction was performed
in 0.5 mmol scale.
Table 1 Optimization of the reaction conditionsa,b
Entry
Catalyst
(5 mol%)
Oxidant
(1.5 equiv.)
Base
(2.0 equiv.)
Yieldb
(%)
1c AgNO3 K2S2O8 — 34
2 AgNO3 K2S2O8 — 44
3 AgNO3 aq. TBHP — 0
4 AgNO3 (NH4)2S2O8 — 27
5 AgNO3 PhI(OAc)2 — 0
6 AgNO3 (PhCOO)2 — Trace
7 AgOAc K2S2O8 — 34
8 Ag2CO3 K2S2O8 — 36
9 Pd(TFA)2 K2S2O8 — Trace
10 Fe(acac)3 K2S2O8 — 36
11 Ni(OTf)2 K2S2O8 — 35
12 Cu(OAc)2 K2S2O8 — 25
13 TBAI K2S2O8 — 30
14 AgNO3 K2S2O8 CF3CO2Na 50
15 AgNO3 K2S2O8 CF3CO2K 64
16 — K2S2O8 CF3CO2K 37
17 AgNO3 — CF3CO2K 0
a All reactions were carried out in 0.1 mmol scale. b Yields refer to here
are overall isolated yields. c 3.0 equiv. of K2S2O8 was used.
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Interestingly, substrates derived from 1- and 2-naphthols (2i,
2j, 2q, Scheme 2) also furnished the migratory products in
good yields. Similarly, substitutions on the benzoic acid
moiety such as fluoro (2o–2q, Scheme 2), chloro (2r,
Scheme 2), and nitro groups (2s–2u, Scheme 2) were also toler-
ated. A representative structure of the migratory product has
been unambiguously characterized by X-ray crystallography
(2t). An electron-rich benzoic acid such as 5-methoxy-2-phe-
noxybenzoic acid, 1v was unreactive under the reaction con-
dition, however, it was diﬃcult to predict the influence of the
electronic nature of the substituents since a substantial
amount of decomposition products were observed.
Unfortunately, the yield of the products was decreased to some
extent at higher scale. For example, in a reaction at 0.5 mmol
scale, 1a provided 50% yield of the desired product 2a
(Scheme 2). Similarly, 2c and 2e were isolated in 40 and 48%
yields respectively at 0.5 mmol scale. Phenyl ether of nicotinic
acid, 1w, did not provide any desired product. Interestingly,
the corresponding benzamide in place of benzoic acid did not
aﬀord any desired product which indicates a distinct reaction
mechanism to the base-promoted anionic Smiles rearrange-
ment.16 The desired product was hydrolyzed to provide the
corresponding salicylic acid (6a) and phenol in an alcoholic
sodium hydroxide solution (see the ESI†).
On the accomplishment of Smiles rearrangement of 2-aryl-
oxybenzoic acids, we were interested to examine the migratory
event of the corresponding thioethers. Under the optimized
conditions, the corresponding migratory product (4a) with di-
sulfide bond was isolated albeit in moderate yield and a sub-
stantial amount of starting material was recovered.
Gratifyingly, excellent to good yield of the corresponding
Smiles rearrangement product was isolated by simply omitting
the base from the standard reaction conditions. From 1H NMR
and mass spectroscopy it was also confirmed that the free
thiol groups underwent oxidative homocoupling to furnish the
disulfide linkage in situ. This rearranged disulfide product was
also observed as a byproduct (15%) in the persulfate mediated
oxidation of diphenyl sulfide-2-carboxylic acids.17 Gratifyingly,
under our optimized conditions, a number of 2-arylmarcapto
benzoic acids with diﬀerent substituents provided the 1,5-aryl
migratory products followed by oxidative homocoupling pro-
ducts in good to high yields (Scheme 3). Unfortunately,
5-methoxy-2-(phenylthio)benzoic acid was unreactive under
the reaction conditions. The disulfide linkage was easily
reduced to the corresponding thiols (5a) with triphenyl-
phosphine (see the ESI†).
Investigation of the reaction mechanism
We performed several control experiments to understand the
mechanism of this unexpected result. Generation of an aryl
radical through the decomposition of aryl diazonium salts and
aryl boronates is an energetically favourable process which
occurs spontaneously under mild conditions.11,18 However,
generation of an aryl radical through decarboxylation is a high
energetic process which occurs at elevated temperature.12 In
the case of 2-aroylbenzoic acid, the incipient radical generated
through decarboxylation is stabilized by the ortho-ketone
group.10 In contrast, in this present study, the incipient radical
is destabilized by the ortho ether moiety. This is consistent
with our previous observation that ortho, ortho-dimethoxy car-
boxylic acid does not decarboxylate with silver(I) catalyst
whereas palladium catalyst is eﬀective.19 Previously, an Ag(I)/
K2S2O8 catalytic system has been utilized for C–H carboxyla-
tion in the biaryl system.20 However, in this case C–H insertion
of the carboxyl radical is not favoured due to the formation of
a seven-membered ring. Instead, an ipso attack to the ether
carbon is favoured and a concomitant homolytic C–O bond
cleavage may occur. Typically, reductive cleavage of an inert
diaryl ether linkage is possible by nickel catalyst.21 However,
simple diaryl ethers or 2-aryloxybenzamides did not furnish
any product under this optimized condition. Therefore, 2-car-
boxylic acid was found to be crucial for the reaction to occur.
The reaction was completely arrested with the addition of
radical scavengers such as 2.0 equiv. of 2,2,6,6-tetramethyl-
piperidinyl-1-oxy (TEMPO) or 4.0 equiv. of butylated hydroxy-
toluene (BHT) (Scheme 4a). Therefore, the reaction would
appear to proceed through a radical mechanism. The involve-
ment of a radical mechanism is further supported by the fact
that the reaction also proceeds with persulfate in the absence
of silver(I) nitrate to provide the desired product in moderate
yield (entry 16, Table 1).14,17 In order to gain insight further,
we performed a cross-over experiment. When an equimolar
mixture of 1e and 1t was subjected to the reaction conditions
no cross-over products were detected in 1H NMR as well as ESI
mass spectrometry (Scheme 4b) (see the ESI†). This suggests
that the reaction may involve an intramolecular rearrangement
for 1,5-aryl migration.
From the control experiments and substitution pattern of
the observed products, we postulated the reaction mechanism.
In the presence of catalytic silver(I) salt and stoichiometric per-
sulfate anion the carboxyl radical I (Scheme 5) is generated.
Instead of decarboxylation the carboxyl radical then undergoes
Scheme 3 Substrate scope with diaryl thioethers. The reaction was
carried out in 0.2 mmol scale, 0.05 M. The yield referred to here is the
average isolated yield of at least two experiments.
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an ipso attack to the arylether moiety II (Scheme 5). A concomi-
tant homolytic C–O bond cleavage occurs which lead to the
formation of aryl ester through 1,5 aryl migration IV
(Scheme 5). The incipient phenoxyl radical may abstract a
hydrogen atom from solvent or reaction medium to give the
final migratory product 2c (Scheme 5). This phenomenon is
well-established in the previous literature.14,22 Additionally,
the reaction in nitromethane also provides the migratory
product 2a in lower (48%) yield. However, the exact nature of
hydrogen, whether it is a proton or hydride, is not clear at this
moment. In the case of thioethers, the homocoupling product
may occur through thiyl radical dimerization. The dimeriza-
tion also may occur from the final migratory thiol product
under the oxidative reaction conditions. To probe, when
monomer of 4a was subjected to the reaction conditions it
furnished the dimerised product 4a in quantitative yield.
However, the possibility of thiyl radical dimerization is also
plausible.
Conclusions
In conclusion, we have developed a silver(I)-catalyzed selective
1,5-aryl migration of 2-aryloxy- or 2-(arylthio)benzoic acids
through radical Smiles rearrangement. This unexpected aryl
translocation occurs through an intramolecular ipso attack of
the carboxyl radical to the aryl ether instead of expected intra-
molecular decarboxylative arylation to aﬀord dibenzofuran.
Subsequently, inert C–O bond cleavage of the diaryl ether
occurs selectively. The corresponding thioethers also furnished
the migratory products with disulfide linkage under this oxi-
dative condition. We anticipate that the present catalytic
system could be useful for the selective C–O bond cleavage in
biomass conversion.
Experimental section
General information
Melting points were determined in open end-capillary tubes
and are uncorrected. TLC was performed on silica gel plates
(silica gel 60, f254), and the spots were visualized with UV light
(254 and 365 nm) and KMnO4 stain.
1H and 13C NMR spectra
were recorded in CDCl3 using TMS as the internal standard.
HRMS (m/z) were measured using EI (magnetic sector, positive
ion) and ESI (Q-TOF, positive ion) techniques. Infrared (IR)
spectra were recorded on a Fourier transform infrared spectro-
meter; only intense peaks were reported.
General experimental procedure for the preparation of
2-phenoxybenzoic acids, Scheme 223
To an oven-dried 100 mL round bottom flask equipped with
magnetic stir bar, 2-halobenzoic acid (6.2 mmol, 1.0 equiv.)
was added in 50 mL of dimethylformamide (DMF), followed by
phenol (12.4 mmol, 2.0 equiv.), 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU) (2.6 mL, 18.6 mmol, 3.0 equiv.), pyridine (0.1 mL),
copper(0) (52 mg, 0.81 mmol), and copper(I) iodide (53 mg,
0.28 mmol). The reaction mixture was heated to 160 °C under
nitrogen atmosphere. After consumption of the starting
materials as indicated by TLC (typically 2 h) the reaction
mixture was cooled and acidified with 3 M HCl until no more
precipitate was formed. The resulting precipitates and reaction
mixture were extracted with dichloromethane (60 mL) and cold
water (70 mL). The organic layer was washed with cold water
(20 mL × 3) and brine (10 mL), dried over anhydrous Na2SO4
and the solvent was evaporated under reduced pressure. The
crude product was purified by column chromatography using
Scheme 5 Plausible mechanism of 1,5-aryl migration.
Scheme 4 Control experiments.
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ethyl acetate–hexane as eluent to aﬀord the desired white solid
product.
2-Phenoxybenzoic acid, 1a, Scheme 2.23 The same general
procedure was followed by using 2-iodobenzoic acid (1.55 g,
6.2 mmol, 1.0 equiv.) and phenol (1.20 g, 12.4 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
7 : 3 hexane–ethyl acetate) aﬀorded the desired product as a
white solid, (1.14 g, 86%), mp 107–109 °C. 1H NMR (300 MHz,
DMSO-d6): δ 12.84 (br s, 1H), 7.81 (d, J = 7.8 Hz, 1H), 7.54 (td,
J = 8.1 Hz, 1.8 Hz, 1H), 7.33 (t, J = 8.4 Hz, 2H), 7.24 (t, J =
7.5 Hz, 1H), 7.06 (t, J = 7.2 Hz, 1H), 6.98 (d, J = 8.1 Hz, 1H),
6.88 (d, J = 8.4 Hz, 2H); 13C NMR (75 MHz, DMSO-d6): δ 166.6,
157.5, 154.9, 133.5, 131.4, 129.9, 124.6, 124.0, 122.8,
121.0, 117.6.
2-(4-Fluorophenoxy)benzoic acid, 1b, Scheme 2.9 The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and 4-fluorophenol (1.40 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.12 g, 78%), mp 142–144 °C. 1H NMR
(300 MHz, DMSO-d6): δ 12.91 (br s, 1H), 7.82 (dd, J = 7.8 Hz,
1.8 Hz, 1H), 7.56 (td, J = 8.4 Hz, 1.8 Hz, 1H), 7.15–7.29 (m, 3H),
6.93–7.00 (m, 3H); 13C NMR (75 MHz, DMSO-d6): δ 166.6,
157.9 (d, J = 237.8 Hz), 155.2, 153.5 (d, J = 2.2 Hz), 133.6, 131.4,
124.3, 124.0, 120.6, 119.5 (d, J = 8.2 Hz), 116.4 (d, J = 23.2 Hz).
2-(4-Chlorophenoxy)benzoic acid, 1c, Scheme 2. The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and 4-chlorophenol (1.60 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.3 g, 84%), mp 115–117 °C. 1H NMR (300 MHz,
DMSO-d6): δ 7.85 (dd, J = 7.5 Hz, 1.5 Hz, 1H), 7.60 (td, J =
8.1 Hz, 1.8 Hz, 1H), 7.36–7.41 (m, 2H), 7.31 (td, J = 8.1 Hz,
0.6 Hz, 1H), 7.08 (d, J = 8.1 Hz, 1H), 6.87–6.92 (m, 2H);
13C NMR (75 MHz, DMSO-d6): δ 166.4, 156.7, 154.3, 133.8,
131.6, 129.7, 126.5, 124.74, 124.67, 121.6, 119.0; IR (neat):
νmax 1690, 1484, 1313, 1244, 1091, 826 cm
−1; HRMS (ESI, m/z)
calcd for C13H9ClO3Na [M + Na]
+: 271.0138; found: 271.0130.
2-(4-Bromophenoxy)benzoic acid, 1d, Scheme 2.9 The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and 4-bromophenol (1.2 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.27 g, 70%), mp 118–120 °C. 1H NMR
(300 MHz, DMSO-d6): δ 12.94 (br s, 1H), 7.86 (d, J = 6.9 Hz,
1H), 7.60 (t, J = 7.5 Hz, 1H), 7.50 (d, J = 8.7 Hz, 2H), 7.32 (t, J =
7.5 Hz, 1H), 7.09 (d, J = 8.1 Hz, 1H), 6.84 (d, J = 9.0 Hz, 2H);
13C NMR (75 MHz, DMSO-d6): δ 166.3, 157.2, 154.2, 133.8,
132.6, 131.6, 124.7, 121.7, 119.3, 114.2.
2-(4-Methoxyphenoxy)benzoic acid, 1e, Scheme 2.9 The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and 4-methoxyphenol (1.54 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 6 : 4 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.29 g, 85%), mp 143–145 °C. 1H NMR
(300 MHz, DMSO-d6): δ 7.77 (dd, J = 7.5 Hz, 1.5 Hz, 1H), 7.48
(td, J = 8.4 Hz, 1.5 Hz, 1H), 7.17 (t, J = 7.5 Hz, 1H), 6.89–6.95
(m, 4H), 6.84 (d, J = 8.1 Hz, 1H), 3.72 (s, 3H); 13C NMR
(75 MHz, DMSO-d6): δ 167.1, 156.4, 155.5, 150.3, 133.4, 131.3,
123.8, 123.1, 120.0, 119.2, 115.2, 55.6.
2-(4-(Benzyloxy)phenoxy)benzoic acid, 1f, Scheme 2. The
same general procedure was followed by using 2-iodobenzoic
acid (1.55 g, 6.2 mmol, 1.0 equiv.) and 4-(benzyloxy)phenol
(2.48 g, 12.4 mmol, 2.0 equiv.). Column chromatography (SiO2,
eluting with 6 : 4 hexane–ethyl acetate) aﬀorded the desired
product as a white solid, (1.47 g, 74%), mp 153–155 °C. 1H
NMR (300 MHz, DMSO-d6): δ 12.85 (br s, 1H), 7.78 (dd, J = 7.5
Hz, 1.2 Hz, 1H), 7.31–7.52 (m, 6H), 7.18 (t, J = 7.5 Hz, 1H), 7.02
(d, J = 9.0 Hz, 2H), 6.92 (d, J = 9.0 Hz, 2H), 6.87 (d, J = 8.4 Hz,
1H), 5.07 (s, 2H); 13C NMR (75 MHz, DMSO-d6): δ 166.8, 156.3,
154.5, 150.4, 137.1, 133.3, 131.3, 128.5, 127.9, 127.8, 123.7,
123.0, 119.9, 119.2, 116.0, 69.7; IR (neat): νmax 1684, 1503,
1311, 1216, 1019, 784 cm−1; HRMS (ESI, m/z) calcd for
C20H16O4Na [M + Na]
+: 343.0946; found: 343.0950.
2-(p-Tolyloxy)benzoic acid, 1g, Scheme 2.9 The same general
procedure was followed by using 2-iodobenzoic acid (1.55 g,
6.2 mmol, 1.0 equiv.) and p-cresol (1.34 g, 12.4 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
7 : 3 hexane–ethyl acetate) aﬀorded the desired product as a
white solid, (1.13 g, 80%), mp 122–124 °C. 1H NMR (300 MHz,
DMSO-d6): δ 7.80 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 7.52 (td, J =
8.4 Hz, 1.5 Hz, 1H), 7.22 (td, J = 7.5 Hz, 0.6 Hz, 1H), 7.16 (d, J =
8.1 Hz, 2H), 6.93 (d, J = 8.1 Hz, 1H), 6.82 (d, J = 8.4 Hz, 2H),
2.27 (s, 3H); 13C NMR (75 MHz, DMSO-d6): δ 166.7,
155.5, 155.0, 133.4, 132.1, 131.3, 130.3, 124.2, 123.5, 120.3,
118.0, 20.3.
4-Diphenyl-2-phenoxybenzoic acid, 1h, Scheme 2. The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and 4-phenylphenol (2.11 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.48 g, 82%), mp 149–151 °C. 1H NMR
(300 MHz, DMSO-d6): δ 12.94 (br s, 1H), 7.86 (d, J = 7.5 Hz,
1H), 7.58–7.65 (m, 5H), 7.44 (t, J = 7.5 Hz, 2H), 7.28–7.35 (m,
2H), 7.10 (d, J = 8.1 Hz, 1H), 6.97 (d, J = 8.4 Hz, 2H); 13C NMR
(75 MHz, DMSO-d6): δ 167.0, 157.8, 155.1, 140.0, 135.2, 134.2,
132.0, 129.4, 128.6, 127.6, 126.9, 125.2, 124.8, 122.0, 118.0;
IR (neat): νmax 1689, 1482, 1312, 1220, 758 cm
−1; HRMS (ESI,
m/z) calcd for C19H14O3Na [M + Na]
+: 313.0841; found:
313.0838.
2-(Naphthalen-3-yloxy)benzoic acid, 1i, Scheme 2.9 The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and naphthalen-2-ol (1.79 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.31 g, 80%), mp 118–120 °C. 1H NMR
(300 MHz, DMSO-d6): δ 7.94 (d, J = 9.0 Hz, 1H), 7.89 (d, J = 7.5
Hz, 2H), 7.77 (d, J = 7.8 Hz, 1H), 7.60 (t, J = 8.1 Hz, 1H),
7.39–7.49 (m, 2H), 7.25–7.35 (m, 2H), 7.20 (s, 1H), 7.12 (d, J =
8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6): δ 166.6, 155.6,
154.8, 134.0, 133.8, 131.6, 130.0, 129.6, 127.7, 127.0, 126.7,
124.72, 124.67, 124.4, 121.5, 119.3, 112.1.
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2-(o-Tolyloxy)benzoic acid, 1k, Scheme 2.9 The same general
procedure was followed by using 2-iodobenzoic acid (1.55 g,
6.2 mmol, 1.0 equiv.) and o-cresol (1.3 mL, 12.4 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
7 : 3 hexane–ethyl acetate) aﬀorded the desired product as a
white solid, (990 mg, 70%), mp 122–124 °C. 1H NMR
(300 MHz, DMSO-d6): δ 12.86 (br s, 1H), 7.81 (dd, J = 7.8 Hz,
1.5 Hz, 1H), 7.50 (td, J = 8.7 Hz, 1.8 Hz, 1H), 7.30 (d, J = 7.2 Hz,
1H), 7.15–7.22 (m, 2H), 7.06 (t, J = 7.5 Hz, 1H), 6.80 (d, J = 8.1
Hz, 1H), 6.73 (d, J = 7.8 Hz, 1H), 2.30 (s, 3H); 13C NMR
(75 MHz, DMSO-d6): δ 167.1, 156.0, 155.0, 133.8, 131.8, 128.9,
127.7, 124.0, 123.8, 123.4, 119.2, 118.4, 16.2.
2-(2-Methoxyphenoxy)benzoic acid, 1l, Scheme 2. The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and 2-methoxyphenol (1.54 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 6 : 4 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.09 g, 72%), mp 114–116 °C. 1H NMR
(300 MHz, DMSO-d6): δ 12.82 (br s, 1H), 7.77 (d, J = 7.5 Hz,
1H), 7.43 (t, J = 7.2 Hz, 1H), 7.09–7.21 (m, 3H), 6.92–6.98 (m,
2H), 6.65 (d, J = 8.4 Hz, 1H), 3.74 (s, 3H); 13C NMR (75 MHz,
DMSO-d6): δ 166.8, 156.5, 151.0, 144.1, 133.2, 131.2, 125.3,
122.3, 122.2, 121.2, 120.8, 117.0, 113.5, 55.7; IR (neat): νmax
1666, 1494, 1306, 1260, 749 cm−1; HRMS (ESI, m/z) calcd for
C14H12O4Na [M + Na]
+: 267.0633; found: 267.0628.
2-(3-Chlorophenoxy)benzoic acid, 1m, Scheme 2. The same
general procedure was followed by using 2-iodobenzoic acid
(1.55 g, 6.2 mmol, 1.0 equiv.) and 3-chlorophenol (1.33 mL,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (1.09 g, 71%), mp 98–100 °C. 1H NMR (300 MHz,
DMSO-d6): δ 12.97 (br s, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.63 (t,
J = 7.5 Hz, 1H), 7.32–7.39 (m, 2H), 7.14 (d, J = 7.8 Hz, 2H), 6.92
(s, 1H), 6.83 (dd, J = 8.4 Hz, 2.1 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6): δ 166.2, 158.9, 153.8, 133.9, 133.8, 131.6, 131.2,
125.0, 124.9, 122.5, 122.1, 117.0, 115.7; IR (neat): νmax 1693,
1593, 1468, 1417, 1239, 913, 763 cm−1; HRMS (ESI, m/z) calcd
for C13H9ClO3Na [M + Na]
+: 271.0138; found: 271.0134.
2-(3-Methoxyphenoxy)benzoic acid, 1n, Scheme 2.24 The
same general procedure was followed by using 2-iodobenzoic
acid (1.55 g, 6.2 mmol, 1.0 equiv.) and 3-methoxyphenol
(1.54 g, 12.4 mmol, 2.0 equiv.). Column chromatography (SiO2,
eluting with 6 : 4 hexane–ethyl acetate) aﬀorded the desired
product as a white solid, (1.14 g, 75%), mp 118–120 °C. 1H
NMR (300 MHz, DMSO-d6): δ 7.82 (d, J = 7.5 Hz, 1H), 7.57 (t,
J = 7.2 Hz, 1H), 7.21–7.30 (m, 2H), 7.03 (d, J = 8.1 Hz, 1H), 6.67
(dd, J = 8.1 Hz, 1.2 Hz, 1H), 6.49 (s, 1H), 6.42 (d, J = 8.1 Hz,
1H), 3.72 (s, 3H); 13C NMR (75 MHz, DMSO-d6): δ 166.6, 160.7,
158.7, 154.7, 133.4, 131.4, 130.4, 124.6, 124.1, 121.2, 109.6,
108.5, 103.9, 55.3.
4-Chloro-2-phenoxybenzoic acid, 1r, Scheme 2. The same
general procedure was followed by using 2,4-dichlorobenzoic
acid (1.18 g, 6.2 mmol, 1.0 equiv.) and phenol (1.2 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 7 : 3 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (462 mg, 30%), mp 155–157 °C. 1H NMR
(300 MHz, DMSO-d6): δ 7.86 (d, J = 8.1 Hz, 1H), 7.32–7.42 (m,
3H), 7.15 (t, J = 7.2 Hz, 1H), 6.99 (t, J = 7.8 Hz, 3H); 13C NMR
(75 MHz, DMSO-d6): δ 157.0, 156.7, 156.6, 137.8, 133.8, 130.5,
124.4, 124.1, 120.7, 118.6, 100.0; IR (neat): νmax 1675, 1591,
1482, 1308, 1229, 919 cm−1; HRMS (ESI, m/z) calcd for
C13H9ClO3Na [M + Na]
+: 271.0138; found: 271.0125.
5-Nitro-2-phenoxybenzoic acid, 1t, Scheme 2. The same
general procedure was followed by using 2-bromo-5-nitroben-
zoic acid (1.52 g, 6.2 mmol, 1.0 equiv.) and phenol (1.2 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 6 : 4 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (804 mg, 50%), mp 160–162 °C. 1H NMR
(600 MHz, DMSO-d6): δ 8.58 (d, J = 3.0 Hz, 1H), 8.33 (dd, J =
9.0 Hz, 3.0 Hz, 1H), 7.48 (t, J = 7.8 Hz, 2H), 7.27 (t, J = 7.8 Hz,
1H), 7.14 (t, J = 7.8 Hz, 2H), 7.00 (d, J = 9.0 Hz, 1H); 13C NMR
(150 MHz, DMSO-d6): δ 165.3, 161.5, 155.3, 142.3, 130.9, 129.0,
127.4, 125.6, 123.8, 120.3, 119.2; IR (neat): νmax 1691, 1614,
1479, 1348, 1257, 745 cm−1; HRMS (ESI, m/z) calcd for
C13H9NO5Na [M + Na]
+: 282.0378; found: 282.0401.
2-(4-Chlorophenoxy)-5-nitrobenzoic acid, 1u, Scheme 2. The
same general procedure was followed by using 2-bromo-
5-nitrobenzoic acid (1.52 g, 6.2 mmol, 1.0 equiv.) and 4-chloro-
phenol (1.60 g, 12.4 mmol, 2.0 equiv.). Column chromato-
graphy (SiO2, eluting with 6 : 4 hexane–ethyl acetate) aﬀorded
the desired product as a white solid, (838 mg, 46%), mp
159–161 °C. 1H NMR (600 MHz, DMSO-d6): δ 8.60 (d, J =
2.4 Hz, 1H), 8.35 (dd, J = 9.0 Hz, 3.0 Hz, 1H), 7.50–7.53 (m,
2H), 7.15–7.18 (m, 2H), 7.11 (d, J = 9.0 Hz, 1H); 13C NMR
(150 MHz, DMSO-d6): δ 165.1, 160.9, 154.5, 142.7, 130.7, 129.3,
129.1, 127.5, 124.1, 121.8, 120.1; IR (neat): νmax 1707, 1478,
1345, 845 cm−1; HRMS (EI, m/z) calcd for C13H8ClNO5Na [M]
+:
315.9989; found: 315.9986.
5-Methoxy-2-phenoxybenzoic acid, 1v, Scheme 2. The same
general procedure was followed by using 2-bromo-5-methoxy-
benzoic acid (1.43 g, 6.2 mmol, 1.0 equiv.) and Phenol (1.2 g,
12.4 mmol, 2.0 equiv.). Column chromatography (SiO2, eluting
with 6 : 4 hexane–ethyl acetate) aﬀorded the desired product as
a white solid, (760 mg, 50%), mp 142–144 °C. 1H NMR
(300 MHz, DMSO-d6): δ 7.26–7.31 (m, 3H), 7.15 (dd, J = 8.7 Hz,
2.4 Hz, 1H), 6.97–7.04 (m, 2H), 6.80 (d, J = 7.8 Hz, 2H), 3.78 (s,
3H); 13C NMR (75 MHz, DMSO-d6): δ 166.3, 158.8, 155.6, 147.6,
129.8, 126.0, 123.8, 122.1, 119.5, 116.5, 115.3, 55.7; IR (neat):
νmax 1692, 1598, 1482, 1275, 1218, 746 cm
−1; HRMS (ESI, m/z)
calcd for C14H12O4Na [M + Na]
+: 267.0633; found: 267.0635.
For the experimental procedure for the preparation of com-
pounds 1o, 1p, 1q, 1j, 1s, 1w, 3a, 3b, 3c, 3d, 3e and 3f see the
ESI.†
General experimental procedure for the carboxyl radical-
assisted 1,5-aryl migration through Smiles rearrangement
using 2-phenoxybenzoic acids, Scheme 2
To an oven-dried 15 mL sealed tube, a mixture of 2-phenoxy-
benzoic acids (0.1 mmol, 1.0 equiv.), silver nitrate (0.9 mg,
0.005 mmol), potassium persulfate (40.5 mg, 0.15 mmol, 1.5
equiv.) and potassium trifluoroacetate (30.5 mg, 0.2 mmol, 2.0
equiv.) was taken and dry MeCN (2.0 mL) was added to it. After
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flushing with nitrogen, the vessel was sealed with a screw cap.
The reaction mixture was allowed to stir for 36 h at 130 °C.
After completion (as indicated by TLC), the reaction mixture
was cooled to room temperature. Then the reaction mixture
was poured into water (20 mL) and extracted with ethyl acetate
(20 mL). The organic layer was washed with water (10 mL) and
brine (10 mL), dried over anhydrous Na2SO4 and the solvent
was evaporated under reduced pressure. The crude product
was purified by column chromatography using ethyl acetate–
hexane as eluent to aﬀord the desired product.
Phenyl 2-hydroxybenzoate, 2a, Scheme 2.25 The same
general procedure was followed by using 2-phenoxybenzoic
acid (21.5 mg, 0.1 mmol, 1.0 equiv.), silver nitrate (0.9 mg,
0.005 mmol), potassium persulfate (40.5 mg, 0.15 mmol, 1.5
equiv.) and potassium trifluoroacetate (30.5 mg, 0.2 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
96 : 4 hexane–ethyl acetate) aﬀorded the desired product as a
colourless oil, (14 mg, 64%). 1H NMR (600 MHz, CDCl3): δ
10.53 (s, 1H), 8.10 (d, J = 7.8 Hz, 1H), 7.56 (t, J = 8.4 Hz, 1H),
7.48 (t, J = 8.4 Hz, 2H), 7.34 (t, J = 7.2 Hz, 1H),7.24 (d, J = 8.4
Hz, 2H), 7.07 (d, J = 8.4 Hz, 1H), 7.00 (t, J = 7.2 Hz, 1H); 13C
NMR (150 MHz, CDCl3): δ 168.9, 162.2, 150.1, 136.5, 130.3,
129.6, 126.4, 121.6, 119.4, 117.8, 111.8.
4-Fluorophenyl 2-hydroxybenzoate, 2b, Scheme 2. The same
general procedure was followed by using 2-(4-fluorophenoxy)
benzoic acid (23.5 mg, 0.1 mmol, 1.0 equiv.), silver nitrate
(0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a colourless oil, (12.5 mg, 54%). 1H NMR
(600 MHz, CDCl3): δ 10.45 (s, 1H), 8.08 (dd, J = 7.8 Hz, 1.2 Hz,
1H), 7.55–7.58 (m, 1H), 7.19–7.21 (m, 2H), 7.14–7.17 (m, 2H),
7.06 (d, J = 8.4 Hz, 1H), 7.00 (t, J = 7.8 Hz, 1H); 13C NMR
(150 MHz, CDCl3): δ 168.9, 162.2, 160.5 (d, J = 244.5 Hz), 145.8
(d, J = 3.0 Hz), 136.6, 130.3, 123.1 (d, J = 7.5 Hz), 119.5, 117.9,
116.3 (d, J = 24.0 Hz), 111.6; IR (neat): νmax 3230, 1692, 1504,
1300, 1182, 1064, 757 cm−1; HRMS (ESI, m/z) calcd for
C13H9FO3Na [M + Na]
+: 255.0433; found: 255.0451.
4-Chlorophenyl 2-hydroxybenzoate, 2c, Scheme 2.26 The
same general procedure was followed by using 2-(4-chlorophe-
noxy)benzoic acid (25.0 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (15 mg, 60%), mp 98–100 °C.
1H NMR (300 MHz, CDCl3): δ 10.39 (s, 1H), 8.05 (dd, J = 8.1
Hz, 1.5 Hz, 1H), 7.52–7.58 (m, 1H), 7.42 (d, J = 8.7 Hz, 2H),
7.16 (d, J = 9.0 Hz, 2H), 7.04 (d, J = 8.4 Hz, 1H), 6.97 (t, J = 7.8
Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 168.6, 162.2, 148.5,
136.7, 131.8, 130.3, 129.7, 123.0, 119.6, 117.9, 111.5; IR (neat):
νmax 3256, 1686, 1486, 1304, 1195, 755 cm
−1; HRMS (ESI, m/z)
calcd for C13H9ClO3Na [M + Na]
+: 271.0138; found: 271.0145.
4-Bromophenyl 2-hydroxybenzoate, 2d, Scheme 2. The same
general procedure was followed by using 2-(4-bromophenoxy)
benzoic acid (29.5 mg, 0.1 mmol, 1.0 equiv.), silver nitrate
(0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (13.5 mg, 46%), mp 67–69 °C.
1H NMR (600 MHz, CDCl3): δ 10.40 (s, 1H), 8.07 (dd, J = 8.4
Hz, 1.2 Hz, 1H), 7.55–7.60 (m, 3H), 7.13 (d, J = 9.0 Hz, 2H),
7.06 (d, J = 8.4 Hz, 1H), 6.99 (t, J = 7.2 Hz, 1H); 13C NMR
(150 MHz, CDCl3): δ 168.5, 162.2, 149.1, 136.7, 132.7, 130.3,
123.4, 119.5, 117.9, 111.5; IR (neat): νmax 3221, 1689, 1506,
1299, 1188, 1067, 755 cm−1; HRMS (EI, m/z) calcd for
C13H9BrO4 [M]
+: 291.9735, 293.9715; found: 291.9738,
293.9727.
4-Methoxyphenyl 2-hydroxybenzoate, 2e, Scheme 2.26 The
same general procedure was followed by using 2-(4-methoxy-
phenoxy)benzoic acid (24.5 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 95 : 5 hexane–ethyl acetate) aﬀorded the
desired product as a colourless oil, (14.5 mg, 60%). 1H NMR
(600 MHz, CDCl3): δ 10.56 (s, 1H), 8.09 (dd, J = 7.8 Hz, 1.8 Hz,
1H), 7.54–7.57 (m, 1H), 7.13–7.16 (m, 2H), 7.06 (dd, J = 8.4 Hz,
0.6 Hz, 1H), 6.96–7.00 (m, 3H), 3.85 (s, 3H); 13C NMR
(150 MHz, CDCl3): δ 169.3, 162.1, 157.6, 143.4, 136.4, 130.3,
122.4, 119.4, 117.8, 114.6, 111.9, 55.6; IR (neat): νmax 3221,
1689, 1506, 1299, 1188, 1067, 755 cm−1; HRMS (EI, m/z) calcd
for C14H12O4 [M]
+: 244.0736; found: 244.0738.
4-(Benzyloxy)phenyl 2-hydroxybenzoate, 2f, Scheme 2. The
same general procedure was followed by using 2-(4-(benzyloxy)
phenoxy)benzoic acid (32.0 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 95 : 5 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (19.5 mg, 61%), mp
98–100 °C. 1H NMR (600 MHz, CDCl3): δ 10.56 (s, 1H), 8.09
(dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.56 (td, J = 8.4 Hz, 1.2 Hz, 1H),
7.47 (d, J = 7.2 Hz, 2H), 7.43 (t, J = 7.2 Hz, 2H), 7.37 (t, J = 7.2
Hz, 1H), 7.14–7.16 (m, 2H), 7.05–7.07 (m, 3H), 6.99 (t, J = 7.8
Hz, 1H), 5.11 (s, 2H); 13C NMR (150 MHz, CDCl3): δ 169.2,
162.1, 156.9, 143.6, 136.7, 136.4, 130.3, 128.6, 128.1, 127.5,
122.4, 119.4, 117.8, 115.6, 111.9, 70.4; IR (neat): νmax 3264,
1693, 1505, 1299, 1196, 749 cm−1; HRMS (ESI, m/z) calcd for
C20H16O4Na [M + Na]
+: 343.0946; found: 343.0938.
p-Tolyl 2-hydroxybenzoate, 2g, Scheme 2.26 The same
general procedure was followed by using 2-(p-tolyloxy)benzoic
acid (23.0 mg, 0.1 mmol, 1.0 equiv.), silver nitrate (0.9 mg,
0.005 mmol), potassium persulfate (40.5 mg, 0.15 mmol, 1.5
equiv.) and potassium trifluoroacetate (30.5 mg, 0.2 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
96 : 4 hexane–ethyl acetate) aﬀorded the desired product as a
colourless oil, (12.5 mg, 54%). 1H NMR (600 MHz, CDCl3):
δ 10.56 (s, 1H), 8.09 (d, J = 7.8 Hz, 1H), 7.55 (t, J = 8.4 Hz, 1H),
7.26–7.28 (m, 2H), 7.11 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 8.4 Hz,
Paper Organic & Biomolecular Chemistry
9774 | Org. Biomol. Chem., 2016, 14, 9768–9779 This journal is © The Royal Society of Chemistry 2016
Pu
bl
ish
ed
 o
n 
14
 S
ep
te
m
be
r 2
01
6.
 D
ow
nl
oa
de
d 
by
 In
di
an
 In
sti
tu
te
 o
f C
he
m
ic
al
 B
io
lo
gy
 o
n 
07
/1
1/
20
16
 0
6:
06
:1
4.
 
View Article Online
1H), 6.99 (t, J = 7.8 Hz, 1H), 2.40 (s, 3H); 13C NMR (150 MHz,
CDCl3): δ 169.1, 162.1, 147.8, 136.4, 136.1, 130.3, 130.1, 121.3,
119.4, 117.8, 111.9, 20.9; IR (neat): νmax 3216, 1690, 1482, 1300,
1193, 757 cm−1; HRMS (EI, m/z) calcd for C14H12O3 [M]
+:
228.0786; found: 228.0778.
4-Diphenyl 2-hydroxybenzoate, 2h, Scheme 2. The same
general procedure was followed by using 2-(4-phenylphenoxy)
benzoic acid (29.0 mg, 0.1 mmol, 1.0 equiv.), silver nitrate
(0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (15 mg, 52%), mp
100–102 °C. 1H NMR (600 MHz, CDCl3): δ 10.53 (s, 1H), 8.12
(d, J = 7.8 Hz, 1H), 7.68 (d, J = 7.8 Hz, 2H), 7.62 (d, J = 7.8 Hz,
2H), 7.58 (t, J = 7.8 Hz, 1H), 7.48 (t, J = 7.2 Hz, 2H), 7.39 (t, J =
7.2 Hz, 1H), 7.31 (d, J = 8.4 Hz, 2H), 7.08 (d, J = 8.4 Hz, 1H),
7.01 (t, J = 7.2 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 169.0,
162.2, 149.4, 140.2, 139.6, 136.5, 130.4, 128.8, 128.3, 127.5,
127.1, 121.9, 119.5, 117.8, 111.8; IR (neat): νmax 3208, 1688,
1483, 1301, 1178, 757, 691 cm−1; HRMS (ESI, m/z) calcd for
C19H14O3Na [M + Na]
+: 313.0841; found: 313.0856.
Naphthalen-2-yl 2-hydroxybenzoate, 2i, Scheme 2. The same
general procedure was followed by using 2-(naphthalen-3-
yloxy)benzoic acid (26.5 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (16.5 mg, 63%), mp 86–88 °C.
1H NMR (600 MHz, CDCl3): δ 10.55 (s, 1H), 8.17 (dd, J = 7.8
Hz, 1.2 Hz, 1H), 7.95 (d, J = 9.0 Hz, 1H), 7.91 (d, J = 7.8 Hz,
1H), 7.87 (d, J = 7.8 Hz, 1H), 7.71 (d, J = 2.4 Hz, 1H), 7.52–7.60
(m, 3H), 7.37 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 7.09 (d, J = 8.4 Hz,
1H), 7.02 (t, J = 7.8 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ
169.1, 162.2, 147.7, 136.5, 133.7, 131.7, 130.4, 129.6, 127.8,
127.7, 126.8, 126.0, 120.9, 119.5, 118.8, 117.9, 111.8; IR (neat):
νmax 3252, 1688, 1479, 1297, 1156, 756 cm
−1; HRMS (ESI, m/z)
calcd for C17H12O3Na [M + Na]
+: 287.0684; found: 287.0675.
Naphthalen-1-yl 2-hydroxybenzoate, 2j, Scheme 2. The same
general procedure was followed by using 2-(naphthalen-1-
yloxy)benzoic acid (26.5 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a colourless oil, (16.4 mg, 62%). 1H NMR
(600 MHz, CDCl3): δ 10.52 (s, 1H), 8.32 (dd, J = 7.8 Hz, 1.8 Hz,
1H), 7.93–7.96 (m, 2H), 7.86 (d, J = 8.4 Hz, 1H), 7.62–7.64 (m,
1H), 7.54–7.59 (m, 3H), 7.40 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 7.12
(dd, J = 8.4 Hz, 0.6 Hz, 1H), 7.08 (td, J = 7.8 Hz, 1.2 Hz, 1H);
13C NMR (150 MHz, CDCl3): δ 169.0, 162.3, 146.0, 136.7, 134.7,
130.4, 128.1, 126.8, 126.72, 126.67, 126.6, 125.4, 121.0, 119.6,
118.2, 118.0, 111.7; IR (neat): νmax 3231, 2927, 1693, 1481,
1296, 1205, 761 cm−1; HRMS (ESI, m/z) calcd for C17H12O3Na
[M + Na]+: 287.0684; found: 287.0669.
o-Tolyl 2-hydroxybenzoate, 2k, Scheme 2.26 The same
general procedure was followed by using 2-(o-tolyloxy)benzoic
acid (23.0 mg, 0.1 mmol, 1.0 equiv.), silver nitrate (0.9 mg,
0.005 mmol), potassium persulfate (40.5 mg, 0.15 mmol, 1.5
equiv.) and potassium trifluoroacetate (30.5 mg, 0.2 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
96 : 4 hexane–ethyl acetate) aﬀorded the desired product as a
colourless oil, (12 mg, 52%). 1H NMR (600 MHz, CDCl3): δ
10.56 (s, 1H), 8.13 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.57 (td, J = 9.0
Hz, 1.8 Hz, 1H), 7.31–7.33 (m, 1H), 7.29 (d, J = 7.8 Hz, 1H),
7.24 (td, J = 7.8 Hz, 1.2 Hz, 1H), 7.15 (d, J = 7.8 Hz, 1H), 7.07
(dd, J = 8.4 Hz, 0.6 Hz, 1H), 7.01 (td, J = 7.8 Hz, 0.6 Hz, 1H),
2.26 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 168.7, 162.2, 148.7,
136.4, 131.3, 130.29, 130.26, 127.1, 126.5, 121.8, 119.5, 117.8,
111.7, 16.2; IR (neat): νmax 3214, 2926, 1689, 1584, 1486, 1299,
1165, 753 cm−1; HRMS (ESI, m/z) calcd for C14H12O3Na
[M + Na]+: 251.0684; found: 251.0672.
2-Methoxyphenyl 2-hydroxybenzoate, 2l, Scheme 2.26 The
same general procedure was followed by using 2-(2-methoxy-
phenoxy)benzoic acid (24.5 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 95 : 5 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (14 mg, 57%), mp 64–66 °C.
1H NMR (600 MHz, CDCl3): δ 10.51 (s, 1H), 8.13 (dd, J = 7.8
Hz, 1.2 Hz, 1H), 7.54–7.57 (m, 1H), 7.30 (td, J = 8.4 Hz, 1.8 Hz,
1H), 7.18 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 7.02–7.06 (m, 3H), 6.99
(t, J = 7.8 Hz, 1H), 3.85 (s, 3H); 13C NMR (150 MHz, CDCl3):
δ 168.4, 162.0, 151.1, 139.0, 136.3, 130.6, 127.4, 122.8, 120.8,
119.4, 117.7, 112.5, 111.8, 55.9; IR (neat): νmax 3212, 1692,
1499, 1296, 754 cm−1; HRMS (ESI, m/z) calcd for C14H12O4Na
[M + Na]+: 267.0633; found: 267.0625.
3-Chlorophenyl 2-hydroxybenzoate, 2m, Scheme 2. The
same general procedure was followed by using 2-(3-chlorophe-
noxy)benzoic acid (25.0 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a colourless oil, (9.0 mg, 36%). 1H NMR
(300 MHz, CDCl3): δ 10.38 (s, 1H), 8.05 (d, J = 8.1 Hz, 1.8 Hz,
1H), 7.56 (td, J = 8.7 Hz, 1.8 Hz, 1H), 7.39 (t, J = 7.8 Hz, 1H),
7.27–7.32 (m, 2H), 7.12–7.15 (m, 1H), 7.05 (d, J = 8.4 Hz, 1H),
6.98 (td, J = 8.4 Hz, 1.2 Hz, 1H); 13C NMR (75 MHz, CDCl3):
δ 148.5, 162.2, 150.5, 136.7, 134.9, 130.32, 130.27, 126.7, 122.4,
120.1, 119.6, 117.9, 111.4; IR (neat): νmax 3216, 1675, 1587,
1479, 1304, 753 cm−1; HRMS (ESI, m/z) calcd for C13H9ClO3Na
[M + Na]+: 271.0138; found: 271.0153.
3-Methoxyphenyl 2-hydroxybenzoate, 2n, Scheme 2. The
same general procedure was followed by using 2-(3-methoxy-
phenoxy)benzoic acid (24.5 mg, 0.1 mmol, 1.0 equiv.), silver
nitrate (0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 95 : 5 hexane–ethyl acetate) aﬀorded the
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desired product as a colourless oil, (8.5 mg, 34%). 1H NMR
(300 MHz, CDCl3): δ 10.53 (s, 1H), 8.09 (dd, J = 8.1 Hz, 1.5 Hz,
1H), 7.56 (td, J = 8.7 Hz, 1.8 Hz, 1H), 7.37 (t, J = 8.1 Hz, 1H),
7.07 (dd, J = 7.8 Hz, 0.6 Hz, 1H), 7.00 (td, J = 8.1 Hz, 0.9 Hz,
1H), 6.87–6.90 (m, 1H), 6.83 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 6.79
(t, J = 2.1 Hz, 1H), 3.85 (s, 3H); 13C NMR (75 MHz, CDCl3):
δ 168.8, 162.2, 160.6, 151.0, 136.5, 130.3, 130.0, 119.5, 117.8,
113.8, 112.2, 111.8, 107.7, 55.5; IR (neat): νmax 3224, 2927,
1691, 1610, 1486, 1143, 760 cm−1; HRMS (ESI, m/z) calcd for
C14H12O4Na [M + Na]
+: 267.0633; found: 267.0635.
Phenyl 4-fluoro-2-hydroxybenzoate, 2o, Scheme 2. The same
general procedure was followed by using 4-fluoro-2-phenoxy-
benzoic acid (23.5 mg, 0.1 mmol, 1.0 equiv.), silver nitrate
(0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a colourless oil, (13.5 mg, 58%). 1H NMR
(600 MHz, CDCl3): δ 10.76 (d, J = 1.2 Hz, 1H), 8.11 (dd, J = 9.0
Hz, 6.6 Hz, 1H), 7.48 (t, J = 8.4 Hz, 2H), 7.34 (t, J = 7.8 Hz, 1H),
7.22 (d, J = 7.8 Hz, 2H), 6.75 (dd, J = 10.2 Hz, J = 2.4 Hz, 1H),
6.72 (td, J = 8.4 Hz, 2.4 Hz, 1H); 13C NMR (150 MHz, CDCl3):
δ 168.3, 167.7 (d, J = 255.0 Hz), 164.3 (d, J = 13.5 Hz), 149.9,
132.6 (d, J = 12.0 Hz), 129.6, 126.5, 121.6, 108.6 (d, J = 3.0 Hz),
107.8 (d, J = 22.5 Hz), 104.6 (d, J = 24.0 Hz); IR (neat): νmax
3180, 1691, 1596, 1500, 1259, 1192, 771 cm−1; HRMS (ESI, m/z)
calcd for C13H9FO3Na [M + Na]
+: 255.0433; found: 255.0455.
p-Tolyl 4-fluoro-2-hydroxybenzoate, 2p, Scheme 2. The same
general procedure was followed by using 2-(p-tolyloxy)-4-fluoro-
benzoic acid (25.0 mg, 0.1 mmol, 1.0 equiv.), silver nitrate
(0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (14.5 mg, 59%), mp 68–70 °C.
1H NMR (600 MHz, CDCl3): δ 10.79 (d, J = 1.8 Hz, 1H), 8.10
(dd, J = 9.0 Hz, 6.6 Hz, 1H), 7.26 (d, J = 8.4 Hz, 2H), 7.10 (d, J =
8.4 Hz, 2H), 6.74 (dd, J = 10.2 Hz, 2.4 Hz, 1H), 6.71 (td, J = 8.4
Hz, 2.4 Hz, 1H), 2.40 (s, 3H); 13C NMR (150 MHz, CDCl3):
δ 168.5, 167.6 (d, J = 253.5 Hz), 164.3 (d, J = 15.0 Hz), 147.6,
136.2, 132.6 (d, J = 12.0 Hz), 130.1, 121.2, 108.6 (d, J = 3.0 Hz),
107.7 (d, J = 24.0 Hz), 104.6 (d, J = 24.0 Hz), 20.9; IR (neat):
νmax 3082, 1685, 1600, 1509, 1265, 1188, 767 cm
−1; HRMS (ESI,
m/z) calcd for C14H11FO3Na [M + Na]
+: 269.0590; found:
269.0556.
Naphthalen-2-yl 4-fluoro-2-hydroxybenzoate, 2q, Scheme 2.
The same general procedure was followed by using 4-fluoro-2-
(naphthalen-3-yloxy)benzoic acid (28.5 mg, 0.1 mmol, 1.0
equiv.), silver nitrate (0.9 mg, 0.005 mmol), potassium persul-
fate (40.5 mg, 0.15 mmol, 1.5 equiv.) and potassium trifluoro-
acetate (30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromato-
graphy (SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded
the desired product as a white solid, (17 mg, 60%), mp
78–80 °C. 1H NMR (600 MHz, CDCl3): δ 10.77 (s, 1H), 8.17 (dd,
J = 9.0 Hz, 6.6 Hz, 1H), 7.95 (d, J = 9.0 Hz, 1H), 7.91 (d, J = 7.2
Hz, 1H), 7.86 (d, J = 7.8 Hz, 1H), 7.70 (d, J = 2.4 Hz, 1H),
7.52–7.57 (m, 2H), 7.36 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 6.77 (dd,
J = 10.2 Hz, 2.4 Hz, 1H), 6.74 (td, J = 8.4 Hz, 2.4 Hz, 1H); 13C
NMR (150 MHz, CDCl3): δ 168.5, 167.8 (d, J = 255.0 Hz), 164.4
(d, J = 13.5 Hz), 147.5, 133.7, 132.6 (d, J = 10.5 Hz), 131.7,
129.7, 127.8, 127.7, 126.8, 126.1, 120.8, 118.8, 108.6 (d, J = 1.5
Hz), 107.8 (d, J = 22.5 Hz), 104.7 (d, J = 2.4 Hz); IR (neat): νmax
1677, 1506, 1262, 1205, 1152, 808 cm−1; HRMS (ESI, m/z) calcd
for C17H11FO3Na [M + Na]
+: 305.0590; found: 305.0598.
Phenyl 4-chloro-2-hydroxybenzoate, 2r, Scheme 2. The same
general procedure was followed by using 4-chloro-2-phenoxy-
benzoic acid (25.0 mg, 0.1 mmol, 1.0 equiv.), silver nitrate
(0.9 mg, 0.005 mmol), potassium persulfate (40.5 mg,
0.15 mmol, 1.5 equiv.) and potassium trifluoroacetate
(30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 96 : 4 hexane–ethyl acetate) aﬀorded the
desired product as a colourless oil, (14 mg, 57%). 1H NMR
(600 MHz, CDCl3): δ 10.62 (s, 1H), 8.02 (d, J = 9.0 Hz, 1H),
7.46–7.49 (m, 2H), 7.34 (t, J = 7.2 Hz, 1H), 7.21–7.23 (m, 2H),
7.09 (d, J = 2.4 Hz, 1H), 6.98 (dd, J = 8.4 Hz, 1.8 Hz, 1H); 13C
NMR (150 MHz, CDCl3): δ 168.4, 162.7, 149.9, 142.3, 131.3,
129.7, 126.5, 121.5, 120.2, 118.0, 110.5; IR (neat): νmax 3202,
1693, 1487, 1192, 1081, 771 cm−1; HRMS (ESI, m/z) calcd for
C13H9ClO3Na [M + Na]
+: 271.0138; found: 271.0151.
Phenyl 2-hydroxy-4-nitrobenzoate, 2s, Scheme 2. The same
general procedure was followed by using 4-nitro-2-phenoxyben-
zoic acid (26.0 mg, 0.1 mmol, 1.0 equiv.), silver nitrate (0.9 mg,
0.005 mmol), potassium persulfate (40.5 mg, 0.15 mmol, 1.5
equiv.) and potassium trifluoroacetate (30.5 mg, 0.2 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
9 : 1 hexane–ethyl acetate) aﬀorded the desired product as a
yellowish solid, (13.5 mg, 52%), mp 146–148 °C. 1H NMR
(600 MHz, CDCl3): δ 10.75 (s, 1H), 8.29 (d, J = 8.4 Hz, 1H), 7.90
(d, J = 1.8 Hz, 1H), 7.81 (dd, J = 8.4 Hz, 1.8 Hz, 1H), 7.50 (t, J =
7.2 Hz, 2H), 7.37 (t, J = 7.8 Hz, 1H), 7.24–7.26 (m, 2H); 13C
NMR (150 MHz, CDCl3): δ 167.6, 162.5, 152.5, 149.6, 131.7,
129.8, 126.9, 121.3, 116.6, 113.7, 113.3; IR (neat): νmax 1690,
1527, 1208, 781 cm−1; HRMS (ESI, m/z) calcd for C13H9NO5Na
[M + Na]+: 282.0378; found: 282.0354.
Phenyl 2-hydroxy-5-nitrobenzoate, 2t, Scheme 2. The same
general procedure was followed by using 5-nitro-2-phenoxyben-
zoic acid (26.0 mg, 0.1 mmol, 1.0 equiv.), silver nitrate (0.9 mg,
0.005 mmol), potassium persulfate (40.5 mg, 0.15 mmol, 1.5
equiv.) and potassium trifluoroacetate (30.5 mg, 0.2 mmol, 2.0
equiv.). Column chromatography (SiO2, eluting with
9 : 1 hexane–ethyl acetate) aﬀorded the desired product as a
yellowish solid, (13 mg, 50%), mp 149–151 °C. 1H NMR
(600 MHz, CDCl3): δ 11.19 (s, 1H), 9.05 (d, J = 2.4 Hz, 1H), 8.43
(dd, J = 9.0 Hz, 3.0 Hz, 1H), 7.50 (t, J = 7.8 Hz, 2H), 7.38 (t, J =
7.8 Hz, 1H), 7.26 (d, J = 7.8 Hz, 2H), 7.18 (d, J = 9.6 Hz, 1H);
13C NMR (150 MHz, CDCl3): δ 167.7, 166.6, 149.6, 140.2, 131.1,
129.8, 127.0, 126.9, 121.3, 118.9, 111.7; IR (neat): νmax 1697,
1624, 1514, 1333, 1194, 751 cm−1; HRMS (ESI, m/z) calcd for
C13H10NO5 [M + H]
+: 260.0559; found: 260.0574.
4-Chlorophenyl 2-hydroxy-5-nitrobenzoate, 2u, Scheme 2.
The same general procedure was followed by using 2-(4-chloro-
phenoxy)-5-nitrobenzoic acid (29.5 mg, 0.1 mmol, 1.0 equiv.),
Paper Organic & Biomolecular Chemistry
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silver nitrate (0.9 mg, 0.005 mmol), potassium persulfate
(40.5 mg, 0.15 mmol, 1.5 equiv.) and potassium trifluoroace-
tate (30.5 mg, 0.2 mmol, 2.0 equiv.). Column chromatography
(SiO2, eluting with 9 : 1 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (13 mg, 45%), mp
148–150 °C. 1H NMR (600 MHz, CDCl3): δ 11.07 (br s, 1H), 9.02
(d, J = 2.4 Hz, 1H), 8.44 (dd, J = 9.0 Hz, 3.0 Hz, 1H), 7.46–7.48
(m, 2H), 7.20–7.23 (m, 2H), 7.18 (d, J = 9.0 Hz, 1H); 13C NMR
(150 MHz, CDCl3): δ 167.4, 166.6, 148.0, 140.2, 132.4, 131.3,
129.9, 127.0, 122.7, 119.0, 111.4; IR (neat): νmax 1696, 1482,
1340, 1196, 723 cm−1; HRMS (EI, m/z) calcd for C13H8ClNO5
[M]+: 295.0061; found: 295.0059.
General experimental procedure for the carboxyl radical-
assisted 1,5-aryl migration through Smiles rearrangement
using 2-(phenylthio)benzoic acids, Scheme 3
To an oven-dried 15 mL sealed tube, a mixture of 2-(phe-
nylthio)benzoic acid (0.2 mmol, 1.0 equiv.), silver nitrate
(1.7 mg, 0.01 mmol) and potassium persulfate (81 mg,
0.3 mmol, 1.5 equiv.) was taken and dry MeCN (4.0 mL) was
added to it. After flushing with nitrogen, the vessel was sealed
with a screw cap. The reaction mixture was allowed to stir for
36 h at 130 °C. After completion (as indicated by TLC), the
reaction mixture was cooled to room temperature. Then the
reaction mixture was poured into water (30 mL) and extracted
with ethyl acetate (40 mL). The organic layer was washed with
water (10 mL × 2) and brine (10 mL), dried over anhydrous
Na2SO4 and the solvent was evaporated under reduced
pressure. The crude product was purified by column chromato-
graphy using ethyl acetate–hexane as eluent to aﬀord the
desired product.
Diphenyl 2,2′-disulfanediyldibenzoate, 4a, Scheme 3. The
same general procedure was followed by using 2-(phenylthio)
benzoic acid (46.0 mg, 0.2 mmol, 1.0 equiv.), silver nitrate
(1.7 mg, 0.01 mmol), potassium persulfate (81 mg, 0.3 mmol,
1.5 equiv.). Column chromatography (SiO2, eluting with
9 : 1 hexane–ethyl acetate) aﬀorded the desired product as a
white solid, (37.5 mg, 82%), mp 104–106 °C. 1H NMR
(600 MHz, CDCl3): δ 8.34 (dd, J = 7.8 Hz, 1.8 Hz, 2H), 7.86 (dd,
J = 8.4 Hz, 0.6 Hz, 2H), 7.53 (td, J = 8.4 Hz, 1.8 Hz, 2H),
7.46–7.49 (m, 4H), 7.29–7.36 (m, 8H); 13C NMR (150 MHz,
CDCl3): δ 164.9, 150.6, 141.4, 133.7, 132.0, 129.6, 126.6, 126.14,
126.07, 125.7, 121.7; IR (neat): νmax 1718, 1488, 1246, 1194,
1036, 743 cm−1; HRMS (ESI, m/z) calcd for C26H18O4S2Na
[M + Na]+: 481.0544; found: 481.0548.
Diphenyl 2,2′-disulfanediylbis(4-fluorobenzoate), 4b,
Scheme 3. The same general procedure was followed by using
4-fluoro-2-(phenylthio)benzoic acid (50.0 mg, 0.2 mmol, 1.0
equiv.), silver nitrate (1.7 mg, 0.01 mmol), potassium persul-
fate (81 mg, 0.3 mmol, 1.5 equiv.). Column chromatography
(SiO2, eluting with 9 : 1 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (33.5 mg, 68%), mp
122–124 °C. 1H NMR (600 MHz, CDCl3): δ 8.37 (dd, J = 8.4 Hz,
6.0 Hz, 2H), 7.55 (dd, J = 9.6 Hz, 2.4 Hz, 2H), 7.45–7.48 (m,
4H), 7.31 (t, J = 7.2 Hz, 2H), 7.26–7.27 (m, 4H), 7.02–7.05 (m,
2H); 13C NMR (150 MHz, CDCl3): δ 166.1 (d, J = 256.5 Hz),
164.1, 150.4, 144.8 (d, J = 9.0 Hz), 134.8 (d, J = 9.0 Hz), 129.6,
126.3, 122.8 (d, J = 3.0 Hz), 121.7, 113.4 (d, J = 22.5 Hz), 113.1
(d, J = 27.0 Hz); IR (neat): νmax 1720, 1578, 1481, 1250, 1189,
1075, 746 cm−1; HRMS (ESI, m/z) calcd for C26H16F2O4S2Na
[M + Na]+: 517.0356; found: 517.0336.
Bis(4-chlorophenyl) 2,2′-disulfanediyldibenzoate, 4c,
Scheme 3. The same general procedure was followed by using
2-(4-chlorophenylthio)benzoic acid (53.0 mg, 0.2 mmol, 1.0
equiv.), silver nitrate (1.7 mg, 0.01 mmol), potassium persul-
fate (81 mg, 0.3 mmol, 1.5 equiv.). Column chromatography
(SiO2, eluting with 9 : 1 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (33 mg, 63%), mp
160–162 °C. 1H NMR (600 MHz, CDCl3): δ 8.31 (dd, J = 7.8 Hz,
1.2 Hz, 2H), 7.85 (d, J = 8.4 Hz, 2H), 7.53 (td, J = 8.4 Hz, 1.2 Hz,
2H), 7.43 (d, J = 9.0 Hz, 4H), 7.35 (t, J = 7.2 Hz, 2H), 7.24 (d, J =
8.4 Hz, 4H); 13C NMR (150 MHz, CDCl3): δ 164.6, 149.0, 141.4,
133.9, 132.1, 131.6, 129.6, 126.2, 126.1, 125.8, 123.1; IR (neat):
νmax 1720, 1485, 1248, 1199, 1036, 736 cm
−1; HRMS (ESI, m/z)
calcd for C26H16Cl2O4S2Na [M + Na]
+: 548.9765; found:
548.9767.
Di-p-tolyl 2,2′-disulfanediyldibenzoate, 4d, Scheme 3. The
same general procedure was followed by using 2-(p-tolylthio)
benzoic acid (49.0 mg, 0.2 mmol, 1.0 equiv.), silver nitrate
(1.7 mg, 0.01 mmol), potassium persulfate (81 mg, 0.3 mmol,
1.5 equiv.). Column chromatography (SiO2, eluting with
9 : 1 hexane–ethyl acetate) aﬀorded the desired product as a
white solid, (29 mg, 60%), mp 147–149 °C. 1H NMR (600 MHz,
CDCl3): δ 8.32 (dd, J = 7.8 Hz, 1.2 Hz, 2H), 7.85 (dd, J = 8.4 Hz,
0.6 Hz, 2H), 7.51 (td, J = 8.4 Hz, 1.2 Hz, 2H), 7.34 (td, J = 8.4
Hz, 1.2 Hz, 2H), 7.26 (d, J = 8.4 Hz, 4H), 7.17 (d, J = 9.0 Hz,
4H), 2.40 (s, 6H); 13C NMR (150 MHz, CDCl3): δ 165.1, 148.3,
141.3, 135.8, 133.6, 132.0, 130.0, 126.7, 126.1, 125.6, 121.4,
20.9; IR (neat): νmax 1717, 1504, 1247, 1193, 1031, 736 cm
−1;
HRMS (ESI, m/z) calcd for C28H22O4S2Na [M + Na]
+: 509.0857;
found: 509.0851.
Diphenyl 6,6′-disulfanediylbis(3-bromobenzoate), 4e,
Scheme 3. The same general procedure was followed by using
5-bromo-2-(phenylthio)benzoic acid (62.0 mg, 0.2 mmol, 1.0
equiv.), silver nitrate (1.7 mg, 0.01 mmol), potassium persul-
fate (81 mg, 0.3 mmol, 1.5 equiv.). Column chromatography
(SiO2, eluting with 9 : 1 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (37.5 mg, 61%), mp
210–212 °C. 1H NMR (600 MHz, CDCl3): δ 8.45 (d, J = 2.4 Hz,
2H), 7.68 (d, J = 9.0 Hz, 2H), 7.62 (dd, J = 9.0 Hz, 2.4 Hz, 2H),
7.47–7.50 (m, 4H), 7.34 (t, J = 7.2 Hz, 2H), 7.27–7.29 (m, 4H);
13C NMR (150 MHz, CDCl3): δ 163.8, 150.3, 140.1, 136.6, 134.7,
129.6, 128.0, 127.7, 126.4, 121.5, 119.6; IR (neat): νmax 1726,
1454, 1289, 1241, 1193, 1077 cm−1; HRMS (ESI, m/z) calcd for
C26H16Br2O4S2Na [M + Na]
+: 636.8754; found: 636.8748.
Diphenyl 6,6′-disulfanediylbis(3-fluorobenzoate), 4f,
Scheme 3. The same general procedure was followed by using
5-fluoro-2-(phenylthio)benzoic acid (50.0 mg, 0.2 mmol, 1.0
equiv.), silver nitrate (1.7 mg, 0.01 mmol), potassium persul-
fate (81 mg, 0.3 mmol, 1.5 equiv.). Column chromatography
(SiO2, eluting with 9 : 1 hexane–ethyl acetate) aﬀorded the
desired product as a white solid, (29.5 mg, 60%), mp
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153–155 °C. 1H NMR (600 MHz, CDCl3): δ 8.02 (dd, J = 8.4 Hz,
2.4 Hz, 2H), 7.79 (dd, J = 9.0 Hz, 4.8 Hz, 2H), 7.45–7.48 (m,
4H), 7.32 (t, J = 7.2 Hz, 2H), 7.23–7.27 (m, 6H); 13C NMR
(150 MHz, CDCl3): δ 163.9 (d, J = 1.5 Hz), 160.8 (d, J = 246.0
Hz), 150.3, 136.2 (d, J = 3.0 Hz), 129.6, 128.0 (d, J = 7.5 Hz),
127.9 (d, J = 6.0 Hz), 126.4, 121.5, 121.2 (d, J = 22.5 Hz), 118.7
(d, J = 24.0 Hz); IR (neat): νmax 1727, 1460, 1243, 1193, 1029,
739 cm−1; HRMS (ESI, m/z) calcd for C26H16F2O4S2Na
[M + Na]+: 517.0356; found: 517.0360.
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ABSTRACT: A palladium-catalyzed 1,2-carboamination
through C−H activation at room temperature is reported for
the synthesis of 2-arylindoles, and indolines from readily
available, inexpensive aryl ureas and vinyl arenes. The reaction
initiates with a urea-directed electrophilic ortho palladation,
alkene insertion, and β-hydride elimination sequences to
provide the Fujiwara−Moritani arylation product. Subse-
quently, aza-Wacker cyclization, and β-hydride elimination
provide the 2-arylindoles in high yields. Intercepting the
common σ-alkyl-Pd intermediate, corresponding indolines are also achieved. The indoline formation is attributed to the
generation of stabilized, cationic π-benzyl-Pd species to suppress β-hydride elimination.
Nitrogen-containing heterocycles, particularly indoles andindolines, are prevalent in numerous pharmaceuticals,
natural products, agrochemicals, and functionalized materials.1
Therefore, a signiﬁcant eﬀort has been devoted to their
synthesis, and sustained progress has been made through
Fisher,2 Larock,3 Buchwald,4 and Hegedus5 indole synthesis. In
the past decade, the transition-metal-catalyzed C−H activation
strategy has enabled the generation of indole moiety directly
from anilines or protected anilines obviating rigorous
prefunctionalizations. In this vein, two distinct strategies have
been well explored: (a) intramolecular cyclization of N-
arylenamines or -imines6 and (b) intermolecular cyclization
of anilines and alkynes.7 We hypothesized that annulation of
aniline derivatives with readily available and inexpensive oleﬁns
such as styrenes to aﬀord 2-arylindoles and 2-arylindolines in
intermolecular fashion will be synthetically attractive but
challenging due to the facile β-hydride elimination. In fact,
the potential of simple oleﬁns was realized in the synthesis of
N-arylindoles from diarylamines.8 However, this methodology
is limited due to the formation of inseparable mixture of
regioisomers from unsymmetrical diarylamines and requires
high temperature to occur. To exploit the full potential of C−H
functionalization in the complex molecule synthesis,9 develop-
ment of expedient methods under mild conditions, particularly
at room temperature,10 is in high demand. Intrigued by the key
mechanistic features, here we report a palladium-catalyzed
divergent synthesis of 2-arylindole and indoline through a
dehydrogenetive coupling of aryl urea and vinyl arene at room
temperature.
Our initial screening with acetanilide and styrene in acetic
acid at 110 °C was in vain due to the deleterious dimerization
of styrene. Switching to other solvents such as 1,4-dioxane, the
dimerization was reduced but not diminished. Therefore, we
turned our attention to optimize this cascade reaction at room
temperature. Cationic palladium complexes are known to
undergo facile electrophilic palladation to aryl urea derivatives
at room temperature.10d,g−i Gratifyingly, using N,N-dimethyl-
N′-phenylurea and commercially available electrophilic Pd-
(tfa)2, Pd(CH3CN)4(BF4)2 complexes, the yield of the desired
product was improved at room temperature. Palladium(II)
acetate, in the presence of excess TsOH, is known to generate
highly electrophilic palladium mono- or bistosylate species in
situ.11 Interestingly, ubiquitous Pd(OAc)2 in combination with
TsOH and inexpensive 1,4-benzoquinone (BQ) was found to
be optimal for the catalytic turnover. Other oxidants such as O2,
N-ligands/O2, Cu(OAc)2, AgOAc, and even DDQ were
ineﬀective. Presumably, BQ has a dual role as ligand as well
as oxidant in palladium(II) catalysis, and the redox process is
anticipated to be accelerated under acidic conditions.12 Other
directing/protecting groups such as pivalate, tosylate, N,N-
diethyl-N′-phenylurea, N-methyl, etc. were less eﬀective in this
case. After a rigorous screening (for details, see the Supporting
Information), we found that 10 mol % of Pd(OAc)2 in
combination with 1.0 equiv of TsOH and 2.0 equiv of 1,4-
benzoquinone as terminal oxidant provided 2-phenylindole in
82% yield at room temperature from 1.0 equiv of phenylurea
and 1.5 equiv of styrene (entry 10, Table 1). During
optimization, it was also found that water is detrimental to
the reaction outcome, but dioxygen has little or no eﬀect.
Subsequently, we explored the substrate scope under the
optimized reaction conditions. A wide variety of functional
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groups on aniline as well as styrene were found to be
compatible under this mild reaction protocol. Besides methoxy,
alkyl, and aryl groups, halogens such as bromo (2x, 2ab, 2af,
Scheme 1), chloro (2k, 2t, 2z, 2ah, Scheme 1), and ﬂuoro (2f,
2u, 2y, 2ag, Scheme 1) remain intact which are useful for
further cross-coupling reactions. Interestingly, the acyl group
(2g, 2r, Scheme 1) is well-tolerated under this protocol, which
is a reactive functionality in the Fischer and Yoshikai
method.2,6f An acid-sensitive −OAc (2j, Scheme 1) group is
also stable, which demonstrates the mild nature of this
protocol. The electronic nature has a prominent inﬂuence on
the reaction outcome. In general, a moderate electron-donating
group on the aniline has a positive inﬂuence due to the facile
electrophilic palladation. However, highly electron-rich anilines
are too reactive to provide the desired product. Similarly,
neutral or moderately electron-rich and/or electron-deﬃcient
styrenes underwent annulation smoothly. Highly electron-
deﬁcient 3-nitrostyrene and pentaﬂuorostyrene did not furnish
any desired product, presumably due to the alkene deactivation
for migratory palladium insertion. Interestingly, ortho-sub-
stituted anilines (2n−q, 2ah, 2ai, Scheme 1) also aﬀorded good
to high yields of the desired products, which are known to be
diﬃcult for electrophilic ortho palladation.11 The meta-
substituted anilines provided single regioisomeric indoles
through ortho palladation from the sterically less hindered
side (2k−m, 2ae, 2af, Scheme 1). All compounds are new
entities and adequately characterized.13
From a mechanistic perspective, we realized that migratory
insertion to the alkene results in an unstable σ-alkyl-Pd
intermediate that could be intercepted for further functionaliza-
tion.14 The direct 1,2-carboamination strategy to generate
indoline moiety was reported using norbornene15 where β-
hydride elimination is not feasible or using 1,3-dienes via π-
allyl-Pd formation.11 However, direct synthesis of 2-arylindo-
lines through π-benzyl-Pd stabilization is not known. We chose
p-methoxy styrene as a model substrate to explore this
divergent approach to indoline synthesis. Gratifyingly, the
corresponding indoline was obtained in 48% isolated yield
under the same reaction conditions (3a, Scheme 2).
Remarkably, while p-acetoxystyrene (2j, Scheme 1) aﬀorded
indole selectively, the p-methoxy group favors indoline
formation albeit in moderate yield. This subtle change in
electronic nature leads to the generation of two distinct classes
of compounds. This could be attributed to the formation of
stabilized, cationic π-benzyl-Pd species that suppresses β-
hydride elimination. Since naphthalenes have a better ability to
stabilize π-benzyl-Pd species,16 we decided to examine 1-
vinylnaphthalene under the optimized conditions. As antici-
pated, the corresponding indoline was isolated in high yields
with 1- and 2-vinylnaphthalenes. Remarkably, a number of urea
derivatives with ortho substitution also provided the desired
indolines in high yields (3l−o, Scheme 2).
Table 1. Optimization of the Reaction Conditionsa
entry oxidant solvent
temp
(°C)
yieldb
(%)
1 Cu(OAc)2
(1 equiv)
toluene 110 trace
2 AgOAc (1 equiv) toluene 110 8
3 BQ (1 equiv) 1,4-dioxane 110 10
4 BQ (1 equiv) AcOH 110 7
5 BQ (1 equiv) AcOH 50 13
6 BQ (1 equiv) AcOH 25 18
7 BQ (2 equiv) THF 25 58
8 BQ (2 equiv) EtOAc 25 77
9 BQ (1 equiv) 1,4-dioxane 25 52
10 BQ (2 equiv) 1,4-dioxane 25 82
11 DDQ (2 equiv) 1,4-dioxane 25 trace
12 − 1,4-dioxane 25 12
13c BQ (2 equiv) 1,4-dioxane 25 65
14 BQ (3 equiv) 1,4-dioxane 25 80
15 BQ (2 equiv) 1,4-dioxane/AcOH
(2:1)
25 38
aAll reactions were carried out in 0.1 mmol scale. bYields refer to here
are overall isolated yields. c2.0 equiv of TsOH was used.
Scheme 1. Substrate Scope of Indolesa,b
aAll reactions were carried out in 0.2 mmol scale. bYields refer to the
average of isolated yields of at least two experiments. c5 mol % of
Pd(OAc)2 was used.
dReaction time 30 h.
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Mechanistically, the reaction may proceed in two distinct
pathways. In path a, an electrophilic ortho palladation followed
by migratory β-alkene insertion may lead to the intermediate
2a′ (Scheme 3, a). Subsequently, reductive elimination to yield
indolines and oxidation sequences may provide the desired 2-
arylindoles. Alternatively, an initial aza-Wacker reaction
followed by C−H arylation and oxidation cascade may lead
to the desired product as shown in path b (Scheme 3, a). To
understand the plausible mechanism, we performed several
control experiments. From TLC, we observed that initially a
polar, transient intermediate is formed which is converted into
product during the reaction course. Therefore, the reaction was
arrested after 2 h and the intermediate was isolated as
Fujiwara−Moritani Heck arylation product 2a″. Subsequently,
this intermediate was subjected to the standard reaction
conditions, and the desired 2-arylindole was obtained in 78%
yield (Scheme 3, b). Therefore, the reaction may initiate
through path a. To note, depending upon the π-benzyl-Pd
stabilization ability, 8−12% corresponding indoles were also
obtained along with the indolines (Scheme 2). Therefore, in
the subsequent steps, either a concerted aza-Wacker cyclization
followed by β-hydride elimination or initial 1,2-carboamination
of styrenes to yield 2-arylindoline followed by oxidation to yield
the desired product is plausible.8 To probe this, 2-phenylindo-
line was synthesized separately and subjected to the standard
conditions. The indoline remained intact, which eliminates the
possibility of indoline formation/oxidation route (Scheme 3, c).
It also demonstrates that indoles are kinetic in their origin
through concerted β-hydride elimination. From the stoichio-
metric experiment it was observed that the Heck intermediate is
converted to the corresponding indole in 65% yield with 1.0
equiv of Pd(OAc)2/TsOH without 1,4-benzoquinone. There-
fore, BQ may act as a ligand and oxidant to the palladium for
catalytic turnover but may not be involved in the oxidation of
indoline to indole directly.
From all these control experiments it is speculated that the
reaction proceeds through a C−H insertion/carbopalladation/
cyclization/aromatization cascade. The indolines are formed in
a convergent manner from the σ-alkyl-Pd intermediate through
π-benzyl-Pd stabilization as depicted in Scheme 4.
Finally, the corresponding indole and indoline urea were
hydrolyzed with saturated solution of potassium hydroxide in
reﬂuxing ethanol to aﬀord the 2-arylindole and indoline in 85%
and 80% yield, respectively.
In conclusion, we have developed a mild reaction protocol
for the synthesis of 2-arylindole and indoline derivatives from
arylureas and -styrenes at room temperature. The indoles are
Scheme 2. Substrate Scope of Indolinesa,b
aAll reactions were carried out on a 0.2 mmol scale. bYields refer to
the average of isolated yields of at least two experiments. cReaction
time 30 h.
Scheme 3. Mechanistic Possibilities and Elucidations
Scheme 4. Plausible Catalytic Cycle
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formed through C−H insertion/1,2-carboamination/ β-hydride
elimination cascade, whereas the indolines are obtained through
C−H insertion and 1,2-carboamination via π-benzyl-Pd
stabilization. The present intermolecular technique incorpo-
rates a wide range of starting materials using a ubiquitous and
inexpensive catalytic combination. The catalytic conversion is
also reproducible on a gram scale with lower catalyst loading.
Therefore, we anticipate that this methodology will ﬁnd many
applications in academia as well as in industrial processes.
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Chemo-, regio-, and stereoselective
Heck–Matsuda arylation of allylic alcohols under
mild conditions†
Tohasib Yusub Chaudhari, Asik Hossian, Manash Kumar Manna and Ranjan Jana*
Heck arylation with allylic alcohol is extremely challenging due to
chemo-, regio-, and stereoselective scrambling. Here we report a
mild protocol for the alcohol selective β- and α-arylation of allylic
and cinnamyl alcohols respectively with aryldiazonium salts. The
steric and electronic parameters of the alkene play a prominent
role in the regioselectivity.
Since its discovery, significant eﬀort has been dedicated to the
development of highly eﬃcient and selective Heck–Mizoroki
reaction for the arylation of alkenes.1 Consequently, it has
been recognized as one of the most powerful synthetic tools
for C–C bond formation.2 The extent of research on the Heck
reaction over the past few decades has inculcated the false
notion that Heck chemistry is now a mature area. However, the
mechanistic understanding of subtle changes that dictate
regioselectivity and β-hydride elimination is still limited.3
Despite its robustness and eﬃciency, the Heck reaction invol-
ving aryl halides and triflates is mainly limited to the activated
olefins such as acrylates, styrenes etc. In contrast, Heck aryl-
ation of electronically nonbiased olefin is still challenging due
to sluggish alkene insertion and non-specific β-hydride elimi-
nation.4 Similarly, Heck arylation of allylic alcohol is extremely
challenging due to chemo-, regio-, and stereochemical scram-
bling and double bond isomerization (Scheme 1).5
Mechanistically, after oxidative addition of palladium(0)- to
the aryl electrophile, a migratory β-alkene insertion occurs to
generate an unstable σ-alkyl-Pd species. Subsequently, random
β-hydride elimination (either Ha or Hb, Scheme 1) leads to the
formation of a mixture of products, which limits its synthetic
utility. Therefore, a mild reaction protocol that controls
β-hydride elimination is extremely useful in regio- and chemo-
selective arylation of allylic alcohols. In general, oxidative
addition to the aryl electrophiles such as aryl halides, triflates
etc. is the rate limiting step, which requires high temperature,
ligands, bases etc.6 The harsh reaction conditions lead to the
non-specific arylation, β-hydride elimination, and double bond
isomerizations. After the first report by Matsuda and co-
workers in 1977, arenediazonium salts have been exploited as
reactive aryl halide surrogates in Pd-catalyzed cross-coupling
reactions.7 The Sengupta,8 Genêt,9 Correia,10 Felpin11 and
other groups12 have contributed substantially to the Heck–
Matsuda arylation of olefins. Recently, the Sigman group has
accomplished styrenyl selective arylation of electronically non-
biased olefins with aryl diazonium salts.13 Due to the facile
oxidative addition to the aryldiazonium salts, the cross-coup-
ling took place under mild reaction conditions, without any
additional ligands or bases. Therefore, we decided to optimize
Heck–Matsuda arylation of allylic alcohols with aryldiazonium
salts. Although, there are few reports of Heck arylation with
allyl or crotyl alcohol,14 most of them provide a mixture of
aldehyde(or ketone) and alcohol. In addition, Heck–Matsuda
arylation with β-substituted alkenes especially cinnamyl alco-
hols is underexplored.15 Heck arylation of cinnamyl alcohol
with expensive aryl iodide has been reported by the Cacchi
group.16 However, a high reaction temperature, a stoichio-
metric base, and a longer reaction time were required to aﬀord
only a low to moderate yield of the desired products. Here we
report an alcohol selective, β- and α-arylation of allyl and
cinnamyl alcohols respectively using aryldiazonium salts
(Scheme 2). From the systematic study, we have observed that
besides steric factors, electronic parameters of the alkene also
play an important role in regioselectivity.
To begin, we tested simple allyl alcohol and phenyldiazo-
nium salt with a catalytic amount of Pd2dba3. A rapid eﬀerve-
Scheme 1 Chemoselectivity in Heck arylation with allylic alcohol.
†Electronic supplementary information (ESI) available: Full experimental
details, spectral characterization and 1H, and 13C spectra. See DOI: 10.1039/
c5ob00235d
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scence of nitrogen was observed after the addition of the cata-
lyst in DMF at room temperature. Unfortunately, the yield of
the desired cinnamyl alcohol was low (∼20%) although, all
starting material was consumed. Next, we screened several sol-
vents which are frequently used in the Heck–Matsuda reaction,
e.g. MeOH, CH3CN, DMA, NMP etc. It was observed that amide
solvents are superior and NMP is the best solvent for this
transformation. It was also found that a tetrafluoroborate
counterion is crucial for the reaction outcome. Presumably, in
addition to the improved stability of the diazonium moiety, its
non-coordinating nature imparts electrophilicity to the metal
center for the facile alkene insertion.17 The amide solvent
stabilizes the incipient electrophilic Pd-species which is
formed through oxidative addition.18 All of our screening with
simple allyl alcohol aﬀorded only a moderate yield of the
desired products (2a, 2b, Table 1) and a substantial amount of
oligomerization was observed. However, using secondary
allylic alcohols, the yield of the arylation product was
increased. The arylation with 3-butene-2-ol aﬀorded the corres-
ponding alcohol in good to high yields (2c–2g, Table 1).
A homoallylic alcohol also underwent the Heck–Matsuda
reaction aﬀording moderate yield of the arylation product (2h,
Table 1). Interestingly, protected allyl alcohols such as allyl
acetate (2i, Table 1) and allyl carbonate (2j, Table 1) underwent
smooth arylation providing β-arylation in high yields. In
general, these substrates are unstable under Pd(0)-catalysis e.g.
Tsuji–Trost conditions.19 This demonstrates the mild nature of
these reaction conditions.
Next we turned our attention to the arylation of cinnamyl
alcohol derivatives. From our previous experience with allyl
alcohol we realized that cinnamyl alcohol may lead to the
selective α-arylation due to steric hindrance with the terminal
phenyl group. That said, we investigated the analogous Heck–
Matsuda reaction with cinnamyl alcohol and arenediazonium
tetrafluoroborate. Gratifyingly, a good yield of the arylation
product was obtained simply by changing the solvent to DMA.
As anticipated, the α-arylation was obtained exclusively to
aﬀord (Z)-2-3-diarylallylic alcohol. The stereochemistry of the
arylation product was assigned by NOESY experiment and
comparison with literature reports (see the ESI†).20 A number
of cinnamyl alcohol derivatives and arenediazonium salts were
examined for the coupling reaction, and a wide range of func-
tional groups such as methoxy (3b, 3d, 3m, 3n, 3r, Table 2),
nitro (3c, 3e, 3f, 3m, 3o, Table 2), ester (3k, Table 2), bromo
(3f, 3h, 3p, Table 2), chloro (3i, 3j, Table 2), and even iodo (3l,
Table 2), were compatible under the reaction conditions.
However, reaction with p-iodophenyldiazonium (3l) also gave
∼10% of the corresponding aldehyde via double bond isomeri-
zation. These halogen substituents are useful for further cross-
couplings. Gratifyingly, a sterically hindered mesitylenediazo-
nium salt provided excellent yield of the arylation products
(3n–3r, Table 2). Interestingly, no arylation was observed with
cinnamyl acetate which indicates that besides steric eﬀects the
free hydroxyl group also may have a role in regioselectivity
through coordination with the metal center.
Finally, we carried out a sequential Heck–Matsuda arylation
to aﬀord (Z)-2-3-diarylallylic alcohol. Since allyl alcohol pro-
vided low yield, we took allyl acetate for the β-arylation
followed by hydrolysis to provide cinnamyl alcohol derivative,
4. The subsequent α-arylation provided 3f in 76% yield
(Scheme 3a). Since halogens are compatible with our reaction
conditions, we have demonstrated a sequential Heck/Suzuki
coupling reaction. Initially, the Heck reaction was performed
with 3-butene-2-ol and 4-bromo-phenyldiazonium salt to give
2e. The product was further cross-coupled with phenyl boronic
acid to yield 5 (Scheme 3b). We have also showed that syntheti-
cally useful β,β- and β,α-diarylallylic alcohols can easily be
accessed through the Heck–Matsuda reactions. The arylation
of cinnamic ester occurs at the β-position selectively,21 and the
Scheme 2 Regioselective arylation with aryldiazonium salts.
Table 1 Substrate scope with allylic alcoholsa,b
a The reaction was performed on a 0.2 mmol scale. b Yield refers to the
isolated pure product.
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ester is reduced to the corresponding alcohol with DIBAL-H,
whereas, in this present protocol cinnamyl alcohol leads to the
α-arylation product selectively (Scheme 3c). This phenomenon
demonstrates that besides steric parameters, electronic nature
of the alkene also plays an important role in regioselective
arylation.
Conclusions
We have developed a mild protocol for the alcohol-selective
Heck–Matsuda arylation of allylic alcohols in a highly regio-
and stereoselective manner. In sharp contrast to the allylic
alcohols, a selective α-arylation of the cinnamyl alcohols was
observed to aﬀord (Z)-2-3-diarylallylic alcohol. Taking advan-
tage of mild reaction conditions, we have also demonstrated
the sequential diarylation and Heck/Suzuki coupling. From
Table 2 Substrate scope with cinnamyl alcoholsa,b
a The reaction was performed on a 0.2 mmol scale. b Yield refers to the
isolated pure product.
Scheme 3 Synthetic manipulations of the present protocol.
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the systematic study, we observed that besides steric factors,
electronic parameters also play an important role in regioselec-
tivity. Therefore, selective β,β- and β,α-diaryl allylic alcohols
have been synthesized from cinnamic ester and cinnamyl
alcohol respectively.
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